{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "7765\n"
     ]
    }
   ],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import json\n",
    "import os"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Convert PDF to Images , each page converted into seprate image\n",
    "\n",
    "from pdf2image import convert_from_path\n",
    "\n",
    "from pdf2image.exceptions import (\n",
    " PDFInfoNotInstalledError,\n",
    " PDFPageCountError,\n",
    " PDFSyntaxError\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Function to convert to Strings  \n",
    "def listToString(s):  \n",
    "    \n",
    "    # initialize an empty string \n",
    "    str1 = \"\"  \n",
    "    \n",
    "    # traverse in the string   \n",
    "    for ele in s:  \n",
    "        str1 += ele   \n",
    "    \n",
    "    # return string   \n",
    "    return str1  "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "#function to find all floats values from list\n",
    "def solve(lis):\n",
    "    for x in lis:\n",
    "        try:\n",
    "            float(x)\n",
    "            return True\n",
    "        except:\n",
    "            return False"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [],
   "source": [
    "# OCR Works Here\n",
    "\n",
    "try:\n",
    "    from PIL import Image\n",
    "except ImportError:\n",
    "    import Image\n",
    "import pytesseract\n",
    "\n",
    "def ocr_core(filename):\n",
    "  \n",
    "    text = pytesseract.pytesseract.image_to_string(Image.open(filename))\n",
    "    return text  # Then we will print the text in the image\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "word_list = [\n",
    "    'HbA1c',\n",
    "    'H.P.L.C',\n",
    "    'AVERAGE BLOOD GLUCOSE (ABG)',\n",
    "    'TOTAL LEUCOCYTES COUNT',\n",
    "    'NEUTROPHILS',\n",
    "    'LYMPHOCYTE PERCENTAGE',\n",
    "    'MONOCYTES',\n",
    "    'EOSINOPHILS',\n",
    "    'BASOPHILS',\n",
    "    'IMMATURE GRANULOCYTE PERCENTAGE(IG%)',\n",
    "    'NEUTROPHILS - ABSOLUTE COUNT',\n",
    "    'LYMPHOCYTES - ABSOLUTE COUNT',\n",
    "    'MONOCYTES - ABSOLUTE COUNT',\n",
    "    'BASOPHILS - ABSOLUTE COUNT',\n",
    "    'EOSINOPHILS - ABSOLUTE COUNT',\n",
    "    'IMMATURE GRANULOCYTES(IG)',\n",
    "    'TOTAL RBC',\n",
    "    'HEMOGLOBIN',\n",
    "    'HEMATOCRIT(PCV)',\n",
    "    'MEAN CORPUSCULAR VOLUME(MCV)',\n",
    "    'MEAN CORPUSCULAR HEMOGLOBIN(MCH)',\n",
    "    'MEAN CORP.HEMO.CONC(MCHC)',\n",
    "    'RED CELL DISTRIBUTION WIDTH - SD(RDW-SD)',\n",
    "    'RED CELL DISTRIBUTION WIDTH (RDW-CV)',\n",
    "    'PLATELET DISTRIBUTION WIDTH(PDW)',\n",
    "    'MEAN PLATELET VOLUME(MPV)',\n",
    "    'PLATELET COUNT',\n",
    "    'PLATELET TO LARGE CELL RATIO(PLCR)',\n",
    "    'PLATELETCRIT(PCT)',\n",
    "    'ARSENIC',\n",
    "    'CADMIUM',\n",
    "    'MERCURY',\n",
    "    'LEAD',\n",
    "    'CHROMIUM',\n",
    "    'BARIUM',\n",
    "    'COBALT',\n",
    "    'CAESIUM',\n",
    "    'THALLIUM',\n",
    "    'URANIUM',\n",
    "    'STRONTIUM',\n",
    "    'ANTIMONY',\n",
    "    'TIN',\n",
    "    'MOLYBDENUM',\n",
    "    'SILVER',\n",
    "    'VANADIUM',\n",
    "    'BERYLLIUM',\n",
    "    'BISMUTH',\n",
    "    'SELENIUM',\n",
    "    'ALUMINIUM',\n",
    "    'NICKEL',\n",
    "    'MANGANESE',\n",
    "    'HOMOCYSTEINE',\n",
    "    'CYSTATIN C',\n",
    "    'LIPOPROTEIN',\n",
    "    'VITAMIN D',\n",
    "    'VITAMIN B-12',\n",
    "    'APOLIPOPROTEIN - A1 (APO-A1)',\n",
    "    'APOLIPOPROTEIN - B (APO-B)',\n",
    "    'APO B / APO A1 RATIO (APO B/A1)',\n",
    "    'HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP)',\n",
    "    'SERUM COPPER',\n",
    "    'SERUM ZINC',\n",
    "    'TESTOSTERONE',\n",
    "    'IRON',\n",
    "    'TOTAL IRON BINDING CAPACITY (TIBC)',\n",
    "    '% TRANSFERRIN SATURATION',\n",
    "    'TRANSFERRIN SATURATION',\n",
    "    'ALKALINE PHOSPHATASE',\n",
    "    'BILIRUBIN - TOTAL',\n",
    "    'BILIRUBIN -DIRECT',\n",
    "    'BILIRUBIN (INDIRECT)',\n",
    "    'GAMMA GLUTAMYL TRANSFERASE (GGT)',\n",
    "    'ASPARTATE AMINOTRANSFERASE (SGOT )',\n",
    "    'ALANINE TRANSAMINASE (SGPT)',\n",
    "    'PROTEIN - TOTAL',\n",
    "    'ALBUMIN - SERUM',\n",
    "    'SERUM ALB/GLOBULIN RATIO',\n",
    "    'SERUM GLOBULIN',\n",
    "    'TOTAL CHOLESTEROL',\n",
    "    'HDL CHOLESTEROL - DIRECT',\n",
    "    'LDL CHOLESTEROL - DIRECT',\n",
    "    'TRIGLYCERIDES',\n",
    "    'TC/ HDL CHOLESTEROL RATIO',\n",
    "    'LDL / HDL RATIO',\n",
    "    'VLDL CHOLESTEROL',\n",
    "    'NON-HDL CHOLESTEROL',\n",
    "    'TOTAL TRIIODOTHYRONINE (T3)',\n",
    "    'TOTAL THYROXINE',\n",
    "    'THYROID STIMULATING HORMONE',\n",
    "    'BLOOD UREA NITROGEN (BUN)',\n",
    "    'CREATININE - SERUM',\n",
    "    'BUN / SR.CREATININE RATIO',\n",
    "    'CALCIUM',\n",
    "    'URIC ACID',\n",
    "    'EST. GLOMERULAR FILTRATION RATE (eGFR)',\n",
    "    'Vitamin',\n",
    "    ]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Wordlist to Delete Useless data from the list\n",
    "stopwords = ['0.02-0.1','3.9-4.8','58-159','X103pL','X103/pL','-','4.0-10.0','X103/uL','2.0-7.0','1.0-3.0','%','CLIA','ng/d|',\n",
    "                 'C.LI.A','HIU/ml','C.L.L.A','(SGOT','(SGOT)','CLA','<','<2','20.0-40.0','0.0-0.4','ul','39.0-46.0','0.0-0.3',\n",
    "                '20-40','PERCENTAGE(IG%)','0-0.5','40-80','0.0-6.0','0.0-6.0','0-0.1','mg/dl','CLIA','HIU/ml','U/I','12.0-15.0',\n",
    "                '<2','0-10','<','>', 'X', '103', '/', 'pL', '0.2-1','X1046/pL','<0.01','g/dL','13-17','fl','83-101','C.M.1.A','ng/di',\n",
    "                'pq', '27-32','g/dL', '31.5-34.5','0-0.3','40-50','fL', '39-46','11.6-14','9.6-15.2','4.5-5.5','g/dl',\n",
    "                 'IMMUNOTURBIDIMETRY','ICP-MS','ug/l','<5','ug/I','0.10 - 1.50','<1','<4','<4','<15','yumol/L',\n",
    "             'mg/L','(A)','[LP(A)]','pg/ml','mg/dL','ng/dL','Hg/dl',\n",
    "               'PHOTOMETRY','CALCULATED','(eGFR)', 'Ratio', '9:1-23:1', '(mg/dl)','0.02-0.5','X10%6/uL =:','36.0-46.0',\n",
    "                 'mL/min/1.73', 'm2','uIU/ml', '0.3-5.5','85-130','35-80','125-200','gm/dL', '2.5-3.4','u/|', '<35','(',')','0.35 - 4.94',\n",
    "                'u/I', '<55','gm/dl', '3.2-4.8''5.7-8.2','6.5-12','19.7-42.4','0.19-0.39','0.3-1.2','0-0.9','5.7-8.2',\n",
    "                '3.2-4.8','3-5', 'ng/dl', '60-200','ug/dl', '4.5-12','7-25','0.6-1.1','8.8-10.6','-7.3','5-40','U/L','1.5-3.5',\n",
    "                'RATIO','150-400','4.0-10.0','25-200','B12 pg/mL 911','B12' ,'pg/mL','911','0.2-1.0','uL','0.0-10.0','0.02-0.1',\n",
    "                '83.0-101.0','27.0-32.0','3.2-6.1','0.5-0.8','C.M.1.A 0.35','C.M.1.A ng/di','ma/dl','0.9-2','<31','11.6-14.0','27.0-32.0','X%/uL','=:','=:',\n",
    "\n",
    "            ]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'HPLC': 5.9, 'AVERAGE_BLOOD_GLUCOSE': 123.0, 'TOTAL_LEUCOCYTES_COUNT': 8.3, 'NEUTROPHILS': 52.2, 'LYMPHOCYTE_PERCENTAGE': 42.8, 'MONOCYTES': 3.3, 'EOSINOPHILS': 1.3, 'BASOPHILS': 0.2, 'IMMATURE_GRANULOCYTE_PERCENTAGE': 0.2, 'NEUTROPHILS_ABSOLUTE_COUNT': None, 'LYMPHOCYTES_ABSOLUTE_COUNT': 3.55, 'MONOCYTES_ABSOLUTE_COUNT': 0.27, 'BASOPHILS_ABSOLUTE_COUNT': 0.02, 'EOSINOPHILS_ABSOLUTE_COUNT': None, 'IMMATURE_GRANULOCYTES': None, 'TOTAL_RBC': 4.83, 'NUCLEATED_RED_BLOOD_CELLS': None, 'HEMOGLOBIN': 9.4, 'HEMATOCRIT': 37.2, 'MEAN_CORPUSCULAR_VOLUME': 77.0, 'MEAN_CORPUSCULAR_HEMOGLOBIN': 19.5, 'MEAN_CORP_HEMO_CONC': 25.3, 'RED_CELL_DISTRIBUTION_WIDTH_SD': 54.5, 'RED_CELL_DISTRIBUTION_WIDTH_CV': 19.7, 'PLATELET_DISTRIBUTION_WIDTH': 10.8, 'MEAN_PLATELET_VOLUME': 10.2, 'PLATELET_COUNT': 518.0, 'PLATELET_TO_LARGE_CELL_RATIO': 25.6, 'PLATELETCRIT': 0.53, 'ARSENIC': 1.05, 'CADMIUM': 0.37, 'MERCURY': 0.3, 'LEAD': 40.95, 'CHROMIUM': 1.18, 'BARIUM': 1.7, 'COBALT': 1.5, 'CAESIUM': 1.48, 'THALLIUM': 0.03, 'URANIUM': 0.08, 'STRONTIUM': 38.0, 'ANTIMONY': 18.0, 'TIN': 0.31, 'MOLYBDENUM': 4.0, 'SILVER': 1.07, 'VANADIUM': 0.2, 'BERYLLIUM': 0.8, 'BISMUTH': 0.8, 'SELENIUM': 340.0, 'ALUMINIUM': 9.32, 'NICKEL': 3.64, 'MANGANESE': 20.0, 'HOMOCYSTEINE': 13.7, 'CYSTATIN_C': 0.98, 'LIPOPROTEIN': 55.5, 'VITAMIN_B': 211.0, 'APOLIPOPROTEIN_A_APOA': 115.0, 'APOLIPOPROTEIN_B_APOB': 80.0, 'APOB_APOA_RATIO': None, 'HSCRP': 6.2, 'SERUM_COPPER': None, 'SERUM_ZINC': None, 'TESTOSTERONE': None, 'IRON': 20.2, 'TOTAL_IRON_BINDING_CAPACITY': None, 'TRANSFERRIN_SATURATION': None, 'ALKALINE_PHOSPHATASE': 129.0, 'BILIRUBIN_TOTAL': 0.32, 'BILIRUBIN_DIRECT': 0.11, 'BILIRUBIN_INDIRECT': 0.21, 'GAMMA_GLUTAMYL_TRANSFERASE': None, 'ASPARTATE_AMINOTRANSFERASE': None, 'ALANINE_TRANSAMINASE': None, 'PROTEIN_TOTAL': None, 'ALBUMIN_SERUM': 4.1, 'SERUM_ALB': -2.0, 'SERUM_GLOBULIN': 3.3, 'TOTAL_CHOLESTEROL': 153.0, 'HDL_CHOLESTEROL_DIRECT': 44.0, 'LDL_CHOLESTEROL_DIRECT': 90.0, 'TRIGLYCERIDES': 179.0, 'TC_HDL_CHOLESTEROL_RATIO': 3.5, 'LDL_HDL_RATIO': 2.1, 'VLDL_CHOLESTEROL': 35.8, 'NON_HDL_CHOLESTEROL': 109.2, 'TOTAL_TRIIODOTHYRONINE': 115.0, 'TOTAL_THYROXINE': 11.9, 'THYROID_STIMULATING_HORMONE': 1.57, 'BLOOD_UREA_NITROGEN': 8.86, 'CREATININE_SERUM': 0.72, 'BUN_SR_CREATININE_RATIO': 12.31, 'CALCIUM': 8.59, 'URIC_ACID': 4.8, 'EST_GLOMERULAR_FILTRATION_RATE': None}\n",
      "{'HPLC': 6.6, 'AVERAGE_BLOOD_GLUCOSE': 143.0, 'TOTAL_LEUCOCYTES_COUNT': 7.29, 'NEUTROPHILS': 63.7, 'LYMPHOCYTE_PERCENTAGE': 32.1, 'MONOCYTES': 2.5, 'EOSINOPHILS': 1.2, 'BASOPHILS': 0.2, 'IMMATURE_GRANULOCYTE_PERCENTAGE': 0.3, 'NEUTROPHILS_ABSOLUTE_COUNT': 4.64, 'LYMPHOCYTES_ABSOLUTE_COUNT': None, 'MONOCYTES_ABSOLUTE_COUNT': 0.18, 'BASOPHILS_ABSOLUTE_COUNT': 0.01, 'EOSINOPHILS_ABSOLUTE_COUNT': 0.09, 'IMMATURE_GRANULOCYTES': 0.02, 'TOTAL_RBC': 4.59, 'NUCLEATED_RED_BLOOD_CELLS': None, 'HEMOGLOBIN': 11.4, 'HEMATOCRIT': 41.5, 'MEAN_CORPUSCULAR_VOLUME': 90.4, 'MEAN_CORPUSCULAR_HEMOGLOBIN': 24.8, 'MEAN_CORP_HEMO_CONC': 27.5, 'RED_CELL_DISTRIBUTION_WIDTH_SD': 58.2, 'RED_CELL_DISTRIBUTION_WIDTH_CV': 17.4, 'PLATELET_DISTRIBUTION_WIDTH': 14.0, 'MEAN_PLATELET_VOLUME': 11.2, 'PLATELET_COUNT': 304.0, 'PLATELET_TO_LARGE_CELL_RATIO': 34.5, 'PLATELETCRIT': 0.34, 'ARSENIC': 1.16, 'CADMIUM': 0.1, 'MERCURY': 0.43, 'LEAD': 21.59, 'CHROMIUM': 0.64, 'BARIUM': 1.84, 'COBALT': 1.5, 'CAESIUM': 1.5, 'THALLIUM': 0.03, 'URANIUM': 0.08, 'STRONTIUM': 38.0, 'ANTIMONY': 18.0, 'TIN': 0.22, 'MOLYBDENUM': 4.0, 'SILVER': 1.06, 'VANADIUM': 0.71, 'BERYLLIUM': 0.8, 'BISMUTH': 0.8, 'SELENIUM': 340.0, 'ALUMINIUM': 2.83, 'NICKEL': 2.59, 'MANGANESE': 20.0, 'HOMOCYSTEINE': 16.4, 'CYSTATIN_C': 1.02, 'LIPOPROTEIN': 29.2, 'VITAMIN_B': None, 'APOLIPOPROTEIN_A_APOA': 104.0, 'APOLIPOPROTEIN_B_APOB': 91.0, 'APOB_APOA_RATIO': None, 'HSCRP': 4.5, 'SERUM_COPPER': None, 'SERUM_ZINC': None, 'TESTOSTERONE': None, 'IRON': None, 'TOTAL_IRON_BINDING_CAPACITY': 373.0, 'TRANSFERRIN_SATURATION': None, 'ALKALINE_PHOSPHATASE': 129.0, 'BILIRUBIN_TOTAL': 0.41, 'BILIRUBIN_DIRECT': 0.09, 'BILIRUBIN_INDIRECT': 0.32, 'GAMMA_GLUTAMYL_TRANSFERASE': None, 'ASPARTATE_AMINOTRANSFERASE': None, 'ALANINE_TRANSAMINASE': None, 'PROTEIN_TOTAL': None, 'ALBUMIN_SERUM': 4.1, 'SERUM_ALB': -2.0, 'SERUM_GLOBULIN': 2.8, 'TOTAL_CHOLESTEROL': 169.0, 'HDL_CHOLESTEROL_DIRECT': 41.0, 'LDL_CHOLESTEROL_DIRECT': 101.0, 'TRIGLYCERIDES': 202.0, 'TC_HDL_CHOLESTEROL_RATIO': 4.2, 'LDL_HDL_RATIO': 2.5, 'VLDL_CHOLESTEROL': 40.4, 'NON_HDL_CHOLESTEROL': 128.4, 'TOTAL_TRIIODOTHYRONINE': 118.0, 'TOTAL_THYROXINE': 11.6, 'THYROID_STIMULATING_HORMONE': None, 'BLOOD_UREA_NITROGEN': 13.12, 'CREATININE_SERUM': 0.72, 'BUN_SR_CREATININE_RATIO': 18.22, 'CALCIUM': 8.84, 'URIC_ACID': 3.8, 'EST_GLOMERULAR_FILTRATION_RATE': None}\n",
      "{'HPLC': None, 'AVERAGE_BLOOD_GLUCOSE': None, 'TOTAL_LEUCOCYTES_COUNT': None, 'NEUTROPHILS': None, 'LYMPHOCYTE_PERCENTAGE': None, 'MONOCYTES': None, 'EOSINOPHILS': None, 'BASOPHILS': None, 'IMMATURE_GRANULOCYTE_PERCENTAGE': None, 'NEUTROPHILS_ABSOLUTE_COUNT': None, 'LYMPHOCYTES_ABSOLUTE_COUNT': None, 'MONOCYTES_ABSOLUTE_COUNT': None, 'BASOPHILS_ABSOLUTE_COUNT': None, 'EOSINOPHILS_ABSOLUTE_COUNT': None, 'IMMATURE_GRANULOCYTES': None, 'TOTAL_RBC': None, 'NUCLEATED_RED_BLOOD_CELLS': None, 'HEMOGLOBIN': None, 'HEMATOCRIT': None, 'MEAN_CORPUSCULAR_VOLUME': None, 'MEAN_CORPUSCULAR_HEMOGLOBIN': None, 'MEAN_CORP_HEMO_CONC': None, 'RED_CELL_DISTRIBUTION_WIDTH_SD': None, 'RED_CELL_DISTRIBUTION_WIDTH_CV': None, 'PLATELET_DISTRIBUTION_WIDTH': None, 'MEAN_PLATELET_VOLUME': None, 'PLATELET_COUNT': None, 'PLATELET_TO_LARGE_CELL_RATIO': None, 'PLATELETCRIT': None, 'ARSENIC': None, 'CADMIUM': None, 'MERCURY': None, 'LEAD': None, 'CHROMIUM': None, 'BARIUM': None, 'COBALT': None, 'CAESIUM': None, 'THALLIUM': None, 'URANIUM': None, 'STRONTIUM': None, 'ANTIMONY': None, 'TIN': None, 'MOLYBDENUM': None, 'SILVER': None, 'VANADIUM': None, 'BERYLLIUM': None, 'BISMUTH': None, 'SELENIUM': None, 'ALUMINIUM': None, 'NICKEL': None, 'MANGANESE': None, 'HOMOCYSTEINE': None, 'CYSTATIN_C': None, 'LIPOPROTEIN': None, 'VITAMIN_B': None, 'APOLIPOPROTEIN_A_APOA': None, 'APOLIPOPROTEIN_B_APOB': None, 'APOB_APOA_RATIO': None, 'HSCRP': None, 'SERUM_COPPER': None, 'SERUM_ZINC': None, 'TESTOSTERONE': None, 'IRON': None, 'TOTAL_IRON_BINDING_CAPACITY': None, 'TRANSFERRIN_SATURATION': None, 'ALKALINE_PHOSPHATASE': None, 'BILIRUBIN_TOTAL': None, 'BILIRUBIN_DIRECT': None, 'BILIRUBIN_INDIRECT': None, 'GAMMA_GLUTAMYL_TRANSFERASE': None, 'ASPARTATE_AMINOTRANSFERASE': None, 'ALANINE_TRANSAMINASE': None, 'PROTEIN_TOTAL': None, 'ALBUMIN_SERUM': None, 'SERUM_ALB': None, 'SERUM_GLOBULIN': None, 'TOTAL_CHOLESTEROL': None, 'HDL_CHOLESTEROL_DIRECT': None, 'LDL_CHOLESTEROL_DIRECT': None, 'TRIGLYCERIDES': None, 'TC_HDL_CHOLESTEROL_RATIO': None, 'LDL_HDL_RATIO': None, 'VLDL_CHOLESTEROL': None, 'NON_HDL_CHOLESTEROL': None, 'TOTAL_TRIIODOTHYRONINE': 118.0, 'TOTAL_THYROXINE': 12.9, 'THYROID_STIMULATING_HORMONE': 5.14, 'BLOOD_UREA_NITROGEN': None, 'CREATININE_SERUM': None, 'BUN_SR_CREATININE_RATIO': None, 'CALCIUM': None, 'URIC_ACID': None, 'EST_GLOMERULAR_FILTRATION_RATE': None}\n",
      "{'HPLC': 8.3, 'AVERAGE_BLOOD_GLUCOSE': 192.0, 'TOTAL_LEUCOCYTES_COUNT': 6.4, 'NEUTROPHILS': 49.7, 'LYMPHOCYTE_PERCENTAGE': 42.8, 'MONOCYTES': 2.3, 'EOSINOPHILS': 4.7, 'BASOPHILS': 0.2, 'IMMATURE_GRANULOCYTE_PERCENTAGE': 0.3, 'NEUTROPHILS_ABSOLUTE_COUNT': 3.18, 'LYMPHOCYTES_ABSOLUTE_COUNT': 2.74, 'MONOCYTES_ABSOLUTE_COUNT': 0.15, 'BASOPHILS_ABSOLUTE_COUNT': 0.01, 'EOSINOPHILS_ABSOLUTE_COUNT': 0.3, 'IMMATURE_GRANULOCYTES': 0.02, 'TOTAL_RBC': 6.13, 'NUCLEATED_RED_BLOOD_CELLS': None, 'HEMOGLOBIN': 18.1, 'HEMATOCRIT': 50.68, 'MEAN_CORPUSCULAR_VOLUME': 100.2, 'MEAN_CORPUSCULAR_HEMOGLOBIN': 29.5, 'MEAN_CORP_HEMO_CONC': 29.5, 'RED_CELL_DISTRIBUTION_WIDTH_SD': 62.9, 'RED_CELL_DISTRIBUTION_WIDTH_CV': 17.6, 'PLATELET_DISTRIBUTION_WIDTH': 11.1, 'MEAN_PLATELET_VOLUME': 9.4, 'PLATELET_COUNT': 222.0, 'PLATELET_TO_LARGE_CELL_RATIO': 20.5, 'PLATELETCRIT': 0.21, 'ARSENIC': None, 'CADMIUM': None, 'MERCURY': None, 'LEAD': None, 'CHROMIUM': None, 'BARIUM': None, 'COBALT': None, 'CAESIUM': None, 'THALLIUM': None, 'URANIUM': None, 'STRONTIUM': None, 'ANTIMONY': None, 'TIN': None, 'MOLYBDENUM': None, 'SILVER': None, 'VANADIUM': None, 'BERYLLIUM': None, 'BISMUTH': None, 'SELENIUM': None, 'ALUMINIUM': None, 'NICKEL': None, 'MANGANESE': None, 'HOMOCYSTEINE': None, 'CYSTATIN_C': None, 'LIPOPROTEIN': None, 'VITAMIN_B': None, 'APOLIPOPROTEIN_A_APOA': None, 'APOLIPOPROTEIN_B_APOB': None, 'APOB_APOA_RATIO': None, 'HSCRP': None, 'SERUM_COPPER': None, 'SERUM_ZINC': None, 'TESTOSTERONE': None, 'IRON': 69.1, 'TOTAL_IRON_BINDING_CAPACITY': 348.0, 'TRANSFERRIN_SATURATION': 19.86, 'ALKALINE_PHOSPHATASE': 129.0, 'BILIRUBIN_TOTAL': 0.35, 'BILIRUBIN_DIRECT': 0.08, 'BILIRUBIN_INDIRECT': 0.27, 'GAMMA_GLUTAMYL_TRANSFERASE': 91.1, 'ASPARTATE_AMINOTRANSFERASE': 22.5, 'ALANINE_TRANSAMINASE': 21.4, 'PROTEIN_TOTAL': 6.6, 'ALBUMIN_SERUM': 41.0, 'SERUM_ALB': 1.64, 'SERUM_GLOBULIN': 2.5, 'TOTAL_CHOLESTEROL': 220.0, 'HDL_CHOLESTEROL_DIRECT': 36.0, 'LDL_CHOLESTEROL_DIRECT': 167.0, 'TRIGLYCERIDES': 188.0, 'TC_HDL_CHOLESTEROL_RATIO': 6.1, 'LDL_HDL_RATIO': 4.7, 'VLDL_CHOLESTEROL': 37.6, 'NON_HDL_CHOLESTEROL': 184.1, 'TOTAL_TRIIODOTHYRONINE': 99.0, 'TOTAL_THYROXINE': 6.4, 'THYROID_STIMULATING_HORMONE': 3.42, 'BLOOD_UREA_NITROGEN': 12.26, 'CREATININE_SERUM': 0.74, 'BUN_SR_CREATININE_RATIO': 16.57, 'CALCIUM': 9.16, 'URIC_ACID': 3.3, 'EST_GLOMERULAR_FILTRATION_RATE': 117.0}\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'HPLC': 7.2, 'AVERAGE_BLOOD_GLUCOSE': 160.0, 'TOTAL_LEUCOCYTES_COUNT': 6.6, 'NEUTROPHILS': 58.1, 'LYMPHOCYTE_PERCENTAGE': 26.7, 'MONOCYTES': 3.9, 'EOSINOPHILS': 10.2, 'BASOPHILS': 0.8, 'IMMATURE_GRANULOCYTE_PERCENTAGE': 0.3, 'NEUTROPHILS_ABSOLUTE_COUNT': 3.83, 'LYMPHOCYTES_ABSOLUTE_COUNT': 1.76, 'MONOCYTES_ABSOLUTE_COUNT': 0.26, 'BASOPHILS_ABSOLUTE_COUNT': 0.05, 'EOSINOPHILS_ABSOLUTE_COUNT': 0.67, 'IMMATURE_GRANULOCYTES': 0.02, 'TOTAL_RBC': None, 'NUCLEATED_RED_BLOOD_CELLS': None, 'HEMOGLOBIN': 12.1, 'HEMATOCRIT': 43.4, 'MEAN_CORPUSCULAR_VOLUME': 103.6, 'MEAN_CORPUSCULAR_HEMOGLOBIN': 28.9, 'MEAN_CORP_HEMO_CONC': 27.9, 'RED_CELL_DISTRIBUTION_WIDTH_SD': 59.7, 'RED_CELL_DISTRIBUTION_WIDTH_CV': 15.9, 'PLATELET_DISTRIBUTION_WIDTH': 19.0, 'MEAN_PLATELET_VOLUME': 12.9, 'PLATELET_COUNT': 231.0, 'PLATELET_TO_LARGE_CELL_RATIO': 47.3, 'PLATELETCRIT': 0.3, 'ARSENIC': None, 'CADMIUM': None, 'MERCURY': None, 'LEAD': None, 'CHROMIUM': None, 'BARIUM': None, 'COBALT': None, 'CAESIUM': None, 'THALLIUM': None, 'URANIUM': None, 'STRONTIUM': None, 'ANTIMONY': None, 'TIN': None, 'MOLYBDENUM': None, 'SILVER': None, 'VANADIUM': None, 'BERYLLIUM': None, 'BISMUTH': None, 'SELENIUM': None, 'ALUMINIUM': None, 'NICKEL': None, 'MANGANESE': None, 'HOMOCYSTEINE': None, 'CYSTATIN_C': None, 'LIPOPROTEIN': None, 'VITAMIN_B': None, 'APOLIPOPROTEIN_A_APOA': None, 'APOLIPOPROTEIN_B_APOB': None, 'APOB_APOA_RATIO': None, 'HSCRP': None, 'SERUM_COPPER': None, 'SERUM_ZINC': None, 'TESTOSTERONE': None, 'IRON': 55.2, 'TOTAL_IRON_BINDING_CAPACITY': 394.0, 'TRANSFERRIN_SATURATION': 14.01, 'ALKALINE_PHOSPHATASE': 129.0, 'BILIRUBIN_TOTAL': 0.48, 'BILIRUBIN_DIRECT': 0.15, 'BILIRUBIN_INDIRECT': 0.33, 'GAMMA_GLUTAMYL_TRANSFERASE': 12.3, 'ASPARTATE_AMINOTRANSFERASE': 33.4, 'ALANINE_TRANSAMINASE': 27.9, 'PROTEIN_TOTAL': 7.5, 'ALBUMIN_SERUM': 4.3, 'SERUM_ALB': 1.34, 'SERUM_GLOBULIN': 3.2, 'TOTAL_CHOLESTEROL': 148.0, 'HDL_CHOLESTEROL_DIRECT': 23.0, 'LDL_CHOLESTEROL_DIRECT': 91.0, 'TRIGLYCERIDES': 201.0, 'TC_HDL_CHOLESTEROL_RATIO': 6.5, 'LDL_HDL_RATIO': 4.0, 'VLDL_CHOLESTEROL': 40.19, 'NON_HDL_CHOLESTEROL': 125.1, 'TOTAL_TRIIODOTHYRONINE': 87.0, 'TOTAL_THYROXINE': 12.1, 'THYROID_STIMULATING_HORMONE': 4.94, 'BLOOD_UREA_NITROGEN': 7.38, 'CREATININE_SERUM': 0.54, 'BUN_SR_CREATININE_RATIO': 13.67, 'CALCIUM': 9.04, 'URIC_ACID': 3.9, 'EST_GLOMERULAR_FILTRATION_RATE': None}\n",
      "{'HPLC': None, 'AVERAGE_BLOOD_GLUCOSE': None, 'TOTAL_LEUCOCYTES_COUNT': None, 'NEUTROPHILS': None, 'LYMPHOCYTE_PERCENTAGE': None, 'MONOCYTES': None, 'EOSINOPHILS': None, 'BASOPHILS': None, 'IMMATURE_GRANULOCYTE_PERCENTAGE': None, 'NEUTROPHILS_ABSOLUTE_COUNT': None, 'LYMPHOCYTES_ABSOLUTE_COUNT': None, 'MONOCYTES_ABSOLUTE_COUNT': None, 'BASOPHILS_ABSOLUTE_COUNT': None, 'EOSINOPHILS_ABSOLUTE_COUNT': None, 'IMMATURE_GRANULOCYTES': None, 'TOTAL_RBC': None, 'NUCLEATED_RED_BLOOD_CELLS': None, 'HEMOGLOBIN': None, 'HEMATOCRIT': None, 'MEAN_CORPUSCULAR_VOLUME': None, 'MEAN_CORPUSCULAR_HEMOGLOBIN': None, 'MEAN_CORP_HEMO_CONC': None, 'RED_CELL_DISTRIBUTION_WIDTH_SD': None, 'RED_CELL_DISTRIBUTION_WIDTH_CV': None, 'PLATELET_DISTRIBUTION_WIDTH': None, 'MEAN_PLATELET_VOLUME': None, 'PLATELET_COUNT': None, 'PLATELET_TO_LARGE_CELL_RATIO': None, 'PLATELETCRIT': None, 'ARSENIC': None, 'CADMIUM': None, 'MERCURY': None, 'LEAD': None, 'CHROMIUM': None, 'BARIUM': None, 'COBALT': None, 'CAESIUM': None, 'THALLIUM': None, 'URANIUM': None, 'STRONTIUM': None, 'ANTIMONY': None, 'TIN': None, 'MOLYBDENUM': None, 'SILVER': None, 'VANADIUM': None, 'BERYLLIUM': None, 'BISMUTH': None, 'SELENIUM': None, 'ALUMINIUM': None, 'NICKEL': None, 'MANGANESE': None, 'HOMOCYSTEINE': None, 'CYSTATIN_C': None, 'LIPOPROTEIN': None, 'VITAMIN_B': None, 'APOLIPOPROTEIN_A_APOA': None, 'APOLIPOPROTEIN_B_APOB': None, 'APOB_APOA_RATIO': None, 'HSCRP': None, 'SERUM_COPPER': None, 'SERUM_ZINC': None, 'TESTOSTERONE': None, 'IRON': None, 'TOTAL_IRON_BINDING_CAPACITY': None, 'TRANSFERRIN_SATURATION': None, 'ALKALINE_PHOSPHATASE': None, 'BILIRUBIN_TOTAL': None, 'BILIRUBIN_DIRECT': None, 'BILIRUBIN_INDIRECT': None, 'GAMMA_GLUTAMYL_TRANSFERASE': None, 'ASPARTATE_AMINOTRANSFERASE': None, 'ALANINE_TRANSAMINASE': None, 'PROTEIN_TOTAL': None, 'ALBUMIN_SERUM': None, 'SERUM_ALB': None, 'SERUM_GLOBULIN': None, 'TOTAL_CHOLESTEROL': None, 'HDL_CHOLESTEROL_DIRECT': None, 'LDL_CHOLESTEROL_DIRECT': None, 'TRIGLYCERIDES': None, 'TC_HDL_CHOLESTEROL_RATIO': None, 'LDL_HDL_RATIO': None, 'VLDL_CHOLESTEROL': None, 'NON_HDL_CHOLESTEROL': None, 'TOTAL_TRIIODOTHYRONINE': 118.0, 'TOTAL_THYROXINE': 12.9, 'THYROID_STIMULATING_HORMONE': 5.14, 'BLOOD_UREA_NITROGEN': None, 'CREATININE_SERUM': None, 'BUN_SR_CREATININE_RATIO': None, 'CALCIUM': None, 'URIC_ACID': None, 'EST_GLOMERULAR_FILTRATION_RATE': None}\n"
     ]
    }
   ],
   "source": [
    "import glob\n",
    "main = []\n",
    "i = 0\n",
    "pdf_dir = \"pdd_info\"\n",
    "pdf_files = glob.glob(\"%s/*.pdf\" % pdf_dir)\n",
    "for file in pdf_files:\n",
    "    images = convert_from_path(file)\n",
    "    texts = []\n",
    "    for i, image in enumerate(images):\n",
    "        fname = \"image\" + str(i) + \".png\"\n",
    "        img.append(fname)\n",
    "        image.save(fname, \"PNG\")\n",
    "        text  =  ocr_core(fname)\n",
    "        text = listToString(text)  \n",
    "        texts.append(text)\n",
    "        os.remove(fname)\n",
    "        extracted_text = listToString(texts)\n",
    "        Report_List = []\n",
    "        for row in extracted_text.split('\\n'):\n",
    "            for word in list(word_list):\n",
    "                if row.startswith(word):\n",
    "                    word = row.split()\n",
    "                    word = word\n",
    "                    for word_name in list(word):\n",
    "                        if word_name in stopwords:\n",
    "                            word.remove(word_name)\n",
    "                    for i in word:\n",
    "                        if  solve(i):\n",
    "                            null = i\n",
    "                            word.remove(null)\n",
    "                            i = float(i)\n",
    "                    word = [x for x in word if not isinstance(x, int)]\n",
    "                    word = [' '.join(word)]\n",
    "                    #print(word)\n",
    "                    word.append(i)\n",
    "                    #word.remove(str(i))\n",
    "                    #print(word)\n",
    "                    Report_List.append(word)\n",
    "        extracted_DataFrame = pd.DataFrame(Report_List)\n",
    "        #Data Cleaning\n",
    "        extracted_DataFrame.columns = ['Keys','Values']\n",
    "    #        extracted_DataFrame.rename(columns={'Keys':'Values'},inplace=True)\n",
    "        extracted_DataFrame['Keys'] = extracted_DataFrame['Keys'].str.replace('\\d+', '')\n",
    "        extracted_DataFrame['Keys'] = extracted_DataFrame['Keys'].str.replace('\\.','')\n",
    "        extracted_DataFrame['Keys'] = extracted_DataFrame['Keys'].str.replace('\\-','')\n",
    "        extracted_DataFrame['Keys'] = extracted_DataFrame['Keys'].str.rstrip()\n",
    "        extracted_DataFrame['Values'] = extracted_DataFrame['Values'].apply(lambda x: pd.to_numeric(x, errors = 'coerce')).dropna()\n",
    "        extracted_DataFrame = extracted_DataFrame.dropna(axis=0)\n",
    "        #DataFrame to Dictionary\n",
    "        extracted_Dictionary = extracted_DataFrame.set_index('Keys')['Values'].to_dict()\n",
    "        Report_Dictionary = {}\n",
    "\n",
    "        if 'HPLC' in extracted_Dictionary.keys():\n",
    "            HPLC = extracted_Dictionary['HPLC']\n",
    "            Report_Dictionary[\"HPLC\"] = HPLC\n",
    "        else:\n",
    "            Report_Dictionary[\"HPLC\"] = None\n",
    "        if 'AVERAGE BLOOD GLUCOSE (ABG)' in extracted_Dictionary.keys():\n",
    "            AVERAGE_BLOOD_GLUCOSE = extracted_Dictionary['AVERAGE BLOOD GLUCOSE (ABG)']\n",
    "            Report_Dictionary[\"AVERAGE_BLOOD_GLUCOSE\"] = AVERAGE_BLOOD_GLUCOSE\n",
    "        else:\n",
    "            Report_Dictionary[\"AVERAGE_BLOOD_GLUCOSE\"] = None\n",
    "        if 'TOTAL LEUCOCYTES COUNT' in extracted_Dictionary.keys():\n",
    "            TOTAL_LEUCOCYTES_COUNT = extracted_Dictionary['TOTAL LEUCOCYTES COUNT']\n",
    "            Report_Dictionary[\"TOTAL_LEUCOCYTES_COUNT\"] = TOTAL_LEUCOCYTES_COUNT\n",
    "        else:\n",
    "            Report_Dictionary[\"TOTAL_LEUCOCYTES_COUNT\"] = None\n",
    "\n",
    "        if 'NEUTROPHILS' in extracted_Dictionary.keys():\n",
    "            NEUTROPHILS = extracted_Dictionary['NEUTROPHILS']\n",
    "            Report_Dictionary[\"NEUTROPHILS\"] = NEUTROPHILS\n",
    "        else:\n",
    "            Report_Dictionary[\"NEUTROPHILS\"] = None\n",
    "\n",
    "        if 'LYMPHOCYTE PERCENTAGE' in extracted_Dictionary.keys():\n",
    "            LYMPHOCYTE_PERCENTAGE = extracted_Dictionary['LYMPHOCYTE PERCENTAGE']\n",
    "            Report_Dictionary[\"LYMPHOCYTE_PERCENTAGE\"] = LYMPHOCYTE_PERCENTAGE\n",
    "        else:\n",
    "            Report_Dictionary[\"LYMPHOCYTE_PERCENTAGE\"] = None\n",
    "\n",
    "        if 'MONOCYTES' in extracted_Dictionary.keys():\n",
    "            MONOCYTES = extracted_Dictionary['MONOCYTES']\n",
    "            Report_Dictionary[\"MONOCYTES\"] = MONOCYTES\n",
    "        else:\n",
    "            Report_Dictionary[\"MONOCYTES\"] = None\n",
    "\n",
    "        if 'EOSINOPHILS' in extracted_Dictionary.keys():\n",
    "            EOSINOPHILS = extracted_Dictionary['EOSINOPHILS']\n",
    "            Report_Dictionary[\"EOSINOPHILS\"] = EOSINOPHILS\n",
    "        else:\n",
    "            Report_Dictionary[\"EOSINOPHILS\"] = None\n",
    "\n",
    "        if 'BASOPHILS' in extracted_Dictionary.keys():\n",
    "            BASOPHILS = extracted_Dictionary['BASOPHILS']\n",
    "            Report_Dictionary[\"BASOPHILS\"] = BASOPHILS\n",
    "        else:\n",
    "            Report_Dictionary[\"BASOPHILS\"] = None\n",
    "\n",
    "        if 'IMMATURE GRANULOCYTE' in extracted_Dictionary.keys():\n",
    "            IMMATURE_GRANULOCYTE_PERCENTAGE = extracted_Dictionary['IMMATURE GRANULOCYTE']\n",
    "            Report_Dictionary[\"IMMATURE_GRANULOCYTE_PERCENTAGE\"] = IMMATURE_GRANULOCYTE_PERCENTAGE\n",
    "        else:\n",
    "            Report_Dictionary[\"IMMATURE_GRANULOCYTE_PERCENTAGE\"] = None\n",
    "\n",
    "        if 'NEUTROPHILS ABSOLUTE COUNT' in extracted_Dictionary.keys():\n",
    "            NEUTROPHILS_ABSOLUTE_COUNT = extracted_Dictionary['NEUTROPHILS ABSOLUTE COUNT']\n",
    "            Report_Dictionary[\"NEUTROPHILS_ABSOLUTE_COUNT\"] = NEUTROPHILS_ABSOLUTE_COUNT\n",
    "        else:\n",
    "            Report_Dictionary[\"NEUTROPHILS_ABSOLUTE_COUNT\"] = None\n",
    "\n",
    "        if 'LYMPHOCYTES ABSOLUTE COUNT' in extracted_Dictionary.keys():\n",
    "            LYMPHOCYTES_ABSOLUTE_COUNT = extracted_Dictionary['LYMPHOCYTES ABSOLUTE COUNT']\n",
    "            Report_Dictionary[\"LYMPHOCYTES_ABSOLUTE_COUNT\"] = LYMPHOCYTES_ABSOLUTE_COUNT\n",
    "        else:\n",
    "            Report_Dictionary[\"LYMPHOCYTES_ABSOLUTE_COUNT\"] = None\n",
    "\n",
    "        if 'MONOCYTES ABSOLUTE COUNT' in extracted_Dictionary.keys():\n",
    "            MONOCYTES_ABSOLUTE_COUNT = extracted_Dictionary['MONOCYTES ABSOLUTE COUNT']\n",
    "            Report_Dictionary[\"MONOCYTES_ABSOLUTE_COUNT\"] = MONOCYTES_ABSOLUTE_COUNT\n",
    "        else:\n",
    "            Report_Dictionary[\"MONOCYTES_ABSOLUTE_COUNT\"] = None\n",
    "\n",
    "        if 'BASOPHILS ABSOLUTE COUNT' in extracted_Dictionary.keys():\n",
    "            BASOPHILS_ABSOLUTE_COUNT = extracted_Dictionary['BASOPHILS ABSOLUTE COUNT']\n",
    "            Report_Dictionary[\"BASOPHILS_ABSOLUTE_COUNT\"] = BASOPHILS_ABSOLUTE_COUNT\n",
    "        else:\n",
    "            Report_Dictionary[\"BASOPHILS_ABSOLUTE_COUNT\"] = None\n",
    "\n",
    "        if 'EOSINOPHILS ABSOLUTE COUNT' in extracted_Dictionary.keys():\n",
    "            EOSINOPHILS_ABSOLUTE_COUNT = extracted_Dictionary['EOSINOPHILS ABSOLUTE COUNT']\n",
    "            Report_Dictionary[\"EOSINOPHILS_ABSOLUTE_COUNT\"] = EOSINOPHILS_ABSOLUTE_COUNT\n",
    "        else:\n",
    "            Report_Dictionary[\"EOSINOPHILS_ABSOLUTE_COUNT\"] = None\n",
    "\n",
    "        if 'IMMATURE GRANULOCYTES(IG)' in extracted_Dictionary.keys():\n",
    "            IMMATURE_GRANULOCYTES = extracted_Dictionary['IMMATURE GRANULOCYTES(IG)']\n",
    "            Report_Dictionary[\"IMMATURE_GRANULOCYTES\"] = IMMATURE_GRANULOCYTES\n",
    "        else:\n",
    "            Report_Dictionary[\"IMMATURE_GRANULOCYTES\"] = None\n",
    "\n",
    "        if 'TOTAL RBC' in extracted_Dictionary.keys():\n",
    "            TOTAL_RBC = extracted_Dictionary['TOTAL RBC']\n",
    "            Report_Dictionary[\"TOTAL_RBC\"] = TOTAL_RBC\n",
    "        else:\n",
    "            Report_Dictionary[\"TOTAL_RBC\"] = None\n",
    "\n",
    "        if 'NUCLEATED RED BLOOD CELLS' in extracted_Dictionary.keys():\n",
    "            NUCLEATED_RED_BLOOD_CELLS = extracted_Dictionary['NUCLEATED RED BLOOD CELLS']\n",
    "            Report_Dictionary[\"NUCLEATED_RED_BLOOD_CELLS\"] = NUCLEATED_RED_BLOOD_CELL\n",
    "\n",
    "        else:\n",
    "            Report_Dictionary[\"NUCLEATED_RED_BLOOD_CELLS\"] = None\n",
    "\n",
    "\n",
    "        if 'HEMOGLOBIN' in extracted_Dictionary.keys():\n",
    "            HEMOGLOBIN = extracted_Dictionary['HEMOGLOBIN']\n",
    "            Report_Dictionary[\"HEMOGLOBIN\"] = HEMOGLOBIN\n",
    "        else:\n",
    "            Report_Dictionary[\"HEMOGLOBIN\"] = None\n",
    "\n",
    "        if 'HEMATOCRIT(PCV)' in extracted_Dictionary.keys():\n",
    "            HEMATOCRIT = extracted_Dictionary['HEMATOCRIT(PCV)']\n",
    "            Report_Dictionary[\"HEMATOCRIT\"] = HEMATOCRIT\n",
    "        else:\n",
    "            Report_Dictionary[\"HEMATOCRIT\"] = None\n",
    "\n",
    "        if 'MEAN CORPUSCULAR VOLUME(MCV)' in extracted_Dictionary.keys():\n",
    "            MEAN_CORPUSCULAR_VOLUME = extracted_Dictionary['MEAN CORPUSCULAR VOLUME(MCV)']\n",
    "            Report_Dictionary[\"MEAN_CORPUSCULAR_VOLUME\"] = MEAN_CORPUSCULAR_VOLUME\n",
    "        else:\n",
    "            Report_Dictionary[\"MEAN_CORPUSCULAR_VOLUME\"] = None\n",
    "\n",
    "        if 'MEAN CORPUSCULAR HEMOGLOBIN(MCH)' in extracted_Dictionary.keys():\n",
    "            MEAN_CORPUSCULAR_HEMOGLOBIN = extracted_Dictionary['MEAN CORPUSCULAR HEMOGLOBIN(MCH)']\n",
    "            Report_Dictionary[\"MEAN_CORPUSCULAR_HEMOGLOBIN\"] = MEAN_CORPUSCULAR_HEMOGLOBIN\n",
    "        else:\n",
    "            Report_Dictionary[\"MEAN_CORPUSCULAR_HEMOGLOBIN\"] = None\n",
    "\n",
    "        if 'MEAN CORPHEMOCONC(MCHC)' in extracted_Dictionary.keys():\n",
    "            MEAN_CORP_HEMO_CONC = extracted_Dictionary['MEAN CORPHEMOCONC(MCHC)']\n",
    "            Report_Dictionary[\"MEAN_CORP_HEMO_CONC\"] = MEAN_CORP_HEMO_CONC\n",
    "        else:\n",
    "            Report_Dictionary[\"MEAN_CORP_HEMO_CONC\"] = None\n",
    "\n",
    "        if 'RED CELL DISTRIBUTION WIDTH SD(RDWSD)' in extracted_Dictionary.keys():\n",
    "            RED_CELL_DISTRIBUTION_WIDTH_SD = extracted_Dictionary['RED CELL DISTRIBUTION WIDTH SD(RDWSD)']\n",
    "            Report_Dictionary[\"RED_CELL_DISTRIBUTION_WIDTH_SD\"] = RED_CELL_DISTRIBUTION_WIDTH_SD\n",
    "        else:\n",
    "            Report_Dictionary[\"RED_CELL_DISTRIBUTION_WIDTH_SD\"] = None\n",
    "\n",
    "        if 'RED CELL DISTRIBUTION WIDTH (RDWCV)' in extracted_Dictionary.keys():\n",
    "            RED_CELL_DISTRIBUTION_WIDTH_CV = extracted_Dictionary['RED CELL DISTRIBUTION WIDTH (RDWCV)']\n",
    "            Report_Dictionary[\"RED_CELL_DISTRIBUTION_WIDTH_CV\"] = RED_CELL_DISTRIBUTION_WIDTH_CV\n",
    "        else:\n",
    "            Report_Dictionary[\"RED_CELL_DISTRIBUTION_WIDTH_CV\"] = None\n",
    "\n",
    "        if 'PLATELET DISTRIBUTION WIDTH(PDW)' in extracted_Dictionary.keys():\n",
    "            PLATELET_DISTRIBUTION_WIDTH = extracted_Dictionary['PLATELET DISTRIBUTION WIDTH(PDW)']\n",
    "            Report_Dictionary[\"PLATELET_DISTRIBUTION_WIDTH\"] = PLATELET_DISTRIBUTION_WIDTH\n",
    "        else:\n",
    "            Report_Dictionary[\"PLATELET_DISTRIBUTION_WIDTH\"] = None\n",
    "\n",
    "        if 'MEAN PLATELET VOLUME(MPV)' in extracted_Dictionary.keys():\n",
    "            MEAN_PLATELET_VOLUME = extracted_Dictionary['MEAN PLATELET VOLUME(MPV)']\n",
    "            Report_Dictionary[\"MEAN_PLATELET_VOLUME\"] = MEAN_PLATELET_VOLUME\n",
    "        else:\n",
    "            Report_Dictionary[\"MEAN_PLATELET_VOLUME\"] = None\n",
    "\n",
    "        if 'PLATELET COUNT' in extracted_Dictionary.keys():\n",
    "            PLATELET_COUNT = extracted_Dictionary['PLATELET COUNT']\n",
    "            Report_Dictionary[\"PLATELET_COUNT\"] = PLATELET_COUNT\n",
    "        else:\n",
    "            Report_Dictionary[\"PLATELET_COUNT\"] = None\n",
    "\n",
    "        if 'PLATELET TO LARGE CELL RATIO(PLCR)' in extracted_Dictionary.keys():\n",
    "            PLATELET_TO_LARGE_CELL_RATIO = extracted_Dictionary['PLATELET TO LARGE CELL RATIO(PLCR)']\n",
    "            Report_Dictionary[\"PLATELET_TO_LARGE_CELL_RATIO\"] = PLATELET_TO_LARGE_CELL_RATIO\n",
    "        else:\n",
    "            Report_Dictionary[\"PLATELET_TO_LARGE_CELL_RATIO\"] = None\n",
    "\n",
    "        if 'PLATELETCRIT(PCT)' in extracted_Dictionary.keys():\n",
    "            PLATELETCRIT = extracted_Dictionary['PLATELETCRIT(PCT)']\n",
    "            Report_Dictionary[\"PLATELETCRIT\"] = PLATELETCRIT\n",
    "        else:\n",
    "            Report_Dictionary[\"PLATELETCRIT\"] = None\n",
    "\n",
    "        if 'ARSENIC' in extracted_Dictionary.keys():\n",
    "            ARSENIC = extracted_Dictionary['ARSENIC']\n",
    "            Report_Dictionary[\"ARSENIC\"] = ARSENIC\n",
    "        else:\n",
    "            Report_Dictionary[\"ARSENIC\"] = None\n",
    "\n",
    "\n",
    "        if 'CADMIUM' in extracted_Dictionary.keys():\n",
    "            CADMIUM = extracted_Dictionary['CADMIUM']\n",
    "            Report_Dictionary[\"CADMIUM\"] = CADMIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"CADMIUM\"] = None\n",
    "\n",
    "\n",
    "        if 'MERCURY' in extracted_Dictionary.keys():\n",
    "            MERCURY = extracted_Dictionary['MERCURY']\n",
    "            Report_Dictionary[\"MERCURY\"] = MERCURY\n",
    "        else:\n",
    "            Report_Dictionary[\"MERCURY\"] = None\n",
    "\n",
    "\n",
    "        if 'LEAD' in extracted_Dictionary.keys():\n",
    "            LEAD = extracted_Dictionary['LEAD']\n",
    "            Report_Dictionary[\"LEAD\"] = LEAD\n",
    "        else:\n",
    "            Report_Dictionary[\"LEAD\"] = None\n",
    "\n",
    "\n",
    "        if 'CHROMIUM' in extracted_Dictionary.keys():\n",
    "            CHROMIUM = extracted_Dictionary['CHROMIUM']\n",
    "            Report_Dictionary[\"CHROMIUM\"] = CHROMIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"CHROMIUM\"] = None\n",
    "\n",
    "\n",
    "        if 'BARIUM' in extracted_Dictionary.keys():\n",
    "            BARIUM = extracted_Dictionary['BARIUM']\n",
    "            Report_Dictionary[\"BARIUM\"] = BARIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"BARIUM\"] = None\n",
    "\n",
    "\n",
    "        if 'COBALT' in extracted_Dictionary.keys():\n",
    "            COBALT = extracted_Dictionary['COBALT']\n",
    "            Report_Dictionary[\"COBALT\"] = COBALT\n",
    "        else:\n",
    "            Report_Dictionary[\"COBALT\"] = None\n",
    "\n",
    "\n",
    "        if 'CAESIUM' in extracted_Dictionary.keys():\n",
    "            CAESIUM = extracted_Dictionary['CAESIUM']\n",
    "            Report_Dictionary[\"CAESIUM\"] = CAESIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"CAESIUM\"] = None\n",
    "\n",
    "\n",
    "        if 'THALLIUM' in extracted_Dictionary.keys():\n",
    "            THALLIUM = extracted_Dictionary['THALLIUM']\n",
    "            Report_Dictionary[\"THALLIUM\"] = THALLIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"THALLIUM\"] = None\n",
    "\n",
    "\n",
    "        if 'URANIUM' in extracted_Dictionary.keys():\n",
    "            URANIUM = extracted_Dictionary['URANIUM']\n",
    "            Report_Dictionary[\"URANIUM\"] = URANIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"URANIUM\"] = None\n",
    "\n",
    "\n",
    "        if 'STRONTIUM' in extracted_Dictionary.keys():\n",
    "            STRONTIUM = extracted_Dictionary['STRONTIUM']\n",
    "            Report_Dictionary[\"STRONTIUM\"] = STRONTIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"STRONTIUM\"] = None\n",
    "\n",
    "\n",
    "        if 'ANTIMONY' in extracted_Dictionary.keys():\n",
    "            ANTIMONY = extracted_Dictionary['ANTIMONY']\n",
    "            Report_Dictionary[\"ANTIMONY\"] = ANTIMONY\n",
    "        else:\n",
    "            Report_Dictionary[\"ANTIMONY\"] = None\n",
    "\n",
    "\n",
    "        if 'TIN' in extracted_Dictionary.keys():\n",
    "            TIN = extracted_Dictionary['TIN']\n",
    "            Report_Dictionary[\"TIN\"] = TIN\n",
    "        else:\n",
    "            Report_Dictionary[\"TIN\"] = None\n",
    "\n",
    "\n",
    "        if 'MOLYBDENUM' in extracted_Dictionary.keys():\n",
    "            MOLYBDENUM = extracted_Dictionary['MOLYBDENUM']\n",
    "            Report_Dictionary[\"MOLYBDENUM\"] = MOLYBDENUM\n",
    "        else:\n",
    "            Report_Dictionary[\"MOLYBDENUM\"] = None\n",
    "\n",
    "\n",
    "\n",
    "        if 'SILVER' in extracted_Dictionary.keys():\n",
    "            SILVER = extracted_Dictionary['SILVER']\n",
    "            Report_Dictionary[\"SILVER\"] = SILVER\n",
    "        else:\n",
    "            Report_Dictionary[\"SILVER\"] = None\n",
    "\n",
    "\n",
    "        if 'VANADIUM' in extracted_Dictionary.keys():\n",
    "            VANADIUM = extracted_Dictionary['VANADIUM']\n",
    "            Report_Dictionary[\"VANADIUM\"] = VANADIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"VANADIUM\"] = None\n",
    "\n",
    "\n",
    "        if 'BERYLLIUM' in extracted_Dictionary.keys():\n",
    "            BERYLLIUM = extracted_Dictionary['BERYLLIUM']\n",
    "            Report_Dictionary[\"BERYLLIUM\"] = BERYLLIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"BERYLLIUM\"] = None\n",
    "\n",
    "\n",
    "\n",
    "        if 'BISMUTH' in extracted_Dictionary.keys():\n",
    "            BISMUTH = extracted_Dictionary['BISMUTH']\n",
    "            Report_Dictionary[\"BISMUTH\"] = BISMUTH\n",
    "        else:\n",
    "            Report_Dictionary[\"BISMUTH\"] = None\n",
    "\n",
    "\n",
    "        if 'SELENIUM' in extracted_Dictionary.keys():\n",
    "            SELENIUM = extracted_Dictionary['SELENIUM']\n",
    "            Report_Dictionary[\"SELENIUM\"] = SELENIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"SELENIUM\"] = None\n",
    "\n",
    "\n",
    "        if 'ALUMINIUM' in extracted_Dictionary.keys():\n",
    "            ALUMINIUM = extracted_Dictionary['ALUMINIUM']\n",
    "            Report_Dictionary[\"ALUMINIUM\"] = ALUMINIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"ALUMINIUM\"] = None\n",
    "\n",
    "\n",
    "        if 'NICKEL' in extracted_Dictionary.keys():\n",
    "            NICKEL = extracted_Dictionary['NICKEL']\n",
    "            Report_Dictionary[\"NICKEL\"] = NICKEL\n",
    "        else:\n",
    "            Report_Dictionary[\"NICKEL\"] = None\n",
    "\n",
    "\n",
    "        if 'MANGANESE' in extracted_Dictionary.keys():\n",
    "            MANGANESE = extracted_Dictionary['MANGANESE']\n",
    "            Report_Dictionary[\"MANGANESE\"] = MANGANESE\n",
    "        else:\n",
    "            Report_Dictionary[\"MANGANESE\"] = None\n",
    "\n",
    "\n",
    "        if 'HOMOCYSTEINE' in extracted_Dictionary.keys():\n",
    "            HOMOCYSTEINE = extracted_Dictionary['HOMOCYSTEINE']\n",
    "            Report_Dictionary[\"HOMOCYSTEINE\"] = HOMOCYSTEINE\n",
    "        else:\n",
    "            Report_Dictionary[\"HOMOCYSTEINE\"] = None\n",
    "\n",
    "\n",
    "        if 'CYSTATIN C' in extracted_Dictionary.keys():\n",
    "            CYSTATIN_C = extracted_Dictionary['CYSTATIN C']\n",
    "            Report_Dictionary[\"CYSTATIN_C\"] = CYSTATIN_C\n",
    "        else:\n",
    "            Report_Dictionary[\"CYSTATIN_C\"] = None\n",
    "\n",
    "        if 'LIPOPROTEIN' in extracted_Dictionary.keys():\n",
    "            LIPOPROTEIN = extracted_Dictionary['LIPOPROTEIN']\n",
    "            Report_Dictionary[\"LIPOPROTEIN\"] = LIPOPROTEIN\n",
    "        else:\n",
    "            Report_Dictionary[\"LIPOPROTEIN\"] = None\n",
    "\n",
    "\n",
    "        if 'VITAMIN B' in extracted_Dictionary.keys():\n",
    "            VITAMIN_B = extracted_Dictionary['VITAMIN B']\n",
    "            Report_Dictionary[\"VITAMIN_B\"] = VITAMIN_B\n",
    "        else:\n",
    "            Report_Dictionary[\"VITAMIN_B\"] = None\n",
    "\n",
    "\n",
    "        if 'APOLIPOPROTEIN A (APOA)' in extracted_Dictionary.keys():\n",
    "            APOLIPOPROTEIN_A_APOA = extracted_Dictionary['APOLIPOPROTEIN A (APOA)']\n",
    "            Report_Dictionary[\"APOLIPOPROTEIN_A_APOA\"] = APOLIPOPROTEIN_A_APOA\n",
    "        else:\n",
    "            Report_Dictionary[\"APOLIPOPROTEIN_A_APOA\"] = None\n",
    "\n",
    "\n",
    "        if 'APOLIPOPROTEIN B (APOB)' in extracted_Dictionary.keys():\n",
    "            APOLIPOPROTEIN_B_APOB = extracted_Dictionary['APOLIPOPROTEIN B (APOB)']\n",
    "            Report_Dictionary[\"APOLIPOPROTEIN_B_APOB\"] = APOLIPOPROTEIN_B_APOB\n",
    "        else:\n",
    "            Report_Dictionary[\"APOLIPOPROTEIN_B_APOB\"] = None\n",
    "\n",
    "        if 'APO B APO Ai (APO B/A)' in extracted_Dictionary.keys():\n",
    "            APOB_APOA_RATIO = extracted_Dictionary['APO B APO Ai (APO B/A)']\n",
    "            Report_Dictionary[\"APOB_APOA_RATIO\"] = APOB_APOA_RATIO\n",
    "        else:\n",
    "            Report_Dictionary[\"APOB_APOA_RATIO\"] = None\n",
    "\n",
    "\n",
    "\n",
    "        if 'HIGH SENSITIVITY CREACTIVE PROTEIN (HSCRP)' in extracted_Dictionary.keys():\n",
    "            HSCRP = extracted_Dictionary['HIGH SENSITIVITY CREACTIVE PROTEIN (HSCRP)']\n",
    "            Report_Dictionary[\"HSCRP\"] = HSCRP\n",
    "        else:\n",
    "            Report_Dictionary[\"HSCRP\"] = None\n",
    "\n",
    "\n",
    "        if 'SERUM COPPER' in extracted_Dictionary.keys():\n",
    "            SERUM_COPPER = extracted_Dictionary['SERUM COPPER']\n",
    "            Report_Dictionary[\"SERUM_COPPER\"] = SERUM_COPPER\n",
    "        else:\n",
    "            Report_Dictionary[\"SERUM_COPPER\"] = None\n",
    "\n",
    "\n",
    "        if 'SERUM ZINC' in extracted_Dictionary.keys():\n",
    "            SERUM_ZINC = extracted_Dictionary['SERUM ZINC']\n",
    "            Report_Dictionary[\"SERUM_ZINC\"] = SERUM_ZINC\n",
    "        else:\n",
    "            Report_Dictionary[\"SERUM_ZINC\"] = None\n",
    "\n",
    "\n",
    "        if 'TESTOSTERONE' in extracted_Dictionary.keys():\n",
    "            TESTOSTERONE = extracted_Dictionary['TESTOSTERONE']\n",
    "            Report_Dictionary[\"TESTOSTERONE\"] = TESTOSTERONE\n",
    "        else:\n",
    "            Report_Dictionary[\"TESTOSTERONE\"] = None\n",
    "\n",
    "        if 'IRON' in extracted_Dictionary.keys():\n",
    "            IRON = extracted_Dictionary['IRON']\n",
    "            Report_Dictionary[\"IRON\"] = IRON\n",
    "        else:\n",
    "            Report_Dictionary[\"IRON\"] = None\n",
    "\n",
    "        if 'TOTAL IRON BINDING CAPACITY (TIBC)' in extracted_Dictionary.keys():\n",
    "            TOTAL_IRON_BINDING_CAPACITY = extracted_Dictionary['TOTAL IRON BINDING CAPACITY (TIBC)']\n",
    "            Report_Dictionary[\"TOTAL_IRON_BINDING_CAPACITY\"] = TOTAL_IRON_BINDING_CAPACITY\n",
    "        else:\n",
    "            Report_Dictionary[\"TOTAL_IRON_BINDING_CAPACITY\"] = None\n",
    "\n",
    "\n",
    "        if 'TRANSFERRIN SATURATION' in extracted_Dictionary.keys():\n",
    "            TRANSFERRIN_SATURATION = extracted_Dictionary['TRANSFERRIN SATURATION']\n",
    "            Report_Dictionary[\"TRANSFERRIN_SATURATION\"] = TRANSFERRIN_SATURATION\n",
    "        else:\n",
    "            Report_Dictionary[\"TRANSFERRIN_SATURATION\"] = None\n",
    "\n",
    "        if 'ALKALINE PHOSPHATASE' in extracted_Dictionary.keys():\n",
    "            ALKALINE_PHOSPHATASE = extracted_Dictionary['ALKALINE PHOSPHATASE']\n",
    "            Report_Dictionary[\"ALKALINE_PHOSPHATASE\"] = ALKALINE_PHOSPHATASE\n",
    "        else:\n",
    "            Report_Dictionary[\"ALKALINE_PHOSPHATASE\"] = None\n",
    "\n",
    "        if 'BILIRUBIN TOTAL' in extracted_Dictionary.keys():\n",
    "            BILIRUBIN_TOTAL = extracted_Dictionary['BILIRUBIN TOTAL']\n",
    "            Report_Dictionary[\"BILIRUBIN_TOTAL\"] = BILIRUBIN_TOTAL\n",
    "        else:\n",
    "            Report_Dictionary[\"BILIRUBIN_TOTAL\"] = None\n",
    "\n",
    "        if 'BILIRUBIN DIRECT' in extracted_Dictionary.keys():\n",
    "            BILIRUBIN_DIRECT = extracted_Dictionary['BILIRUBIN DIRECT']\n",
    "            Report_Dictionary[\"BILIRUBIN_DIRECT\"] = BILIRUBIN_DIRECT\n",
    "        else:\n",
    "            Report_Dictionary[\"BILIRUBIN_DIRECT\"] = None\n",
    "\n",
    "        if 'BILIRUBIN (INDIRECT)' in extracted_Dictionary.keys():\n",
    "            BILIRUBIN_INDIRECT = extracted_Dictionary['BILIRUBIN (INDIRECT)']\n",
    "            Report_Dictionary[\"BILIRUBIN_INDIRECT\"] = BILIRUBIN_INDIRECT\n",
    "        else:\n",
    "            Report_Dictionary[\"BILIRUBIN_INDIRECT\"] = None\n",
    "\n",
    "        if 'GAMMA GLUTAMYL TRANSFERASE (GGT)' in extracted_Dictionary.keys():\n",
    "            GAMMA_GLUTAMYL_TRANSFERASE = extracted_Dictionary['GAMMA GLUTAMYL TRANSFERASE (GGT)']\n",
    "            Report_Dictionary[\"GAMMA_GLUTAMYL_TRANSFERASE\"] = GAMMA_GLUTAMYL_TRANSFERASE\n",
    "        else:\n",
    "            Report_Dictionary[\"GAMMA_GLUTAMYL_TRANSFERASE\"] = None\n",
    "\n",
    "\n",
    "        if 'ASPARTATE AMINOTRANSFERASE' in extracted_Dictionary.keys():\n",
    "            ASPARTATE_AMINOTRANSFERASE = extracted_Dictionary['ASPARTATE AMINOTRANSFERASE']\n",
    "            Report_Dictionary[\"ASPARTATE_AMINOTRANSFERASE\"] = ASPARTATE_AMINOTRANSFERASE\n",
    "        else:\n",
    "            Report_Dictionary[\"ASPARTATE_AMINOTRANSFERASE\"] = None\n",
    "\n",
    "        if 'ALANINE TRANSAMINASE (SGPT)' in extracted_Dictionary.keys():\n",
    "            ALANINE_TRANSAMINASE = extracted_Dictionary['ALANINE TRANSAMINASE (SGPT)']\n",
    "            Report_Dictionary[\"ALANINE_TRANSAMINASE\"] = ALANINE_TRANSAMINASE\n",
    "        else:\n",
    "            Report_Dictionary[\"ALANINE_TRANSAMINASE\"] = None\n",
    "\n",
    "        if 'PROTEIN TOTAL' in extracted_Dictionary.keys():\n",
    "            PROTEIN_TOTAL = extracted_Dictionary['PROTEIN TOTAL']\n",
    "            Report_Dictionary[\"PROTEIN_TOTAL\"] = PROTEIN_TOTAL\n",
    "        else:\n",
    "            Report_Dictionary[\"PROTEIN_TOTAL\"] = None\n",
    "\n",
    "        if 'ALBUMIN SERUM' in extracted_Dictionary.keys():\n",
    "            ALBUMIN_SERUM = extracted_Dictionary['ALBUMIN SERUM']\n",
    "            Report_Dictionary[\"ALBUMIN_SERUM\"] = ALBUMIN_SERUM\n",
    "        else:\n",
    "            Report_Dictionary[\"ALBUMIN_SERUM\"] = None\n",
    "\n",
    "        if 'SERUM ALB/GLOBULIN' in extracted_Dictionary.keys():\n",
    "            SERUM_ALB = extracted_Dictionary['SERUM ALB/GLOBULIN']\n",
    "            Report_Dictionary[\"SERUM_ALB\"] = SERUM_ALB\n",
    "        else:\n",
    "            Report_Dictionary[\"SERUM_ALB\"] = None\n",
    "\n",
    "        if 'SERUM GLOBULIN' in extracted_Dictionary.keys():\n",
    "            SERUM_GLOBULIN = extracted_Dictionary['SERUM GLOBULIN']\n",
    "            Report_Dictionary[\"SERUM_GLOBULIN\"] = SERUM_GLOBULIN\n",
    "        else:\n",
    "            Report_Dictionary[\"SERUM_GLOBULIN\"] = None\n",
    "\n",
    "        if 'TOTAL CHOLESTEROL' in extracted_Dictionary.keys():\n",
    "            TOTAL_CHOLESTEROL = extracted_Dictionary['TOTAL CHOLESTEROL']\n",
    "            Report_Dictionary[\"TOTAL_CHOLESTEROL\"] = TOTAL_CHOLESTEROL\n",
    "        else:\n",
    "            Report_Dictionary[\"TOTAL_CHOLESTEROL\"] = None\n",
    "\n",
    "        if 'HDL CHOLESTEROL DIRECT' in extracted_Dictionary.keys():\n",
    "            HDL_CHOLESTEROL_DIRECT = extracted_Dictionary['HDL CHOLESTEROL DIRECT']\n",
    "            Report_Dictionary[\"HDL_CHOLESTEROL_DIRECT\"] = HDL_CHOLESTEROL_DIRECT\n",
    "        else:\n",
    "            Report_Dictionary[\"HDL_CHOLESTEROL_DIRECT\"] = None\n",
    "\n",
    "        if 'LDL CHOLESTEROL DIRECT' in extracted_Dictionary.keys():\n",
    "            LDL_CHOLESTEROL_DIRECT = extracted_Dictionary['LDL CHOLESTEROL DIRECT']\n",
    "            Report_Dictionary[\"LDL_CHOLESTEROL_DIRECT\"] = LDL_CHOLESTEROL_DIRECT\n",
    "        else:\n",
    "            Report_Dictionary[\"LDL_CHOLESTEROL_DIRECT\"] = None\n",
    "\n",
    "        if 'TRIGLYCERIDES' in extracted_Dictionary.keys():\n",
    "            TRIGLYCERIDES = extracted_Dictionary['TRIGLYCERIDES']\n",
    "            Report_Dictionary[\"TRIGLYCERIDES\"] = TRIGLYCERIDES\n",
    "        else:\n",
    "            Report_Dictionary[\"TRIGLYCERIDES\"] = None\n",
    "\n",
    "        if 'TC/ HDL CHOLESTEROL' in extracted_Dictionary.keys():\n",
    "            TC_HDL_CHOLESTEROL_RATIO = extracted_Dictionary['TC/ HDL CHOLESTEROL']\n",
    "            Report_Dictionary[\"TC_HDL_CHOLESTEROL_RATIO\"] = TC_HDL_CHOLESTEROL_RATIO\n",
    "        else:\n",
    "            Report_Dictionary[\"TC_HDL_CHOLESTEROL_RATIO\"] = None\n",
    "\n",
    "        if 'LDL HDL' in extracted_Dictionary.keys():\n",
    "            LDL_HDL_RATIO = extracted_Dictionary['LDL HDL']\n",
    "            Report_Dictionary[\"LDL_HDL_RATIO\"] = LDL_HDL_RATIO\n",
    "        else:\n",
    "            Report_Dictionary[\"LDL_HDL_RATIO\"] = None\n",
    "\n",
    "\n",
    "        if 'VLDL CHOLESTEROL' in extracted_Dictionary.keys():\n",
    "            VLDL_CHOLESTEROL = extracted_Dictionary['VLDL CHOLESTEROL']\n",
    "            Report_Dictionary[\"VLDL_CHOLESTEROL\"] = VLDL_CHOLESTEROL\n",
    "        else:\n",
    "            Report_Dictionary[\"VLDL_CHOLESTEROL\"] = None\n",
    "\n",
    "        if 'NONHDL CHOLESTEROL' in extracted_Dictionary.keys():\n",
    "            NON_HDL_CHOLESTEROL = extracted_Dictionary['NONHDL CHOLESTEROL']\n",
    "            Report_Dictionary[\"NON_HDL_CHOLESTEROL\"] = NON_HDL_CHOLESTEROL\n",
    "        else:\n",
    "            Report_Dictionary[\"NON_HDL_CHOLESTEROL\"] = None\n",
    "\n",
    "\n",
    "        if 'TOTAL TRIIODOTHYRONINE (T)' in extracted_Dictionary.keys():\n",
    "            TOTAL_TRIIODOTHYRONINE = extracted_Dictionary['TOTAL TRIIODOTHYRONINE (T)']\n",
    "            Report_Dictionary[\"TOTAL_TRIIODOTHYRONINE\"] = TOTAL_TRIIODOTHYRONINE\n",
    "        else:\n",
    "            Report_Dictionary[\"TOTAL_TRIIODOTHYRONINE\"] = None\n",
    "\n",
    "        if 'TOTAL THYROXINE (T)' in extracted_Dictionary.keys():\n",
    "            TOTAL_THYROXINE = extracted_Dictionary['TOTAL THYROXINE (T)']\n",
    "            Report_Dictionary[\"TOTAL_THYROXINE\"] = TOTAL_THYROXINE\n",
    "        else:\n",
    "            Report_Dictionary[\"TOTAL_THYROXINE\"] = None\n",
    "\n",
    "        if 'THYROID STIMULATING HORMONE (TSH)' in extracted_Dictionary.keys():\n",
    "            THYROID_STIMULATING_HORMONE = extracted_Dictionary['THYROID STIMULATING HORMONE (TSH)']\n",
    "            Report_Dictionary[\"THYROID_STIMULATING_HORMONE\"] = THYROID_STIMULATING_HORMONE\n",
    "        else:\n",
    "            Report_Dictionary[\"THYROID_STIMULATING_HORMONE\"] = None\n",
    "\n",
    "        if 'BLOOD UREA NITROGEN (BUN)' in extracted_Dictionary.keys():\n",
    "            BLOOD_UREA_NITROGEN = extracted_Dictionary['BLOOD UREA NITROGEN (BUN)']\n",
    "            Report_Dictionary[\"BLOOD_UREA_NITROGEN\"] = BLOOD_UREA_NITROGEN\n",
    "        else:\n",
    "            Report_Dictionary[\"BLOOD_UREA_NITROGEN\"] = None\n",
    "\n",
    "        if 'CREATININE SERUM' in extracted_Dictionary.keys():\n",
    "            CREATININE_SERUM = extracted_Dictionary['CREATININE SERUM']\n",
    "            Report_Dictionary[\"CREATININE_SERUM\"] = CREATININE_SERUM\n",
    "        else:\n",
    "            Report_Dictionary[\"CREATININE_SERUM\"] = None\n",
    "\n",
    "        if 'BUN SRCREATININE' in extracted_Dictionary.keys():\n",
    "            BUN_SR_CREATININE_RATIO = extracted_Dictionary['BUN SRCREATININE']\n",
    "            Report_Dictionary[\"BUN_SR_CREATININE_RATIO\"] = BUN_SR_CREATININE_RATIO\n",
    "        else:\n",
    "            Report_Dictionary[\"BUN_SR_CREATININE_RATIO\"] = None\n",
    "\n",
    "        if 'CALCIUM' in extracted_Dictionary.keys():\n",
    "            CALCIUM = extracted_Dictionary['CALCIUM']\n",
    "            Report_Dictionary[\"CALCIUM\"] = CALCIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"CALCIUM\"] = None\n",
    "\n",
    "        if 'URIC ACID' in extracted_Dictionary.keys():\n",
    "            URIC_ACID = extracted_Dictionary['URIC ACID']\n",
    "            Report_Dictionary[\"URIC_ACID\"] = URIC_ACID\n",
    "        else:\n",
    "            Report_Dictionary[\"URIC_ACID\"] = None\n",
    "\n",
    "\n",
    "        if 'EST GLOMERULAR FILTRATION RATE' in extracted_Dictionary.keys():\n",
    "            EST_GLOMERULAR_FILTRATION_RATE = extracted_Dictionary['EST GLOMERULAR FILTRATION RATE']\n",
    "            Report_Dictionary[\"EST_GLOMERULAR_FILTRATION_RATE\"] = EST_GLOMERULAR_FILTRATION_RATE\n",
    "        else:\n",
    "            Report_Dictionary[\"EST_GLOMERULAR_FILTRATION_RATE\"] = None\n",
    "    print(Report_Dictionary)\n",
    "   \n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'h' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "\u001b[0;32m<ipython-input-30-244aa7266b3f>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0mh\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[0;31mNameError\u001b[0m: name 'h' is not defined"
     ]
    }
   ],
   "source": [
    "\n",
    "h"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 5.9 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n22 Jul 2019 00:06 ac tt?\\n122 Jul 2019 03:42 Oe\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n1 2107031728/A6750 .\\n\\nPage : 1 of 19\\n:M9261472\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 5.9 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n22 Jul 2019 00:06 ac tt?\\n122 Jul 2019 03:42 Oe\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n1 2107031728/A6750 .\\n\\nPage : 1 of 19\\n:M9261472\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 8.3 X103/uL  4.0-10.0\\nNEUTROPHILS 52.2 % 40-80\\nLYMPHOCYTE PERCENTAGE 42.8 % 20.0-40.0\\nMONOCYTES 3.3 % 0.0-10.0\\nEOSINOPHILS 1.3 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.2 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.33 X 103 / UL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 3.55 X 103 / pL 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.27 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.02 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.11 X 103 / UL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / UL 0.0-0.3\\nTOTAL RBC 4.83 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 9.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 37.2 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 77 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 19.5 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 25.3 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 54.5 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 19.7 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 10.8 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 10.2 fL 6.5-12\\nPLATELET COUNT 518 X 103 / pL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 25.6 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.53 % 0.19-0.39\\nRemarks: = Alert!!! RBCs:Moderate anisocytosis mild poikilocytosis. Predominantly normocytic normochromic with microcytes &\\n\\novalocytes.\\nPlease Correlate with clinical conditions.\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n122 Jul 2019 00:06\\n122 Jul 2019 03:42\\n\\n: EDTA\\n\\n: 2107031728/A6750\\n: M9261472\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 19\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 5.9 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n22 Jul 2019 00:06 ac tt?\\n122 Jul 2019 03:42 Oe\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n1 2107031728/A6750 .\\n\\nPage : 1 of 19\\n:M9261472\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 8.3 X103/uL  4.0-10.0\\nNEUTROPHILS 52.2 % 40-80\\nLYMPHOCYTE PERCENTAGE 42.8 % 20.0-40.0\\nMONOCYTES 3.3 % 0.0-10.0\\nEOSINOPHILS 1.3 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.2 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.33 X 103 / UL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 3.55 X 103 / pL 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.27 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.02 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.11 X 103 / UL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / UL 0.0-0.3\\nTOTAL RBC 4.83 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 9.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 37.2 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 77 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 19.5 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 25.3 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 54.5 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 19.7 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 10.8 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 10.2 fL 6.5-12\\nPLATELET COUNT 518 X 103 / pL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 25.6 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.53 % 0.19-0.39\\nRemarks: = Alert!!! RBCs:Moderate anisocytosis mild poikilocytosis. Predominantly normocytic normochromic with microcytes &\\n\\novalocytes.\\nPlease Correlate with clinical conditions.\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n122 Jul 2019 00:06\\n122 Jul 2019 03:42\\n\\n: EDTA\\n\\n: 2107031728/A6750\\n: M9261472\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 19\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.05 ug/l <5\\nCADMIUM ICP-MS 0.37 ug/l < 1.5\\nMERCURY ICP-MS 0.3 ug/l <5\\nLEAD ICP-MS 40.95 ug/l < 150\\nCHROMIUM ICP-MS 1.18 ug/l < 30\\nBARIUM ICP-MS 1.7 ug/l < 30\\nCOBALT ICP-MS 0.49 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.48 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 32.34 ug/l 8 - 38\\nANTIMONY ICP-MS 12.37 ug/l 0.10 - 18\\nTIN ICP-MS 0.31 ug/l <2\\nMOLYBDENUM ICP-MS 0.76 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.07 ug/l <4\\nVANADIUM ICP-MS 0.2 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.18 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 124.79 ug/l 60 - 340\\nALUMINIUM ICP-MS 9.32 ug/l < 30\\nNICKEL ICP-MS 3.64 ug/l <15\\nMANGANESE ICP-MS 12.55 ug/l 7.10 - 20\\n\\n \\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:06 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 03:42 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107031728/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261472 Page : 3 of 19\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 5.9 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n22 Jul 2019 00:06 ac tt?\\n122 Jul 2019 03:42 Oe\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n1 2107031728/A6750 .\\n\\nPage : 1 of 19\\n:M9261472\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 8.3 X103/uL  4.0-10.0\\nNEUTROPHILS 52.2 % 40-80\\nLYMPHOCYTE PERCENTAGE 42.8 % 20.0-40.0\\nMONOCYTES 3.3 % 0.0-10.0\\nEOSINOPHILS 1.3 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.2 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.33 X 103 / UL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 3.55 X 103 / pL 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.27 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.02 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.11 X 103 / UL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / UL 0.0-0.3\\nTOTAL RBC 4.83 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 9.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 37.2 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 77 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 19.5 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 25.3 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 54.5 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 19.7 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 10.8 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 10.2 fL 6.5-12\\nPLATELET COUNT 518 X 103 / pL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 25.6 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.53 % 0.19-0.39\\nRemarks: = Alert!!! RBCs:Moderate anisocytosis mild poikilocytosis. Predominantly normocytic normochromic with microcytes &\\n\\novalocytes.\\nPlease Correlate with clinical conditions.\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n122 Jul 2019 00:06\\n122 Jul 2019 03:42\\n\\n: EDTA\\n\\n: 2107031728/A6750\\n: M9261472\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 19\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.05 ug/l <5\\nCADMIUM ICP-MS 0.37 ug/l < 1.5\\nMERCURY ICP-MS 0.3 ug/l <5\\nLEAD ICP-MS 40.95 ug/l < 150\\nCHROMIUM ICP-MS 1.18 ug/l < 30\\nBARIUM ICP-MS 1.7 ug/l < 30\\nCOBALT ICP-MS 0.49 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.48 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 32.34 ug/l 8 - 38\\nANTIMONY ICP-MS 12.37 ug/l 0.10 - 18\\nTIN ICP-MS 0.31 ug/l <2\\nMOLYBDENUM ICP-MS 0.76 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.07 ug/l <4\\nVANADIUM ICP-MS 0.2 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.18 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 124.79 ug/l 60 - 340\\nALUMINIUM ICP-MS 9.32 ug/l < 30\\nNICKEL ICP-MS 3.64 ug/l <15\\nMANGANESE ICP-MS 12.55 ug/l 7.10 - 20\\n\\n \\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:06 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 03:42 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107031728/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261472 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 13.7 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : N7608083\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 5.9 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n22 Jul 2019 00:06 ac tt?\\n122 Jul 2019 03:42 Oe\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n1 2107031728/A6750 .\\n\\nPage : 1 of 19\\n:M9261472\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 8.3 X103/uL  4.0-10.0\\nNEUTROPHILS 52.2 % 40-80\\nLYMPHOCYTE PERCENTAGE 42.8 % 20.0-40.0\\nMONOCYTES 3.3 % 0.0-10.0\\nEOSINOPHILS 1.3 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.2 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.33 X 103 / UL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 3.55 X 103 / pL 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.27 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.02 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.11 X 103 / UL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / UL 0.0-0.3\\nTOTAL RBC 4.83 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 9.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 37.2 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 77 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 19.5 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 25.3 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 54.5 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 19.7 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 10.8 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 10.2 fL 6.5-12\\nPLATELET COUNT 518 X 103 / pL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 25.6 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.53 % 0.19-0.39\\nRemarks: = Alert!!! RBCs:Moderate anisocytosis mild poikilocytosis. Predominantly normocytic normochromic with microcytes &\\n\\novalocytes.\\nPlease Correlate with clinical conditions.\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n122 Jul 2019 00:06\\n122 Jul 2019 03:42\\n\\n: EDTA\\n\\n: 2107031728/A6750\\n: M9261472\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 19\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.05 ug/l <5\\nCADMIUM ICP-MS 0.37 ug/l < 1.5\\nMERCURY ICP-MS 0.3 ug/l <5\\nLEAD ICP-MS 40.95 ug/l < 150\\nCHROMIUM ICP-MS 1.18 ug/l < 30\\nBARIUM ICP-MS 1.7 ug/l < 30\\nCOBALT ICP-MS 0.49 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.48 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 32.34 ug/l 8 - 38\\nANTIMONY ICP-MS 12.37 ug/l 0.10 - 18\\nTIN ICP-MS 0.31 ug/l <2\\nMOLYBDENUM ICP-MS 0.76 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.07 ug/l <4\\nVANADIUM ICP-MS 0.2 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.18 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 124.79 ug/l 60 - 340\\nALUMINIUM ICP-MS 9.32 ug/l < 30\\nNICKEL ICP-MS 3.64 ug/l <15\\nMANGANESE ICP-MS 12.55 ug/l 7.10 - 20\\n\\n \\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:06 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 03:42 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107031728/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261472 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 13.7 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 0.98 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : N7608083\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 5.9 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n22 Jul 2019 00:06 ac tt?\\n122 Jul 2019 03:42 Oe\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n1 2107031728/A6750 .\\n\\nPage : 1 of 19\\n:M9261472\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 8.3 X103/uL  4.0-10.0\\nNEUTROPHILS 52.2 % 40-80\\nLYMPHOCYTE PERCENTAGE 42.8 % 20.0-40.0\\nMONOCYTES 3.3 % 0.0-10.0\\nEOSINOPHILS 1.3 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.2 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.33 X 103 / UL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 3.55 X 103 / pL 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.27 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.02 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.11 X 103 / UL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / UL 0.0-0.3\\nTOTAL RBC 4.83 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 9.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 37.2 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 77 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 19.5 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 25.3 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 54.5 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 19.7 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 10.8 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 10.2 fL 6.5-12\\nPLATELET COUNT 518 X 103 / pL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 25.6 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.53 % 0.19-0.39\\nRemarks: = Alert!!! RBCs:Moderate anisocytosis mild poikilocytosis. Predominantly normocytic normochromic with microcytes &\\n\\novalocytes.\\nPlease Correlate with clinical conditions.\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n122 Jul 2019 00:06\\n122 Jul 2019 03:42\\n\\n: EDTA\\n\\n: 2107031728/A6750\\n: M9261472\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 19\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.05 ug/l <5\\nCADMIUM ICP-MS 0.37 ug/l < 1.5\\nMERCURY ICP-MS 0.3 ug/l <5\\nLEAD ICP-MS 40.95 ug/l < 150\\nCHROMIUM ICP-MS 1.18 ug/l < 30\\nBARIUM ICP-MS 1.7 ug/l < 30\\nCOBALT ICP-MS 0.49 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.48 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 32.34 ug/l 8 - 38\\nANTIMONY ICP-MS 12.37 ug/l 0.10 - 18\\nTIN ICP-MS 0.31 ug/l <2\\nMOLYBDENUM ICP-MS 0.76 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.07 ug/l <4\\nVANADIUM ICP-MS 0.2 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.18 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 124.79 ug/l 60 - 340\\nALUMINIUM ICP-MS 9.32 ug/l < 30\\nNICKEL ICP-MS 3.64 ug/l <15\\nMANGANESE ICP-MS 12.55 ug/l 7.10 - 20\\n\\n \\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:06 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 03:42 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107031728/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261472 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 13.7 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 0.98 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 55.5 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : N7608083\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 5.9 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n22 Jul 2019 00:06 ac tt?\\n122 Jul 2019 03:42 Oe\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n1 2107031728/A6750 .\\n\\nPage : 1 of 19\\n:M9261472\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 8.3 X103/uL  4.0-10.0\\nNEUTROPHILS 52.2 % 40-80\\nLYMPHOCYTE PERCENTAGE 42.8 % 20.0-40.0\\nMONOCYTES 3.3 % 0.0-10.0\\nEOSINOPHILS 1.3 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.2 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.33 X 103 / UL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 3.55 X 103 / pL 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.27 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.02 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.11 X 103 / UL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / UL 0.0-0.3\\nTOTAL RBC 4.83 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 9.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 37.2 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 77 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 19.5 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 25.3 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 54.5 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 19.7 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 10.8 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 10.2 fL 6.5-12\\nPLATELET COUNT 518 X 103 / pL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 25.6 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.53 % 0.19-0.39\\nRemarks: = Alert!!! RBCs:Moderate anisocytosis mild poikilocytosis. Predominantly normocytic normochromic with microcytes &\\n\\novalocytes.\\nPlease Correlate with clinical conditions.\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n122 Jul 2019 00:06\\n122 Jul 2019 03:42\\n\\n: EDTA\\n\\n: 2107031728/A6750\\n: M9261472\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 19\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.05 ug/l <5\\nCADMIUM ICP-MS 0.37 ug/l < 1.5\\nMERCURY ICP-MS 0.3 ug/l <5\\nLEAD ICP-MS 40.95 ug/l < 150\\nCHROMIUM ICP-MS 1.18 ug/l < 30\\nBARIUM ICP-MS 1.7 ug/l < 30\\nCOBALT ICP-MS 0.49 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.48 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 32.34 ug/l 8 - 38\\nANTIMONY ICP-MS 12.37 ug/l 0.10 - 18\\nTIN ICP-MS 0.31 ug/l <2\\nMOLYBDENUM ICP-MS 0.76 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.07 ug/l <4\\nVANADIUM ICP-MS 0.2 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.18 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 124.79 ug/l 60 - 340\\nALUMINIUM ICP-MS 9.32 ug/l < 30\\nNICKEL ICP-MS 3.64 ug/l <15\\nMANGANESE ICP-MS 12.55 ug/l 7.10 - 20\\n\\n \\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:06 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 03:42 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107031728/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261472 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 13.7 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 0.98 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 55.5 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 18.77 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.L.A 211 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 7 of 19\\nBarcode :N7608083\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 5.9 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n22 Jul 2019 00:06 ac tt?\\n122 Jul 2019 03:42 Oe\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n1 2107031728/A6750 .\\n\\nPage : 1 of 19\\n:M9261472\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 8.3 X103/uL  4.0-10.0\\nNEUTROPHILS 52.2 % 40-80\\nLYMPHOCYTE PERCENTAGE 42.8 % 20.0-40.0\\nMONOCYTES 3.3 % 0.0-10.0\\nEOSINOPHILS 1.3 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.2 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.33 X 103 / UL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 3.55 X 103 / pL 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.27 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.02 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.11 X 103 / UL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / UL 0.0-0.3\\nTOTAL RBC 4.83 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 9.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 37.2 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 77 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 19.5 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 25.3 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 54.5 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 19.7 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 10.8 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 10.2 fL 6.5-12\\nPLATELET COUNT 518 X 103 / pL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 25.6 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.53 % 0.19-0.39\\nRemarks: = Alert!!! RBCs:Moderate anisocytosis mild poikilocytosis. Predominantly normocytic normochromic with microcytes &\\n\\novalocytes.\\nPlease Correlate with clinical conditions.\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n122 Jul 2019 00:06\\n122 Jul 2019 03:42\\n\\n: EDTA\\n\\n: 2107031728/A6750\\n: M9261472\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 19\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.05 ug/l <5\\nCADMIUM ICP-MS 0.37 ug/l < 1.5\\nMERCURY ICP-MS 0.3 ug/l <5\\nLEAD ICP-MS 40.95 ug/l < 150\\nCHROMIUM ICP-MS 1.18 ug/l < 30\\nBARIUM ICP-MS 1.7 ug/l < 30\\nCOBALT ICP-MS 0.49 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.48 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 32.34 ug/l 8 - 38\\nANTIMONY ICP-MS 12.37 ug/l 0.10 - 18\\nTIN ICP-MS 0.31 ug/l <2\\nMOLYBDENUM ICP-MS 0.76 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.07 ug/l <4\\nVANADIUM ICP-MS 0.2 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.18 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 124.79 ug/l 60 - 340\\nALUMINIUM ICP-MS 9.32 ug/l < 30\\nNICKEL ICP-MS 3.64 ug/l <15\\nMANGANESE ICP-MS 12.55 ug/l 7.10 - 20\\n\\n \\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:06 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 03:42 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107031728/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261472 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 13.7 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 0.98 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 55.5 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 18.77 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.L.A 211 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 7 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 115 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 80 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.7 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 8 of 19\\nBarcode :N7608083\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 5.9 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n22 Jul 2019 00:06 ac tt?\\n122 Jul 2019 03:42 Oe\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n1 2107031728/A6750 .\\n\\nPage : 1 of 19\\n:M9261472\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 8.3 X103/uL  4.0-10.0\\nNEUTROPHILS 52.2 % 40-80\\nLYMPHOCYTE PERCENTAGE 42.8 % 20.0-40.0\\nMONOCYTES 3.3 % 0.0-10.0\\nEOSINOPHILS 1.3 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.2 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.33 X 103 / UL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 3.55 X 103 / pL 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.27 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.02 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.11 X 103 / UL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / UL 0.0-0.3\\nTOTAL RBC 4.83 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 9.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 37.2 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 77 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 19.5 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 25.3 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 54.5 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 19.7 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 10.8 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 10.2 fL 6.5-12\\nPLATELET COUNT 518 X 103 / pL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 25.6 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.53 % 0.19-0.39\\nRemarks: = Alert!!! RBCs:Moderate anisocytosis mild poikilocytosis. Predominantly normocytic normochromic with microcytes &\\n\\novalocytes.\\nPlease Correlate with clinical conditions.\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n122 Jul 2019 00:06\\n122 Jul 2019 03:42\\n\\n: EDTA\\n\\n: 2107031728/A6750\\n: M9261472\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 19\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.05 ug/l <5\\nCADMIUM ICP-MS 0.37 ug/l < 1.5\\nMERCURY ICP-MS 0.3 ug/l <5\\nLEAD ICP-MS 40.95 ug/l < 150\\nCHROMIUM ICP-MS 1.18 ug/l < 30\\nBARIUM ICP-MS 1.7 ug/l < 30\\nCOBALT ICP-MS 0.49 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.48 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 32.34 ug/l 8 - 38\\nANTIMONY ICP-MS 12.37 ug/l 0.10 - 18\\nTIN ICP-MS 0.31 ug/l <2\\nMOLYBDENUM ICP-MS 0.76 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.07 ug/l <4\\nVANADIUM ICP-MS 0.2 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.18 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 124.79 ug/l 60 - 340\\nALUMINIUM ICP-MS 9.32 ug/l < 30\\nNICKEL ICP-MS 3.64 ug/l <15\\nMANGANESE ICP-MS 12.55 ug/l 7.10 - 20\\n\\n \\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:06 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 03:42 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107031728/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261472 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 13.7 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 0.98 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 55.5 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 18.77 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.L.A 211 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 7 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 115 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 80 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.7 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 8 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 6.2 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : N7608083\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 5.9 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n22 Jul 2019 00:06 ac tt?\\n122 Jul 2019 03:42 Oe\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n1 2107031728/A6750 .\\n\\nPage : 1 of 19\\n:M9261472\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 8.3 X103/uL  4.0-10.0\\nNEUTROPHILS 52.2 % 40-80\\nLYMPHOCYTE PERCENTAGE 42.8 % 20.0-40.0\\nMONOCYTES 3.3 % 0.0-10.0\\nEOSINOPHILS 1.3 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.2 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.33 X 103 / UL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 3.55 X 103 / pL 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.27 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.02 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.11 X 103 / UL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / UL 0.0-0.3\\nTOTAL RBC 4.83 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 9.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 37.2 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 77 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 19.5 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 25.3 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 54.5 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 19.7 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 10.8 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 10.2 fL 6.5-12\\nPLATELET COUNT 518 X 103 / pL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 25.6 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.53 % 0.19-0.39\\nRemarks: = Alert!!! RBCs:Moderate anisocytosis mild poikilocytosis. Predominantly normocytic normochromic with microcytes &\\n\\novalocytes.\\nPlease Correlate with clinical conditions.\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n122 Jul 2019 00:06\\n122 Jul 2019 03:42\\n\\n: EDTA\\n\\n: 2107031728/A6750\\n: M9261472\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 19\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.05 ug/l <5\\nCADMIUM ICP-MS 0.37 ug/l < 1.5\\nMERCURY ICP-MS 0.3 ug/l <5\\nLEAD ICP-MS 40.95 ug/l < 150\\nCHROMIUM ICP-MS 1.18 ug/l < 30\\nBARIUM ICP-MS 1.7 ug/l < 30\\nCOBALT ICP-MS 0.49 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.48 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 32.34 ug/l 8 - 38\\nANTIMONY ICP-MS 12.37 ug/l 0.10 - 18\\nTIN ICP-MS 0.31 ug/l <2\\nMOLYBDENUM ICP-MS 0.76 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.07 ug/l <4\\nVANADIUM ICP-MS 0.2 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.18 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 124.79 ug/l 60 - 340\\nALUMINIUM ICP-MS 9.32 ug/l < 30\\nNICKEL ICP-MS 3.64 ug/l <15\\nMANGANESE ICP-MS 12.55 ug/l 7.10 - 20\\n\\n \\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:06 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 03:42 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107031728/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261472 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 13.7 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 0.98 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 55.5 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 18.77 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.L.A 211 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 7 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 115 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 80 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.7 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 8 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 6.2 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM COPPER PHOTOMETRY 119.8 yg/dL\\n\\nReference Range :-\\n\\nMALE : 63.5 - 150\\nFEMALE : 80 - 155\\n\\nCLINICAL SIGNIFICANCE\\n\\nCOPPER IS AN IMPORTANT TRACE ELEMENT AND A COMPONENT OF NUMEROUS ENZYMES AND PROTEINS INVOLVED\\nIN ENERGY PRODUCTION, CONNECTIVE TISSUE FORMATION, MELANIN SYNTHESIS, IRON METABOLISM,\\nDEVELOPMENT OF CENTRAL NERVOUS SYSTEM, ANGIOGENESIS AS WELL AS AN ANTIOXIDANT.\\n\\nDEFICIENCY CAN CAUSE - MALNOURISHMENT, CARDIOVASCULAR DISEASE, ANEMIA & NEUROPATHY. TOXICITY MAY\\nBE MANIFESTED AS ACUTE RENAL FAILURE, GASTROENTERITIS & CHRONIC LIVER DISEASE.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE: 948-952.\\n\\nPlease correlate with clinical conditions.\\nMethod:- 3,5-DIBR-PAESA\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 10 of 19\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 5.9 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n22 Jul 2019 00:06 ac tt?\\n122 Jul 2019 03:42 Oe\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n1 2107031728/A6750 .\\n\\nPage : 1 of 19\\n:M9261472\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 8.3 X103/uL  4.0-10.0\\nNEUTROPHILS 52.2 % 40-80\\nLYMPHOCYTE PERCENTAGE 42.8 % 20.0-40.0\\nMONOCYTES 3.3 % 0.0-10.0\\nEOSINOPHILS 1.3 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.2 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.33 X 103 / UL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 3.55 X 103 / pL 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.27 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.02 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.11 X 103 / UL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / UL 0.0-0.3\\nTOTAL RBC 4.83 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 9.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 37.2 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 77 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 19.5 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 25.3 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 54.5 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 19.7 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 10.8 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 10.2 fL 6.5-12\\nPLATELET COUNT 518 X 103 / pL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 25.6 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.53 % 0.19-0.39\\nRemarks: = Alert!!! RBCs:Moderate anisocytosis mild poikilocytosis. Predominantly normocytic normochromic with microcytes &\\n\\novalocytes.\\nPlease Correlate with clinical conditions.\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n122 Jul 2019 00:06\\n122 Jul 2019 03:42\\n\\n: EDTA\\n\\n: 2107031728/A6750\\n: M9261472\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 19\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.05 ug/l <5\\nCADMIUM ICP-MS 0.37 ug/l < 1.5\\nMERCURY ICP-MS 0.3 ug/l <5\\nLEAD ICP-MS 40.95 ug/l < 150\\nCHROMIUM ICP-MS 1.18 ug/l < 30\\nBARIUM ICP-MS 1.7 ug/l < 30\\nCOBALT ICP-MS 0.49 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.48 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 32.34 ug/l 8 - 38\\nANTIMONY ICP-MS 12.37 ug/l 0.10 - 18\\nTIN ICP-MS 0.31 ug/l <2\\nMOLYBDENUM ICP-MS 0.76 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.07 ug/l <4\\nVANADIUM ICP-MS 0.2 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.18 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 124.79 ug/l 60 - 340\\nALUMINIUM ICP-MS 9.32 ug/l < 30\\nNICKEL ICP-MS 3.64 ug/l <15\\nMANGANESE ICP-MS 12.55 ug/l 7.10 - 20\\n\\n \\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:06 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 03:42 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107031728/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261472 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 13.7 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 0.98 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 55.5 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 18.77 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.L.A 211 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 7 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 115 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 80 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.7 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 8 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 6.2 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM COPPER PHOTOMETRY 119.8 yg/dL\\n\\nReference Range :-\\n\\nMALE : 63.5 - 150\\nFEMALE : 80 - 155\\n\\nCLINICAL SIGNIFICANCE\\n\\nCOPPER IS AN IMPORTANT TRACE ELEMENT AND A COMPONENT OF NUMEROUS ENZYMES AND PROTEINS INVOLVED\\nIN ENERGY PRODUCTION, CONNECTIVE TISSUE FORMATION, MELANIN SYNTHESIS, IRON METABOLISM,\\nDEVELOPMENT OF CENTRAL NERVOUS SYSTEM, ANGIOGENESIS AS WELL AS AN ANTIOXIDANT.\\n\\nDEFICIENCY CAN CAUSE - MALNOURISHMENT, CARDIOVASCULAR DISEASE, ANEMIA & NEUROPATHY. TOXICITY MAY\\nBE MANIFESTED AS ACUTE RENAL FAILURE, GASTROENTERITIS & CHRONIC LIVER DISEASE.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE: 948-952.\\n\\nPlease correlate with clinical conditions.\\nMethod:- 3,5-DIBR-PAESA\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 10 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM ZINC PHOTOMETRY 75.2 yg/dL\\n\\nReference Range :-\\n\\n52 - 286\\n\\nCLINICAL SIGNIFICANCE\\nZINC IS ONE OF THE ESSENTIAL TRACE ELEMENTS IN THE BODY. ITS METALLOENZYMES PLAY A KEY ROLE IN\\nPROTEIN AND NUCLEIC ACID SYNTHESIS, GENE EXPRESSION, WOUND HEALING, AS AN ANTIOXIDANT, ETC.\\n\\nDEFICIENCY CAN CAUSE - POOR WOUND HEALING, GASTROENTERITIS, IMPAIRED SPERMATOGENESIS, ALZHEIMER’S\\nDISEASE, ETC. TOXICITY MAY BE MANIFESTED AS PANCREATITIS, GASTRIC ULCER, ANEMIA, PULMONARY FIBROSIS.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE:960-965.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- NITRO - PAPS\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 11 of 19\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 5.9 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n22 Jul 2019 00:06 ac tt?\\n122 Jul 2019 03:42 Oe\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n1 2107031728/A6750 .\\n\\nPage : 1 of 19\\n:M9261472\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 8.3 X103/uL  4.0-10.0\\nNEUTROPHILS 52.2 % 40-80\\nLYMPHOCYTE PERCENTAGE 42.8 % 20.0-40.0\\nMONOCYTES 3.3 % 0.0-10.0\\nEOSINOPHILS 1.3 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.2 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.33 X 103 / UL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 3.55 X 103 / pL 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.27 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.02 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.11 X 103 / UL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / UL 0.0-0.3\\nTOTAL RBC 4.83 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 9.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 37.2 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 77 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 19.5 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 25.3 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 54.5 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 19.7 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 10.8 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 10.2 fL 6.5-12\\nPLATELET COUNT 518 X 103 / pL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 25.6 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.53 % 0.19-0.39\\nRemarks: = Alert!!! RBCs:Moderate anisocytosis mild poikilocytosis. Predominantly normocytic normochromic with microcytes &\\n\\novalocytes.\\nPlease Correlate with clinical conditions.\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n122 Jul 2019 00:06\\n122 Jul 2019 03:42\\n\\n: EDTA\\n\\n: 2107031728/A6750\\n: M9261472\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 19\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.05 ug/l <5\\nCADMIUM ICP-MS 0.37 ug/l < 1.5\\nMERCURY ICP-MS 0.3 ug/l <5\\nLEAD ICP-MS 40.95 ug/l < 150\\nCHROMIUM ICP-MS 1.18 ug/l < 30\\nBARIUM ICP-MS 1.7 ug/l < 30\\nCOBALT ICP-MS 0.49 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.48 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 32.34 ug/l 8 - 38\\nANTIMONY ICP-MS 12.37 ug/l 0.10 - 18\\nTIN ICP-MS 0.31 ug/l <2\\nMOLYBDENUM ICP-MS 0.76 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.07 ug/l <4\\nVANADIUM ICP-MS 0.2 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.18 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 124.79 ug/l 60 - 340\\nALUMINIUM ICP-MS 9.32 ug/l < 30\\nNICKEL ICP-MS 3.64 ug/l <15\\nMANGANESE ICP-MS 12.55 ug/l 7.10 - 20\\n\\n \\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:06 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 03:42 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107031728/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261472 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 13.7 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 0.98 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 55.5 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 18.77 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.L.A 211 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 7 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 115 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 80 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.7 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 8 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 6.2 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM COPPER PHOTOMETRY 119.8 yg/dL\\n\\nReference Range :-\\n\\nMALE : 63.5 - 150\\nFEMALE : 80 - 155\\n\\nCLINICAL SIGNIFICANCE\\n\\nCOPPER IS AN IMPORTANT TRACE ELEMENT AND A COMPONENT OF NUMEROUS ENZYMES AND PROTEINS INVOLVED\\nIN ENERGY PRODUCTION, CONNECTIVE TISSUE FORMATION, MELANIN SYNTHESIS, IRON METABOLISM,\\nDEVELOPMENT OF CENTRAL NERVOUS SYSTEM, ANGIOGENESIS AS WELL AS AN ANTIOXIDANT.\\n\\nDEFICIENCY CAN CAUSE - MALNOURISHMENT, CARDIOVASCULAR DISEASE, ANEMIA & NEUROPATHY. TOXICITY MAY\\nBE MANIFESTED AS ACUTE RENAL FAILURE, GASTROENTERITIS & CHRONIC LIVER DISEASE.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE: 948-952.\\n\\nPlease correlate with clinical conditions.\\nMethod:- 3,5-DIBR-PAESA\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 10 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM ZINC PHOTOMETRY 75.2 yg/dL\\n\\nReference Range :-\\n\\n52 - 286\\n\\nCLINICAL SIGNIFICANCE\\nZINC IS ONE OF THE ESSENTIAL TRACE ELEMENTS IN THE BODY. ITS METALLOENZYMES PLAY A KEY ROLE IN\\nPROTEIN AND NUCLEIC ACID SYNTHESIS, GENE EXPRESSION, WOUND HEALING, AS AN ANTIOXIDANT, ETC.\\n\\nDEFICIENCY CAN CAUSE - POOR WOUND HEALING, GASTROENTERITIS, IMPAIRED SPERMATOGENESIS, ALZHEIMER’S\\nDISEASE, ETC. TOXICITY MAY BE MANIFESTED AS PANCREATITIS, GASTRIC ULCER, ANEMIA, PULMONARY FIBROSIS.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE:960-965.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- NITRO - PAPS\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 11 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nTESTOSTERONE C.L.I.A 16.02 ng/dL\\n\\nReference Range :-\\n\\nAdult Male\\n\\n21-49Yrs: 164.94 - 753.38\\n50 - 89 Yrs: 86.49 - 788.22\\nAdult Female\\n\\nPre-Menopause : 12.09 - 59.46\\nPost-Menopause: < 7.00 - 48.93\\nBoys\\n\\n2-10 Years : < 7.00 - 25.91\\n\\n11 Years : < 7.00 - 341.53\\n\\n12 Years : < 7.00 - 562.59\\n\\n13 Years : 9.34 - 562.93\\n\\n14 Years : 23.28 - 742.46\\n\\n15 Years : 144.15 - 841.44\\n\\n16-21 Years : 118.22 - 948.56\\n\\nGirls\\n\\n2-10 Years: < 7.00 - 108.30\\n11-15 Years : < 7.00- 48.40\\n16-21 Years : 17.55- 50.41\\n\\nClinical Significance:\\n\\nClinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males. Major\\ncauses of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,\\nHypopituitarism some types of liver and kidney diseases and critical illness.\\n\\nSpecifications: Precision: Intra assay (%CV): 8.5 %, Inter assay (%CV): 12.6%; Sensitivity: 7 ng/dL.\\nExternal quality control program participation:\\n\\nCollege of American pathologists: Ligand assay (special) survey; cap number: 7193855-01\\n\\nPlease correlate with clinical conditions.\\nMethod:- FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 12 of 19\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 5.9 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n22 Jul 2019 00:06 ac tt?\\n122 Jul 2019 03:42 Oe\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n1 2107031728/A6750 .\\n\\nPage : 1 of 19\\n:M9261472\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 8.3 X103/uL  4.0-10.0\\nNEUTROPHILS 52.2 % 40-80\\nLYMPHOCYTE PERCENTAGE 42.8 % 20.0-40.0\\nMONOCYTES 3.3 % 0.0-10.0\\nEOSINOPHILS 1.3 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.2 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.33 X 103 / UL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 3.55 X 103 / pL 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.27 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.02 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.11 X 103 / UL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / UL 0.0-0.3\\nTOTAL RBC 4.83 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 9.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 37.2 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 77 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 19.5 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 25.3 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 54.5 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 19.7 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 10.8 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 10.2 fL 6.5-12\\nPLATELET COUNT 518 X 103 / pL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 25.6 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.53 % 0.19-0.39\\nRemarks: = Alert!!! RBCs:Moderate anisocytosis mild poikilocytosis. Predominantly normocytic normochromic with microcytes &\\n\\novalocytes.\\nPlease Correlate with clinical conditions.\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n122 Jul 2019 00:06\\n122 Jul 2019 03:42\\n\\n: EDTA\\n\\n: 2107031728/A6750\\n: M9261472\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 19\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.05 ug/l <5\\nCADMIUM ICP-MS 0.37 ug/l < 1.5\\nMERCURY ICP-MS 0.3 ug/l <5\\nLEAD ICP-MS 40.95 ug/l < 150\\nCHROMIUM ICP-MS 1.18 ug/l < 30\\nBARIUM ICP-MS 1.7 ug/l < 30\\nCOBALT ICP-MS 0.49 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.48 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 32.34 ug/l 8 - 38\\nANTIMONY ICP-MS 12.37 ug/l 0.10 - 18\\nTIN ICP-MS 0.31 ug/l <2\\nMOLYBDENUM ICP-MS 0.76 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.07 ug/l <4\\nVANADIUM ICP-MS 0.2 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.18 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 124.79 ug/l 60 - 340\\nALUMINIUM ICP-MS 9.32 ug/l < 30\\nNICKEL ICP-MS 3.64 ug/l <15\\nMANGANESE ICP-MS 12.55 ug/l 7.10 - 20\\n\\n \\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:06 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 03:42 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107031728/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261472 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 13.7 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 0.98 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 55.5 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 18.77 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.L.A 211 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 7 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 115 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 80 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.7 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 8 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 6.2 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM COPPER PHOTOMETRY 119.8 yg/dL\\n\\nReference Range :-\\n\\nMALE : 63.5 - 150\\nFEMALE : 80 - 155\\n\\nCLINICAL SIGNIFICANCE\\n\\nCOPPER IS AN IMPORTANT TRACE ELEMENT AND A COMPONENT OF NUMEROUS ENZYMES AND PROTEINS INVOLVED\\nIN ENERGY PRODUCTION, CONNECTIVE TISSUE FORMATION, MELANIN SYNTHESIS, IRON METABOLISM,\\nDEVELOPMENT OF CENTRAL NERVOUS SYSTEM, ANGIOGENESIS AS WELL AS AN ANTIOXIDANT.\\n\\nDEFICIENCY CAN CAUSE - MALNOURISHMENT, CARDIOVASCULAR DISEASE, ANEMIA & NEUROPATHY. TOXICITY MAY\\nBE MANIFESTED AS ACUTE RENAL FAILURE, GASTROENTERITIS & CHRONIC LIVER DISEASE.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE: 948-952.\\n\\nPlease correlate with clinical conditions.\\nMethod:- 3,5-DIBR-PAESA\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 10 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM ZINC PHOTOMETRY 75.2 yg/dL\\n\\nReference Range :-\\n\\n52 - 286\\n\\nCLINICAL SIGNIFICANCE\\nZINC IS ONE OF THE ESSENTIAL TRACE ELEMENTS IN THE BODY. ITS METALLOENZYMES PLAY A KEY ROLE IN\\nPROTEIN AND NUCLEIC ACID SYNTHESIS, GENE EXPRESSION, WOUND HEALING, AS AN ANTIOXIDANT, ETC.\\n\\nDEFICIENCY CAN CAUSE - POOR WOUND HEALING, GASTROENTERITIS, IMPAIRED SPERMATOGENESIS, ALZHEIMER’S\\nDISEASE, ETC. TOXICITY MAY BE MANIFESTED AS PANCREATITIS, GASTRIC ULCER, ANEMIA, PULMONARY FIBROSIS.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE:960-965.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- NITRO - PAPS\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 11 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nTESTOSTERONE C.L.I.A 16.02 ng/dL\\n\\nReference Range :-\\n\\nAdult Male\\n\\n21-49Yrs: 164.94 - 753.38\\n50 - 89 Yrs: 86.49 - 788.22\\nAdult Female\\n\\nPre-Menopause : 12.09 - 59.46\\nPost-Menopause: < 7.00 - 48.93\\nBoys\\n\\n2-10 Years : < 7.00 - 25.91\\n\\n11 Years : < 7.00 - 341.53\\n\\n12 Years : < 7.00 - 562.59\\n\\n13 Years : 9.34 - 562.93\\n\\n14 Years : 23.28 - 742.46\\n\\n15 Years : 144.15 - 841.44\\n\\n16-21 Years : 118.22 - 948.56\\n\\nGirls\\n\\n2-10 Years: < 7.00 - 108.30\\n11-15 Years : < 7.00- 48.40\\n16-21 Years : 17.55- 50.41\\n\\nClinical Significance:\\n\\nClinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males. Major\\ncauses of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,\\nHypopituitarism some types of liver and kidney diseases and critical illness.\\n\\nSpecifications: Precision: Intra assay (%CV): 8.5 %, Inter assay (%CV): 12.6%; Sensitivity: 7 ng/dL.\\nExternal quality control program participation:\\n\\nCollege of American pathologists: Ligand assay (special) survey; cap number: 7193855-01\\n\\nPlease correlate with clinical conditions.\\nMethod:- FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 12 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n    \\n\\ncay Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nIRON PHOTOMETRY 20.2 Hg/dl\\n\\nReference Range :\\nMale : 65-175\\nFemale : 50 - 170\\n\\nMethod : _FERROZINE METHOD WITHOUT DEPROTEINIZATION\\n\\nTOTAL IRON BINDING CAPACITY (TIBC)\\n\\nReference Range :\\n\\nPHOTOMETRY 439 g/dl\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n% TRANSFERRIN SATURATION\\n\\nReference Range :\\n13-45\\n\\nCALCULATED 4.6 %\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n121 Jul 2019 06:00\\n\\n22 Jul 2019 00:19 ac tt?\\n122 Jul 2019 12:44 Oe 2\\n\\n# SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032769/A6750 Page : 13 of 19\\n: N7608083\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 5.9 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n22 Jul 2019 00:06 ac tt?\\n122 Jul 2019 03:42 Oe\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n1 2107031728/A6750 .\\n\\nPage : 1 of 19\\n:M9261472\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 8.3 X103/uL  4.0-10.0\\nNEUTROPHILS 52.2 % 40-80\\nLYMPHOCYTE PERCENTAGE 42.8 % 20.0-40.0\\nMONOCYTES 3.3 % 0.0-10.0\\nEOSINOPHILS 1.3 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.2 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.33 X 103 / UL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 3.55 X 103 / pL 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.27 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.02 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.11 X 103 / UL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / UL 0.0-0.3\\nTOTAL RBC 4.83 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 9.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 37.2 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 77 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 19.5 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 25.3 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 54.5 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 19.7 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 10.8 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 10.2 fL 6.5-12\\nPLATELET COUNT 518 X 103 / pL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 25.6 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.53 % 0.19-0.39\\nRemarks: = Alert!!! RBCs:Moderate anisocytosis mild poikilocytosis. Predominantly normocytic normochromic with microcytes &\\n\\novalocytes.\\nPlease Correlate with clinical conditions.\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n122 Jul 2019 00:06\\n122 Jul 2019 03:42\\n\\n: EDTA\\n\\n: 2107031728/A6750\\n: M9261472\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 19\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.05 ug/l <5\\nCADMIUM ICP-MS 0.37 ug/l < 1.5\\nMERCURY ICP-MS 0.3 ug/l <5\\nLEAD ICP-MS 40.95 ug/l < 150\\nCHROMIUM ICP-MS 1.18 ug/l < 30\\nBARIUM ICP-MS 1.7 ug/l < 30\\nCOBALT ICP-MS 0.49 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.48 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 32.34 ug/l 8 - 38\\nANTIMONY ICP-MS 12.37 ug/l 0.10 - 18\\nTIN ICP-MS 0.31 ug/l <2\\nMOLYBDENUM ICP-MS 0.76 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.07 ug/l <4\\nVANADIUM ICP-MS 0.2 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.18 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 124.79 ug/l 60 - 340\\nALUMINIUM ICP-MS 9.32 ug/l < 30\\nNICKEL ICP-MS 3.64 ug/l <15\\nMANGANESE ICP-MS 12.55 ug/l 7.10 - 20\\n\\n \\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:06 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 03:42 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107031728/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261472 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 13.7 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 0.98 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 55.5 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 18.77 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.L.A 211 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 7 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 115 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 80 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.7 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 8 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 6.2 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM COPPER PHOTOMETRY 119.8 yg/dL\\n\\nReference Range :-\\n\\nMALE : 63.5 - 150\\nFEMALE : 80 - 155\\n\\nCLINICAL SIGNIFICANCE\\n\\nCOPPER IS AN IMPORTANT TRACE ELEMENT AND A COMPONENT OF NUMEROUS ENZYMES AND PROTEINS INVOLVED\\nIN ENERGY PRODUCTION, CONNECTIVE TISSUE FORMATION, MELANIN SYNTHESIS, IRON METABOLISM,\\nDEVELOPMENT OF CENTRAL NERVOUS SYSTEM, ANGIOGENESIS AS WELL AS AN ANTIOXIDANT.\\n\\nDEFICIENCY CAN CAUSE - MALNOURISHMENT, CARDIOVASCULAR DISEASE, ANEMIA & NEUROPATHY. TOXICITY MAY\\nBE MANIFESTED AS ACUTE RENAL FAILURE, GASTROENTERITIS & CHRONIC LIVER DISEASE.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE: 948-952.\\n\\nPlease correlate with clinical conditions.\\nMethod:- 3,5-DIBR-PAESA\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 10 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM ZINC PHOTOMETRY 75.2 yg/dL\\n\\nReference Range :-\\n\\n52 - 286\\n\\nCLINICAL SIGNIFICANCE\\nZINC IS ONE OF THE ESSENTIAL TRACE ELEMENTS IN THE BODY. ITS METALLOENZYMES PLAY A KEY ROLE IN\\nPROTEIN AND NUCLEIC ACID SYNTHESIS, GENE EXPRESSION, WOUND HEALING, AS AN ANTIOXIDANT, ETC.\\n\\nDEFICIENCY CAN CAUSE - POOR WOUND HEALING, GASTROENTERITIS, IMPAIRED SPERMATOGENESIS, ALZHEIMER’S\\nDISEASE, ETC. TOXICITY MAY BE MANIFESTED AS PANCREATITIS, GASTRIC ULCER, ANEMIA, PULMONARY FIBROSIS.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE:960-965.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- NITRO - PAPS\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 11 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nTESTOSTERONE C.L.I.A 16.02 ng/dL\\n\\nReference Range :-\\n\\nAdult Male\\n\\n21-49Yrs: 164.94 - 753.38\\n50 - 89 Yrs: 86.49 - 788.22\\nAdult Female\\n\\nPre-Menopause : 12.09 - 59.46\\nPost-Menopause: < 7.00 - 48.93\\nBoys\\n\\n2-10 Years : < 7.00 - 25.91\\n\\n11 Years : < 7.00 - 341.53\\n\\n12 Years : < 7.00 - 562.59\\n\\n13 Years : 9.34 - 562.93\\n\\n14 Years : 23.28 - 742.46\\n\\n15 Years : 144.15 - 841.44\\n\\n16-21 Years : 118.22 - 948.56\\n\\nGirls\\n\\n2-10 Years: < 7.00 - 108.30\\n11-15 Years : < 7.00- 48.40\\n16-21 Years : 17.55- 50.41\\n\\nClinical Significance:\\n\\nClinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males. Major\\ncauses of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,\\nHypopituitarism some types of liver and kidney diseases and critical illness.\\n\\nSpecifications: Precision: Intra assay (%CV): 8.5 %, Inter assay (%CV): 12.6%; Sensitivity: 7 ng/dL.\\nExternal quality control program participation:\\n\\nCollege of American pathologists: Ligand assay (special) survey; cap number: 7193855-01\\n\\nPlease correlate with clinical conditions.\\nMethod:- FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 12 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n    \\n\\ncay Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nIRON PHOTOMETRY 20.2 Hg/dl\\n\\nReference Range :\\nMale : 65-175\\nFemale : 50 - 170\\n\\nMethod : _FERROZINE METHOD WITHOUT DEPROTEINIZATION\\n\\nTOTAL IRON BINDING CAPACITY (TIBC)\\n\\nReference Range :\\n\\nPHOTOMETRY 439 g/dl\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n% TRANSFERRIN SATURATION\\n\\nReference Range :\\n13-45\\n\\nCALCULATED 4.6 %\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n121 Jul 2019 06:00\\n\\n22 Jul 2019 00:19 ac tt?\\n122 Jul 2019 12:44 Oe 2\\n\\n# SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032769/A6750 Page : 13 of 19\\n: N7608083\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 71.9 U/L 45 - 129\\nBILIRUBIN -DIRECT PHOTOMETRY 0.11 mg/dl < 0.3\\nBILIRUBIN - TOTAL PHOTOMETRY 0.32 mg/dl 0.3-1.2\\nBILIRUBIN (INDIRECT) CALCULATED 0.21 mg/dl 0-0.9\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 12.3 u/l < 38\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 12 u/l < 31\\n\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 11.7 u/l < 34\\n\\nPROTEIN - TOTAL PHOTOMETRY 7.4 am/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 4.1 gm/dl 3.2-4.8\\nSERUM GLOBULIN PHOTOMETRY 3.3 gm/dL 2.5-3.4\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.24 Ratio 0.9 -2\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - Modified IFCC method\\n\\nBILD - Vanadate Oxidation\\n\\nBILT - Vanadate Oxidation\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - Modified IFCC method\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:19 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107032769/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7608083 Page : 14 of 19\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 5.9 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n22 Jul 2019 00:06 ac tt?\\n122 Jul 2019 03:42 Oe\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n1 2107031728/A6750 .\\n\\nPage : 1 of 19\\n:M9261472\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 8.3 X103/uL  4.0-10.0\\nNEUTROPHILS 52.2 % 40-80\\nLYMPHOCYTE PERCENTAGE 42.8 % 20.0-40.0\\nMONOCYTES 3.3 % 0.0-10.0\\nEOSINOPHILS 1.3 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.2 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.33 X 103 / UL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 3.55 X 103 / pL 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.27 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.02 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.11 X 103 / UL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / UL 0.0-0.3\\nTOTAL RBC 4.83 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 9.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 37.2 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 77 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 19.5 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 25.3 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 54.5 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 19.7 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 10.8 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 10.2 fL 6.5-12\\nPLATELET COUNT 518 X 103 / pL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 25.6 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.53 % 0.19-0.39\\nRemarks: = Alert!!! RBCs:Moderate anisocytosis mild poikilocytosis. Predominantly normocytic normochromic with microcytes &\\n\\novalocytes.\\nPlease Correlate with clinical conditions.\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n122 Jul 2019 00:06\\n122 Jul 2019 03:42\\n\\n: EDTA\\n\\n: 2107031728/A6750\\n: M9261472\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 19\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.05 ug/l <5\\nCADMIUM ICP-MS 0.37 ug/l < 1.5\\nMERCURY ICP-MS 0.3 ug/l <5\\nLEAD ICP-MS 40.95 ug/l < 150\\nCHROMIUM ICP-MS 1.18 ug/l < 30\\nBARIUM ICP-MS 1.7 ug/l < 30\\nCOBALT ICP-MS 0.49 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.48 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 32.34 ug/l 8 - 38\\nANTIMONY ICP-MS 12.37 ug/l 0.10 - 18\\nTIN ICP-MS 0.31 ug/l <2\\nMOLYBDENUM ICP-MS 0.76 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.07 ug/l <4\\nVANADIUM ICP-MS 0.2 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.18 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 124.79 ug/l 60 - 340\\nALUMINIUM ICP-MS 9.32 ug/l < 30\\nNICKEL ICP-MS 3.64 ug/l <15\\nMANGANESE ICP-MS 12.55 ug/l 7.10 - 20\\n\\n \\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:06 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 03:42 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107031728/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261472 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 13.7 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 0.98 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 55.5 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 18.77 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.L.A 211 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 7 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 115 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 80 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.7 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 8 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 6.2 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM COPPER PHOTOMETRY 119.8 yg/dL\\n\\nReference Range :-\\n\\nMALE : 63.5 - 150\\nFEMALE : 80 - 155\\n\\nCLINICAL SIGNIFICANCE\\n\\nCOPPER IS AN IMPORTANT TRACE ELEMENT AND A COMPONENT OF NUMEROUS ENZYMES AND PROTEINS INVOLVED\\nIN ENERGY PRODUCTION, CONNECTIVE TISSUE FORMATION, MELANIN SYNTHESIS, IRON METABOLISM,\\nDEVELOPMENT OF CENTRAL NERVOUS SYSTEM, ANGIOGENESIS AS WELL AS AN ANTIOXIDANT.\\n\\nDEFICIENCY CAN CAUSE - MALNOURISHMENT, CARDIOVASCULAR DISEASE, ANEMIA & NEUROPATHY. TOXICITY MAY\\nBE MANIFESTED AS ACUTE RENAL FAILURE, GASTROENTERITIS & CHRONIC LIVER DISEASE.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE: 948-952.\\n\\nPlease correlate with clinical conditions.\\nMethod:- 3,5-DIBR-PAESA\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 10 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM ZINC PHOTOMETRY 75.2 yg/dL\\n\\nReference Range :-\\n\\n52 - 286\\n\\nCLINICAL SIGNIFICANCE\\nZINC IS ONE OF THE ESSENTIAL TRACE ELEMENTS IN THE BODY. ITS METALLOENZYMES PLAY A KEY ROLE IN\\nPROTEIN AND NUCLEIC ACID SYNTHESIS, GENE EXPRESSION, WOUND HEALING, AS AN ANTIOXIDANT, ETC.\\n\\nDEFICIENCY CAN CAUSE - POOR WOUND HEALING, GASTROENTERITIS, IMPAIRED SPERMATOGENESIS, ALZHEIMER’S\\nDISEASE, ETC. TOXICITY MAY BE MANIFESTED AS PANCREATITIS, GASTRIC ULCER, ANEMIA, PULMONARY FIBROSIS.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE:960-965.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- NITRO - PAPS\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 11 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nTESTOSTERONE C.L.I.A 16.02 ng/dL\\n\\nReference Range :-\\n\\nAdult Male\\n\\n21-49Yrs: 164.94 - 753.38\\n50 - 89 Yrs: 86.49 - 788.22\\nAdult Female\\n\\nPre-Menopause : 12.09 - 59.46\\nPost-Menopause: < 7.00 - 48.93\\nBoys\\n\\n2-10 Years : < 7.00 - 25.91\\n\\n11 Years : < 7.00 - 341.53\\n\\n12 Years : < 7.00 - 562.59\\n\\n13 Years : 9.34 - 562.93\\n\\n14 Years : 23.28 - 742.46\\n\\n15 Years : 144.15 - 841.44\\n\\n16-21 Years : 118.22 - 948.56\\n\\nGirls\\n\\n2-10 Years: < 7.00 - 108.30\\n11-15 Years : < 7.00- 48.40\\n16-21 Years : 17.55- 50.41\\n\\nClinical Significance:\\n\\nClinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males. Major\\ncauses of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,\\nHypopituitarism some types of liver and kidney diseases and critical illness.\\n\\nSpecifications: Precision: Intra assay (%CV): 8.5 %, Inter assay (%CV): 12.6%; Sensitivity: 7 ng/dL.\\nExternal quality control program participation:\\n\\nCollege of American pathologists: Ligand assay (special) survey; cap number: 7193855-01\\n\\nPlease correlate with clinical conditions.\\nMethod:- FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 12 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n    \\n\\ncay Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nIRON PHOTOMETRY 20.2 Hg/dl\\n\\nReference Range :\\nMale : 65-175\\nFemale : 50 - 170\\n\\nMethod : _FERROZINE METHOD WITHOUT DEPROTEINIZATION\\n\\nTOTAL IRON BINDING CAPACITY (TIBC)\\n\\nReference Range :\\n\\nPHOTOMETRY 439 g/dl\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n% TRANSFERRIN SATURATION\\n\\nReference Range :\\n13-45\\n\\nCALCULATED 4.6 %\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n121 Jul 2019 06:00\\n\\n22 Jul 2019 00:19 ac tt?\\n122 Jul 2019 12:44 Oe 2\\n\\n# SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032769/A6750 Page : 13 of 19\\n: N7608083\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 71.9 U/L 45 - 129\\nBILIRUBIN -DIRECT PHOTOMETRY 0.11 mg/dl < 0.3\\nBILIRUBIN - TOTAL PHOTOMETRY 0.32 mg/dl 0.3-1.2\\nBILIRUBIN (INDIRECT) CALCULATED 0.21 mg/dl 0-0.9\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 12.3 u/l < 38\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 12 u/l < 31\\n\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 11.7 u/l < 34\\n\\nPROTEIN - TOTAL PHOTOMETRY 7.4 am/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 4.1 gm/dl 3.2-4.8\\nSERUM GLOBULIN PHOTOMETRY 3.3 gm/dL 2.5-3.4\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.24 Ratio 0.9 -2\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - Modified IFCC method\\n\\nBILD - Vanadate Oxidation\\n\\nBILT - Vanadate Oxidation\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - Modified IFCC method\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:19 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107032769/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7608083 Page : 14 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nTOTAL CHOLESTEROL PHOTOMETRY 153 mg/dl 125-200\\n\\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 44 mg/dl 35-80\\nTRIGLYCERIDES PHOTOMETRY 179 mg/dl 25-200\\n\\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 90 mg/dl 85-130\\n\\nTC/ HDL CHOLESTEROL RATIO CALCULATED 3.5 Ratio 3-5\\n\\nLDL / HDL RATIO CALCULATED 2.1 Ratio 1.5-3.5\\n\\nVLDL CHOLESTEROL CALCULATED 35.8 mg/dl 5-40\\nNON-HDL CHOLESTEROL CALCULATED 109.2 mg/dl < 160\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nCHOL - CHOD POD METHOD\\n\\nHCHO - ENZYME SELECTIVE PROTECTION METHOD\\n\\nTRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]\\nLDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY\\n\\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\nLDL/ - Derived from serum HDL and LDL Values\\n\\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\\n\\nNHDL - Derived from serum Cholesterol and HDL values\\n\\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\\n\\nTOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\\n\\nDESIRABLE <200 Low <40 OPTIMAL <100 NORMAL <150\\n\\nBORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\\n\\nHIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499\\nHIGH 160-189 VERY HIGH >500\\nVERY HIGH >190\\n\\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:19 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107032769/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7608083 Page : 15 of 19\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 5.9 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n22 Jul 2019 00:06 ac tt?\\n122 Jul 2019 03:42 Oe\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n1 2107031728/A6750 .\\n\\nPage : 1 of 19\\n:M9261472\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 8.3 X103/uL  4.0-10.0\\nNEUTROPHILS 52.2 % 40-80\\nLYMPHOCYTE PERCENTAGE 42.8 % 20.0-40.0\\nMONOCYTES 3.3 % 0.0-10.0\\nEOSINOPHILS 1.3 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.2 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.33 X 103 / UL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 3.55 X 103 / pL 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.27 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.02 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.11 X 103 / UL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / UL 0.0-0.3\\nTOTAL RBC 4.83 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 9.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 37.2 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 77 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 19.5 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 25.3 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 54.5 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 19.7 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 10.8 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 10.2 fL 6.5-12\\nPLATELET COUNT 518 X 103 / pL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 25.6 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.53 % 0.19-0.39\\nRemarks: = Alert!!! RBCs:Moderate anisocytosis mild poikilocytosis. Predominantly normocytic normochromic with microcytes &\\n\\novalocytes.\\nPlease Correlate with clinical conditions.\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n122 Jul 2019 00:06\\n122 Jul 2019 03:42\\n\\n: EDTA\\n\\n: 2107031728/A6750\\n: M9261472\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 19\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.05 ug/l <5\\nCADMIUM ICP-MS 0.37 ug/l < 1.5\\nMERCURY ICP-MS 0.3 ug/l <5\\nLEAD ICP-MS 40.95 ug/l < 150\\nCHROMIUM ICP-MS 1.18 ug/l < 30\\nBARIUM ICP-MS 1.7 ug/l < 30\\nCOBALT ICP-MS 0.49 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.48 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 32.34 ug/l 8 - 38\\nANTIMONY ICP-MS 12.37 ug/l 0.10 - 18\\nTIN ICP-MS 0.31 ug/l <2\\nMOLYBDENUM ICP-MS 0.76 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.07 ug/l <4\\nVANADIUM ICP-MS 0.2 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.18 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 124.79 ug/l 60 - 340\\nALUMINIUM ICP-MS 9.32 ug/l < 30\\nNICKEL ICP-MS 3.64 ug/l <15\\nMANGANESE ICP-MS 12.55 ug/l 7.10 - 20\\n\\n \\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:06 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 03:42 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107031728/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261472 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 13.7 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 0.98 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 55.5 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 18.77 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.L.A 211 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 7 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 115 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 80 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.7 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 8 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 6.2 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM COPPER PHOTOMETRY 119.8 yg/dL\\n\\nReference Range :-\\n\\nMALE : 63.5 - 150\\nFEMALE : 80 - 155\\n\\nCLINICAL SIGNIFICANCE\\n\\nCOPPER IS AN IMPORTANT TRACE ELEMENT AND A COMPONENT OF NUMEROUS ENZYMES AND PROTEINS INVOLVED\\nIN ENERGY PRODUCTION, CONNECTIVE TISSUE FORMATION, MELANIN SYNTHESIS, IRON METABOLISM,\\nDEVELOPMENT OF CENTRAL NERVOUS SYSTEM, ANGIOGENESIS AS WELL AS AN ANTIOXIDANT.\\n\\nDEFICIENCY CAN CAUSE - MALNOURISHMENT, CARDIOVASCULAR DISEASE, ANEMIA & NEUROPATHY. TOXICITY MAY\\nBE MANIFESTED AS ACUTE RENAL FAILURE, GASTROENTERITIS & CHRONIC LIVER DISEASE.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE: 948-952.\\n\\nPlease correlate with clinical conditions.\\nMethod:- 3,5-DIBR-PAESA\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 10 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM ZINC PHOTOMETRY 75.2 yg/dL\\n\\nReference Range :-\\n\\n52 - 286\\n\\nCLINICAL SIGNIFICANCE\\nZINC IS ONE OF THE ESSENTIAL TRACE ELEMENTS IN THE BODY. ITS METALLOENZYMES PLAY A KEY ROLE IN\\nPROTEIN AND NUCLEIC ACID SYNTHESIS, GENE EXPRESSION, WOUND HEALING, AS AN ANTIOXIDANT, ETC.\\n\\nDEFICIENCY CAN CAUSE - POOR WOUND HEALING, GASTROENTERITIS, IMPAIRED SPERMATOGENESIS, ALZHEIMER’S\\nDISEASE, ETC. TOXICITY MAY BE MANIFESTED AS PANCREATITIS, GASTRIC ULCER, ANEMIA, PULMONARY FIBROSIS.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE:960-965.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- NITRO - PAPS\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 11 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nTESTOSTERONE C.L.I.A 16.02 ng/dL\\n\\nReference Range :-\\n\\nAdult Male\\n\\n21-49Yrs: 164.94 - 753.38\\n50 - 89 Yrs: 86.49 - 788.22\\nAdult Female\\n\\nPre-Menopause : 12.09 - 59.46\\nPost-Menopause: < 7.00 - 48.93\\nBoys\\n\\n2-10 Years : < 7.00 - 25.91\\n\\n11 Years : < 7.00 - 341.53\\n\\n12 Years : < 7.00 - 562.59\\n\\n13 Years : 9.34 - 562.93\\n\\n14 Years : 23.28 - 742.46\\n\\n15 Years : 144.15 - 841.44\\n\\n16-21 Years : 118.22 - 948.56\\n\\nGirls\\n\\n2-10 Years: < 7.00 - 108.30\\n11-15 Years : < 7.00- 48.40\\n16-21 Years : 17.55- 50.41\\n\\nClinical Significance:\\n\\nClinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males. Major\\ncauses of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,\\nHypopituitarism some types of liver and kidney diseases and critical illness.\\n\\nSpecifications: Precision: Intra assay (%CV): 8.5 %, Inter assay (%CV): 12.6%; Sensitivity: 7 ng/dL.\\nExternal quality control program participation:\\n\\nCollege of American pathologists: Ligand assay (special) survey; cap number: 7193855-01\\n\\nPlease correlate with clinical conditions.\\nMethod:- FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 12 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n    \\n\\ncay Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nIRON PHOTOMETRY 20.2 Hg/dl\\n\\nReference Range :\\nMale : 65-175\\nFemale : 50 - 170\\n\\nMethod : _FERROZINE METHOD WITHOUT DEPROTEINIZATION\\n\\nTOTAL IRON BINDING CAPACITY (TIBC)\\n\\nReference Range :\\n\\nPHOTOMETRY 439 g/dl\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n% TRANSFERRIN SATURATION\\n\\nReference Range :\\n13-45\\n\\nCALCULATED 4.6 %\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n121 Jul 2019 06:00\\n\\n22 Jul 2019 00:19 ac tt?\\n122 Jul 2019 12:44 Oe 2\\n\\n# SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032769/A6750 Page : 13 of 19\\n: N7608083\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 71.9 U/L 45 - 129\\nBILIRUBIN -DIRECT PHOTOMETRY 0.11 mg/dl < 0.3\\nBILIRUBIN - TOTAL PHOTOMETRY 0.32 mg/dl 0.3-1.2\\nBILIRUBIN (INDIRECT) CALCULATED 0.21 mg/dl 0-0.9\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 12.3 u/l < 38\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 12 u/l < 31\\n\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 11.7 u/l < 34\\n\\nPROTEIN - TOTAL PHOTOMETRY 7.4 am/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 4.1 gm/dl 3.2-4.8\\nSERUM GLOBULIN PHOTOMETRY 3.3 gm/dL 2.5-3.4\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.24 Ratio 0.9 -2\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - Modified IFCC method\\n\\nBILD - Vanadate Oxidation\\n\\nBILT - Vanadate Oxidation\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - Modified IFCC method\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:19 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107032769/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7608083 Page : 14 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nTOTAL CHOLESTEROL PHOTOMETRY 153 mg/dl 125-200\\n\\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 44 mg/dl 35-80\\nTRIGLYCERIDES PHOTOMETRY 179 mg/dl 25-200\\n\\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 90 mg/dl 85-130\\n\\nTC/ HDL CHOLESTEROL RATIO CALCULATED 3.5 Ratio 3-5\\n\\nLDL / HDL RATIO CALCULATED 2.1 Ratio 1.5-3.5\\n\\nVLDL CHOLESTEROL CALCULATED 35.8 mg/dl 5-40\\nNON-HDL CHOLESTEROL CALCULATED 109.2 mg/dl < 160\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nCHOL - CHOD POD METHOD\\n\\nHCHO - ENZYME SELECTIVE PROTECTION METHOD\\n\\nTRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]\\nLDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY\\n\\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\nLDL/ - Derived from serum HDL and LDL Values\\n\\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\\n\\nNHDL - Derived from serum Cholesterol and HDL values\\n\\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\\n\\nTOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\\n\\nDESIRABLE <200 Low <40 OPTIMAL <100 NORMAL <150\\n\\nBORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\\n\\nHIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499\\nHIGH 160-189 VERY HIGH >500\\nVERY HIGH >190\\n\\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:19 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107032769/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7608083 Page : 15 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro C ar e\\n\\nD-37/1,TTC MIDC,Turbhe, i COLLEGE of AMERICAN PATHOLOGISTS . . .\\nNavi Mumbai-400 703 ceanthewo. NSsaor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\nREF. BY + SELF ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLA 115 ng/dl 60-200\\nTOTAL THYROXINE (T4) CLA 11.9 ug/dl 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) CLA 1.57 uIU/ml 0.3-5.5\\n\\nComments : SUGGESTING THYRONORMALCY\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nT3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nT4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nTSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY\\nPregnancy reference ranges for TSH\\n\\n1st Trimester : 0.10 - 2.50\\n\\n2nd Trimester : 0.20 - 3.00\\n\\n3rd Trimester : 0.30 - 3.00\\n\\nReference:\\nGuidelines of American Thyroid Association for the Diagnosis and Management of Thyroid Disease During\\nPregnancy and Postpartum, Thyroid, 2011, 21; 1-46\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:19 ac tt?\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 Oe -\\n\\nSample Type : SERUM oo. .\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nLabcode : 2107032769/A6750\\n\\nPage : 16 of 19\\nBarcode : N7608083\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 5.9 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n22 Jul 2019 00:06 ac tt?\\n122 Jul 2019 03:42 Oe\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n1 2107031728/A6750 .\\n\\nPage : 1 of 19\\n:M9261472\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 8.3 X103/uL  4.0-10.0\\nNEUTROPHILS 52.2 % 40-80\\nLYMPHOCYTE PERCENTAGE 42.8 % 20.0-40.0\\nMONOCYTES 3.3 % 0.0-10.0\\nEOSINOPHILS 1.3 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.2 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.33 X 103 / UL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 3.55 X 103 / pL 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.27 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.02 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.11 X 103 / UL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / UL 0.0-0.3\\nTOTAL RBC 4.83 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 9.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 37.2 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 77 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 19.5 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 25.3 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 54.5 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 19.7 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 10.8 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 10.2 fL 6.5-12\\nPLATELET COUNT 518 X 103 / pL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 25.6 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.53 % 0.19-0.39\\nRemarks: = Alert!!! RBCs:Moderate anisocytosis mild poikilocytosis. Predominantly normocytic normochromic with microcytes &\\n\\novalocytes.\\nPlease Correlate with clinical conditions.\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n122 Jul 2019 00:06\\n122 Jul 2019 03:42\\n\\n: EDTA\\n\\n: 2107031728/A6750\\n: M9261472\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 19\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.05 ug/l <5\\nCADMIUM ICP-MS 0.37 ug/l < 1.5\\nMERCURY ICP-MS 0.3 ug/l <5\\nLEAD ICP-MS 40.95 ug/l < 150\\nCHROMIUM ICP-MS 1.18 ug/l < 30\\nBARIUM ICP-MS 1.7 ug/l < 30\\nCOBALT ICP-MS 0.49 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.48 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 32.34 ug/l 8 - 38\\nANTIMONY ICP-MS 12.37 ug/l 0.10 - 18\\nTIN ICP-MS 0.31 ug/l <2\\nMOLYBDENUM ICP-MS 0.76 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.07 ug/l <4\\nVANADIUM ICP-MS 0.2 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.18 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 124.79 ug/l 60 - 340\\nALUMINIUM ICP-MS 9.32 ug/l < 30\\nNICKEL ICP-MS 3.64 ug/l <15\\nMANGANESE ICP-MS 12.55 ug/l 7.10 - 20\\n\\n \\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:06 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 03:42 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107031728/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261472 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 13.7 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 0.98 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 55.5 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 18.77 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.L.A 211 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 7 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 115 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 80 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.7 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 8 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 6.2 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM COPPER PHOTOMETRY 119.8 yg/dL\\n\\nReference Range :-\\n\\nMALE : 63.5 - 150\\nFEMALE : 80 - 155\\n\\nCLINICAL SIGNIFICANCE\\n\\nCOPPER IS AN IMPORTANT TRACE ELEMENT AND A COMPONENT OF NUMEROUS ENZYMES AND PROTEINS INVOLVED\\nIN ENERGY PRODUCTION, CONNECTIVE TISSUE FORMATION, MELANIN SYNTHESIS, IRON METABOLISM,\\nDEVELOPMENT OF CENTRAL NERVOUS SYSTEM, ANGIOGENESIS AS WELL AS AN ANTIOXIDANT.\\n\\nDEFICIENCY CAN CAUSE - MALNOURISHMENT, CARDIOVASCULAR DISEASE, ANEMIA & NEUROPATHY. TOXICITY MAY\\nBE MANIFESTED AS ACUTE RENAL FAILURE, GASTROENTERITIS & CHRONIC LIVER DISEASE.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE: 948-952.\\n\\nPlease correlate with clinical conditions.\\nMethod:- 3,5-DIBR-PAESA\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 10 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM ZINC PHOTOMETRY 75.2 yg/dL\\n\\nReference Range :-\\n\\n52 - 286\\n\\nCLINICAL SIGNIFICANCE\\nZINC IS ONE OF THE ESSENTIAL TRACE ELEMENTS IN THE BODY. ITS METALLOENZYMES PLAY A KEY ROLE IN\\nPROTEIN AND NUCLEIC ACID SYNTHESIS, GENE EXPRESSION, WOUND HEALING, AS AN ANTIOXIDANT, ETC.\\n\\nDEFICIENCY CAN CAUSE - POOR WOUND HEALING, GASTROENTERITIS, IMPAIRED SPERMATOGENESIS, ALZHEIMER’S\\nDISEASE, ETC. TOXICITY MAY BE MANIFESTED AS PANCREATITIS, GASTRIC ULCER, ANEMIA, PULMONARY FIBROSIS.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE:960-965.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- NITRO - PAPS\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 11 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nTESTOSTERONE C.L.I.A 16.02 ng/dL\\n\\nReference Range :-\\n\\nAdult Male\\n\\n21-49Yrs: 164.94 - 753.38\\n50 - 89 Yrs: 86.49 - 788.22\\nAdult Female\\n\\nPre-Menopause : 12.09 - 59.46\\nPost-Menopause: < 7.00 - 48.93\\nBoys\\n\\n2-10 Years : < 7.00 - 25.91\\n\\n11 Years : < 7.00 - 341.53\\n\\n12 Years : < 7.00 - 562.59\\n\\n13 Years : 9.34 - 562.93\\n\\n14 Years : 23.28 - 742.46\\n\\n15 Years : 144.15 - 841.44\\n\\n16-21 Years : 118.22 - 948.56\\n\\nGirls\\n\\n2-10 Years: < 7.00 - 108.30\\n11-15 Years : < 7.00- 48.40\\n16-21 Years : 17.55- 50.41\\n\\nClinical Significance:\\n\\nClinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males. Major\\ncauses of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,\\nHypopituitarism some types of liver and kidney diseases and critical illness.\\n\\nSpecifications: Precision: Intra assay (%CV): 8.5 %, Inter assay (%CV): 12.6%; Sensitivity: 7 ng/dL.\\nExternal quality control program participation:\\n\\nCollege of American pathologists: Ligand assay (special) survey; cap number: 7193855-01\\n\\nPlease correlate with clinical conditions.\\nMethod:- FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 12 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n    \\n\\ncay Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nIRON PHOTOMETRY 20.2 Hg/dl\\n\\nReference Range :\\nMale : 65-175\\nFemale : 50 - 170\\n\\nMethod : _FERROZINE METHOD WITHOUT DEPROTEINIZATION\\n\\nTOTAL IRON BINDING CAPACITY (TIBC)\\n\\nReference Range :\\n\\nPHOTOMETRY 439 g/dl\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n% TRANSFERRIN SATURATION\\n\\nReference Range :\\n13-45\\n\\nCALCULATED 4.6 %\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n121 Jul 2019 06:00\\n\\n22 Jul 2019 00:19 ac tt?\\n122 Jul 2019 12:44 Oe 2\\n\\n# SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032769/A6750 Page : 13 of 19\\n: N7608083\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 71.9 U/L 45 - 129\\nBILIRUBIN -DIRECT PHOTOMETRY 0.11 mg/dl < 0.3\\nBILIRUBIN - TOTAL PHOTOMETRY 0.32 mg/dl 0.3-1.2\\nBILIRUBIN (INDIRECT) CALCULATED 0.21 mg/dl 0-0.9\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 12.3 u/l < 38\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 12 u/l < 31\\n\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 11.7 u/l < 34\\n\\nPROTEIN - TOTAL PHOTOMETRY 7.4 am/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 4.1 gm/dl 3.2-4.8\\nSERUM GLOBULIN PHOTOMETRY 3.3 gm/dL 2.5-3.4\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.24 Ratio 0.9 -2\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - Modified IFCC method\\n\\nBILD - Vanadate Oxidation\\n\\nBILT - Vanadate Oxidation\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - Modified IFCC method\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:19 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107032769/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7608083 Page : 14 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nTOTAL CHOLESTEROL PHOTOMETRY 153 mg/dl 125-200\\n\\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 44 mg/dl 35-80\\nTRIGLYCERIDES PHOTOMETRY 179 mg/dl 25-200\\n\\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 90 mg/dl 85-130\\n\\nTC/ HDL CHOLESTEROL RATIO CALCULATED 3.5 Ratio 3-5\\n\\nLDL / HDL RATIO CALCULATED 2.1 Ratio 1.5-3.5\\n\\nVLDL CHOLESTEROL CALCULATED 35.8 mg/dl 5-40\\nNON-HDL CHOLESTEROL CALCULATED 109.2 mg/dl < 160\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nCHOL - CHOD POD METHOD\\n\\nHCHO - ENZYME SELECTIVE PROTECTION METHOD\\n\\nTRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]\\nLDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY\\n\\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\nLDL/ - Derived from serum HDL and LDL Values\\n\\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\\n\\nNHDL - Derived from serum Cholesterol and HDL values\\n\\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\\n\\nTOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\\n\\nDESIRABLE <200 Low <40 OPTIMAL <100 NORMAL <150\\n\\nBORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\\n\\nHIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499\\nHIGH 160-189 VERY HIGH >500\\nVERY HIGH >190\\n\\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:19 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107032769/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7608083 Page : 15 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro C ar e\\n\\nD-37/1,TTC MIDC,Turbhe, i COLLEGE of AMERICAN PATHOLOGISTS . . .\\nNavi Mumbai-400 703 ceanthewo. NSsaor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\nREF. BY + SELF ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLA 115 ng/dl 60-200\\nTOTAL THYROXINE (T4) CLA 11.9 ug/dl 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) CLA 1.57 uIU/ml 0.3-5.5\\n\\nComments : SUGGESTING THYRONORMALCY\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nT3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nT4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nTSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY\\nPregnancy reference ranges for TSH\\n\\n1st Trimester : 0.10 - 2.50\\n\\n2nd Trimester : 0.20 - 3.00\\n\\n3rd Trimester : 0.30 - 3.00\\n\\nReference:\\nGuidelines of American Thyroid Association for the Diagnosis and Management of Thyroid Disease During\\nPregnancy and Postpartum, Thyroid, 2011, 21; 1-46\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:19 ac tt?\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 Oe -\\n\\nSample Type : SERUM oo. .\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nLabcode : 2107032769/A6750\\n\\nPage : 16 of 19\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nBLOOD UREA NITROGEN (BUN) PHOTOMETRY 8.86 mg/dl 7-25\\nCREATININE - SERUM PHOTOMETRY 0.72 mg/dl 0.5-0.8\\n\\nURIC ACID PHOTOMETRY 4.8 mg/dl 3.2-6.1\\nCALCIUM PHOTOMETRY 8.59 mg/dl 8.8-10.6\\n\\nBUN / SR.CREATININE RATIO CALCULATED 12.31 Ratio 9:1-23:1\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nBUN - KINETIC UV ASSAY.\\n\\nSCRE - CREATININE ENZYMATIC METHOD\\n\\nURIC - Uricase / Peroxidase Method\\n\\nCALC - ARSENAZO III METHOD, END POINT.\\n\\nB/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:19 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107032769/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7608083 Page : 17 of 19\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 5.9 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n22 Jul 2019 00:06 ac tt?\\n122 Jul 2019 03:42 Oe\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n1 2107031728/A6750 .\\n\\nPage : 1 of 19\\n:M9261472\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 8.3 X103/uL  4.0-10.0\\nNEUTROPHILS 52.2 % 40-80\\nLYMPHOCYTE PERCENTAGE 42.8 % 20.0-40.0\\nMONOCYTES 3.3 % 0.0-10.0\\nEOSINOPHILS 1.3 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.2 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.33 X 103 / UL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 3.55 X 103 / pL 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.27 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.02 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.11 X 103 / UL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / UL 0.0-0.3\\nTOTAL RBC 4.83 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 9.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 37.2 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 77 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 19.5 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 25.3 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 54.5 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 19.7 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 10.8 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 10.2 fL 6.5-12\\nPLATELET COUNT 518 X 103 / pL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 25.6 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.53 % 0.19-0.39\\nRemarks: = Alert!!! RBCs:Moderate anisocytosis mild poikilocytosis. Predominantly normocytic normochromic with microcytes &\\n\\novalocytes.\\nPlease Correlate with clinical conditions.\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n122 Jul 2019 00:06\\n122 Jul 2019 03:42\\n\\n: EDTA\\n\\n: 2107031728/A6750\\n: M9261472\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 19\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.05 ug/l <5\\nCADMIUM ICP-MS 0.37 ug/l < 1.5\\nMERCURY ICP-MS 0.3 ug/l <5\\nLEAD ICP-MS 40.95 ug/l < 150\\nCHROMIUM ICP-MS 1.18 ug/l < 30\\nBARIUM ICP-MS 1.7 ug/l < 30\\nCOBALT ICP-MS 0.49 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.48 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 32.34 ug/l 8 - 38\\nANTIMONY ICP-MS 12.37 ug/l 0.10 - 18\\nTIN ICP-MS 0.31 ug/l <2\\nMOLYBDENUM ICP-MS 0.76 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.07 ug/l <4\\nVANADIUM ICP-MS 0.2 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.18 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 124.79 ug/l 60 - 340\\nALUMINIUM ICP-MS 9.32 ug/l < 30\\nNICKEL ICP-MS 3.64 ug/l <15\\nMANGANESE ICP-MS 12.55 ug/l 7.10 - 20\\n\\n \\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:06 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 03:42 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107031728/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261472 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 13.7 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 0.98 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 55.5 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 18.77 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.L.A 211 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 7 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 115 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 80 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.7 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 8 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 6.2 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM COPPER PHOTOMETRY 119.8 yg/dL\\n\\nReference Range :-\\n\\nMALE : 63.5 - 150\\nFEMALE : 80 - 155\\n\\nCLINICAL SIGNIFICANCE\\n\\nCOPPER IS AN IMPORTANT TRACE ELEMENT AND A COMPONENT OF NUMEROUS ENZYMES AND PROTEINS INVOLVED\\nIN ENERGY PRODUCTION, CONNECTIVE TISSUE FORMATION, MELANIN SYNTHESIS, IRON METABOLISM,\\nDEVELOPMENT OF CENTRAL NERVOUS SYSTEM, ANGIOGENESIS AS WELL AS AN ANTIOXIDANT.\\n\\nDEFICIENCY CAN CAUSE - MALNOURISHMENT, CARDIOVASCULAR DISEASE, ANEMIA & NEUROPATHY. TOXICITY MAY\\nBE MANIFESTED AS ACUTE RENAL FAILURE, GASTROENTERITIS & CHRONIC LIVER DISEASE.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE: 948-952.\\n\\nPlease correlate with clinical conditions.\\nMethod:- 3,5-DIBR-PAESA\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 10 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM ZINC PHOTOMETRY 75.2 yg/dL\\n\\nReference Range :-\\n\\n52 - 286\\n\\nCLINICAL SIGNIFICANCE\\nZINC IS ONE OF THE ESSENTIAL TRACE ELEMENTS IN THE BODY. ITS METALLOENZYMES PLAY A KEY ROLE IN\\nPROTEIN AND NUCLEIC ACID SYNTHESIS, GENE EXPRESSION, WOUND HEALING, AS AN ANTIOXIDANT, ETC.\\n\\nDEFICIENCY CAN CAUSE - POOR WOUND HEALING, GASTROENTERITIS, IMPAIRED SPERMATOGENESIS, ALZHEIMER’S\\nDISEASE, ETC. TOXICITY MAY BE MANIFESTED AS PANCREATITIS, GASTRIC ULCER, ANEMIA, PULMONARY FIBROSIS.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE:960-965.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- NITRO - PAPS\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 11 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nTESTOSTERONE C.L.I.A 16.02 ng/dL\\n\\nReference Range :-\\n\\nAdult Male\\n\\n21-49Yrs: 164.94 - 753.38\\n50 - 89 Yrs: 86.49 - 788.22\\nAdult Female\\n\\nPre-Menopause : 12.09 - 59.46\\nPost-Menopause: < 7.00 - 48.93\\nBoys\\n\\n2-10 Years : < 7.00 - 25.91\\n\\n11 Years : < 7.00 - 341.53\\n\\n12 Years : < 7.00 - 562.59\\n\\n13 Years : 9.34 - 562.93\\n\\n14 Years : 23.28 - 742.46\\n\\n15 Years : 144.15 - 841.44\\n\\n16-21 Years : 118.22 - 948.56\\n\\nGirls\\n\\n2-10 Years: < 7.00 - 108.30\\n11-15 Years : < 7.00- 48.40\\n16-21 Years : 17.55- 50.41\\n\\nClinical Significance:\\n\\nClinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males. Major\\ncauses of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,\\nHypopituitarism some types of liver and kidney diseases and critical illness.\\n\\nSpecifications: Precision: Intra assay (%CV): 8.5 %, Inter assay (%CV): 12.6%; Sensitivity: 7 ng/dL.\\nExternal quality control program participation:\\n\\nCollege of American pathologists: Ligand assay (special) survey; cap number: 7193855-01\\n\\nPlease correlate with clinical conditions.\\nMethod:- FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 12 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n    \\n\\ncay Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nIRON PHOTOMETRY 20.2 Hg/dl\\n\\nReference Range :\\nMale : 65-175\\nFemale : 50 - 170\\n\\nMethod : _FERROZINE METHOD WITHOUT DEPROTEINIZATION\\n\\nTOTAL IRON BINDING CAPACITY (TIBC)\\n\\nReference Range :\\n\\nPHOTOMETRY 439 g/dl\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n% TRANSFERRIN SATURATION\\n\\nReference Range :\\n13-45\\n\\nCALCULATED 4.6 %\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n121 Jul 2019 06:00\\n\\n22 Jul 2019 00:19 ac tt?\\n122 Jul 2019 12:44 Oe 2\\n\\n# SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032769/A6750 Page : 13 of 19\\n: N7608083\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 71.9 U/L 45 - 129\\nBILIRUBIN -DIRECT PHOTOMETRY 0.11 mg/dl < 0.3\\nBILIRUBIN - TOTAL PHOTOMETRY 0.32 mg/dl 0.3-1.2\\nBILIRUBIN (INDIRECT) CALCULATED 0.21 mg/dl 0-0.9\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 12.3 u/l < 38\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 12 u/l < 31\\n\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 11.7 u/l < 34\\n\\nPROTEIN - TOTAL PHOTOMETRY 7.4 am/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 4.1 gm/dl 3.2-4.8\\nSERUM GLOBULIN PHOTOMETRY 3.3 gm/dL 2.5-3.4\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.24 Ratio 0.9 -2\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - Modified IFCC method\\n\\nBILD - Vanadate Oxidation\\n\\nBILT - Vanadate Oxidation\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - Modified IFCC method\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:19 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107032769/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7608083 Page : 14 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nTOTAL CHOLESTEROL PHOTOMETRY 153 mg/dl 125-200\\n\\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 44 mg/dl 35-80\\nTRIGLYCERIDES PHOTOMETRY 179 mg/dl 25-200\\n\\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 90 mg/dl 85-130\\n\\nTC/ HDL CHOLESTEROL RATIO CALCULATED 3.5 Ratio 3-5\\n\\nLDL / HDL RATIO CALCULATED 2.1 Ratio 1.5-3.5\\n\\nVLDL CHOLESTEROL CALCULATED 35.8 mg/dl 5-40\\nNON-HDL CHOLESTEROL CALCULATED 109.2 mg/dl < 160\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nCHOL - CHOD POD METHOD\\n\\nHCHO - ENZYME SELECTIVE PROTECTION METHOD\\n\\nTRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]\\nLDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY\\n\\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\nLDL/ - Derived from serum HDL and LDL Values\\n\\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\\n\\nNHDL - Derived from serum Cholesterol and HDL values\\n\\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\\n\\nTOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\\n\\nDESIRABLE <200 Low <40 OPTIMAL <100 NORMAL <150\\n\\nBORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\\n\\nHIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499\\nHIGH 160-189 VERY HIGH >500\\nVERY HIGH >190\\n\\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:19 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107032769/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7608083 Page : 15 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro C ar e\\n\\nD-37/1,TTC MIDC,Turbhe, i COLLEGE of AMERICAN PATHOLOGISTS . . .\\nNavi Mumbai-400 703 ceanthewo. NSsaor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\nREF. BY + SELF ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLA 115 ng/dl 60-200\\nTOTAL THYROXINE (T4) CLA 11.9 ug/dl 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) CLA 1.57 uIU/ml 0.3-5.5\\n\\nComments : SUGGESTING THYRONORMALCY\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nT3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nT4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nTSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY\\nPregnancy reference ranges for TSH\\n\\n1st Trimester : 0.10 - 2.50\\n\\n2nd Trimester : 0.20 - 3.00\\n\\n3rd Trimester : 0.30 - 3.00\\n\\nReference:\\nGuidelines of American Thyroid Association for the Diagnosis and Management of Thyroid Disease During\\nPregnancy and Postpartum, Thyroid, 2011, 21; 1-46\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:19 ac tt?\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 Oe -\\n\\nSample Type : SERUM oo. .\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nLabcode : 2107032769/A6750\\n\\nPage : 16 of 19\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nBLOOD UREA NITROGEN (BUN) PHOTOMETRY 8.86 mg/dl 7-25\\nCREATININE - SERUM PHOTOMETRY 0.72 mg/dl 0.5-0.8\\n\\nURIC ACID PHOTOMETRY 4.8 mg/dl 3.2-6.1\\nCALCIUM PHOTOMETRY 8.59 mg/dl 8.8-10.6\\n\\nBUN / SR.CREATININE RATIO CALCULATED 12.31 Ratio 9:1-23:1\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nBUN - KINETIC UV ASSAY.\\n\\nSCRE - CREATININE ENZYMATIC METHOD\\n\\nURIC - Uricase / Peroxidase Method\\n\\nCALC - ARSENAZO III METHOD, END POINT.\\n\\nB/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:19 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107032769/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7608083 Page : 17 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F)\\nREF. BY : SELF\\nTEST ASKED : AAROGYAM 1.3\\n\\nTEST NAME\\n\\nEST. GLOMERULAR FILTRATION RATE (eGFR)\\nReference Range :-\\n\\nTECHNOLOGY\\nCALCULATED\\n\\n> = 90 : Normal\\n60 - 89 : Mild Decrease\\n45-59 : Mild to Moderate Decrease\\n\\n30-44 : Moderate to Severe Decrease\\n15-29 : Severe Decrease\\n\\nClinical Significance\\n\\nVALUE\\n114 mL/min/1.73 m2\\n\\nSAMPLE COLLECTED AT\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\n\\nUNITS\\n\\nThe normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild\\nand moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical\\nlaboratories to routinely estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of\\nrenal function, and report the value when serum creatinine is measured for patients 18 and older, when appropriate\\nand feasible. It cannot be measured easily in clinical practice, instead, GFR is estimated from equations using serum\\ncreatinine, age, race and sex. This provides easy to interpret information for the doctor and patient on the degree of\\nrenal impairment since it approximately equates to the percentage of kidney function remaining. Application of\\nCKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and\\n\\nmanagement of patients with CKD.\\n\\nReference\\n\\nLevey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular\\n\\nfiltration rate. Ann Intern Med. 2009;150(9):604-12.\\nPlease correlate with clinical conditions.\\nMethod:- CKD-EPI Creatinine Equation\\n\\n«ww End of report ~~\\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type ©; :\\n\\nLabcode ©\\nSas\\n\\nBarcode\\n\\n121 Jul 2019 06:00\\n122 Jul 2019 00:19 Goole?\\n122 Jul 2019 12:44 .\\n\\n: SERUM Dr.Prachi Sinkar MD(Path)\\n\\n1 2107032769/A6750\\n: N7608083\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 18 of 19\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 5.9 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n22 Jul 2019 00:06 ac tt?\\n122 Jul 2019 03:42 Oe\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n1 2107031728/A6750 .\\n\\nPage : 1 of 19\\n:M9261472\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 8.3 X103/uL  4.0-10.0\\nNEUTROPHILS 52.2 % 40-80\\nLYMPHOCYTE PERCENTAGE 42.8 % 20.0-40.0\\nMONOCYTES 3.3 % 0.0-10.0\\nEOSINOPHILS 1.3 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.2 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.33 X 103 / UL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 3.55 X 103 / pL 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.27 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.02 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.11 X 103 / UL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / UL 0.0-0.3\\nTOTAL RBC 4.83 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 9.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 37.2 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 77 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 19.5 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 25.3 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 54.5 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 19.7 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 10.8 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 10.2 fL 6.5-12\\nPLATELET COUNT 518 X 103 / pL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 25.6 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.53 % 0.19-0.39\\nRemarks: = Alert!!! RBCs:Moderate anisocytosis mild poikilocytosis. Predominantly normocytic normochromic with microcytes &\\n\\novalocytes.\\nPlease Correlate with clinical conditions.\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n122 Jul 2019 00:06\\n122 Jul 2019 03:42\\n\\n: EDTA\\n\\n: 2107031728/A6750\\n: M9261472\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 19\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.05 ug/l <5\\nCADMIUM ICP-MS 0.37 ug/l < 1.5\\nMERCURY ICP-MS 0.3 ug/l <5\\nLEAD ICP-MS 40.95 ug/l < 150\\nCHROMIUM ICP-MS 1.18 ug/l < 30\\nBARIUM ICP-MS 1.7 ug/l < 30\\nCOBALT ICP-MS 0.49 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.48 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 32.34 ug/l 8 - 38\\nANTIMONY ICP-MS 12.37 ug/l 0.10 - 18\\nTIN ICP-MS 0.31 ug/l <2\\nMOLYBDENUM ICP-MS 0.76 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.07 ug/l <4\\nVANADIUM ICP-MS 0.2 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.18 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 124.79 ug/l 60 - 340\\nALUMINIUM ICP-MS 9.32 ug/l < 30\\nNICKEL ICP-MS 3.64 ug/l <15\\nMANGANESE ICP-MS 12.55 ug/l 7.10 - 20\\n\\n \\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:06 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 03:42 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107031728/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261472 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 13.7 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 0.98 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 55.5 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 18.77 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.L.A 211 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 7 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : DRG SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 115 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 80 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.7 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107032769/A6750\\n\\nPage : 8 of 19\\nBarcode :N7608083\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 6.2 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 22 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : N7608083\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM COPPER PHOTOMETRY 119.8 yg/dL\\n\\nReference Range :-\\n\\nMALE : 63.5 - 150\\nFEMALE : 80 - 155\\n\\nCLINICAL SIGNIFICANCE\\n\\nCOPPER IS AN IMPORTANT TRACE ELEMENT AND A COMPONENT OF NUMEROUS ENZYMES AND PROTEINS INVOLVED\\nIN ENERGY PRODUCTION, CONNECTIVE TISSUE FORMATION, MELANIN SYNTHESIS, IRON METABOLISM,\\nDEVELOPMENT OF CENTRAL NERVOUS SYSTEM, ANGIOGENESIS AS WELL AS AN ANTIOXIDANT.\\n\\nDEFICIENCY CAN CAUSE - MALNOURISHMENT, CARDIOVASCULAR DISEASE, ANEMIA & NEUROPATHY. TOXICITY MAY\\nBE MANIFESTED AS ACUTE RENAL FAILURE, GASTROENTERITIS & CHRONIC LIVER DISEASE.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE: 948-952.\\n\\nPlease correlate with clinical conditions.\\nMethod:- 3,5-DIBR-PAESA\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 10 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM ZINC PHOTOMETRY 75.2 yg/dL\\n\\nReference Range :-\\n\\n52 - 286\\n\\nCLINICAL SIGNIFICANCE\\nZINC IS ONE OF THE ESSENTIAL TRACE ELEMENTS IN THE BODY. ITS METALLOENZYMES PLAY A KEY ROLE IN\\nPROTEIN AND NUCLEIC ACID SYNTHESIS, GENE EXPRESSION, WOUND HEALING, AS AN ANTIOXIDANT, ETC.\\n\\nDEFICIENCY CAN CAUSE - POOR WOUND HEALING, GASTROENTERITIS, IMPAIRED SPERMATOGENESIS, ALZHEIMER’S\\nDISEASE, ETC. TOXICITY MAY BE MANIFESTED AS PANCREATITIS, GASTRIC ULCER, ANEMIA, PULMONARY FIBROSIS.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE:960-965.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- NITRO - PAPS\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 11 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nTESTOSTERONE C.L.I.A 16.02 ng/dL\\n\\nReference Range :-\\n\\nAdult Male\\n\\n21-49Yrs: 164.94 - 753.38\\n50 - 89 Yrs: 86.49 - 788.22\\nAdult Female\\n\\nPre-Menopause : 12.09 - 59.46\\nPost-Menopause: < 7.00 - 48.93\\nBoys\\n\\n2-10 Years : < 7.00 - 25.91\\n\\n11 Years : < 7.00 - 341.53\\n\\n12 Years : < 7.00 - 562.59\\n\\n13 Years : 9.34 - 562.93\\n\\n14 Years : 23.28 - 742.46\\n\\n15 Years : 144.15 - 841.44\\n\\n16-21 Years : 118.22 - 948.56\\n\\nGirls\\n\\n2-10 Years: < 7.00 - 108.30\\n11-15 Years : < 7.00- 48.40\\n16-21 Years : 17.55- 50.41\\n\\nClinical Significance:\\n\\nClinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males. Major\\ncauses of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,\\nHypopituitarism some types of liver and kidney diseases and critical illness.\\n\\nSpecifications: Precision: Intra assay (%CV): 8.5 %, Inter assay (%CV): 12.6%; Sensitivity: 7 ng/dL.\\nExternal quality control program participation:\\n\\nCollege of American pathologists: Ligand assay (special) survey; cap number: 7193855-01\\n\\nPlease correlate with clinical conditions.\\nMethod:- FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nSample Collected on (SCT) :21 Jul 2019 06:00\\nSample Received on (SRT) 122 Jul 2019 00:19 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032769/A6750\\n\\nBarcode :N7608083 Page : 12 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n    \\n\\ncay Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nIRON PHOTOMETRY 20.2 Hg/dl\\n\\nReference Range :\\nMale : 65-175\\nFemale : 50 - 170\\n\\nMethod : _FERROZINE METHOD WITHOUT DEPROTEINIZATION\\n\\nTOTAL IRON BINDING CAPACITY (TIBC)\\n\\nReference Range :\\n\\nPHOTOMETRY 439 g/dl\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n% TRANSFERRIN SATURATION\\n\\nReference Range :\\n13-45\\n\\nCALCULATED 4.6 %\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n121 Jul 2019 06:00\\n\\n22 Jul 2019 00:19 ac tt?\\n122 Jul 2019 12:44 Oe 2\\n\\n# SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032769/A6750 Page : 13 of 19\\n: N7608083\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 71.9 U/L 45 - 129\\nBILIRUBIN -DIRECT PHOTOMETRY 0.11 mg/dl < 0.3\\nBILIRUBIN - TOTAL PHOTOMETRY 0.32 mg/dl 0.3-1.2\\nBILIRUBIN (INDIRECT) CALCULATED 0.21 mg/dl 0-0.9\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 12.3 u/l < 38\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 12 u/l < 31\\n\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 11.7 u/l < 34\\n\\nPROTEIN - TOTAL PHOTOMETRY 7.4 am/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 4.1 gm/dl 3.2-4.8\\nSERUM GLOBULIN PHOTOMETRY 3.3 gm/dL 2.5-3.4\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.24 Ratio 0.9 -2\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - Modified IFCC method\\n\\nBILD - Vanadate Oxidation\\n\\nBILT - Vanadate Oxidation\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - Modified IFCC method\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:19 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107032769/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7608083 Page : 14 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nTOTAL CHOLESTEROL PHOTOMETRY 153 mg/dl 125-200\\n\\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 44 mg/dl 35-80\\nTRIGLYCERIDES PHOTOMETRY 179 mg/dl 25-200\\n\\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 90 mg/dl 85-130\\n\\nTC/ HDL CHOLESTEROL RATIO CALCULATED 3.5 Ratio 3-5\\n\\nLDL / HDL RATIO CALCULATED 2.1 Ratio 1.5-3.5\\n\\nVLDL CHOLESTEROL CALCULATED 35.8 mg/dl 5-40\\nNON-HDL CHOLESTEROL CALCULATED 109.2 mg/dl < 160\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nCHOL - CHOD POD METHOD\\n\\nHCHO - ENZYME SELECTIVE PROTECTION METHOD\\n\\nTRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]\\nLDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY\\n\\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\nLDL/ - Derived from serum HDL and LDL Values\\n\\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\\n\\nNHDL - Derived from serum Cholesterol and HDL values\\n\\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\\n\\nTOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\\n\\nDESIRABLE <200 Low <40 OPTIMAL <100 NORMAL <150\\n\\nBORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\\n\\nHIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499\\nHIGH 160-189 VERY HIGH >500\\nVERY HIGH >190\\n\\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:19 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107032769/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7608083 Page : 15 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro C ar e\\n\\nD-37/1,TTC MIDC,Turbhe, i COLLEGE of AMERICAN PATHOLOGISTS . . .\\nNavi Mumbai-400 703 ceanthewo. NSsaor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\nREF. BY + SELF ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLA 115 ng/dl 60-200\\nTOTAL THYROXINE (T4) CLA 11.9 ug/dl 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) CLA 1.57 uIU/ml 0.3-5.5\\n\\nComments : SUGGESTING THYRONORMALCY\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nT3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nT4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nTSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY\\nPregnancy reference ranges for TSH\\n\\n1st Trimester : 0.10 - 2.50\\n\\n2nd Trimester : 0.20 - 3.00\\n\\n3rd Trimester : 0.30 - 3.00\\n\\nReference:\\nGuidelines of American Thyroid Association for the Diagnosis and Management of Thyroid Disease During\\nPregnancy and Postpartum, Thyroid, 2011, 21; 1-46\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:19 ac tt?\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 Oe -\\n\\nSample Type : SERUM oo. .\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nLabcode : 2107032769/A6750\\n\\nPage : 16 of 19\\nBarcode : N7608083\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : DR G SANTHI PRIYA (28Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nBLOOD UREA NITROGEN (BUN) PHOTOMETRY 8.86 mg/dl 7-25\\nCREATININE - SERUM PHOTOMETRY 0.72 mg/dl 0.5-0.8\\n\\nURIC ACID PHOTOMETRY 4.8 mg/dl 3.2-6.1\\nCALCIUM PHOTOMETRY 8.59 mg/dl 8.8-10.6\\n\\nBUN / SR.CREATININE RATIO CALCULATED 12.31 Ratio 9:1-23:1\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nBUN - KINETIC UV ASSAY.\\n\\nSCRE - CREATININE ENZYMATIC METHOD\\n\\nURIC - Uricase / Peroxidase Method\\n\\nCALC - ARSENAZO III METHOD, END POINT.\\n\\nB/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES\\n\\nSample Collected on (SCT) : 21 Jul 2019 06:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:19 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107032769/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7608083 Page : 17 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = DR G SANTHI PRIYA (28Y/F)\\nREF. BY : SELF\\nTEST ASKED : AAROGYAM 1.3\\n\\nTEST NAME\\n\\nEST. GLOMERULAR FILTRATION RATE (eGFR)\\nReference Range :-\\n\\nTECHNOLOGY\\nCALCULATED\\n\\n> = 90 : Normal\\n60 - 89 : Mild Decrease\\n45-59 : Mild to Moderate Decrease\\n\\n30-44 : Moderate to Severe Decrease\\n15-29 : Severe Decrease\\n\\nClinical Significance\\n\\nVALUE\\n114 mL/min/1.73 m2\\n\\nSAMPLE COLLECTED AT\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\n\\nUNITS\\n\\nThe normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild\\nand moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical\\nlaboratories to routinely estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of\\nrenal function, and report the value when serum creatinine is measured for patients 18 and older, when appropriate\\nand feasible. It cannot be measured easily in clinical practice, instead, GFR is estimated from equations using serum\\ncreatinine, age, race and sex. This provides easy to interpret information for the doctor and patient on the degree of\\nrenal impairment since it approximately equates to the percentage of kidney function remaining. Application of\\nCKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and\\n\\nmanagement of patients with CKD.\\n\\nReference\\n\\nLevey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular\\n\\nfiltration rate. Ann Intern Med. 2009;150(9):604-12.\\nPlease correlate with clinical conditions.\\nMethod:- CKD-EPI Creatinine Equation\\n\\n«ww End of report ~~\\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type ©; :\\n\\nLabcode ©\\nSas\\n\\nBarcode\\n\\n121 Jul 2019 06:00\\n122 Jul 2019 00:19 Goole?\\n122 Jul 2019 12:44 .\\n\\n: SERUM Dr.Prachi Sinkar MD(Path)\\n\\n1 2107032769/A6750\\n: N7608083\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 18 of 19\\n\\x0cCONDITIONS OF REPORTING\\n\\n“ The reported results are for information and interpretation of the referring doctor only.\\n\\n“It is presumed that the tests performed on the specimen belong to the patient; named or identified.\\n\\n“Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the\\nsame patient.\\n\\n“Should the results indicate an unexpected abnormality, the same should be reconfirmed.\\n\\n“Only such medical professionals who understand reporting units, reference ranges and limitations of\\ntechnologies should interpret results.\\n\\n“This report is not valid for medico-legal purpose.\\n\\n“Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or\\ndamage that may be incurred by any person as a result of presuming the meaning or contents of the report.\\n\\nEXPLANATIONS\\n\\n“Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them\\nas \"Clients\".\\n\\n~* Name - The name is as declared by the client and recored by the personnel who collected the specimen.\\n\\n“  Ref.Dr - The name of the doctor who has recommended testing as declared by the client.\\n\\n“ Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.\\n\\n“Barcode - This is the specimen identity number and it states that the results are for the specimen bearing\\nthe barcode (irrespective of the name).\\n\\nSCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by\\nthe client.\\n\\n“SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.\\n\\n“SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.\\n\\n“* RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.\\n\\n“ Reference Range - Means the range of values in which 95% of the normal population would fall.\\n\\nSUGGESTIONS\\n\\n“+ Values out of reference range requires reconfirmation before starting any medical treatment.\\n\\n“* Retesting is needed if you suspect any quality shortcomings.\\n\\n“* Testing or retesting should be done in accredited laboratories.\\n\\n“For suggestions, complaints or feedback, write to us at info@thyrocare.com or call us on\\n022-3090 0000 / 4125 2525\\n\\n“* SMS:<Labcode No.> to 9870666333\\n\\nPreventive Healthcare is now at your fingertips!\\nt=)\\nBooking\\n\\nTrack your\\nConfirmatios Technician\\n\\n     \\n \\n\\n \\n\\n \\n\\n       \\n\\n       \\n      \\n  \\n\\nRig tT Nt\\n\\n \\n\\n        \\n\\nLy\\n\\nSample\\nTesting\\n\\n=\\na &\\n&\\n\\nexplore & Select\\nTest / Profil\\n\\n     \\n\\n     \\n\\n  \\n\\nBlood\\nCollection\\n\\n   \\n\\n \\n\\n \\n\\n   \\n\\nFocus TB\\n\\nTowards a TB free world\\n\\n   \\n\\n“Fight TB with power of\\nRapid Technology”\\n\\n  \\n \\n \\n \\n \\n \\n \\n \\n   \\n\\nFocus TB, powered by Thyrocare.\\nA brand that will focus on TB, which is one of the major public health\\n\\na eae eee Call : 022 - 3090 0000/4125 2525\\n\\nTuberculosis (TB) is a transmissible, airborne infection caused by info@focustb.com\\nMycobacterium tuberculosis (MTB). \\\\t transpires usually when a\\nperson inhales microscopic droplet nuclei containing viable\\nbacteria, spread through coughing by persons who have\\ninfectious TB.\\n\\nPage : 19 of 19\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 6.6 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 143 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n122 Jul 2019 00:10\\n122 Jul 2019 08:13\\n\\nGul\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032040/A6750 .\\n\\nPage : 1 of 19\\n:M9261427\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 6.6 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 143 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n122 Jul 2019 00:10\\n122 Jul 2019 08:13\\n\\nGul\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032040/A6750 .\\n\\nPage : 1 of 19\\n:M9261427\\n\\x0c   \\n\\nPROCESSED AT: F\\nThyrecare cap, Thyrocare’\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 emir Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED s:_~_ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n\\n- 6 PART (DIFF)\\n\\nREF. BY : SELF\\n\\n \\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 7.29 X103/uL  4.0-10.0\\nNEUTROPHILS 63.7 % 40-80\\nLYMPHOCYTE PERCENTAGE 32.1 % 20.0-40.0\\nMONOCYTES 2.5 % 0.0-10.0\\nEOSINOPHILS 1.2 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.64 X103/uL  2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 2.34 X103/uL — 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.18 X 103 / pL 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.01 X 103 / pL 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.09 X103/uL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0.0-0.3\\nTOTAL RBC 4.59 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 11.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 41.5 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 90.4 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 24.8 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.5 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 58.2 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.4 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 14 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 11.2 fL 6.5-12\\nPLATELET COUNT 304 X103/uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 34.5 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.34 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis, Hypochromia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:10 ac tt?\\nReport Released on (RRT) 122 Jul 2019 08:13 Oe <=\\nSample Type : EDTA oo\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032040/A6750\\n\\nPage : 2 of 19\\nBarcode : M9261427\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 6.6 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 143 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n122 Jul 2019 00:10\\n122 Jul 2019 08:13\\n\\nGul\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032040/A6750 .\\n\\nPage : 1 of 19\\n:M9261427\\n\\x0c   \\n\\nPROCESSED AT: F\\nThyrecare cap, Thyrocare’\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 emir Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED s:_~_ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n\\n- 6 PART (DIFF)\\n\\nREF. BY : SELF\\n\\n \\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 7.29 X103/uL  4.0-10.0\\nNEUTROPHILS 63.7 % 40-80\\nLYMPHOCYTE PERCENTAGE 32.1 % 20.0-40.0\\nMONOCYTES 2.5 % 0.0-10.0\\nEOSINOPHILS 1.2 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.64 X103/uL  2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 2.34 X103/uL — 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.18 X 103 / pL 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.01 X 103 / pL 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.09 X103/uL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0.0-0.3\\nTOTAL RBC 4.59 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 11.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 41.5 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 90.4 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 24.8 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.5 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 58.2 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.4 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 14 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 11.2 fL 6.5-12\\nPLATELET COUNT 304 X103/uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 34.5 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.34 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis, Hypochromia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:10 ac tt?\\nReport Released on (RRT) 122 Jul 2019 08:13 Oe <=\\nSample Type : EDTA oo\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032040/A6750\\n\\nPage : 2 of 19\\nBarcode : M9261427\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.16 ug/l <5\\nCADMIUM ICP-MS 0.1 ug/l < 1.5\\nMERCURY ICP-MS 0.43 ug/l <5\\nLEAD ICP-MS 21.59 ug/l < 150\\nCHROMIUM ICP-MS 0.64 ug/l < 30\\nBARIUM ICP-MS 1.84 ug/l < 30\\nCOBALT ICP-MS 0.3 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.5 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 17.51 ug/l 8 - 38\\nANTIMONY ICP-MS 7.93 ug/l 0.10 - 18\\nTIN ICP-MS 0.22 ug/l <2\\nMOLYBDENUM ICP-MS 0.37 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.06 ug/l <4\\nVANADIUM ICP-MS 0.71 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.16 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 146.82 ug/l 60 - 340\\nALUMINIUM ICP-MS 2.83 ug/l < 30\\nNICKEL ICP-MS 2.59 ug/l <15\\nMANGANESE ICP-MS 20.76 ug/I 7.10 - 20\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:10 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 08:13 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107032040/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261427 Page : 3 of 19\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 6.6 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 143 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n122 Jul 2019 00:10\\n122 Jul 2019 08:13\\n\\nGul\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032040/A6750 .\\n\\nPage : 1 of 19\\n:M9261427\\n\\x0c   \\n\\nPROCESSED AT: F\\nThyrecare cap, Thyrocare’\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 emir Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED s:_~_ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n\\n- 6 PART (DIFF)\\n\\nREF. BY : SELF\\n\\n \\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 7.29 X103/uL  4.0-10.0\\nNEUTROPHILS 63.7 % 40-80\\nLYMPHOCYTE PERCENTAGE 32.1 % 20.0-40.0\\nMONOCYTES 2.5 % 0.0-10.0\\nEOSINOPHILS 1.2 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.64 X103/uL  2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 2.34 X103/uL — 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.18 X 103 / pL 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.01 X 103 / pL 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.09 X103/uL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0.0-0.3\\nTOTAL RBC 4.59 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 11.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 41.5 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 90.4 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 24.8 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.5 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 58.2 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.4 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 14 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 11.2 fL 6.5-12\\nPLATELET COUNT 304 X103/uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 34.5 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.34 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis, Hypochromia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:10 ac tt?\\nReport Released on (RRT) 122 Jul 2019 08:13 Oe <=\\nSample Type : EDTA oo\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032040/A6750\\n\\nPage : 2 of 19\\nBarcode : M9261427\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.16 ug/l <5\\nCADMIUM ICP-MS 0.1 ug/l < 1.5\\nMERCURY ICP-MS 0.43 ug/l <5\\nLEAD ICP-MS 21.59 ug/l < 150\\nCHROMIUM ICP-MS 0.64 ug/l < 30\\nBARIUM ICP-MS 1.84 ug/l < 30\\nCOBALT ICP-MS 0.3 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.5 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 17.51 ug/l 8 - 38\\nANTIMONY ICP-MS 7.93 ug/l 0.10 - 18\\nTIN ICP-MS 0.22 ug/l <2\\nMOLYBDENUM ICP-MS 0.37 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.06 ug/l <4\\nVANADIUM ICP-MS 0.71 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.16 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 146.82 ug/l 60 - 340\\nALUMINIUM ICP-MS 2.83 ug/l < 30\\nNICKEL ICP-MS 2.59 ug/l <15\\nMANGANESE ICP-MS 20.76 ug/I 7.10 - 20\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:10 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 08:13 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107032040/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261427 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 16.4 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : 00274163\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 6.6 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 143 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n122 Jul 2019 00:10\\n122 Jul 2019 08:13\\n\\nGul\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032040/A6750 .\\n\\nPage : 1 of 19\\n:M9261427\\n\\x0c   \\n\\nPROCESSED AT: F\\nThyrecare cap, Thyrocare’\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 emir Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED s:_~_ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n\\n- 6 PART (DIFF)\\n\\nREF. BY : SELF\\n\\n \\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 7.29 X103/uL  4.0-10.0\\nNEUTROPHILS 63.7 % 40-80\\nLYMPHOCYTE PERCENTAGE 32.1 % 20.0-40.0\\nMONOCYTES 2.5 % 0.0-10.0\\nEOSINOPHILS 1.2 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.64 X103/uL  2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 2.34 X103/uL — 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.18 X 103 / pL 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.01 X 103 / pL 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.09 X103/uL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0.0-0.3\\nTOTAL RBC 4.59 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 11.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 41.5 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 90.4 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 24.8 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.5 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 58.2 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.4 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 14 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 11.2 fL 6.5-12\\nPLATELET COUNT 304 X103/uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 34.5 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.34 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis, Hypochromia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:10 ac tt?\\nReport Released on (RRT) 122 Jul 2019 08:13 Oe <=\\nSample Type : EDTA oo\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032040/A6750\\n\\nPage : 2 of 19\\nBarcode : M9261427\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.16 ug/l <5\\nCADMIUM ICP-MS 0.1 ug/l < 1.5\\nMERCURY ICP-MS 0.43 ug/l <5\\nLEAD ICP-MS 21.59 ug/l < 150\\nCHROMIUM ICP-MS 0.64 ug/l < 30\\nBARIUM ICP-MS 1.84 ug/l < 30\\nCOBALT ICP-MS 0.3 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.5 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 17.51 ug/l 8 - 38\\nANTIMONY ICP-MS 7.93 ug/l 0.10 - 18\\nTIN ICP-MS 0.22 ug/l <2\\nMOLYBDENUM ICP-MS 0.37 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.06 ug/l <4\\nVANADIUM ICP-MS 0.71 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.16 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 146.82 ug/l 60 - 340\\nALUMINIUM ICP-MS 2.83 ug/l < 30\\nNICKEL ICP-MS 2.59 ug/l <15\\nMANGANESE ICP-MS 20.76 ug/I 7.10 - 20\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:10 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 08:13 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107032040/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261427 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 16.4 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 1.02 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : 00274163\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 6.6 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 143 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n122 Jul 2019 00:10\\n122 Jul 2019 08:13\\n\\nGul\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032040/A6750 .\\n\\nPage : 1 of 19\\n:M9261427\\n\\x0c   \\n\\nPROCESSED AT: F\\nThyrecare cap, Thyrocare’\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 emir Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED s:_~_ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n\\n- 6 PART (DIFF)\\n\\nREF. BY : SELF\\n\\n \\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 7.29 X103/uL  4.0-10.0\\nNEUTROPHILS 63.7 % 40-80\\nLYMPHOCYTE PERCENTAGE 32.1 % 20.0-40.0\\nMONOCYTES 2.5 % 0.0-10.0\\nEOSINOPHILS 1.2 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.64 X103/uL  2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 2.34 X103/uL — 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.18 X 103 / pL 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.01 X 103 / pL 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.09 X103/uL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0.0-0.3\\nTOTAL RBC 4.59 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 11.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 41.5 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 90.4 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 24.8 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.5 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 58.2 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.4 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 14 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 11.2 fL 6.5-12\\nPLATELET COUNT 304 X103/uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 34.5 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.34 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis, Hypochromia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:10 ac tt?\\nReport Released on (RRT) 122 Jul 2019 08:13 Oe <=\\nSample Type : EDTA oo\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032040/A6750\\n\\nPage : 2 of 19\\nBarcode : M9261427\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.16 ug/l <5\\nCADMIUM ICP-MS 0.1 ug/l < 1.5\\nMERCURY ICP-MS 0.43 ug/l <5\\nLEAD ICP-MS 21.59 ug/l < 150\\nCHROMIUM ICP-MS 0.64 ug/l < 30\\nBARIUM ICP-MS 1.84 ug/l < 30\\nCOBALT ICP-MS 0.3 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.5 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 17.51 ug/l 8 - 38\\nANTIMONY ICP-MS 7.93 ug/l 0.10 - 18\\nTIN ICP-MS 0.22 ug/l <2\\nMOLYBDENUM ICP-MS 0.37 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.06 ug/l <4\\nVANADIUM ICP-MS 0.71 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.16 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 146.82 ug/l 60 - 340\\nALUMINIUM ICP-MS 2.83 ug/l < 30\\nNICKEL ICP-MS 2.59 ug/l <15\\nMANGANESE ICP-MS 20.76 ug/I 7.10 - 20\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:10 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 08:13 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107032040/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261427 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 16.4 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 1.02 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 29.2 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : 00274163\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 6.6 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 143 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n122 Jul 2019 00:10\\n122 Jul 2019 08:13\\n\\nGul\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032040/A6750 .\\n\\nPage : 1 of 19\\n:M9261427\\n\\x0c   \\n\\nPROCESSED AT: F\\nThyrecare cap, Thyrocare’\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 emir Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED s:_~_ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n\\n- 6 PART (DIFF)\\n\\nREF. BY : SELF\\n\\n \\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 7.29 X103/uL  4.0-10.0\\nNEUTROPHILS 63.7 % 40-80\\nLYMPHOCYTE PERCENTAGE 32.1 % 20.0-40.0\\nMONOCYTES 2.5 % 0.0-10.0\\nEOSINOPHILS 1.2 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.64 X103/uL  2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 2.34 X103/uL — 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.18 X 103 / pL 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.01 X 103 / pL 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.09 X103/uL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0.0-0.3\\nTOTAL RBC 4.59 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 11.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 41.5 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 90.4 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 24.8 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.5 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 58.2 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.4 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 14 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 11.2 fL 6.5-12\\nPLATELET COUNT 304 X103/uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 34.5 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.34 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis, Hypochromia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:10 ac tt?\\nReport Released on (RRT) 122 Jul 2019 08:13 Oe <=\\nSample Type : EDTA oo\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032040/A6750\\n\\nPage : 2 of 19\\nBarcode : M9261427\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.16 ug/l <5\\nCADMIUM ICP-MS 0.1 ug/l < 1.5\\nMERCURY ICP-MS 0.43 ug/l <5\\nLEAD ICP-MS 21.59 ug/l < 150\\nCHROMIUM ICP-MS 0.64 ug/l < 30\\nBARIUM ICP-MS 1.84 ug/l < 30\\nCOBALT ICP-MS 0.3 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.5 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 17.51 ug/l 8 - 38\\nANTIMONY ICP-MS 7.93 ug/l 0.10 - 18\\nTIN ICP-MS 0.22 ug/l <2\\nMOLYBDENUM ICP-MS 0.37 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.06 ug/l <4\\nVANADIUM ICP-MS 0.71 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.16 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 146.82 ug/l 60 - 340\\nALUMINIUM ICP-MS 2.83 ug/l < 30\\nNICKEL ICP-MS 2.59 ug/l <15\\nMANGANESE ICP-MS 20.76 ug/I 7.10 - 20\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:10 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 08:13 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107032040/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261427 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 16.4 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 1.02 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 29.2 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 31.7 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.I.A 176 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 7 of 19\\nBarcode 100274163\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 6.6 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 143 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n122 Jul 2019 00:10\\n122 Jul 2019 08:13\\n\\nGul\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032040/A6750 .\\n\\nPage : 1 of 19\\n:M9261427\\n\\x0c   \\n\\nPROCESSED AT: F\\nThyrecare cap, Thyrocare’\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 emir Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED s:_~_ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n\\n- 6 PART (DIFF)\\n\\nREF. BY : SELF\\n\\n \\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 7.29 X103/uL  4.0-10.0\\nNEUTROPHILS 63.7 % 40-80\\nLYMPHOCYTE PERCENTAGE 32.1 % 20.0-40.0\\nMONOCYTES 2.5 % 0.0-10.0\\nEOSINOPHILS 1.2 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.64 X103/uL  2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 2.34 X103/uL — 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.18 X 103 / pL 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.01 X 103 / pL 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.09 X103/uL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0.0-0.3\\nTOTAL RBC 4.59 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 11.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 41.5 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 90.4 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 24.8 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.5 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 58.2 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.4 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 14 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 11.2 fL 6.5-12\\nPLATELET COUNT 304 X103/uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 34.5 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.34 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis, Hypochromia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:10 ac tt?\\nReport Released on (RRT) 122 Jul 2019 08:13 Oe <=\\nSample Type : EDTA oo\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032040/A6750\\n\\nPage : 2 of 19\\nBarcode : M9261427\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.16 ug/l <5\\nCADMIUM ICP-MS 0.1 ug/l < 1.5\\nMERCURY ICP-MS 0.43 ug/l <5\\nLEAD ICP-MS 21.59 ug/l < 150\\nCHROMIUM ICP-MS 0.64 ug/l < 30\\nBARIUM ICP-MS 1.84 ug/l < 30\\nCOBALT ICP-MS 0.3 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.5 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 17.51 ug/l 8 - 38\\nANTIMONY ICP-MS 7.93 ug/l 0.10 - 18\\nTIN ICP-MS 0.22 ug/l <2\\nMOLYBDENUM ICP-MS 0.37 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.06 ug/l <4\\nVANADIUM ICP-MS 0.71 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.16 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 146.82 ug/l 60 - 340\\nALUMINIUM ICP-MS 2.83 ug/l < 30\\nNICKEL ICP-MS 2.59 ug/l <15\\nMANGANESE ICP-MS 20.76 ug/I 7.10 - 20\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:10 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 08:13 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107032040/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261427 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 16.4 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 1.02 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 29.2 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 31.7 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.I.A 176 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 7 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 104 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 91 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.9 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 8 of 19\\nBarcode 100274163\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 6.6 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 143 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n122 Jul 2019 00:10\\n122 Jul 2019 08:13\\n\\nGul\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032040/A6750 .\\n\\nPage : 1 of 19\\n:M9261427\\n\\x0c   \\n\\nPROCESSED AT: F\\nThyrecare cap, Thyrocare’\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 emir Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED s:_~_ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n\\n- 6 PART (DIFF)\\n\\nREF. BY : SELF\\n\\n \\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 7.29 X103/uL  4.0-10.0\\nNEUTROPHILS 63.7 % 40-80\\nLYMPHOCYTE PERCENTAGE 32.1 % 20.0-40.0\\nMONOCYTES 2.5 % 0.0-10.0\\nEOSINOPHILS 1.2 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.64 X103/uL  2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 2.34 X103/uL — 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.18 X 103 / pL 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.01 X 103 / pL 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.09 X103/uL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0.0-0.3\\nTOTAL RBC 4.59 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 11.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 41.5 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 90.4 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 24.8 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.5 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 58.2 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.4 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 14 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 11.2 fL 6.5-12\\nPLATELET COUNT 304 X103/uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 34.5 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.34 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis, Hypochromia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:10 ac tt?\\nReport Released on (RRT) 122 Jul 2019 08:13 Oe <=\\nSample Type : EDTA oo\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032040/A6750\\n\\nPage : 2 of 19\\nBarcode : M9261427\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.16 ug/l <5\\nCADMIUM ICP-MS 0.1 ug/l < 1.5\\nMERCURY ICP-MS 0.43 ug/l <5\\nLEAD ICP-MS 21.59 ug/l < 150\\nCHROMIUM ICP-MS 0.64 ug/l < 30\\nBARIUM ICP-MS 1.84 ug/l < 30\\nCOBALT ICP-MS 0.3 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.5 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 17.51 ug/l 8 - 38\\nANTIMONY ICP-MS 7.93 ug/l 0.10 - 18\\nTIN ICP-MS 0.22 ug/l <2\\nMOLYBDENUM ICP-MS 0.37 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.06 ug/l <4\\nVANADIUM ICP-MS 0.71 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.16 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 146.82 ug/l 60 - 340\\nALUMINIUM ICP-MS 2.83 ug/l < 30\\nNICKEL ICP-MS 2.59 ug/l <15\\nMANGANESE ICP-MS 20.76 ug/I 7.10 - 20\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:10 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 08:13 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107032040/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261427 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 16.4 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 1.02 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 29.2 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 31.7 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.I.A 176 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 7 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 104 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 91 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.9 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 8 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 4.5 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : 00274163\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 6.6 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 143 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n122 Jul 2019 00:10\\n122 Jul 2019 08:13\\n\\nGul\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032040/A6750 .\\n\\nPage : 1 of 19\\n:M9261427\\n\\x0c   \\n\\nPROCESSED AT: F\\nThyrecare cap, Thyrocare’\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 emir Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED s:_~_ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n\\n- 6 PART (DIFF)\\n\\nREF. BY : SELF\\n\\n \\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 7.29 X103/uL  4.0-10.0\\nNEUTROPHILS 63.7 % 40-80\\nLYMPHOCYTE PERCENTAGE 32.1 % 20.0-40.0\\nMONOCYTES 2.5 % 0.0-10.0\\nEOSINOPHILS 1.2 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.64 X103/uL  2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 2.34 X103/uL — 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.18 X 103 / pL 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.01 X 103 / pL 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.09 X103/uL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0.0-0.3\\nTOTAL RBC 4.59 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 11.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 41.5 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 90.4 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 24.8 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.5 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 58.2 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.4 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 14 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 11.2 fL 6.5-12\\nPLATELET COUNT 304 X103/uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 34.5 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.34 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis, Hypochromia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:10 ac tt?\\nReport Released on (RRT) 122 Jul 2019 08:13 Oe <=\\nSample Type : EDTA oo\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032040/A6750\\n\\nPage : 2 of 19\\nBarcode : M9261427\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.16 ug/l <5\\nCADMIUM ICP-MS 0.1 ug/l < 1.5\\nMERCURY ICP-MS 0.43 ug/l <5\\nLEAD ICP-MS 21.59 ug/l < 150\\nCHROMIUM ICP-MS 0.64 ug/l < 30\\nBARIUM ICP-MS 1.84 ug/l < 30\\nCOBALT ICP-MS 0.3 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.5 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 17.51 ug/l 8 - 38\\nANTIMONY ICP-MS 7.93 ug/l 0.10 - 18\\nTIN ICP-MS 0.22 ug/l <2\\nMOLYBDENUM ICP-MS 0.37 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.06 ug/l <4\\nVANADIUM ICP-MS 0.71 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.16 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 146.82 ug/l 60 - 340\\nALUMINIUM ICP-MS 2.83 ug/l < 30\\nNICKEL ICP-MS 2.59 ug/l <15\\nMANGANESE ICP-MS 20.76 ug/I 7.10 - 20\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:10 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 08:13 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107032040/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261427 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 16.4 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 1.02 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 29.2 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 31.7 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.I.A 176 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 7 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 104 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 91 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.9 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 8 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 4.5 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM COPPER PHOTOMETRY 154.7 yg/dL\\n\\nReference Range :-\\n\\nMALE : 63.5 - 150\\nFEMALE : 80 - 155\\n\\nCLINICAL SIGNIFICANCE\\n\\nCOPPER IS AN IMPORTANT TRACE ELEMENT AND A COMPONENT OF NUMEROUS ENZYMES AND PROTEINS INVOLVED\\nIN ENERGY PRODUCTION, CONNECTIVE TISSUE FORMATION, MELANIN SYNTHESIS, IRON METABOLISM,\\nDEVELOPMENT OF CENTRAL NERVOUS SYSTEM, ANGIOGENESIS AS WELL AS AN ANTIOXIDANT.\\n\\nDEFICIENCY CAN CAUSE - MALNOURISHMENT, CARDIOVASCULAR DISEASE, ANEMIA & NEUROPATHY. TOXICITY MAY\\nBE MANIFESTED AS ACUTE RENAL FAILURE, GASTROENTERITIS & CHRONIC LIVER DISEASE.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE: 948-952.\\n\\nPlease correlate with clinical conditions.\\nMethod:- 3,5-DIBR-PAESA\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 10 of 19\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 6.6 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 143 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n122 Jul 2019 00:10\\n122 Jul 2019 08:13\\n\\nGul\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032040/A6750 .\\n\\nPage : 1 of 19\\n:M9261427\\n\\x0c   \\n\\nPROCESSED AT: F\\nThyrecare cap, Thyrocare’\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 emir Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED s:_~_ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n\\n- 6 PART (DIFF)\\n\\nREF. BY : SELF\\n\\n \\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 7.29 X103/uL  4.0-10.0\\nNEUTROPHILS 63.7 % 40-80\\nLYMPHOCYTE PERCENTAGE 32.1 % 20.0-40.0\\nMONOCYTES 2.5 % 0.0-10.0\\nEOSINOPHILS 1.2 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.64 X103/uL  2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 2.34 X103/uL — 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.18 X 103 / pL 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.01 X 103 / pL 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.09 X103/uL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0.0-0.3\\nTOTAL RBC 4.59 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 11.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 41.5 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 90.4 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 24.8 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.5 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 58.2 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.4 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 14 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 11.2 fL 6.5-12\\nPLATELET COUNT 304 X103/uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 34.5 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.34 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis, Hypochromia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:10 ac tt?\\nReport Released on (RRT) 122 Jul 2019 08:13 Oe <=\\nSample Type : EDTA oo\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032040/A6750\\n\\nPage : 2 of 19\\nBarcode : M9261427\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.16 ug/l <5\\nCADMIUM ICP-MS 0.1 ug/l < 1.5\\nMERCURY ICP-MS 0.43 ug/l <5\\nLEAD ICP-MS 21.59 ug/l < 150\\nCHROMIUM ICP-MS 0.64 ug/l < 30\\nBARIUM ICP-MS 1.84 ug/l < 30\\nCOBALT ICP-MS 0.3 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.5 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 17.51 ug/l 8 - 38\\nANTIMONY ICP-MS 7.93 ug/l 0.10 - 18\\nTIN ICP-MS 0.22 ug/l <2\\nMOLYBDENUM ICP-MS 0.37 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.06 ug/l <4\\nVANADIUM ICP-MS 0.71 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.16 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 146.82 ug/l 60 - 340\\nALUMINIUM ICP-MS 2.83 ug/l < 30\\nNICKEL ICP-MS 2.59 ug/l <15\\nMANGANESE ICP-MS 20.76 ug/I 7.10 - 20\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:10 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 08:13 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107032040/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261427 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 16.4 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 1.02 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 29.2 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 31.7 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.I.A 176 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 7 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 104 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 91 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.9 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 8 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 4.5 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM COPPER PHOTOMETRY 154.7 yg/dL\\n\\nReference Range :-\\n\\nMALE : 63.5 - 150\\nFEMALE : 80 - 155\\n\\nCLINICAL SIGNIFICANCE\\n\\nCOPPER IS AN IMPORTANT TRACE ELEMENT AND A COMPONENT OF NUMEROUS ENZYMES AND PROTEINS INVOLVED\\nIN ENERGY PRODUCTION, CONNECTIVE TISSUE FORMATION, MELANIN SYNTHESIS, IRON METABOLISM,\\nDEVELOPMENT OF CENTRAL NERVOUS SYSTEM, ANGIOGENESIS AS WELL AS AN ANTIOXIDANT.\\n\\nDEFICIENCY CAN CAUSE - MALNOURISHMENT, CARDIOVASCULAR DISEASE, ANEMIA & NEUROPATHY. TOXICITY MAY\\nBE MANIFESTED AS ACUTE RENAL FAILURE, GASTROENTERITIS & CHRONIC LIVER DISEASE.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE: 948-952.\\n\\nPlease correlate with clinical conditions.\\nMethod:- 3,5-DIBR-PAESA\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 10 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM ZINC PHOTOMETRY 55.38 yg/dL\\n\\nReference Range :-\\n\\n52 - 286\\n\\nCLINICAL SIGNIFICANCE\\nZINC IS ONE OF THE ESSENTIAL TRACE ELEMENTS IN THE BODY. ITS METALLOENZYMES PLAY A KEY ROLE IN\\nPROTEIN AND NUCLEIC ACID SYNTHESIS, GENE EXPRESSION, WOUND HEALING, AS AN ANTIOXIDANT, ETC.\\n\\nDEFICIENCY CAN CAUSE - POOR WOUND HEALING, GASTROENTERITIS, IMPAIRED SPERMATOGENESIS, ALZHEIMER’S\\nDISEASE, ETC. TOXICITY MAY BE MANIFESTED AS PANCREATITIS, GASTRIC ULCER, ANEMIA, PULMONARY FIBROSIS.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE:960-965.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- NITRO - PAPS\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 11 of 19\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 6.6 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 143 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n122 Jul 2019 00:10\\n122 Jul 2019 08:13\\n\\nGul\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032040/A6750 .\\n\\nPage : 1 of 19\\n:M9261427\\n\\x0c   \\n\\nPROCESSED AT: F\\nThyrecare cap, Thyrocare’\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 emir Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED s:_~_ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n\\n- 6 PART (DIFF)\\n\\nREF. BY : SELF\\n\\n \\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 7.29 X103/uL  4.0-10.0\\nNEUTROPHILS 63.7 % 40-80\\nLYMPHOCYTE PERCENTAGE 32.1 % 20.0-40.0\\nMONOCYTES 2.5 % 0.0-10.0\\nEOSINOPHILS 1.2 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.64 X103/uL  2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 2.34 X103/uL — 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.18 X 103 / pL 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.01 X 103 / pL 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.09 X103/uL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0.0-0.3\\nTOTAL RBC 4.59 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 11.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 41.5 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 90.4 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 24.8 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.5 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 58.2 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.4 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 14 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 11.2 fL 6.5-12\\nPLATELET COUNT 304 X103/uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 34.5 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.34 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis, Hypochromia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:10 ac tt?\\nReport Released on (RRT) 122 Jul 2019 08:13 Oe <=\\nSample Type : EDTA oo\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032040/A6750\\n\\nPage : 2 of 19\\nBarcode : M9261427\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.16 ug/l <5\\nCADMIUM ICP-MS 0.1 ug/l < 1.5\\nMERCURY ICP-MS 0.43 ug/l <5\\nLEAD ICP-MS 21.59 ug/l < 150\\nCHROMIUM ICP-MS 0.64 ug/l < 30\\nBARIUM ICP-MS 1.84 ug/l < 30\\nCOBALT ICP-MS 0.3 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.5 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 17.51 ug/l 8 - 38\\nANTIMONY ICP-MS 7.93 ug/l 0.10 - 18\\nTIN ICP-MS 0.22 ug/l <2\\nMOLYBDENUM ICP-MS 0.37 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.06 ug/l <4\\nVANADIUM ICP-MS 0.71 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.16 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 146.82 ug/l 60 - 340\\nALUMINIUM ICP-MS 2.83 ug/l < 30\\nNICKEL ICP-MS 2.59 ug/l <15\\nMANGANESE ICP-MS 20.76 ug/I 7.10 - 20\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:10 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 08:13 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107032040/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261427 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 16.4 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 1.02 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 29.2 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 31.7 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.I.A 176 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 7 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 104 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 91 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.9 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 8 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 4.5 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM COPPER PHOTOMETRY 154.7 yg/dL\\n\\nReference Range :-\\n\\nMALE : 63.5 - 150\\nFEMALE : 80 - 155\\n\\nCLINICAL SIGNIFICANCE\\n\\nCOPPER IS AN IMPORTANT TRACE ELEMENT AND A COMPONENT OF NUMEROUS ENZYMES AND PROTEINS INVOLVED\\nIN ENERGY PRODUCTION, CONNECTIVE TISSUE FORMATION, MELANIN SYNTHESIS, IRON METABOLISM,\\nDEVELOPMENT OF CENTRAL NERVOUS SYSTEM, ANGIOGENESIS AS WELL AS AN ANTIOXIDANT.\\n\\nDEFICIENCY CAN CAUSE - MALNOURISHMENT, CARDIOVASCULAR DISEASE, ANEMIA & NEUROPATHY. TOXICITY MAY\\nBE MANIFESTED AS ACUTE RENAL FAILURE, GASTROENTERITIS & CHRONIC LIVER DISEASE.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE: 948-952.\\n\\nPlease correlate with clinical conditions.\\nMethod:- 3,5-DIBR-PAESA\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 10 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM ZINC PHOTOMETRY 55.38 yg/dL\\n\\nReference Range :-\\n\\n52 - 286\\n\\nCLINICAL SIGNIFICANCE\\nZINC IS ONE OF THE ESSENTIAL TRACE ELEMENTS IN THE BODY. ITS METALLOENZYMES PLAY A KEY ROLE IN\\nPROTEIN AND NUCLEIC ACID SYNTHESIS, GENE EXPRESSION, WOUND HEALING, AS AN ANTIOXIDANT, ETC.\\n\\nDEFICIENCY CAN CAUSE - POOR WOUND HEALING, GASTROENTERITIS, IMPAIRED SPERMATOGENESIS, ALZHEIMER’S\\nDISEASE, ETC. TOXICITY MAY BE MANIFESTED AS PANCREATITIS, GASTRIC ULCER, ANEMIA, PULMONARY FIBROSIS.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE:960-965.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- NITRO - PAPS\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 11 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nTESTOSTERONE C.L.I.A 15.04 ng/dL\\n\\nReference Range :-\\n\\nAdult Male\\n\\n21-49Yrs: 164.94 - 753.38\\n50 - 89 Yrs: 86.49 - 788.22\\nAdult Female\\n\\nPre-Menopause : 12.09 - 59.46\\nPost-Menopause: < 7.00 - 48.93\\nBoys\\n\\n2-10 Years : < 7.00 - 25.91\\n\\n11 Years : < 7.00 - 341.53\\n\\n12 Years : < 7.00 - 562.59\\n\\n13 Years : 9.34 - 562.93\\n\\n14 Years : 23.28 - 742.46\\n\\n15 Years : 144.15 - 841.44\\n\\n16-21 Years : 118.22 - 948.56\\n\\nGirls\\n\\n2-10 Years: < 7.00 - 108.30\\n11-15 Years : < 7.00- 48.40\\n16-21 Years : 17.55- 50.41\\n\\nClinical Significance:\\n\\nClinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males. Major\\ncauses of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,\\nHypopituitarism some types of liver and kidney diseases and critical illness.\\n\\nSpecifications: Precision: Intra assay (%CV): 8.5 %, Inter assay (%CV): 12.6%; Sensitivity: 7 ng/dL.\\nExternal quality control program participation:\\n\\nCollege of American pathologists: Ligand assay (special) survey; cap number: 7193855-01\\n\\nPlease correlate with clinical conditions.\\nMethod:- FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 12 of 19\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 6.6 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 143 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n122 Jul 2019 00:10\\n122 Jul 2019 08:13\\n\\nGul\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032040/A6750 .\\n\\nPage : 1 of 19\\n:M9261427\\n\\x0c   \\n\\nPROCESSED AT: F\\nThyrecare cap, Thyrocare’\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 emir Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED s:_~_ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n\\n- 6 PART (DIFF)\\n\\nREF. BY : SELF\\n\\n \\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 7.29 X103/uL  4.0-10.0\\nNEUTROPHILS 63.7 % 40-80\\nLYMPHOCYTE PERCENTAGE 32.1 % 20.0-40.0\\nMONOCYTES 2.5 % 0.0-10.0\\nEOSINOPHILS 1.2 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.64 X103/uL  2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 2.34 X103/uL — 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.18 X 103 / pL 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.01 X 103 / pL 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.09 X103/uL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0.0-0.3\\nTOTAL RBC 4.59 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 11.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 41.5 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 90.4 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 24.8 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.5 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 58.2 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.4 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 14 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 11.2 fL 6.5-12\\nPLATELET COUNT 304 X103/uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 34.5 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.34 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis, Hypochromia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:10 ac tt?\\nReport Released on (RRT) 122 Jul 2019 08:13 Oe <=\\nSample Type : EDTA oo\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032040/A6750\\n\\nPage : 2 of 19\\nBarcode : M9261427\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.16 ug/l <5\\nCADMIUM ICP-MS 0.1 ug/l < 1.5\\nMERCURY ICP-MS 0.43 ug/l <5\\nLEAD ICP-MS 21.59 ug/l < 150\\nCHROMIUM ICP-MS 0.64 ug/l < 30\\nBARIUM ICP-MS 1.84 ug/l < 30\\nCOBALT ICP-MS 0.3 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.5 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 17.51 ug/l 8 - 38\\nANTIMONY ICP-MS 7.93 ug/l 0.10 - 18\\nTIN ICP-MS 0.22 ug/l <2\\nMOLYBDENUM ICP-MS 0.37 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.06 ug/l <4\\nVANADIUM ICP-MS 0.71 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.16 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 146.82 ug/l 60 - 340\\nALUMINIUM ICP-MS 2.83 ug/l < 30\\nNICKEL ICP-MS 2.59 ug/l <15\\nMANGANESE ICP-MS 20.76 ug/I 7.10 - 20\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:10 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 08:13 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107032040/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261427 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 16.4 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 1.02 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 29.2 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 31.7 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.I.A 176 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 7 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 104 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 91 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.9 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 8 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 4.5 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM COPPER PHOTOMETRY 154.7 yg/dL\\n\\nReference Range :-\\n\\nMALE : 63.5 - 150\\nFEMALE : 80 - 155\\n\\nCLINICAL SIGNIFICANCE\\n\\nCOPPER IS AN IMPORTANT TRACE ELEMENT AND A COMPONENT OF NUMEROUS ENZYMES AND PROTEINS INVOLVED\\nIN ENERGY PRODUCTION, CONNECTIVE TISSUE FORMATION, MELANIN SYNTHESIS, IRON METABOLISM,\\nDEVELOPMENT OF CENTRAL NERVOUS SYSTEM, ANGIOGENESIS AS WELL AS AN ANTIOXIDANT.\\n\\nDEFICIENCY CAN CAUSE - MALNOURISHMENT, CARDIOVASCULAR DISEASE, ANEMIA & NEUROPATHY. TOXICITY MAY\\nBE MANIFESTED AS ACUTE RENAL FAILURE, GASTROENTERITIS & CHRONIC LIVER DISEASE.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE: 948-952.\\n\\nPlease correlate with clinical conditions.\\nMethod:- 3,5-DIBR-PAESA\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 10 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM ZINC PHOTOMETRY 55.38 yg/dL\\n\\nReference Range :-\\n\\n52 - 286\\n\\nCLINICAL SIGNIFICANCE\\nZINC IS ONE OF THE ESSENTIAL TRACE ELEMENTS IN THE BODY. ITS METALLOENZYMES PLAY A KEY ROLE IN\\nPROTEIN AND NUCLEIC ACID SYNTHESIS, GENE EXPRESSION, WOUND HEALING, AS AN ANTIOXIDANT, ETC.\\n\\nDEFICIENCY CAN CAUSE - POOR WOUND HEALING, GASTROENTERITIS, IMPAIRED SPERMATOGENESIS, ALZHEIMER’S\\nDISEASE, ETC. TOXICITY MAY BE MANIFESTED AS PANCREATITIS, GASTRIC ULCER, ANEMIA, PULMONARY FIBROSIS.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE:960-965.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- NITRO - PAPS\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 11 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nTESTOSTERONE C.L.I.A 15.04 ng/dL\\n\\nReference Range :-\\n\\nAdult Male\\n\\n21-49Yrs: 164.94 - 753.38\\n50 - 89 Yrs: 86.49 - 788.22\\nAdult Female\\n\\nPre-Menopause : 12.09 - 59.46\\nPost-Menopause: < 7.00 - 48.93\\nBoys\\n\\n2-10 Years : < 7.00 - 25.91\\n\\n11 Years : < 7.00 - 341.53\\n\\n12 Years : < 7.00 - 562.59\\n\\n13 Years : 9.34 - 562.93\\n\\n14 Years : 23.28 - 742.46\\n\\n15 Years : 144.15 - 841.44\\n\\n16-21 Years : 118.22 - 948.56\\n\\nGirls\\n\\n2-10 Years: < 7.00 - 108.30\\n11-15 Years : < 7.00- 48.40\\n16-21 Years : 17.55- 50.41\\n\\nClinical Significance:\\n\\nClinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males. Major\\ncauses of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,\\nHypopituitarism some types of liver and kidney diseases and critical illness.\\n\\nSpecifications: Precision: Intra assay (%CV): 8.5 %, Inter assay (%CV): 12.6%; Sensitivity: 7 ng/dL.\\nExternal quality control program participation:\\n\\nCollege of American pathologists: Ligand assay (special) survey; cap number: 7193855-01\\n\\nPlease correlate with clinical conditions.\\nMethod:- FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 12 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n    \\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\ncentiieAte no: C2407\\n\\ncay Thyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\nREF. BY : SELF\\n\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME\\n\\nIRON\\n\\nReference Range :\\nMale : 65-175\\nFemale : 50 - 170\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nPRADESH,531116\\n\\nTECHNOLOGY VALUE UNITS\\n\\nPHOTOMETRY 44.3 ug/dl\\n\\nMethod : _FERROZINE METHOD WITHOUT DEPROTEINIZATION\\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 373 g/dl\\n\\nReference Range :\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n% TRANSFERRIN SATURATION\\n\\nReference Range :\\n13-45\\n\\nCALCULATED 11.88 %\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n1 2107033280/A6750\\n100274163\\n\\n:20 Jul 2019 18:00\\n22 Jul 2019 00:28 ac tt?\\n122 Jul 2019 12:44 Oe\\n\\n: SERUM\\n\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nPage : 13 of 19\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 6.6 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 143 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n122 Jul 2019 00:10\\n122 Jul 2019 08:13\\n\\nGul\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032040/A6750 .\\n\\nPage : 1 of 19\\n:M9261427\\n\\x0c   \\n\\nPROCESSED AT: F\\nThyrecare cap, Thyrocare’\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 emir Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED s:_~_ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n\\n- 6 PART (DIFF)\\n\\nREF. BY : SELF\\n\\n \\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 7.29 X103/uL  4.0-10.0\\nNEUTROPHILS 63.7 % 40-80\\nLYMPHOCYTE PERCENTAGE 32.1 % 20.0-40.0\\nMONOCYTES 2.5 % 0.0-10.0\\nEOSINOPHILS 1.2 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.64 X103/uL  2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 2.34 X103/uL — 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.18 X 103 / pL 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.01 X 103 / pL 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.09 X103/uL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0.0-0.3\\nTOTAL RBC 4.59 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 11.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 41.5 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 90.4 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 24.8 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.5 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 58.2 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.4 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 14 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 11.2 fL 6.5-12\\nPLATELET COUNT 304 X103/uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 34.5 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.34 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis, Hypochromia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:10 ac tt?\\nReport Released on (RRT) 122 Jul 2019 08:13 Oe <=\\nSample Type : EDTA oo\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032040/A6750\\n\\nPage : 2 of 19\\nBarcode : M9261427\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.16 ug/l <5\\nCADMIUM ICP-MS 0.1 ug/l < 1.5\\nMERCURY ICP-MS 0.43 ug/l <5\\nLEAD ICP-MS 21.59 ug/l < 150\\nCHROMIUM ICP-MS 0.64 ug/l < 30\\nBARIUM ICP-MS 1.84 ug/l < 30\\nCOBALT ICP-MS 0.3 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.5 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 17.51 ug/l 8 - 38\\nANTIMONY ICP-MS 7.93 ug/l 0.10 - 18\\nTIN ICP-MS 0.22 ug/l <2\\nMOLYBDENUM ICP-MS 0.37 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.06 ug/l <4\\nVANADIUM ICP-MS 0.71 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.16 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 146.82 ug/l 60 - 340\\nALUMINIUM ICP-MS 2.83 ug/l < 30\\nNICKEL ICP-MS 2.59 ug/l <15\\nMANGANESE ICP-MS 20.76 ug/I 7.10 - 20\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:10 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 08:13 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107032040/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261427 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 16.4 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 1.02 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 29.2 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 31.7 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.I.A 176 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 7 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 104 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 91 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.9 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 8 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 4.5 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM COPPER PHOTOMETRY 154.7 yg/dL\\n\\nReference Range :-\\n\\nMALE : 63.5 - 150\\nFEMALE : 80 - 155\\n\\nCLINICAL SIGNIFICANCE\\n\\nCOPPER IS AN IMPORTANT TRACE ELEMENT AND A COMPONENT OF NUMEROUS ENZYMES AND PROTEINS INVOLVED\\nIN ENERGY PRODUCTION, CONNECTIVE TISSUE FORMATION, MELANIN SYNTHESIS, IRON METABOLISM,\\nDEVELOPMENT OF CENTRAL NERVOUS SYSTEM, ANGIOGENESIS AS WELL AS AN ANTIOXIDANT.\\n\\nDEFICIENCY CAN CAUSE - MALNOURISHMENT, CARDIOVASCULAR DISEASE, ANEMIA & NEUROPATHY. TOXICITY MAY\\nBE MANIFESTED AS ACUTE RENAL FAILURE, GASTROENTERITIS & CHRONIC LIVER DISEASE.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE: 948-952.\\n\\nPlease correlate with clinical conditions.\\nMethod:- 3,5-DIBR-PAESA\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 10 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM ZINC PHOTOMETRY 55.38 yg/dL\\n\\nReference Range :-\\n\\n52 - 286\\n\\nCLINICAL SIGNIFICANCE\\nZINC IS ONE OF THE ESSENTIAL TRACE ELEMENTS IN THE BODY. ITS METALLOENZYMES PLAY A KEY ROLE IN\\nPROTEIN AND NUCLEIC ACID SYNTHESIS, GENE EXPRESSION, WOUND HEALING, AS AN ANTIOXIDANT, ETC.\\n\\nDEFICIENCY CAN CAUSE - POOR WOUND HEALING, GASTROENTERITIS, IMPAIRED SPERMATOGENESIS, ALZHEIMER’S\\nDISEASE, ETC. TOXICITY MAY BE MANIFESTED AS PANCREATITIS, GASTRIC ULCER, ANEMIA, PULMONARY FIBROSIS.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE:960-965.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- NITRO - PAPS\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 11 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nTESTOSTERONE C.L.I.A 15.04 ng/dL\\n\\nReference Range :-\\n\\nAdult Male\\n\\n21-49Yrs: 164.94 - 753.38\\n50 - 89 Yrs: 86.49 - 788.22\\nAdult Female\\n\\nPre-Menopause : 12.09 - 59.46\\nPost-Menopause: < 7.00 - 48.93\\nBoys\\n\\n2-10 Years : < 7.00 - 25.91\\n\\n11 Years : < 7.00 - 341.53\\n\\n12 Years : < 7.00 - 562.59\\n\\n13 Years : 9.34 - 562.93\\n\\n14 Years : 23.28 - 742.46\\n\\n15 Years : 144.15 - 841.44\\n\\n16-21 Years : 118.22 - 948.56\\n\\nGirls\\n\\n2-10 Years: < 7.00 - 108.30\\n11-15 Years : < 7.00- 48.40\\n16-21 Years : 17.55- 50.41\\n\\nClinical Significance:\\n\\nClinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males. Major\\ncauses of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,\\nHypopituitarism some types of liver and kidney diseases and critical illness.\\n\\nSpecifications: Precision: Intra assay (%CV): 8.5 %, Inter assay (%CV): 12.6%; Sensitivity: 7 ng/dL.\\nExternal quality control program participation:\\n\\nCollege of American pathologists: Ligand assay (special) survey; cap number: 7193855-01\\n\\nPlease correlate with clinical conditions.\\nMethod:- FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 12 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n    \\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\ncentiieAte no: C2407\\n\\ncay Thyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\nREF. BY : SELF\\n\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME\\n\\nIRON\\n\\nReference Range :\\nMale : 65-175\\nFemale : 50 - 170\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nPRADESH,531116\\n\\nTECHNOLOGY VALUE UNITS\\n\\nPHOTOMETRY 44.3 ug/dl\\n\\nMethod : _FERROZINE METHOD WITHOUT DEPROTEINIZATION\\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 373 g/dl\\n\\nReference Range :\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n% TRANSFERRIN SATURATION\\n\\nReference Range :\\n13-45\\n\\nCALCULATED 11.88 %\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n1 2107033280/A6750\\n100274163\\n\\n:20 Jul 2019 18:00\\n22 Jul 2019 00:28 ac tt?\\n122 Jul 2019 12:44 Oe\\n\\n: SERUM\\n\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nPage : 13 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 50.4 U/L 45 - 129\\nBILIRUBIN -DIRECT PHOTOMETRY 0.09 mg/dl < 0.3\\nBILIRUBIN - TOTAL PHOTOMETRY 0.41 mg/dl 0.3-1.2\\nBILIRUBIN (INDIRECT) CALCULATED 0.32 mg/dl 0-0.9\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 11.3 u/l < 38\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 10.1 u/l < 31\\n\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 7.9 u/l < 34\\n\\nPROTEIN - TOTAL PHOTOMETRY 6.9 am/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 4.1 gm/dl 3.2-4.8\\nSERUM GLOBULIN PHOTOMETRY 2.8 gm/dL 2.5-3.4\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.46 Ratio 0.9 -2\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - Modified IFCC method\\n\\nBILD - Vanadate Oxidation\\n\\nBILT - Vanadate Oxidation\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - Modified IFCC method\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:28 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107033280/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : 00274163 Page : 14 of 19\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 6.6 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 143 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n122 Jul 2019 00:10\\n122 Jul 2019 08:13\\n\\nGul\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032040/A6750 .\\n\\nPage : 1 of 19\\n:M9261427\\n\\x0c   \\n\\nPROCESSED AT: F\\nThyrecare cap, Thyrocare’\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 emir Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED s:_~_ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n\\n- 6 PART (DIFF)\\n\\nREF. BY : SELF\\n\\n \\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 7.29 X103/uL  4.0-10.0\\nNEUTROPHILS 63.7 % 40-80\\nLYMPHOCYTE PERCENTAGE 32.1 % 20.0-40.0\\nMONOCYTES 2.5 % 0.0-10.0\\nEOSINOPHILS 1.2 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.64 X103/uL  2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 2.34 X103/uL — 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.18 X 103 / pL 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.01 X 103 / pL 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.09 X103/uL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0.0-0.3\\nTOTAL RBC 4.59 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 11.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 41.5 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 90.4 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 24.8 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.5 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 58.2 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.4 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 14 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 11.2 fL 6.5-12\\nPLATELET COUNT 304 X103/uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 34.5 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.34 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis, Hypochromia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:10 ac tt?\\nReport Released on (RRT) 122 Jul 2019 08:13 Oe <=\\nSample Type : EDTA oo\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032040/A6750\\n\\nPage : 2 of 19\\nBarcode : M9261427\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.16 ug/l <5\\nCADMIUM ICP-MS 0.1 ug/l < 1.5\\nMERCURY ICP-MS 0.43 ug/l <5\\nLEAD ICP-MS 21.59 ug/l < 150\\nCHROMIUM ICP-MS 0.64 ug/l < 30\\nBARIUM ICP-MS 1.84 ug/l < 30\\nCOBALT ICP-MS 0.3 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.5 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 17.51 ug/l 8 - 38\\nANTIMONY ICP-MS 7.93 ug/l 0.10 - 18\\nTIN ICP-MS 0.22 ug/l <2\\nMOLYBDENUM ICP-MS 0.37 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.06 ug/l <4\\nVANADIUM ICP-MS 0.71 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.16 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 146.82 ug/l 60 - 340\\nALUMINIUM ICP-MS 2.83 ug/l < 30\\nNICKEL ICP-MS 2.59 ug/l <15\\nMANGANESE ICP-MS 20.76 ug/I 7.10 - 20\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:10 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 08:13 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107032040/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261427 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 16.4 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 1.02 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 29.2 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 31.7 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.I.A 176 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 7 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 104 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 91 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.9 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 8 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 4.5 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM COPPER PHOTOMETRY 154.7 yg/dL\\n\\nReference Range :-\\n\\nMALE : 63.5 - 150\\nFEMALE : 80 - 155\\n\\nCLINICAL SIGNIFICANCE\\n\\nCOPPER IS AN IMPORTANT TRACE ELEMENT AND A COMPONENT OF NUMEROUS ENZYMES AND PROTEINS INVOLVED\\nIN ENERGY PRODUCTION, CONNECTIVE TISSUE FORMATION, MELANIN SYNTHESIS, IRON METABOLISM,\\nDEVELOPMENT OF CENTRAL NERVOUS SYSTEM, ANGIOGENESIS AS WELL AS AN ANTIOXIDANT.\\n\\nDEFICIENCY CAN CAUSE - MALNOURISHMENT, CARDIOVASCULAR DISEASE, ANEMIA & NEUROPATHY. TOXICITY MAY\\nBE MANIFESTED AS ACUTE RENAL FAILURE, GASTROENTERITIS & CHRONIC LIVER DISEASE.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE: 948-952.\\n\\nPlease correlate with clinical conditions.\\nMethod:- 3,5-DIBR-PAESA\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 10 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM ZINC PHOTOMETRY 55.38 yg/dL\\n\\nReference Range :-\\n\\n52 - 286\\n\\nCLINICAL SIGNIFICANCE\\nZINC IS ONE OF THE ESSENTIAL TRACE ELEMENTS IN THE BODY. ITS METALLOENZYMES PLAY A KEY ROLE IN\\nPROTEIN AND NUCLEIC ACID SYNTHESIS, GENE EXPRESSION, WOUND HEALING, AS AN ANTIOXIDANT, ETC.\\n\\nDEFICIENCY CAN CAUSE - POOR WOUND HEALING, GASTROENTERITIS, IMPAIRED SPERMATOGENESIS, ALZHEIMER’S\\nDISEASE, ETC. TOXICITY MAY BE MANIFESTED AS PANCREATITIS, GASTRIC ULCER, ANEMIA, PULMONARY FIBROSIS.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE:960-965.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- NITRO - PAPS\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 11 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nTESTOSTERONE C.L.I.A 15.04 ng/dL\\n\\nReference Range :-\\n\\nAdult Male\\n\\n21-49Yrs: 164.94 - 753.38\\n50 - 89 Yrs: 86.49 - 788.22\\nAdult Female\\n\\nPre-Menopause : 12.09 - 59.46\\nPost-Menopause: < 7.00 - 48.93\\nBoys\\n\\n2-10 Years : < 7.00 - 25.91\\n\\n11 Years : < 7.00 - 341.53\\n\\n12 Years : < 7.00 - 562.59\\n\\n13 Years : 9.34 - 562.93\\n\\n14 Years : 23.28 - 742.46\\n\\n15 Years : 144.15 - 841.44\\n\\n16-21 Years : 118.22 - 948.56\\n\\nGirls\\n\\n2-10 Years: < 7.00 - 108.30\\n11-15 Years : < 7.00- 48.40\\n16-21 Years : 17.55- 50.41\\n\\nClinical Significance:\\n\\nClinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males. Major\\ncauses of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,\\nHypopituitarism some types of liver and kidney diseases and critical illness.\\n\\nSpecifications: Precision: Intra assay (%CV): 8.5 %, Inter assay (%CV): 12.6%; Sensitivity: 7 ng/dL.\\nExternal quality control program participation:\\n\\nCollege of American pathologists: Ligand assay (special) survey; cap number: 7193855-01\\n\\nPlease correlate with clinical conditions.\\nMethod:- FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 12 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n    \\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\ncentiieAte no: C2407\\n\\ncay Thyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\nREF. BY : SELF\\n\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME\\n\\nIRON\\n\\nReference Range :\\nMale : 65-175\\nFemale : 50 - 170\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nPRADESH,531116\\n\\nTECHNOLOGY VALUE UNITS\\n\\nPHOTOMETRY 44.3 ug/dl\\n\\nMethod : _FERROZINE METHOD WITHOUT DEPROTEINIZATION\\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 373 g/dl\\n\\nReference Range :\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n% TRANSFERRIN SATURATION\\n\\nReference Range :\\n13-45\\n\\nCALCULATED 11.88 %\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n1 2107033280/A6750\\n100274163\\n\\n:20 Jul 2019 18:00\\n22 Jul 2019 00:28 ac tt?\\n122 Jul 2019 12:44 Oe\\n\\n: SERUM\\n\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nPage : 13 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 50.4 U/L 45 - 129\\nBILIRUBIN -DIRECT PHOTOMETRY 0.09 mg/dl < 0.3\\nBILIRUBIN - TOTAL PHOTOMETRY 0.41 mg/dl 0.3-1.2\\nBILIRUBIN (INDIRECT) CALCULATED 0.32 mg/dl 0-0.9\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 11.3 u/l < 38\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 10.1 u/l < 31\\n\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 7.9 u/l < 34\\n\\nPROTEIN - TOTAL PHOTOMETRY 6.9 am/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 4.1 gm/dl 3.2-4.8\\nSERUM GLOBULIN PHOTOMETRY 2.8 gm/dL 2.5-3.4\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.46 Ratio 0.9 -2\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - Modified IFCC method\\n\\nBILD - Vanadate Oxidation\\n\\nBILT - Vanadate Oxidation\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - Modified IFCC method\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:28 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107033280/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : 00274163 Page : 14 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nTOTAL CHOLESTEROL PHOTOMETRY 169 mg/dl 125-200\\n\\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 41 mg/dl 35-80\\nTRIGLYCERIDES PHOTOMETRY 202 mg/dl 25-200\\n\\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 101 mg/dl 85-130\\n\\nTC/ HDL CHOLESTEROL RATIO CALCULATED 4.2 Ratio 3-5\\n\\nLDL / HDL RATIO CALCULATED 2.5 Ratio 1.5-3.5\\n\\nVLDL CHOLESTEROL CALCULATED 40.4 mg/dl 5-40\\nNON-HDL CHOLESTEROL CALCULATED 128.4 mg/dl < 160\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nCHOL - CHOD POD METHOD\\n\\nHCHO - ENZYME SELECTIVE PROTECTION METHOD\\n\\nTRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]\\nLDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY\\n\\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\nLDL/ - Derived from serum HDL and LDL Values\\n\\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\\n\\nNHDL - Derived from serum Cholesterol and HDL values\\n\\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\\n\\nTOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\\n\\nDESIRABLE <200 Low <40 OPTIMAL <100 NORMAL <150\\n\\nBORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\\n\\nHIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499\\nHIGH 160-189 VERY HIGH >500\\nVERY HIGH >190\\n\\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:28 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107033280/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : 00274163 Page : 15 of 19\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 6.6 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 143 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n122 Jul 2019 00:10\\n122 Jul 2019 08:13\\n\\nGul\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032040/A6750 .\\n\\nPage : 1 of 19\\n:M9261427\\n\\x0c   \\n\\nPROCESSED AT: F\\nThyrecare cap, Thyrocare’\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 emir Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED s:_~_ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n\\n- 6 PART (DIFF)\\n\\nREF. BY : SELF\\n\\n \\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 7.29 X103/uL  4.0-10.0\\nNEUTROPHILS 63.7 % 40-80\\nLYMPHOCYTE PERCENTAGE 32.1 % 20.0-40.0\\nMONOCYTES 2.5 % 0.0-10.0\\nEOSINOPHILS 1.2 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.64 X103/uL  2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 2.34 X103/uL — 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.18 X 103 / pL 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.01 X 103 / pL 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.09 X103/uL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0.0-0.3\\nTOTAL RBC 4.59 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 11.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 41.5 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 90.4 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 24.8 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.5 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 58.2 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.4 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 14 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 11.2 fL 6.5-12\\nPLATELET COUNT 304 X103/uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 34.5 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.34 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis, Hypochromia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:10 ac tt?\\nReport Released on (RRT) 122 Jul 2019 08:13 Oe <=\\nSample Type : EDTA oo\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032040/A6750\\n\\nPage : 2 of 19\\nBarcode : M9261427\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.16 ug/l <5\\nCADMIUM ICP-MS 0.1 ug/l < 1.5\\nMERCURY ICP-MS 0.43 ug/l <5\\nLEAD ICP-MS 21.59 ug/l < 150\\nCHROMIUM ICP-MS 0.64 ug/l < 30\\nBARIUM ICP-MS 1.84 ug/l < 30\\nCOBALT ICP-MS 0.3 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.5 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 17.51 ug/l 8 - 38\\nANTIMONY ICP-MS 7.93 ug/l 0.10 - 18\\nTIN ICP-MS 0.22 ug/l <2\\nMOLYBDENUM ICP-MS 0.37 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.06 ug/l <4\\nVANADIUM ICP-MS 0.71 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.16 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 146.82 ug/l 60 - 340\\nALUMINIUM ICP-MS 2.83 ug/l < 30\\nNICKEL ICP-MS 2.59 ug/l <15\\nMANGANESE ICP-MS 20.76 ug/I 7.10 - 20\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:10 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 08:13 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107032040/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261427 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 16.4 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 1.02 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 29.2 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 31.7 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.I.A 176 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 7 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 104 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 91 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.9 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 8 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 4.5 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM COPPER PHOTOMETRY 154.7 yg/dL\\n\\nReference Range :-\\n\\nMALE : 63.5 - 150\\nFEMALE : 80 - 155\\n\\nCLINICAL SIGNIFICANCE\\n\\nCOPPER IS AN IMPORTANT TRACE ELEMENT AND A COMPONENT OF NUMEROUS ENZYMES AND PROTEINS INVOLVED\\nIN ENERGY PRODUCTION, CONNECTIVE TISSUE FORMATION, MELANIN SYNTHESIS, IRON METABOLISM,\\nDEVELOPMENT OF CENTRAL NERVOUS SYSTEM, ANGIOGENESIS AS WELL AS AN ANTIOXIDANT.\\n\\nDEFICIENCY CAN CAUSE - MALNOURISHMENT, CARDIOVASCULAR DISEASE, ANEMIA & NEUROPATHY. TOXICITY MAY\\nBE MANIFESTED AS ACUTE RENAL FAILURE, GASTROENTERITIS & CHRONIC LIVER DISEASE.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE: 948-952.\\n\\nPlease correlate with clinical conditions.\\nMethod:- 3,5-DIBR-PAESA\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 10 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM ZINC PHOTOMETRY 55.38 yg/dL\\n\\nReference Range :-\\n\\n52 - 286\\n\\nCLINICAL SIGNIFICANCE\\nZINC IS ONE OF THE ESSENTIAL TRACE ELEMENTS IN THE BODY. ITS METALLOENZYMES PLAY A KEY ROLE IN\\nPROTEIN AND NUCLEIC ACID SYNTHESIS, GENE EXPRESSION, WOUND HEALING, AS AN ANTIOXIDANT, ETC.\\n\\nDEFICIENCY CAN CAUSE - POOR WOUND HEALING, GASTROENTERITIS, IMPAIRED SPERMATOGENESIS, ALZHEIMER’S\\nDISEASE, ETC. TOXICITY MAY BE MANIFESTED AS PANCREATITIS, GASTRIC ULCER, ANEMIA, PULMONARY FIBROSIS.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE:960-965.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- NITRO - PAPS\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 11 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nTESTOSTERONE C.L.I.A 15.04 ng/dL\\n\\nReference Range :-\\n\\nAdult Male\\n\\n21-49Yrs: 164.94 - 753.38\\n50 - 89 Yrs: 86.49 - 788.22\\nAdult Female\\n\\nPre-Menopause : 12.09 - 59.46\\nPost-Menopause: < 7.00 - 48.93\\nBoys\\n\\n2-10 Years : < 7.00 - 25.91\\n\\n11 Years : < 7.00 - 341.53\\n\\n12 Years : < 7.00 - 562.59\\n\\n13 Years : 9.34 - 562.93\\n\\n14 Years : 23.28 - 742.46\\n\\n15 Years : 144.15 - 841.44\\n\\n16-21 Years : 118.22 - 948.56\\n\\nGirls\\n\\n2-10 Years: < 7.00 - 108.30\\n11-15 Years : < 7.00- 48.40\\n16-21 Years : 17.55- 50.41\\n\\nClinical Significance:\\n\\nClinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males. Major\\ncauses of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,\\nHypopituitarism some types of liver and kidney diseases and critical illness.\\n\\nSpecifications: Precision: Intra assay (%CV): 8.5 %, Inter assay (%CV): 12.6%; Sensitivity: 7 ng/dL.\\nExternal quality control program participation:\\n\\nCollege of American pathologists: Ligand assay (special) survey; cap number: 7193855-01\\n\\nPlease correlate with clinical conditions.\\nMethod:- FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 12 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n    \\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\ncentiieAte no: C2407\\n\\ncay Thyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\nREF. BY : SELF\\n\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME\\n\\nIRON\\n\\nReference Range :\\nMale : 65-175\\nFemale : 50 - 170\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nPRADESH,531116\\n\\nTECHNOLOGY VALUE UNITS\\n\\nPHOTOMETRY 44.3 ug/dl\\n\\nMethod : _FERROZINE METHOD WITHOUT DEPROTEINIZATION\\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 373 g/dl\\n\\nReference Range :\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n% TRANSFERRIN SATURATION\\n\\nReference Range :\\n13-45\\n\\nCALCULATED 11.88 %\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n1 2107033280/A6750\\n100274163\\n\\n:20 Jul 2019 18:00\\n22 Jul 2019 00:28 ac tt?\\n122 Jul 2019 12:44 Oe\\n\\n: SERUM\\n\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nPage : 13 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 50.4 U/L 45 - 129\\nBILIRUBIN -DIRECT PHOTOMETRY 0.09 mg/dl < 0.3\\nBILIRUBIN - TOTAL PHOTOMETRY 0.41 mg/dl 0.3-1.2\\nBILIRUBIN (INDIRECT) CALCULATED 0.32 mg/dl 0-0.9\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 11.3 u/l < 38\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 10.1 u/l < 31\\n\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 7.9 u/l < 34\\n\\nPROTEIN - TOTAL PHOTOMETRY 6.9 am/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 4.1 gm/dl 3.2-4.8\\nSERUM GLOBULIN PHOTOMETRY 2.8 gm/dL 2.5-3.4\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.46 Ratio 0.9 -2\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - Modified IFCC method\\n\\nBILD - Vanadate Oxidation\\n\\nBILT - Vanadate Oxidation\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - Modified IFCC method\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:28 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107033280/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : 00274163 Page : 14 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nTOTAL CHOLESTEROL PHOTOMETRY 169 mg/dl 125-200\\n\\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 41 mg/dl 35-80\\nTRIGLYCERIDES PHOTOMETRY 202 mg/dl 25-200\\n\\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 101 mg/dl 85-130\\n\\nTC/ HDL CHOLESTEROL RATIO CALCULATED 4.2 Ratio 3-5\\n\\nLDL / HDL RATIO CALCULATED 2.5 Ratio 1.5-3.5\\n\\nVLDL CHOLESTEROL CALCULATED 40.4 mg/dl 5-40\\nNON-HDL CHOLESTEROL CALCULATED 128.4 mg/dl < 160\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nCHOL - CHOD POD METHOD\\n\\nHCHO - ENZYME SELECTIVE PROTECTION METHOD\\n\\nTRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]\\nLDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY\\n\\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\nLDL/ - Derived from serum HDL and LDL Values\\n\\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\\n\\nNHDL - Derived from serum Cholesterol and HDL values\\n\\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\\n\\nTOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\\n\\nDESIRABLE <200 Low <40 OPTIMAL <100 NORMAL <150\\n\\nBORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\\n\\nHIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499\\nHIGH 160-189 VERY HIGH >500\\nVERY HIGH >190\\n\\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:28 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107033280/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : 00274163 Page : 15 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro C ar eC\\n\\nD-37/1,TTC MIDC,Turbhe, COLLEGE of AMERICAN PATHOLOGISTS . . .\\nNavi Mumbai-400 703 ceanthewo. NSsaor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\nREF. BY + SELF ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLA 118 ng/dl 60-200\\nTOTAL THYROXINE (T4) CLA 11.6 ug/dl 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) C.L.I.A <0.01 IU/ml 0.3-5.5\\n\\nComments: IF NOT ON DRUGS SUGGESTED FT3 & FT4 ESTIMATION\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nT3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nT4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nTSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY\\nPregnancy reference ranges for TSH\\n\\n1st Trimester : 0.10 - 2.50\\n\\n2nd Trimester : 0.20 - 3.00\\n\\n3rd Trimester : 0.30 - 3.00\\n\\nReference:\\n\\nGuidelines of American Thyroid Association for the Diagnosis and Management of Thyroid Disease During\\nPregnancy and Postpartum, Thyroid, 2011, 21; 1-46\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:28 ac tt?\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 Oe -\\n\\nSample Type : SERUM oo. .\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nLabcode : 2107033280/A6750\\n\\nPage : 16 of 19\\nBarcode : 00274163\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 6.6 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 143 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n122 Jul 2019 00:10\\n122 Jul 2019 08:13\\n\\nGul\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032040/A6750 .\\n\\nPage : 1 of 19\\n:M9261427\\n\\x0c   \\n\\nPROCESSED AT: F\\nThyrecare cap, Thyrocare’\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 emir Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED s:_~_ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n\\n- 6 PART (DIFF)\\n\\nREF. BY : SELF\\n\\n \\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 7.29 X103/uL  4.0-10.0\\nNEUTROPHILS 63.7 % 40-80\\nLYMPHOCYTE PERCENTAGE 32.1 % 20.0-40.0\\nMONOCYTES 2.5 % 0.0-10.0\\nEOSINOPHILS 1.2 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.64 X103/uL  2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 2.34 X103/uL — 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.18 X 103 / pL 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.01 X 103 / pL 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.09 X103/uL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0.0-0.3\\nTOTAL RBC 4.59 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 11.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 41.5 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 90.4 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 24.8 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.5 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 58.2 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.4 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 14 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 11.2 fL 6.5-12\\nPLATELET COUNT 304 X103/uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 34.5 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.34 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis, Hypochromia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:10 ac tt?\\nReport Released on (RRT) 122 Jul 2019 08:13 Oe <=\\nSample Type : EDTA oo\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032040/A6750\\n\\nPage : 2 of 19\\nBarcode : M9261427\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.16 ug/l <5\\nCADMIUM ICP-MS 0.1 ug/l < 1.5\\nMERCURY ICP-MS 0.43 ug/l <5\\nLEAD ICP-MS 21.59 ug/l < 150\\nCHROMIUM ICP-MS 0.64 ug/l < 30\\nBARIUM ICP-MS 1.84 ug/l < 30\\nCOBALT ICP-MS 0.3 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.5 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 17.51 ug/l 8 - 38\\nANTIMONY ICP-MS 7.93 ug/l 0.10 - 18\\nTIN ICP-MS 0.22 ug/l <2\\nMOLYBDENUM ICP-MS 0.37 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.06 ug/l <4\\nVANADIUM ICP-MS 0.71 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.16 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 146.82 ug/l 60 - 340\\nALUMINIUM ICP-MS 2.83 ug/l < 30\\nNICKEL ICP-MS 2.59 ug/l <15\\nMANGANESE ICP-MS 20.76 ug/I 7.10 - 20\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:10 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 08:13 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107032040/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261427 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 16.4 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 1.02 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 29.2 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 31.7 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.I.A 176 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 7 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 104 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 91 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.9 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 8 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 4.5 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM COPPER PHOTOMETRY 154.7 yg/dL\\n\\nReference Range :-\\n\\nMALE : 63.5 - 150\\nFEMALE : 80 - 155\\n\\nCLINICAL SIGNIFICANCE\\n\\nCOPPER IS AN IMPORTANT TRACE ELEMENT AND A COMPONENT OF NUMEROUS ENZYMES AND PROTEINS INVOLVED\\nIN ENERGY PRODUCTION, CONNECTIVE TISSUE FORMATION, MELANIN SYNTHESIS, IRON METABOLISM,\\nDEVELOPMENT OF CENTRAL NERVOUS SYSTEM, ANGIOGENESIS AS WELL AS AN ANTIOXIDANT.\\n\\nDEFICIENCY CAN CAUSE - MALNOURISHMENT, CARDIOVASCULAR DISEASE, ANEMIA & NEUROPATHY. TOXICITY MAY\\nBE MANIFESTED AS ACUTE RENAL FAILURE, GASTROENTERITIS & CHRONIC LIVER DISEASE.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE: 948-952.\\n\\nPlease correlate with clinical conditions.\\nMethod:- 3,5-DIBR-PAESA\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 10 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM ZINC PHOTOMETRY 55.38 yg/dL\\n\\nReference Range :-\\n\\n52 - 286\\n\\nCLINICAL SIGNIFICANCE\\nZINC IS ONE OF THE ESSENTIAL TRACE ELEMENTS IN THE BODY. ITS METALLOENZYMES PLAY A KEY ROLE IN\\nPROTEIN AND NUCLEIC ACID SYNTHESIS, GENE EXPRESSION, WOUND HEALING, AS AN ANTIOXIDANT, ETC.\\n\\nDEFICIENCY CAN CAUSE - POOR WOUND HEALING, GASTROENTERITIS, IMPAIRED SPERMATOGENESIS, ALZHEIMER’S\\nDISEASE, ETC. TOXICITY MAY BE MANIFESTED AS PANCREATITIS, GASTRIC ULCER, ANEMIA, PULMONARY FIBROSIS.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE:960-965.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- NITRO - PAPS\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 11 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nTESTOSTERONE C.L.I.A 15.04 ng/dL\\n\\nReference Range :-\\n\\nAdult Male\\n\\n21-49Yrs: 164.94 - 753.38\\n50 - 89 Yrs: 86.49 - 788.22\\nAdult Female\\n\\nPre-Menopause : 12.09 - 59.46\\nPost-Menopause: < 7.00 - 48.93\\nBoys\\n\\n2-10 Years : < 7.00 - 25.91\\n\\n11 Years : < 7.00 - 341.53\\n\\n12 Years : < 7.00 - 562.59\\n\\n13 Years : 9.34 - 562.93\\n\\n14 Years : 23.28 - 742.46\\n\\n15 Years : 144.15 - 841.44\\n\\n16-21 Years : 118.22 - 948.56\\n\\nGirls\\n\\n2-10 Years: < 7.00 - 108.30\\n11-15 Years : < 7.00- 48.40\\n16-21 Years : 17.55- 50.41\\n\\nClinical Significance:\\n\\nClinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males. Major\\ncauses of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,\\nHypopituitarism some types of liver and kidney diseases and critical illness.\\n\\nSpecifications: Precision: Intra assay (%CV): 8.5 %, Inter assay (%CV): 12.6%; Sensitivity: 7 ng/dL.\\nExternal quality control program participation:\\n\\nCollege of American pathologists: Ligand assay (special) survey; cap number: 7193855-01\\n\\nPlease correlate with clinical conditions.\\nMethod:- FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 12 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n    \\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\ncentiieAte no: C2407\\n\\ncay Thyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\nREF. BY : SELF\\n\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME\\n\\nIRON\\n\\nReference Range :\\nMale : 65-175\\nFemale : 50 - 170\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nPRADESH,531116\\n\\nTECHNOLOGY VALUE UNITS\\n\\nPHOTOMETRY 44.3 ug/dl\\n\\nMethod : _FERROZINE METHOD WITHOUT DEPROTEINIZATION\\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 373 g/dl\\n\\nReference Range :\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n% TRANSFERRIN SATURATION\\n\\nReference Range :\\n13-45\\n\\nCALCULATED 11.88 %\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n1 2107033280/A6750\\n100274163\\n\\n:20 Jul 2019 18:00\\n22 Jul 2019 00:28 ac tt?\\n122 Jul 2019 12:44 Oe\\n\\n: SERUM\\n\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nPage : 13 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 50.4 U/L 45 - 129\\nBILIRUBIN -DIRECT PHOTOMETRY 0.09 mg/dl < 0.3\\nBILIRUBIN - TOTAL PHOTOMETRY 0.41 mg/dl 0.3-1.2\\nBILIRUBIN (INDIRECT) CALCULATED 0.32 mg/dl 0-0.9\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 11.3 u/l < 38\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 10.1 u/l < 31\\n\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 7.9 u/l < 34\\n\\nPROTEIN - TOTAL PHOTOMETRY 6.9 am/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 4.1 gm/dl 3.2-4.8\\nSERUM GLOBULIN PHOTOMETRY 2.8 gm/dL 2.5-3.4\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.46 Ratio 0.9 -2\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - Modified IFCC method\\n\\nBILD - Vanadate Oxidation\\n\\nBILT - Vanadate Oxidation\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - Modified IFCC method\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:28 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107033280/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : 00274163 Page : 14 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nTOTAL CHOLESTEROL PHOTOMETRY 169 mg/dl 125-200\\n\\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 41 mg/dl 35-80\\nTRIGLYCERIDES PHOTOMETRY 202 mg/dl 25-200\\n\\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 101 mg/dl 85-130\\n\\nTC/ HDL CHOLESTEROL RATIO CALCULATED 4.2 Ratio 3-5\\n\\nLDL / HDL RATIO CALCULATED 2.5 Ratio 1.5-3.5\\n\\nVLDL CHOLESTEROL CALCULATED 40.4 mg/dl 5-40\\nNON-HDL CHOLESTEROL CALCULATED 128.4 mg/dl < 160\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nCHOL - CHOD POD METHOD\\n\\nHCHO - ENZYME SELECTIVE PROTECTION METHOD\\n\\nTRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]\\nLDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY\\n\\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\nLDL/ - Derived from serum HDL and LDL Values\\n\\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\\n\\nNHDL - Derived from serum Cholesterol and HDL values\\n\\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\\n\\nTOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\\n\\nDESIRABLE <200 Low <40 OPTIMAL <100 NORMAL <150\\n\\nBORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\\n\\nHIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499\\nHIGH 160-189 VERY HIGH >500\\nVERY HIGH >190\\n\\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:28 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107033280/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : 00274163 Page : 15 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro C ar eC\\n\\nD-37/1,TTC MIDC,Turbhe, COLLEGE of AMERICAN PATHOLOGISTS . . .\\nNavi Mumbai-400 703 ceanthewo. NSsaor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\nREF. BY + SELF ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLA 118 ng/dl 60-200\\nTOTAL THYROXINE (T4) CLA 11.6 ug/dl 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) C.L.I.A <0.01 IU/ml 0.3-5.5\\n\\nComments: IF NOT ON DRUGS SUGGESTED FT3 & FT4 ESTIMATION\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nT3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nT4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nTSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY\\nPregnancy reference ranges for TSH\\n\\n1st Trimester : 0.10 - 2.50\\n\\n2nd Trimester : 0.20 - 3.00\\n\\n3rd Trimester : 0.30 - 3.00\\n\\nReference:\\n\\nGuidelines of American Thyroid Association for the Diagnosis and Management of Thyroid Disease During\\nPregnancy and Postpartum, Thyroid, 2011, 21; 1-46\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:28 ac tt?\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 Oe -\\n\\nSample Type : SERUM oo. .\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nLabcode : 2107033280/A6750\\n\\nPage : 16 of 19\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nBLOOD UREA NITROGEN (BUN) PHOTOMETRY 13.12 mg/dl 7-25\\nCREATININE - SERUM PHOTOMETRY 0.72 mg/dl 0.5-0.8\\n\\nURIC ACID PHOTOMETRY 3.8 mg/dl 3.2-6.1\\nCALCIUM PHOTOMETRY 8.84 mg/dl 8.8-10.6\\n\\nBUN / SR.CREATININE RATIO CALCULATED 18.22 Ratio 9:1-23:1\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nBUN - KINETIC UV ASSAY.\\n\\nSCRE - CREATININE ENZYMATIC METHOD\\n\\nURIC - Uricase / Peroxidase Method\\n\\nCALC - ARSENAZO III METHOD, END POINT.\\n\\nB/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:28 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107033280/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : 00274163 Page : 17 of 19\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 6.6 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 143 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n122 Jul 2019 00:10\\n122 Jul 2019 08:13\\n\\nGul\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032040/A6750 .\\n\\nPage : 1 of 19\\n:M9261427\\n\\x0c   \\n\\nPROCESSED AT: F\\nThyrecare cap, Thyrocare’\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 emir Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED s:_~_ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n\\n- 6 PART (DIFF)\\n\\nREF. BY : SELF\\n\\n \\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 7.29 X103/uL  4.0-10.0\\nNEUTROPHILS 63.7 % 40-80\\nLYMPHOCYTE PERCENTAGE 32.1 % 20.0-40.0\\nMONOCYTES 2.5 % 0.0-10.0\\nEOSINOPHILS 1.2 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.64 X103/uL  2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 2.34 X103/uL — 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.18 X 103 / pL 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.01 X 103 / pL 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.09 X103/uL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0.0-0.3\\nTOTAL RBC 4.59 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 11.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 41.5 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 90.4 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 24.8 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.5 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 58.2 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.4 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 14 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 11.2 fL 6.5-12\\nPLATELET COUNT 304 X103/uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 34.5 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.34 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis, Hypochromia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:10 ac tt?\\nReport Released on (RRT) 122 Jul 2019 08:13 Oe <=\\nSample Type : EDTA oo\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032040/A6750\\n\\nPage : 2 of 19\\nBarcode : M9261427\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.16 ug/l <5\\nCADMIUM ICP-MS 0.1 ug/l < 1.5\\nMERCURY ICP-MS 0.43 ug/l <5\\nLEAD ICP-MS 21.59 ug/l < 150\\nCHROMIUM ICP-MS 0.64 ug/l < 30\\nBARIUM ICP-MS 1.84 ug/l < 30\\nCOBALT ICP-MS 0.3 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.5 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 17.51 ug/l 8 - 38\\nANTIMONY ICP-MS 7.93 ug/l 0.10 - 18\\nTIN ICP-MS 0.22 ug/l <2\\nMOLYBDENUM ICP-MS 0.37 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.06 ug/l <4\\nVANADIUM ICP-MS 0.71 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.16 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 146.82 ug/l 60 - 340\\nALUMINIUM ICP-MS 2.83 ug/l < 30\\nNICKEL ICP-MS 2.59 ug/l <15\\nMANGANESE ICP-MS 20.76 ug/I 7.10 - 20\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:10 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 08:13 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107032040/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261427 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 16.4 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 1.02 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 29.2 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 31.7 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.I.A 176 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 7 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 104 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 91 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.9 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 8 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 4.5 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM COPPER PHOTOMETRY 154.7 yg/dL\\n\\nReference Range :-\\n\\nMALE : 63.5 - 150\\nFEMALE : 80 - 155\\n\\nCLINICAL SIGNIFICANCE\\n\\nCOPPER IS AN IMPORTANT TRACE ELEMENT AND A COMPONENT OF NUMEROUS ENZYMES AND PROTEINS INVOLVED\\nIN ENERGY PRODUCTION, CONNECTIVE TISSUE FORMATION, MELANIN SYNTHESIS, IRON METABOLISM,\\nDEVELOPMENT OF CENTRAL NERVOUS SYSTEM, ANGIOGENESIS AS WELL AS AN ANTIOXIDANT.\\n\\nDEFICIENCY CAN CAUSE - MALNOURISHMENT, CARDIOVASCULAR DISEASE, ANEMIA & NEUROPATHY. TOXICITY MAY\\nBE MANIFESTED AS ACUTE RENAL FAILURE, GASTROENTERITIS & CHRONIC LIVER DISEASE.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE: 948-952.\\n\\nPlease correlate with clinical conditions.\\nMethod:- 3,5-DIBR-PAESA\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 10 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM ZINC PHOTOMETRY 55.38 yg/dL\\n\\nReference Range :-\\n\\n52 - 286\\n\\nCLINICAL SIGNIFICANCE\\nZINC IS ONE OF THE ESSENTIAL TRACE ELEMENTS IN THE BODY. ITS METALLOENZYMES PLAY A KEY ROLE IN\\nPROTEIN AND NUCLEIC ACID SYNTHESIS, GENE EXPRESSION, WOUND HEALING, AS AN ANTIOXIDANT, ETC.\\n\\nDEFICIENCY CAN CAUSE - POOR WOUND HEALING, GASTROENTERITIS, IMPAIRED SPERMATOGENESIS, ALZHEIMER’S\\nDISEASE, ETC. TOXICITY MAY BE MANIFESTED AS PANCREATITIS, GASTRIC ULCER, ANEMIA, PULMONARY FIBROSIS.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE:960-965.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- NITRO - PAPS\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 11 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nTESTOSTERONE C.L.I.A 15.04 ng/dL\\n\\nReference Range :-\\n\\nAdult Male\\n\\n21-49Yrs: 164.94 - 753.38\\n50 - 89 Yrs: 86.49 - 788.22\\nAdult Female\\n\\nPre-Menopause : 12.09 - 59.46\\nPost-Menopause: < 7.00 - 48.93\\nBoys\\n\\n2-10 Years : < 7.00 - 25.91\\n\\n11 Years : < 7.00 - 341.53\\n\\n12 Years : < 7.00 - 562.59\\n\\n13 Years : 9.34 - 562.93\\n\\n14 Years : 23.28 - 742.46\\n\\n15 Years : 144.15 - 841.44\\n\\n16-21 Years : 118.22 - 948.56\\n\\nGirls\\n\\n2-10 Years: < 7.00 - 108.30\\n11-15 Years : < 7.00- 48.40\\n16-21 Years : 17.55- 50.41\\n\\nClinical Significance:\\n\\nClinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males. Major\\ncauses of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,\\nHypopituitarism some types of liver and kidney diseases and critical illness.\\n\\nSpecifications: Precision: Intra assay (%CV): 8.5 %, Inter assay (%CV): 12.6%; Sensitivity: 7 ng/dL.\\nExternal quality control program participation:\\n\\nCollege of American pathologists: Ligand assay (special) survey; cap number: 7193855-01\\n\\nPlease correlate with clinical conditions.\\nMethod:- FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 12 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n    \\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\ncentiieAte no: C2407\\n\\ncay Thyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\nREF. BY : SELF\\n\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME\\n\\nIRON\\n\\nReference Range :\\nMale : 65-175\\nFemale : 50 - 170\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nPRADESH,531116\\n\\nTECHNOLOGY VALUE UNITS\\n\\nPHOTOMETRY 44.3 ug/dl\\n\\nMethod : _FERROZINE METHOD WITHOUT DEPROTEINIZATION\\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 373 g/dl\\n\\nReference Range :\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n% TRANSFERRIN SATURATION\\n\\nReference Range :\\n13-45\\n\\nCALCULATED 11.88 %\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n1 2107033280/A6750\\n100274163\\n\\n:20 Jul 2019 18:00\\n22 Jul 2019 00:28 ac tt?\\n122 Jul 2019 12:44 Oe\\n\\n: SERUM\\n\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nPage : 13 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 50.4 U/L 45 - 129\\nBILIRUBIN -DIRECT PHOTOMETRY 0.09 mg/dl < 0.3\\nBILIRUBIN - TOTAL PHOTOMETRY 0.41 mg/dl 0.3-1.2\\nBILIRUBIN (INDIRECT) CALCULATED 0.32 mg/dl 0-0.9\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 11.3 u/l < 38\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 10.1 u/l < 31\\n\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 7.9 u/l < 34\\n\\nPROTEIN - TOTAL PHOTOMETRY 6.9 am/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 4.1 gm/dl 3.2-4.8\\nSERUM GLOBULIN PHOTOMETRY 2.8 gm/dL 2.5-3.4\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.46 Ratio 0.9 -2\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - Modified IFCC method\\n\\nBILD - Vanadate Oxidation\\n\\nBILT - Vanadate Oxidation\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - Modified IFCC method\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:28 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107033280/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : 00274163 Page : 14 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nTOTAL CHOLESTEROL PHOTOMETRY 169 mg/dl 125-200\\n\\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 41 mg/dl 35-80\\nTRIGLYCERIDES PHOTOMETRY 202 mg/dl 25-200\\n\\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 101 mg/dl 85-130\\n\\nTC/ HDL CHOLESTEROL RATIO CALCULATED 4.2 Ratio 3-5\\n\\nLDL / HDL RATIO CALCULATED 2.5 Ratio 1.5-3.5\\n\\nVLDL CHOLESTEROL CALCULATED 40.4 mg/dl 5-40\\nNON-HDL CHOLESTEROL CALCULATED 128.4 mg/dl < 160\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nCHOL - CHOD POD METHOD\\n\\nHCHO - ENZYME SELECTIVE PROTECTION METHOD\\n\\nTRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]\\nLDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY\\n\\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\nLDL/ - Derived from serum HDL and LDL Values\\n\\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\\n\\nNHDL - Derived from serum Cholesterol and HDL values\\n\\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\\n\\nTOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\\n\\nDESIRABLE <200 Low <40 OPTIMAL <100 NORMAL <150\\n\\nBORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\\n\\nHIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499\\nHIGH 160-189 VERY HIGH >500\\nVERY HIGH >190\\n\\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:28 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107033280/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : 00274163 Page : 15 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro C ar eC\\n\\nD-37/1,TTC MIDC,Turbhe, COLLEGE of AMERICAN PATHOLOGISTS . . .\\nNavi Mumbai-400 703 ceanthewo. NSsaor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\nREF. BY + SELF ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLA 118 ng/dl 60-200\\nTOTAL THYROXINE (T4) CLA 11.6 ug/dl 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) C.L.I.A <0.01 IU/ml 0.3-5.5\\n\\nComments: IF NOT ON DRUGS SUGGESTED FT3 & FT4 ESTIMATION\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nT3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nT4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nTSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY\\nPregnancy reference ranges for TSH\\n\\n1st Trimester : 0.10 - 2.50\\n\\n2nd Trimester : 0.20 - 3.00\\n\\n3rd Trimester : 0.30 - 3.00\\n\\nReference:\\n\\nGuidelines of American Thyroid Association for the Diagnosis and Management of Thyroid Disease During\\nPregnancy and Postpartum, Thyroid, 2011, 21; 1-46\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:28 ac tt?\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 Oe -\\n\\nSample Type : SERUM oo. .\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nLabcode : 2107033280/A6750\\n\\nPage : 16 of 19\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nBLOOD UREA NITROGEN (BUN) PHOTOMETRY 13.12 mg/dl 7-25\\nCREATININE - SERUM PHOTOMETRY 0.72 mg/dl 0.5-0.8\\n\\nURIC ACID PHOTOMETRY 3.8 mg/dl 3.2-6.1\\nCALCIUM PHOTOMETRY 8.84 mg/dl 8.8-10.6\\n\\nBUN / SR.CREATININE RATIO CALCULATED 18.22 Ratio 9:1-23:1\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nBUN - KINETIC UV ASSAY.\\n\\nSCRE - CREATININE ENZYMATIC METHOD\\n\\nURIC - Uricase / Peroxidase Method\\n\\nCALC - ARSENAZO III METHOD, END POINT.\\n\\nB/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:28 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107033280/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : 00274163 Page : 17 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F)\\nREF. BY : SELF\\nTEST ASKED : AAROGYAM 1.3\\n\\nTEST NAME\\n\\nEST. GLOMERULAR FILTRATION RATE (eGFR)\\nReference Range :-\\n\\nTECHNOLOGY\\nCALCULATED\\n\\n> = 90 : Normal\\n60 - 89 : Mild Decrease\\n45-59 : Mild to Moderate Decrease\\n\\n30-44 : Moderate to Severe Decrease\\n15-29 : Severe Decrease\\n\\nClinical Significance\\n\\nVALUE\\n100 mL/min/1.73 m2\\n\\nSAMPLE COLLECTED AT\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\n\\nUNITS\\n\\nThe normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild\\nand moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical\\nlaboratories to routinely estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of\\nrenal function, and report the value when serum creatinine is measured for patients 18 and older, when appropriate\\nand feasible. It cannot be measured easily in clinical practice, instead, GFR is estimated from equations using serum\\ncreatinine, age, race and sex. This provides easy to interpret information for the doctor and patient on the degree of\\nrenal impairment since it approximately equates to the percentage of kidney function remaining. Application of\\nCKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and\\n\\nmanagement of patients with CKD.\\n\\nReference\\n\\nLevey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular\\n\\nfiltration rate. Ann Intern Med. 2009;150(9):604-12.\\nPlease correlate with clinical conditions.\\nMethod:- CKD-EPI Creatinine Equation\\n\\n«ww End of report ~~\\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type ©; :\\n\\nLabcode ©\\nSas\\n\\nBarcode\\n\\n:20 Jul 2019 18:00\\n122 Jul 2019 00:28 Goole?\\n122 Jul 2019 12:44 .\\n\\n: SERUM Dr.Prachi Sinkar MD(Path)\\n\\n1 2107033280/A6750\\n: 00274163\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 18 of 19\\n\\x0c',\n",
       " 'PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n   \\n\\n@JNGsP\\n\\n \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\ncentiieAte no: C2407\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME\\n\\n: MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n- 6 PART (DIFF)\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbA1c - (HPLC - NGSP Certified)\\nH.P.L.C 6.6 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 143 mg/dl\\n\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type vert\\nLabcode 3)\\nPereode @uty\\n\\n122 Jul 2019 00:10\\n122 Jul 2019 08:13\\n\\nGul\\n\\n#EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n: 2107032040/A6750 .\\n\\nPage : 1 of 19\\n:M9261427\\n\\x0c   \\n\\nPROCESSED AT: F\\nThyrecare cap, Thyrocare’\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 emir Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED s:_~_ELEMENTS 22 (TOXIC AND NUTRIENTS),HBA,HEMOGRAM PRADESH,531116\\n\\n- 6 PART (DIFF)\\n\\nREF. BY : SELF\\n\\n \\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 7.29 X103/uL  4.0-10.0\\nNEUTROPHILS 63.7 % 40-80\\nLYMPHOCYTE PERCENTAGE 32.1 % 20.0-40.0\\nMONOCYTES 2.5 % 0.0-10.0\\nEOSINOPHILS 1.2 % 0.0-6.0\\nBASOPHILS 0.2 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 4.64 X103/uL  2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 2.34 X103/uL — 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.18 X 103 / pL 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.01 X 103 / pL 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.09 X103/uL 0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0.0-0.3\\nTOTAL RBC 4.59 X1046/pL 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 11.4 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 41.5 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 90.4 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 24.8 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.5 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 58.2 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.4 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 14 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 11.2 fL 6.5-12\\nPLATELET COUNT 304 X103/uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 34.5 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.34 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis, Hypochromia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) :22 Jul 2019 00:10 ac tt?\\nReport Released on (RRT) 122 Jul 2019 08:13 Oe <=\\nSample Type : EDTA oo\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107032040/A6750\\n\\nPage : 2 of 19\\nBarcode : M9261427\\n\\x0c \\n\\nPROCESSED AT: 4\\nThyrocare CAP wil | hyro Cc are’\\nD-37/1,TTC MIDC,Turbhe, Seems\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\n\\nANDHRA PRADESH, 531116\\nTEST ASKED : ELEMENTS 22 (TOXIC AND NUTRIENTS), HBA, HEMOGRAM \"\\n- 6 PART (DIFF)\\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nARSENIC ICP-MS 1.16 ug/l <5\\nCADMIUM ICP-MS 0.1 ug/l < 1.5\\nMERCURY ICP-MS 0.43 ug/l <5\\nLEAD ICP-MS 21.59 ug/l < 150\\nCHROMIUM ICP-MS 0.64 ug/l < 30\\nBARIUM ICP-MS 1.84 ug/l < 30\\nCOBALT ICP-MS 0.3 ug/l 0.10 - 1.50\\nCAESIUM ICP-MS 1.5 ug/I <5\\nTHALLIUM ICP-MS 0.03 ug/l <1\\nURANIUM ICP-MS 0.08 ug/l <1\\nSTRONTIUM ICP-MS 17.51 ug/l 8 - 38\\nANTIMONY ICP-MS 7.93 ug/l 0.10 - 18\\nTIN ICP-MS 0.22 ug/l <2\\nMOLYBDENUM ICP-MS 0.37 ug/l 0.70 - 4.0\\nSILVER ICP-MS 1.06 ug/l <4\\nVANADIUM ICP-MS 0.71 ug/l < 0.8\\nBERYLLIUM ICP-MS 0.03 ug/l 0.10 - 0.80\\nBISMUTH ICP-MS 0.16 ug/l 0.10 - 0.80\\nSELENIUM ICP-MS 146.82 ug/l 60 - 340\\nALUMINIUM ICP-MS 2.83 ug/l < 30\\nNICKEL ICP-MS 2.59 ug/l <15\\nMANGANESE ICP-MS 20.76 ug/I 7.10 - 20\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nICP - MASS SPECTROMETRY\\nNote:Reference range has been obtained after considering 95% population as cutoff.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:10 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 08:13 q OL “\\n\\nSample Type : EDTA .\\n\\nLabcode : 2107032040/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : M9261427 Page : 3 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHOMOCYSTEINE PHOTOMETRY 16.4 yumol/L\\n\\nReference Range :-\\n\\n< 30\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHOMOCYSTEINE IS LINKED TO INCREASED RISK OF PREMATURE CORONARY ARTERY DISEASE, STROKE AND\\nTHROMBOEMBOLISM. MOREOVER, ALZHEIMER\\'S DISEASE, OSTEOPOROSIS, VENOUS THROMBOSIS, SCHIZOPHRENIA,\\nCOGNITIVE DEFICIENCY AND PREGNANCY COMPLICATIONS ALSO ELEVATES HOMOCYSTEINE LEVELS.\\n\\nHIGH VALUES:\\n\\nELEVATED HOMOCYSTEINE LEVELS MIGHT BE DUE TO INCREASING AGE, GENETIC TRAITS, DRUGS, RENAL\\nDYSFUNCTION AND DIETARY DEFICIENCY OF VITAMINS OR SMOKING. TO LOWER YOUR HOMOCYSTEINE, EAT MORE\\nGREEN VEGETABLES, STOP SMOKING, ALCOHOL. FOLIC ACID HELPS LOWERING ELEVATED LEVELS.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- ENZYMATIC ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 4 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nCYSTATIN C IMMUNOTURBIDIMETRY 1.02 mg/L\\n\\nReference Range :-\\n\\n<= 60 YEARS : <= 1.03 MG/L\\n> 60 YEARS : < 1.50 MG/L\\n\\nCLINICAL SIGNIFICANCE\\n\\nCYSTATIN C, IS A SMALL 13 -KDA PROTEIN AND IS A MEMBER OF THE CYSTEINE PROTEINASE INHIBITOR FAMILY, IT\\nIS PRODUCED AT A CONSTANT RATE BY ALL NUCLEATED CELLS. DUE TO ITS SMALL SIZE IT IS FREELY FILTERED BY\\nTHE GLOMERULUS AND IS NOT SECRETED BUT IS FULLY REABSORBED AND BROKEN DOWN BY THE RENAL TUBULES.\\nTHIS MEANS THAT THE PRIMARY DETERMINATE OF BLOOD CYSTATIN C LEVELS IS THE RATE AT WHICH IT IS\\nFILTERED AT THE GLOMERULUS MAKING IT AN EXCELLENT GFR MARKER. CYSTATIN C IS ALSO A MARKER OF\\nINFLAMMATION AND LIKE MANY OTHER MARKERS OF INFLAMMATION, ITS SERUM CONCENTRATION MAY BE HIGHER\\nIN PATIENTS WITH DECREASED RENAL CLEARANCE. THERE IS MOUNTING EVIDENCE, HOWEVER, THAT CYSTATIN C\\nMAY BE A PREDICTOR OF ADVERSE OUTCOMES INDEPENDENT OF RENAL FUNCTION WITH ITS HIGHER SENSITIVITY\\nTO DETECT A REDUCED GFR THAN CREATININE DETERMINATION, ALSO IN THE SO-CALLED “CREATININE-BLIND”\\nRANGE. THUS, CYSTATIN C IS SUGGESTED TO BE A BETTER MARKER FOR GFR THAN THE UBIQUITOUS SERUM\\nCREATININE.\\n\\nREFERENCE\\n\\n1. BARRETT AJ, DAVIES ME, GRUBB A. THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN C) AMONG THE CYSTEINE\\nPROTEINASE INHIBITORS. BIOCHEM BIOPHYS RES COMMON 1984; 120: 631-6.\\n\\n2. GRUBB A. DIAGNOSTIC VALUE OF ANALYSIS OF CYSTATIN C AND PROTEIN HC IN BIOLOGICAL FLUIDS. CLIN\\nNEPHROL 1992; 38: S20-7.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 5 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n. . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nLIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 29.2 mg/dl\\n\\nReference Range :-\\n\\nADULTS : < 30.0 MG/DL\\n\\nINTERPRETATION:\\n\\nDETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD\\nOR WITH EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF\\nVARIATION IN A POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD\\nALWAYS BE ASSESSED IN CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND\\nOTHER FINDINGS.\\n\\nSPECIFICATIONS:\\n\\nPRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L\\n\\nEXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:\\n\\nCOLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01\\n\\nKIT VALIDATION REFERENCES:\\n\\nKOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN\\nLAB RES, 1997; 27: 14-23.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 6 of 19\\n\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) C.L.LA 31.7 ng/ml\\n\\nReference Range :\\nDEFICIENCY : <20 ng/ml\\nINSUFFICIENCY : 20-<30 ng/ml\\nSUFFICIENCY : 30-100 ng/ml\\nTOXICITY : >100 ng/ml\\n\\nVitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D\\n\\nStandardization Program (VDSP).\\nMethod : FULLY AUTOMATED _CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nVITAMIN B-12 C.L.I.A 176 pg/ml\\nReference Range :\\nNormal : 211 - 911 pg/ml\\n\\nClinical significance :\\n\\nVitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources,\\nsuch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation\\n\\nand in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA\\nsynthesis associated with macrocytic anemias. For diagnostic purpose, results should always be assessed in\\nconjunction with the patients medical history, clinical examination and other findings.\\n\\nSpecifications: Intra assay (Y%CV):4.0%, Inter assay (%CV):4.4 %;Sensitivity:45 pg/ml\\n\\nExternal quality control program participation:\\nCollege of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nKit validation references:\\nChen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry.\\n\\nSt.Louis:CV Mosby,1987.P.569-73.\\nMethod : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 7 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP oA Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nieee\\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM 1.3 PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nAPOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 104 mg/dL\\nReference Range :\\nMALE : 86-152\\nFEMALE : 94-162\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 91 mg/dL\\nReference Range :\\nMALE : 56-145\\nFEMALE : 53-138\\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY - BECKMAN COULTER\\nAPO B / APO Ai RATIO (APO B/A1) CALCULATED 0.9 Ratio\\n\\nReference Range :\\n\\nMALE : 0.40 - 1.26\\n\\nFEMALE : 0.38 - 1.14\\nMethod : DERIVED FROM SERUM APO Al AND APO B_VALUES.\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\n\\nSample Received on (SRT) 222 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 222 Jul 2019 12:44 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2107033280/A6750\\n\\nPage : 8 of 19\\nBarcode 100274163\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 4.5 mg/L\\n\\nReference Range :-\\n\\nADULT : <=3.0 MG/L\\nINTERPRETATION:\\n\\nHIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY\\nEVALUATION OF ACUTE CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR\\nRECURRENT EVENTS, IN PATIENTS WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP\\nLEVELS SHOULD NOT BE SUBSTITUTED FOR ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS.\\nPATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD\\nBE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES\\n\\nCLINICAL SIGNIFICANCE:\\n\\nHSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF\\nINDIVIDUALS AT RISK FOR FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF\\nPROGNOSIS OF INDIVIDUALS WITH ACUTE CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF\\nSUCH INDIVIDUALS.\\n\\nSPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.\\n\\nREFERENCES:\\n\\n1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS\\nAND REFERENCE LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.\\n\\n2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT\\nMED 1984;5:112-51.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION - BECKMAN COULTER\\n\\n \\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44\\nSample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nPage : 9 of 19\\n\\nBarcode : 00274163\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM COPPER PHOTOMETRY 154.7 yg/dL\\n\\nReference Range :-\\n\\nMALE : 63.5 - 150\\nFEMALE : 80 - 155\\n\\nCLINICAL SIGNIFICANCE\\n\\nCOPPER IS AN IMPORTANT TRACE ELEMENT AND A COMPONENT OF NUMEROUS ENZYMES AND PROTEINS INVOLVED\\nIN ENERGY PRODUCTION, CONNECTIVE TISSUE FORMATION, MELANIN SYNTHESIS, IRON METABOLISM,\\nDEVELOPMENT OF CENTRAL NERVOUS SYSTEM, ANGIOGENESIS AS WELL AS AN ANTIOXIDANT.\\n\\nDEFICIENCY CAN CAUSE - MALNOURISHMENT, CARDIOVASCULAR DISEASE, ANEMIA & NEUROPATHY. TOXICITY MAY\\nBE MANIFESTED AS ACUTE RENAL FAILURE, GASTROENTERITIS & CHRONIC LIVER DISEASE.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE: 948-952.\\n\\nPlease correlate with clinical conditions.\\nMethod:- 3,5-DIBR-PAESA\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 10 of 19\\n\\x0c \\n\\nPROCESSED AT : 7\\nThyrosare CARY Thyrocare\\'\\nD-37/1,TTC MIDC,Turbhe, ACCREDITED\\n\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nSERUM ZINC PHOTOMETRY 55.38 yg/dL\\n\\nReference Range :-\\n\\n52 - 286\\n\\nCLINICAL SIGNIFICANCE\\nZINC IS ONE OF THE ESSENTIAL TRACE ELEMENTS IN THE BODY. ITS METALLOENZYMES PLAY A KEY ROLE IN\\nPROTEIN AND NUCLEIC ACID SYNTHESIS, GENE EXPRESSION, WOUND HEALING, AS AN ANTIOXIDANT, ETC.\\n\\nDEFICIENCY CAN CAUSE - POOR WOUND HEALING, GASTROENTERITIS, IMPAIRED SPERMATOGENESIS, ALZHEIMER’S\\nDISEASE, ETC. TOXICITY MAY BE MANIFESTED AS PANCREATITIS, GASTRIC ULCER, ANEMIA, PULMONARY FIBROSIS.\\n\\nREFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY\\nAND MOLECULAR DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE:960-965.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- NITRO - PAPS\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 11 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\n: : COLLEGE of AMERICAN PATHOLOGISTS\\nNavi Mumbai-400 703 canbe no. Sor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\n\\n‘ . CENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS\\nTESTOSTERONE C.L.I.A 15.04 ng/dL\\n\\nReference Range :-\\n\\nAdult Male\\n\\n21-49Yrs: 164.94 - 753.38\\n50 - 89 Yrs: 86.49 - 788.22\\nAdult Female\\n\\nPre-Menopause : 12.09 - 59.46\\nPost-Menopause: < 7.00 - 48.93\\nBoys\\n\\n2-10 Years : < 7.00 - 25.91\\n\\n11 Years : < 7.00 - 341.53\\n\\n12 Years : < 7.00 - 562.59\\n\\n13 Years : 9.34 - 562.93\\n\\n14 Years : 23.28 - 742.46\\n\\n15 Years : 144.15 - 841.44\\n\\n16-21 Years : 118.22 - 948.56\\n\\nGirls\\n\\n2-10 Years: < 7.00 - 108.30\\n11-15 Years : < 7.00- 48.40\\n16-21 Years : 17.55- 50.41\\n\\nClinical Significance:\\n\\nClinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males. Major\\ncauses of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,\\nHypopituitarism some types of liver and kidney diseases and critical illness.\\n\\nSpecifications: Precision: Intra assay (%CV): 8.5 %, Inter assay (%CV): 12.6%; Sensitivity: 7 ng/dL.\\nExternal quality control program participation:\\n\\nCollege of American pathologists: Ligand assay (special) survey; cap number: 7193855-01\\n\\nPlease correlate with clinical conditions.\\nMethod:- FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nSample Collected on (SCT) :20 Jul 2019 18:00\\nSample Received on (SRT) 122 Jul 2019 00:28 Goole?\\n\\nReport Released on (RRT) 122 Jul 2019 12:44 ™\\nSample Type * SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2107033280/A6750\\n\\nBarcode : 00274163 Page : 12 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n    \\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\ncentiieAte no: C2407\\n\\ncay Thyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n\\nREF. BY : SELF\\n\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME\\n\\nIRON\\n\\nReference Range :\\nMale : 65-175\\nFemale : 50 - 170\\n\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nPRADESH,531116\\n\\nTECHNOLOGY VALUE UNITS\\n\\nPHOTOMETRY 44.3 ug/dl\\n\\nMethod : _FERROZINE METHOD WITHOUT DEPROTEINIZATION\\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 373 g/dl\\n\\nReference Range :\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n% TRANSFERRIN SATURATION\\n\\nReference Range :\\n13-45\\n\\nCALCULATED 11.88 %\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n1 2107033280/A6750\\n100274163\\n\\n:20 Jul 2019 18:00\\n22 Jul 2019 00:28 ac tt?\\n122 Jul 2019 12:44 Oe\\n\\n: SERUM\\n\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nPage : 13 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 50.4 U/L 45 - 129\\nBILIRUBIN -DIRECT PHOTOMETRY 0.09 mg/dl < 0.3\\nBILIRUBIN - TOTAL PHOTOMETRY 0.41 mg/dl 0.3-1.2\\nBILIRUBIN (INDIRECT) CALCULATED 0.32 mg/dl 0-0.9\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 11.3 u/l < 38\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 10.1 u/l < 31\\n\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 7.9 u/l < 34\\n\\nPROTEIN - TOTAL PHOTOMETRY 6.9 am/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 4.1 gm/dl 3.2-4.8\\nSERUM GLOBULIN PHOTOMETRY 2.8 gm/dL 2.5-3.4\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.46 Ratio 0.9 -2\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - Modified IFCC method\\n\\nBILD - Vanadate Oxidation\\n\\nBILT - Vanadate Oxidation\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - Modified IFCC method\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:28 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107033280/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : 00274163 Page : 14 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nTOTAL CHOLESTEROL PHOTOMETRY 169 mg/dl 125-200\\n\\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 41 mg/dl 35-80\\nTRIGLYCERIDES PHOTOMETRY 202 mg/dl 25-200\\n\\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 101 mg/dl 85-130\\n\\nTC/ HDL CHOLESTEROL RATIO CALCULATED 4.2 Ratio 3-5\\n\\nLDL / HDL RATIO CALCULATED 2.5 Ratio 1.5-3.5\\n\\nVLDL CHOLESTEROL CALCULATED 40.4 mg/dl 5-40\\nNON-HDL CHOLESTEROL CALCULATED 128.4 mg/dl < 160\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nCHOL - CHOD POD METHOD\\n\\nHCHO - ENZYME SELECTIVE PROTECTION METHOD\\n\\nTRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]\\nLDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY\\n\\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\nLDL/ - Derived from serum HDL and LDL Values\\n\\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\\n\\nNHDL - Derived from serum Cholesterol and HDL values\\n\\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\\n\\nTOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\\n\\nDESIRABLE <200 Low <40 OPTIMAL <100 NORMAL <150\\n\\nBORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\\n\\nHIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499\\nHIGH 160-189 VERY HIGH >500\\nVERY HIGH >190\\n\\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:28 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107033280/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : 00274163 Page : 15 of 19\\n\\x0cPROCESSED AT:\\n\\nThyrocare meCAP Thyro C ar eC\\n\\nD-37/1,TTC MIDC,Turbhe, COLLEGE of AMERICAN PATHOLOGISTS . . .\\nNavi Mumbai-400 703 ceanthewo. NSsaor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\nREF. BY + SELF ANDHRA PRADESH,531116\\nTEST ASKED : AAROGYAM 1.3\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLA 118 ng/dl 60-200\\nTOTAL THYROXINE (T4) CLA 11.6 ug/dl 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) C.L.I.A <0.01 IU/ml 0.3-5.5\\n\\nComments: IF NOT ON DRUGS SUGGESTED FT3 & FT4 ESTIMATION\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nT3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nT4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nTSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY\\nPregnancy reference ranges for TSH\\n\\n1st Trimester : 0.10 - 2.50\\n\\n2nd Trimester : 0.20 - 3.00\\n\\n3rd Trimester : 0.30 - 3.00\\n\\nReference:\\n\\nGuidelines of American Thyroid Association for the Diagnosis and Management of Thyroid Disease During\\nPregnancy and Postpartum, Thyroid, 2011, 21; 1-46\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:28 ac tt?\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 Oe -\\n\\nSample Type : SERUM oo. .\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nLabcode : 2107033280/A6750\\n\\nPage : 16 of 19\\nBarcode : 00274163\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS G SIVA KUMARI (47Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY © SELF (18900), INDIRA DIAGNOSTIC CENTRE, NARSIPATNAM,\\nTEST ASKED : AAROGYAM 1.3 ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nBLOOD UREA NITROGEN (BUN) PHOTOMETRY 13.12 mg/dl 7-25\\nCREATININE - SERUM PHOTOMETRY 0.72 mg/dl 0.5-0.8\\n\\nURIC ACID PHOTOMETRY 3.8 mg/dl 3.2-6.1\\nCALCIUM PHOTOMETRY 8.84 mg/dl 8.8-10.6\\n\\nBUN / SR.CREATININE RATIO CALCULATED 18.22 Ratio 9:1-23:1\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nBUN - KINETIC UV ASSAY.\\n\\nSCRE - CREATININE ENZYMATIC METHOD\\n\\nURIC - Uricase / Peroxidase Method\\n\\nCALC - ARSENAZO III METHOD, END POINT.\\n\\nB/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES\\n\\nSample Collected on (SCT) : 20 Jul 2019 18:00\\n\\nSample Received on (SRT) : 22 Jul 2019 00:28 heen’\\n\\nReport Released on (RRT) : 22 Jul 2019 12:44 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2107033280/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : 00274163 Page : 17 of 19\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MRS G SIVA KUMARI (47Y/F)\\nREF. BY : SELF\\nTEST ASKED : AAROGYAM 1.3\\n\\nTEST NAME\\n\\nEST. GLOMERULAR FILTRATION RATE (eGFR)\\nReference Range :-\\n\\nTECHNOLOGY\\nCALCULATED\\n\\n> = 90 : Normal\\n60 - 89 : Mild Decrease\\n45-59 : Mild to Moderate Decrease\\n\\n30-44 : Moderate to Severe Decrease\\n15-29 : Severe Decrease\\n\\nClinical Significance\\n\\nVALUE\\n100 mL/min/1.73 m2\\n\\nSAMPLE COLLECTED AT\\n(18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\n\\nUNITS\\n\\nThe normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild\\nand moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical\\nlaboratories to routinely estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of\\nrenal function, and report the value when serum creatinine is measured for patients 18 and older, when appropriate\\nand feasible. It cannot be measured easily in clinical practice, instead, GFR is estimated from equations using serum\\ncreatinine, age, race and sex. This provides easy to interpret information for the doctor and patient on the degree of\\nrenal impairment since it approximately equates to the percentage of kidney function remaining. Application of\\nCKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and\\n\\nmanagement of patients with CKD.\\n\\nReference\\n\\nLevey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular\\n\\nfiltration rate. Ann Intern Med. 2009;150(9):604-12.\\nPlease correlate with clinical conditions.\\nMethod:- CKD-EPI Creatinine Equation\\n\\n«ww End of report ~~\\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type ©; :\\n\\nLabcode ©\\nSas\\n\\nBarcode\\n\\n:20 Jul 2019 18:00\\n122 Jul 2019 00:28 Goole?\\n122 Jul 2019 12:44 .\\n\\n: SERUM Dr.Prachi Sinkar MD(Path)\\n\\n1 2107033280/A6750\\n: 00274163\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 18 of 19\\n\\x0cCONDITIONS OF REPORTING\\n\\n“ The reported results are for information and interpretation of the referring doctor only.\\n\\n“It is presumed that the tests performed on the specimen belong to the patient; named or identified.\\n\\n“Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the\\nsame patient.\\n\\n“Should the results indicate an unexpected abnormality, the same should be reconfirmed.\\n\\n“Only such medical professionals who understand reporting units, reference ranges and limitations of\\ntechnologies should interpret results.\\n\\n“This report is not valid for medico-legal purpose.\\n\\n“Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or\\ndamage that may be incurred by any person as a result of presuming the meaning or contents of the report.\\n\\nEXPLANATIONS\\n\\n“Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them\\nas \"Clients\".\\n\\n~* Name - The name is as declared by the client and recored by the personnel who collected the specimen.\\n\\n“  Ref.Dr - The name of the doctor who has recommended testing as declared by the client.\\n\\n“ Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.\\n\\n“Barcode - This is the specimen identity number and it states that the results are for the specimen bearing\\nthe barcode (irrespective of the name).\\n\\nSCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by\\nthe client.\\n\\n“SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.\\n\\n“SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.\\n\\n“* RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.\\n\\n“ Reference Range - Means the range of values in which 95% of the normal population would fall.\\n\\nSUGGESTIONS\\n\\n“+ Values out of reference range requires reconfirmation before starting any medical treatment.\\n\\n“* Retesting is needed if you suspect any quality shortcomings.\\n\\n“* Testing or retesting should be done in accredited laboratories.\\n\\n“For suggestions, complaints or feedback, write to us at info@thyrocare.com or call us on\\n022-3090 0000 / 4125 2525\\n\\n“* SMS:<Labcode No.> to 9870666333\\n\\nPreventive Healthcare is now at your fingertips!\\nt=)\\nBooking\\n\\nTrack your\\nConfirmatios Technician\\n\\n     \\n \\n\\n \\n\\n \\n\\n       \\n\\n       \\n      \\n  \\n\\nRig tT Nt\\n\\n \\n\\n        \\n\\nLy\\n\\nSample\\nTesting\\n\\n=\\na &\\n&\\n\\nexplore & Select\\nTest / Profil\\n\\n     \\n\\n     \\n\\n  \\n\\nBlood\\nCollection\\n\\n   \\n\\n \\n\\n \\n\\n   \\n\\nFocus TB\\n\\nTowards a TB free world\\n\\n   \\n\\n“Fight TB with power of\\nRapid Technology”\\n\\n  \\n \\n \\n \\n \\n \\n \\n \\n   \\n\\nFocus TB, powered by Thyrocare.\\nA brand that will focus on TB, which is one of the major public health\\n\\na eae eee Call : 022 - 3090 0000/4125 2525\\n\\nTuberculosis (TB) is a transmissible, airborne infection caused by info@focustb.com\\nMycobacterium tuberculosis (MTB). \\\\t transpires usually when a\\nperson inhales microscopic droplet nuclei containing viable\\nbacteria, spread through coughing by persons who have\\ninfectious TB.\\n\\nPage : 19 of 19\\n\\x0c',\n",
       " 'PROCESSED AT:\\n\\nThyrocare meCAP Thyro C ar eC\\n\\nD-37/1,TTC MIDC,Turbhe, COLLEGE of AMERICAN PATHOLOGISTS . . .\\nNavi Mumbai-400 703 ceanthewo. NSsaor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS K DEVI (35Y/F) SAMPLE COLLECTED AT\\n. (5311164139),MYTHRI MEDICAL CENTRE,MAIN RD,\\nREF. BY : DR G VIJAYASANTHI MBBS DGO,OTHER NARSIPATNAM, ANDHRA PRADESH, 531116\\nTEST ASKED : T3-T4-TSH\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) C.LI.A 118 ng/d| 60-200\\nTOTAL THYROXINE (T4) C.L.L.A 12.9 ug/dl 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) C.LI.A 5.14 HIU/ml 0.3-5.5\\n\\nComments: IF NOT ON DRUGS SUGGESTED FT3 & FT4 ESTIMATION\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nT3 - Competitive Chemi Luminescent Immuno Assay\\n\\nT4 - Competitive Chemi Luminescent Immuno Assay\\nTSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY\\nPregnancy reference ranges for TSH\\n\\n1st Trimester : 0.10 - 2.50\\n\\n2nd Trimester : 0.20 - 3.00\\n\\n3rd Trimester : 0.30 - 3.00\\n\\nReference:\\nGuidelines of American Thyroid Association for the Diagnosis and Management of Thyroid Disease During\\nPregnancy and Postpartum, Thyroid, 2011, 21; 1-46\\n\\n~~ End of report ~~\\n\\nSample Collected on (SCT) : 26 Aug 2019 17:00\\n\\nSample Received on (SRT) : 27 Aug 2019 22:52 ac tt?\\nReport Released on (RRT) : 28 Aug 2019 02:22 Oe ea\\n\\nSample Type OF . © : SERUM io .\\n= Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2708040474/A6750\\n\\nF100) . Page : 1 of 2\\nBarcode Ou : 00274398\\n\\x0c',\n",
       " 'PROCESSED AT:\\n\\nThyrocare meCAP Thyro C ar eC\\n\\nD-37/1,TTC MIDC,Turbhe, COLLEGE of AMERICAN PATHOLOGISTS . . .\\nNavi Mumbai-400 703 ceanthewo. NSsaor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS K DEVI (35Y/F) SAMPLE COLLECTED AT\\n. (5311164139),MYTHRI MEDICAL CENTRE,MAIN RD,\\nREF. BY : DR G VIJAYASANTHI MBBS DGO,OTHER NARSIPATNAM, ANDHRA PRADESH, 531116\\nTEST ASKED : T3-T4-TSH\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) C.LI.A 118 ng/d| 60-200\\nTOTAL THYROXINE (T4) C.L.L.A 12.9 ug/dl 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) C.LI.A 5.14 HIU/ml 0.3-5.5\\n\\nComments: IF NOT ON DRUGS SUGGESTED FT3 & FT4 ESTIMATION\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nT3 - Competitive Chemi Luminescent Immuno Assay\\n\\nT4 - Competitive Chemi Luminescent Immuno Assay\\nTSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY\\nPregnancy reference ranges for TSH\\n\\n1st Trimester : 0.10 - 2.50\\n\\n2nd Trimester : 0.20 - 3.00\\n\\n3rd Trimester : 0.30 - 3.00\\n\\nReference:\\nGuidelines of American Thyroid Association for the Diagnosis and Management of Thyroid Disease During\\nPregnancy and Postpartum, Thyroid, 2011, 21; 1-46\\n\\n~~ End of report ~~\\n\\nSample Collected on (SCT) : 26 Aug 2019 17:00\\n\\nSample Received on (SRT) : 27 Aug 2019 22:52 ac tt?\\nReport Released on (RRT) : 28 Aug 2019 02:22 Oe ea\\n\\nSample Type OF . © : SERUM io .\\n= Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2708040474/A6750\\n\\nF100) . Page : 1 of 2\\nBarcode Ou : 00274398\\n\\x0cCONDITIONS OF REPORTING\\n\\n“ The reported results are for information and interpretation of the referring doctor only.\\n\\n“It is presumed that the tests performed on the specimen belong to the patient; named or identified.\\n\\n“Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the\\nsame patient.\\n\\n“Should the results indicate an unexpected abnormality, the same should be reconfirmed.\\n\\n“Only such medical professionals who understand reporting units, reference ranges and limitations of\\ntechnologies should interpret results.\\n\\n“This report is not valid for medico-legal purpose.\\n\\n“Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or\\ndamage that may be incurred by any person as a result of presuming the meaning or contents of the report.\\n\\nEXPLANATIONS\\n\\n“Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them\\nas \"Clients\".\\n\\n~* Name - The name is as declared by the client and recored by the personnel who collected the specimen.\\n\\n“  Ref.Dr - The name of the doctor who has recommended testing as declared by the client.\\n\\n“ Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.\\n\\n“Barcode - This is the specimen identity number and it states that the results are for the specimen bearing\\nthe barcode (irrespective of the name).\\n\\nSCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by\\nthe client.\\n\\n“SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.\\n\\n“SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.\\n\\n“* RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.\\n\\n“ Reference Range - Means the range of values in which 95% of the normal population would fall.\\n\\nSUGGESTIONS\\n\\n“+ Values out of reference range requires reconfirmation before starting any medical treatment.\\n\\n“* Retesting is needed if you suspect any quality shortcomings.\\n\\n“* Testing or retesting should be done in accredited laboratories.\\n\\n“For suggestions, complaints or feedback, write to us at info@thyrocare.com or call us on\\n022-3090 0000 / 4125 2525\\n\\n“* SMS:<Labcode No.> to 9870666333\\n\\nPreventive Healthcare is now at your fingertips!\\nt=)\\nBooking\\n\\nTrack your\\nConfirmatios Technician\\n\\n     \\n \\n\\n \\n\\n \\n\\n       \\n\\n       \\n      \\n  \\n\\nRig tT Nt\\n\\n \\n\\n        \\n\\nLy\\n\\nSample\\nTesting\\n\\n=\\na &\\n&\\n\\nexplore & Select\\nTest / Profil\\n\\n     \\n\\n     \\n\\n  \\n\\nBlood\\nCollection\\n\\n   \\n\\n \\n\\n \\n\\n   \\n\\nFocus TB\\n\\nTowards a TB free world\\n\\n   \\n\\n“Fight TB with power of\\nRapid Technology”\\n\\n  \\n \\n \\n \\n \\n \\n \\n \\n   \\n\\nFocus TB, powered by Thyrocare.\\nA brand that will focus on TB, which is one of the major public health\\n\\nproblems in the country. Call : 022 - 3090 0000/4125 2525\\n\\nTuberculosis (TB) is a transmissible, airborne infection caused by info@focustb.com\\nMycobacterium tuberculosis (MTB). \\\\t transpires usually when a\\nperson inhales microscopic droplet nuclei containing viable\\nbacteria, spread through coughing by persons who have\\ninfectious TB.\\n\\nPage : 2 of 2\\n\\x0c',\n",
       " 'PROCESSED AT: grmontsng Hemoglobin Aye Testing\\nThyrocare @JNGsP\\nD-37/1,TTC MIDC,Turbhe, J\\n\\nNavi Mumbai-400 703 SESE\\n\\n    \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT\\n\\n. (5311169953),PRABHU CLINICAL\\nREF. BY + SELF LABORATORY,DR.YEKKALA RAMAKRISHNA\\nTEST ASKED : HBA,HEMOGRAM - 6 PART (DIFF) HOSPITAL RAMARAOPETA NARSIPATNAM\\n\\n531116,531116\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbAi1c - (HPLC - NGSP Certified)\\nH.P.L.C 8.3 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 192 mg/dl\\nReference Range :\\n90 - 120 mg/dl : Good Control\\n121 - 150 mg/dl : Fair Control\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\nSample Collected on (SCT) :26 Aug 2019 18:00\\nSample Received on (SRT) 27 Aug 2019 22:50 Goole?\\nReport Released on (RRT) :28 Aug 2019 08:25 Oe <a\\n\\nSample Type bres. #EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2708040370/A6750\\n\\nRe . Page : 1 of 9\\nBarcode Ou :M9261080\\n\\x0c',\n",
       " 'PROCESSED AT: grmontsng Hemoglobin Aye Testing\\nThyrocare @JNGsP\\nD-37/1,TTC MIDC,Turbhe, J\\n\\nNavi Mumbai-400 703 SESE\\n\\n    \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT\\n\\n. (5311169953),PRABHU CLINICAL\\nREF. BY + SELF LABORATORY,DR.YEKKALA RAMAKRISHNA\\nTEST ASKED : HBA,HEMOGRAM - 6 PART (DIFF) HOSPITAL RAMARAOPETA NARSIPATNAM\\n\\n531116,531116\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbAi1c - (HPLC - NGSP Certified)\\nH.P.L.C 8.3 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 192 mg/dl\\nReference Range :\\n90 - 120 mg/dl : Good Control\\n121 - 150 mg/dl : Fair Control\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\nSample Collected on (SCT) :26 Aug 2019 18:00\\nSample Received on (SRT) 27 Aug 2019 22:50 Goole?\\nReport Released on (RRT) :28 Aug 2019 08:25 Oe <a\\n\\nSample Type bres. #EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2708040370/A6750\\n\\nRe . Page : 1 of 9\\nBarcode Ou :M9261080\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\ncentiieAte no: C2407\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\n\\nREF. BY + SELF (5311169953),PRABHU CLINICAL\\nLABORATORY,DR.YEKKALA RAMAKRISHNA\\n\\nTEST ASKED HBA,HEMOGRAM - 6 PART (DIFF) HOSPITAL RAMARAOPETA NARSIPATNAM\\n531116,531116\\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\n\\nTOTAL LEUCOCYTES COUNT 6.4 X103/pL  4.0-10.0\\n\\nNEUTROPHILS 49.7 % 40-80\\n\\nLYMPHOCYTE PERCENTAGE 42.8 % 20-40\\n\\nMONOCYTES 2.3 % 0-10\\n\\nEOSINOPHILS 4.7 % 0.0-6.0\\n\\nBASOPHILS 0.2 % <2\\n\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0-0.5\\n\\nNEUTROPHILS - ABSOLUTE COUNT 3.18 X103/uL  2.0-7.0\\n\\nLYMPHOCYTES - ABSOLUTE COUNT 2.74 X103/pL  1.0-3.0\\n\\nMONOCYTES - ABSOLUTE COUNT 0.15 X 103 / pL 0.2-1\\n\\nBASOPHILS - ABSOLUTE COUNT 0.01 X103/pL  0-0.1\\n\\nEOSINOPHILS - ABSOLUTE COUNT 0.3 X103/pL  0-0.5\\n\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0-0.3\\n\\nTOTAL RBC 6.13 X1046/pL 4.5-5.5\\n\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\n\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\n\\nHEMOGLOBIN 18.1 g/dL 13-17\\n\\nHEMATOCRIT(PCV) 50.68 % 40-50\\n\\nMEAN CORPUSCULAR VOLUME(MCV) 100.2 fl 83-101\\n\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 29.5 pq 27-32\\n\\nMEAN CORP.HEMO.CONC(MCHC) 29.5 g/dL 31.5-34.5\\n\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 62.9 fL 39-46\\n\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.6 % 11.6-14\\n\\nPLATELET DISTRIBUTION WIDTH(PDW) 11.1 fL 9.6-15.2\\n\\nMEAN PLATELET VOLUME(MPV) 9.4 fL 6.5-12\\n\\nPLATELET COUNT 222 X103/uL 150-400\\n\\nPLATELET TO LARGE CELL RATIO(PLCR) 20.5 % 19.7-42.4\\n\\nPLATELETCRIT(PCT) 0.21 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n:26 Aug 2019 18:00\\n227 Aug 2019 22:50\\n:28 Aug 2019 08:25\\n: EDTA\\n\\n: 2708040370/A6750\\n: M9261080\\n\\nln!\\n\\nra\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 9\\n\\x0c',\n",
       " 'PROCESSED AT: grmontsng Hemoglobin Aye Testing\\nThyrocare @JNGsP\\nD-37/1,TTC MIDC,Turbhe, J\\n\\nNavi Mumbai-400 703 SESE\\n\\n    \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT\\n\\n. (5311169953),PRABHU CLINICAL\\nREF. BY + SELF LABORATORY,DR.YEKKALA RAMAKRISHNA\\nTEST ASKED : HBA,HEMOGRAM - 6 PART (DIFF) HOSPITAL RAMARAOPETA NARSIPATNAM\\n\\n531116,531116\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbAi1c - (HPLC - NGSP Certified)\\nH.P.L.C 8.3 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 192 mg/dl\\nReference Range :\\n90 - 120 mg/dl : Good Control\\n121 - 150 mg/dl : Fair Control\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\nSample Collected on (SCT) :26 Aug 2019 18:00\\nSample Received on (SRT) 27 Aug 2019 22:50 Goole?\\nReport Released on (RRT) :28 Aug 2019 08:25 Oe <a\\n\\nSample Type bres. #EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2708040370/A6750\\n\\nRe . Page : 1 of 9\\nBarcode Ou :M9261080\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\ncentiieAte no: C2407\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\n\\nREF. BY + SELF (5311169953),PRABHU CLINICAL\\nLABORATORY,DR.YEKKALA RAMAKRISHNA\\n\\nTEST ASKED HBA,HEMOGRAM - 6 PART (DIFF) HOSPITAL RAMARAOPETA NARSIPATNAM\\n531116,531116\\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\n\\nTOTAL LEUCOCYTES COUNT 6.4 X103/pL  4.0-10.0\\n\\nNEUTROPHILS 49.7 % 40-80\\n\\nLYMPHOCYTE PERCENTAGE 42.8 % 20-40\\n\\nMONOCYTES 2.3 % 0-10\\n\\nEOSINOPHILS 4.7 % 0.0-6.0\\n\\nBASOPHILS 0.2 % <2\\n\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0-0.5\\n\\nNEUTROPHILS - ABSOLUTE COUNT 3.18 X103/uL  2.0-7.0\\n\\nLYMPHOCYTES - ABSOLUTE COUNT 2.74 X103/pL  1.0-3.0\\n\\nMONOCYTES - ABSOLUTE COUNT 0.15 X 103 / pL 0.2-1\\n\\nBASOPHILS - ABSOLUTE COUNT 0.01 X103/pL  0-0.1\\n\\nEOSINOPHILS - ABSOLUTE COUNT 0.3 X103/pL  0-0.5\\n\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0-0.3\\n\\nTOTAL RBC 6.13 X1046/pL 4.5-5.5\\n\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\n\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\n\\nHEMOGLOBIN 18.1 g/dL 13-17\\n\\nHEMATOCRIT(PCV) 50.68 % 40-50\\n\\nMEAN CORPUSCULAR VOLUME(MCV) 100.2 fl 83-101\\n\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 29.5 pq 27-32\\n\\nMEAN CORP.HEMO.CONC(MCHC) 29.5 g/dL 31.5-34.5\\n\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 62.9 fL 39-46\\n\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.6 % 11.6-14\\n\\nPLATELET DISTRIBUTION WIDTH(PDW) 11.1 fL 9.6-15.2\\n\\nMEAN PLATELET VOLUME(MPV) 9.4 fL 6.5-12\\n\\nPLATELET COUNT 222 X103/uL 150-400\\n\\nPLATELET TO LARGE CELL RATIO(PLCR) 20.5 % 19.7-42.4\\n\\nPLATELETCRIT(PCT) 0.21 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n:26 Aug 2019 18:00\\n227 Aug 2019 22:50\\n:28 Aug 2019 08:25\\n: EDTA\\n\\n: 2708040370/A6750\\n: M9261080\\n\\nln!\\n\\nra\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 9\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP orl Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT\\n\\n. (5311169953),PRABHU CLINICAL\\n\\nREF. BY + SELF LABORATORY,DR.YEKKALA RAMAKRISHNA\\nTEST ASKED : AAROGYAM B HOSPITAL RAMARAOPETA NARSIPATNAM\\n531116,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\n\\nIRON PHOTOMETRY 69.1 g/dl\\nReference Range :\\n\\nMale : 65-175\\n\\nFemale : 50 - 170\\n\\nMethod : _ FERROZINE METHOD WITHOUT DEPROTEINIZATION\\n\\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 348 g/dl\\nReference Range :\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n\\n% TRANSFERRIN SATURATION CALCULATED 19.86 %\\nReference Range :\\n\\n13-45\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\n\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :26 Aug 2019 18:00\\n\\nSample Received on (SRT) 127 Aug 2019 22:53 Goole?\\n\\nReport Released on (RRT) :28 Aug 2019 02:10 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2708040550/A6750\\n\\nPage : 3 of 9\\nBarcode =N7212022\\n\\x0c',\n",
       " 'PROCESSED AT: grmontsng Hemoglobin Aye Testing\\nThyrocare @JNGsP\\nD-37/1,TTC MIDC,Turbhe, J\\n\\nNavi Mumbai-400 703 SESE\\n\\n    \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT\\n\\n. (5311169953),PRABHU CLINICAL\\nREF. BY + SELF LABORATORY,DR.YEKKALA RAMAKRISHNA\\nTEST ASKED : HBA,HEMOGRAM - 6 PART (DIFF) HOSPITAL RAMARAOPETA NARSIPATNAM\\n\\n531116,531116\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbAi1c - (HPLC - NGSP Certified)\\nH.P.L.C 8.3 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 192 mg/dl\\nReference Range :\\n90 - 120 mg/dl : Good Control\\n121 - 150 mg/dl : Fair Control\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\nSample Collected on (SCT) :26 Aug 2019 18:00\\nSample Received on (SRT) 27 Aug 2019 22:50 Goole?\\nReport Released on (RRT) :28 Aug 2019 08:25 Oe <a\\n\\nSample Type bres. #EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2708040370/A6750\\n\\nRe . Page : 1 of 9\\nBarcode Ou :M9261080\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\ncentiieAte no: C2407\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\n\\nREF. BY + SELF (5311169953),PRABHU CLINICAL\\nLABORATORY,DR.YEKKALA RAMAKRISHNA\\n\\nTEST ASKED HBA,HEMOGRAM - 6 PART (DIFF) HOSPITAL RAMARAOPETA NARSIPATNAM\\n531116,531116\\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\n\\nTOTAL LEUCOCYTES COUNT 6.4 X103/pL  4.0-10.0\\n\\nNEUTROPHILS 49.7 % 40-80\\n\\nLYMPHOCYTE PERCENTAGE 42.8 % 20-40\\n\\nMONOCYTES 2.3 % 0-10\\n\\nEOSINOPHILS 4.7 % 0.0-6.0\\n\\nBASOPHILS 0.2 % <2\\n\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0-0.5\\n\\nNEUTROPHILS - ABSOLUTE COUNT 3.18 X103/uL  2.0-7.0\\n\\nLYMPHOCYTES - ABSOLUTE COUNT 2.74 X103/pL  1.0-3.0\\n\\nMONOCYTES - ABSOLUTE COUNT 0.15 X 103 / pL 0.2-1\\n\\nBASOPHILS - ABSOLUTE COUNT 0.01 X103/pL  0-0.1\\n\\nEOSINOPHILS - ABSOLUTE COUNT 0.3 X103/pL  0-0.5\\n\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0-0.3\\n\\nTOTAL RBC 6.13 X1046/pL 4.5-5.5\\n\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\n\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\n\\nHEMOGLOBIN 18.1 g/dL 13-17\\n\\nHEMATOCRIT(PCV) 50.68 % 40-50\\n\\nMEAN CORPUSCULAR VOLUME(MCV) 100.2 fl 83-101\\n\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 29.5 pq 27-32\\n\\nMEAN CORP.HEMO.CONC(MCHC) 29.5 g/dL 31.5-34.5\\n\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 62.9 fL 39-46\\n\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.6 % 11.6-14\\n\\nPLATELET DISTRIBUTION WIDTH(PDW) 11.1 fL 9.6-15.2\\n\\nMEAN PLATELET VOLUME(MPV) 9.4 fL 6.5-12\\n\\nPLATELET COUNT 222 X103/uL 150-400\\n\\nPLATELET TO LARGE CELL RATIO(PLCR) 20.5 % 19.7-42.4\\n\\nPLATELETCRIT(PCT) 0.21 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n:26 Aug 2019 18:00\\n227 Aug 2019 22:50\\n:28 Aug 2019 08:25\\n: EDTA\\n\\n: 2708040370/A6750\\n: M9261080\\n\\nln!\\n\\nra\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 9\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP orl Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT\\n\\n. (5311169953),PRABHU CLINICAL\\n\\nREF. BY + SELF LABORATORY,DR.YEKKALA RAMAKRISHNA\\nTEST ASKED : AAROGYAM B HOSPITAL RAMARAOPETA NARSIPATNAM\\n531116,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\n\\nIRON PHOTOMETRY 69.1 g/dl\\nReference Range :\\n\\nMale : 65-175\\n\\nFemale : 50 - 170\\n\\nMethod : _ FERROZINE METHOD WITHOUT DEPROTEINIZATION\\n\\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 348 g/dl\\nReference Range :\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n\\n% TRANSFERRIN SATURATION CALCULATED 19.86 %\\nReference Range :\\n\\n13-45\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\n\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :26 Aug 2019 18:00\\n\\nSample Received on (SRT) 127 Aug 2019 22:53 Goole?\\n\\nReport Released on (RRT) :28 Aug 2019 02:10 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2708040550/A6750\\n\\nPage : 3 of 9\\nBarcode =N7212022\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\nREF. BY : SELF (5311169953), PRABHU CLINICAL\\n\\nLABORATORY, DR.YEKKALA RAMAKRISHNA HOSPITAL\\nTEST ASKED  AAROGYAM B RAMARAOPETA NARSIPATNAM 531116,531116\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 64.5 U/L 45 - 129\\nBILIRUBIN - TOTAL PHOTOMETRY 0.35 mg/dl 0.3-1.2\\nBILIRUBIN -DIRECT PHOTOMETRY 0.08 mg/dl < 0.3\\nBILIRUBIN (INDIRECT) CALCULATED 0.27 mg/dl 0-0.9\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 91.1 u/I <55\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 22.5 u/| <35\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 21.4 u/| < 45\\nPROTEIN - TOTAL PHOTOMETRY 6.6 gm/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 41 gm/dl 3.2-4.8\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.64 Ratio 0.9-2\\nSERUM GLOBULIN PHOTOMETRY 2.5 gm/dL 2.5-3.4\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - MODIFIED IFCC METHOD\\n\\nBILT - VANADATE OXIDATION\\n\\nBILD - VANADATE OXIDATION\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - MODIFIED IFCC METHOD\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 26 Aug 2019 18:00\\n\\nSample Received on (SRT) : 27 Aug 2019 22:53 heen’\\n\\nReport Released on (RRT) : 28 Aug 2019 02:10 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2708040550/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7212022 Page : 4 of 9\\n\\x0c',\n",
       " 'PROCESSED AT: grmontsng Hemoglobin Aye Testing\\nThyrocare @JNGsP\\nD-37/1,TTC MIDC,Turbhe, J\\n\\nNavi Mumbai-400 703 SESE\\n\\n    \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT\\n\\n. (5311169953),PRABHU CLINICAL\\nREF. BY + SELF LABORATORY,DR.YEKKALA RAMAKRISHNA\\nTEST ASKED : HBA,HEMOGRAM - 6 PART (DIFF) HOSPITAL RAMARAOPETA NARSIPATNAM\\n\\n531116,531116\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbAi1c - (HPLC - NGSP Certified)\\nH.P.L.C 8.3 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 192 mg/dl\\nReference Range :\\n90 - 120 mg/dl : Good Control\\n121 - 150 mg/dl : Fair Control\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\nSample Collected on (SCT) :26 Aug 2019 18:00\\nSample Received on (SRT) 27 Aug 2019 22:50 Goole?\\nReport Released on (RRT) :28 Aug 2019 08:25 Oe <a\\n\\nSample Type bres. #EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2708040370/A6750\\n\\nRe . Page : 1 of 9\\nBarcode Ou :M9261080\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\ncentiieAte no: C2407\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\n\\nREF. BY + SELF (5311169953),PRABHU CLINICAL\\nLABORATORY,DR.YEKKALA RAMAKRISHNA\\n\\nTEST ASKED HBA,HEMOGRAM - 6 PART (DIFF) HOSPITAL RAMARAOPETA NARSIPATNAM\\n531116,531116\\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\n\\nTOTAL LEUCOCYTES COUNT 6.4 X103/pL  4.0-10.0\\n\\nNEUTROPHILS 49.7 % 40-80\\n\\nLYMPHOCYTE PERCENTAGE 42.8 % 20-40\\n\\nMONOCYTES 2.3 % 0-10\\n\\nEOSINOPHILS 4.7 % 0.0-6.0\\n\\nBASOPHILS 0.2 % <2\\n\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0-0.5\\n\\nNEUTROPHILS - ABSOLUTE COUNT 3.18 X103/uL  2.0-7.0\\n\\nLYMPHOCYTES - ABSOLUTE COUNT 2.74 X103/pL  1.0-3.0\\n\\nMONOCYTES - ABSOLUTE COUNT 0.15 X 103 / pL 0.2-1\\n\\nBASOPHILS - ABSOLUTE COUNT 0.01 X103/pL  0-0.1\\n\\nEOSINOPHILS - ABSOLUTE COUNT 0.3 X103/pL  0-0.5\\n\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0-0.3\\n\\nTOTAL RBC 6.13 X1046/pL 4.5-5.5\\n\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\n\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\n\\nHEMOGLOBIN 18.1 g/dL 13-17\\n\\nHEMATOCRIT(PCV) 50.68 % 40-50\\n\\nMEAN CORPUSCULAR VOLUME(MCV) 100.2 fl 83-101\\n\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 29.5 pq 27-32\\n\\nMEAN CORP.HEMO.CONC(MCHC) 29.5 g/dL 31.5-34.5\\n\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 62.9 fL 39-46\\n\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.6 % 11.6-14\\n\\nPLATELET DISTRIBUTION WIDTH(PDW) 11.1 fL 9.6-15.2\\n\\nMEAN PLATELET VOLUME(MPV) 9.4 fL 6.5-12\\n\\nPLATELET COUNT 222 X103/uL 150-400\\n\\nPLATELET TO LARGE CELL RATIO(PLCR) 20.5 % 19.7-42.4\\n\\nPLATELETCRIT(PCT) 0.21 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n:26 Aug 2019 18:00\\n227 Aug 2019 22:50\\n:28 Aug 2019 08:25\\n: EDTA\\n\\n: 2708040370/A6750\\n: M9261080\\n\\nln!\\n\\nra\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 9\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP orl Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT\\n\\n. (5311169953),PRABHU CLINICAL\\n\\nREF. BY + SELF LABORATORY,DR.YEKKALA RAMAKRISHNA\\nTEST ASKED : AAROGYAM B HOSPITAL RAMARAOPETA NARSIPATNAM\\n531116,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\n\\nIRON PHOTOMETRY 69.1 g/dl\\nReference Range :\\n\\nMale : 65-175\\n\\nFemale : 50 - 170\\n\\nMethod : _ FERROZINE METHOD WITHOUT DEPROTEINIZATION\\n\\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 348 g/dl\\nReference Range :\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n\\n% TRANSFERRIN SATURATION CALCULATED 19.86 %\\nReference Range :\\n\\n13-45\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\n\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :26 Aug 2019 18:00\\n\\nSample Received on (SRT) 127 Aug 2019 22:53 Goole?\\n\\nReport Released on (RRT) :28 Aug 2019 02:10 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2708040550/A6750\\n\\nPage : 3 of 9\\nBarcode =N7212022\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\nREF. BY : SELF (5311169953), PRABHU CLINICAL\\n\\nLABORATORY, DR.YEKKALA RAMAKRISHNA HOSPITAL\\nTEST ASKED  AAROGYAM B RAMARAOPETA NARSIPATNAM 531116,531116\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 64.5 U/L 45 - 129\\nBILIRUBIN - TOTAL PHOTOMETRY 0.35 mg/dl 0.3-1.2\\nBILIRUBIN -DIRECT PHOTOMETRY 0.08 mg/dl < 0.3\\nBILIRUBIN (INDIRECT) CALCULATED 0.27 mg/dl 0-0.9\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 91.1 u/I <55\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 22.5 u/| <35\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 21.4 u/| < 45\\nPROTEIN - TOTAL PHOTOMETRY 6.6 gm/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 41 gm/dl 3.2-4.8\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.64 Ratio 0.9-2\\nSERUM GLOBULIN PHOTOMETRY 2.5 gm/dL 2.5-3.4\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - MODIFIED IFCC METHOD\\n\\nBILT - VANADATE OXIDATION\\n\\nBILD - VANADATE OXIDATION\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - MODIFIED IFCC METHOD\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 26 Aug 2019 18:00\\n\\nSample Received on (SRT) : 27 Aug 2019 22:53 heen’\\n\\nReport Released on (RRT) : 28 Aug 2019 02:10 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2708040550/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7212022 Page : 4 of 9\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\ncanmwoheno. WOsor Think Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\nREF. BY : SELF (5311169953),PRABHU CLINICAL\\nLABORATORY,DR.YEKKALA RAMAKRISHNA HOSPITAL\\n\\n \\n\\nTEST ASKED  AAROGYAM B RAMARAOPETA NARSIPATNAM 531116,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nTOTAL CHOLESTEROL PHOTOMETRY 220 mg/dl 125-200\\n\\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 36 mg/dl 35-80\\n\\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 167 mg/dl 85-130\\nTRIGLYCERIDES PHOTOMETRY 188 mg/dl 25-200\\n\\nTC/ HDL CHOLESTEROL RATIO CALCULATED 6.1 Ratio 3-5\\n\\nLDL / HDL RATIO CALCULATED 4.7 Ratio 1.5-3.5\\n\\nVLDL CHOLESTEROL CALCULATED 37.6 mg/dl 5-40\\n\\nNON-HDL CHOLESTEROL CALCULATED 184.1 mg/dl < 160\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nCHOL - CHOD POD METHOD\\n\\nHCHO - ENZYME SELECTIVE PROTECTION METHOD\\n\\nLDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY\\n\\nTRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]\\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\nLDL/ - DERIVED FROM SERUM HDL AND LDL VALUES\\n\\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\\n\\nNHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\\n\\nTOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\\n\\nDESIRABLE <200 Low <40 OPTIMAL <100 NORMAL <150\\n\\nBORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\\n\\nHIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499\\nHIGH 160-189 VERY HIGH >500\\nVERY HIGH >190\\n\\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\\n\\nSample Collected on (SCT) : 26 Aug 2019 18:00\\n\\nSample Received on (SRT) : 27 Aug 2019 22:53 heen’\\n\\nReport Released on (RRT) : 28 Aug 2019 02:10 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2708040550/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7212022 Page : 5 of 9\\n\\x0c',\n",
       " 'PROCESSED AT: grmontsng Hemoglobin Aye Testing\\nThyrocare @JNGsP\\nD-37/1,TTC MIDC,Turbhe, J\\n\\nNavi Mumbai-400 703 SESE\\n\\n    \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT\\n\\n. (5311169953),PRABHU CLINICAL\\nREF. BY + SELF LABORATORY,DR.YEKKALA RAMAKRISHNA\\nTEST ASKED : HBA,HEMOGRAM - 6 PART (DIFF) HOSPITAL RAMARAOPETA NARSIPATNAM\\n\\n531116,531116\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbAi1c - (HPLC - NGSP Certified)\\nH.P.L.C 8.3 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 192 mg/dl\\nReference Range :\\n90 - 120 mg/dl : Good Control\\n121 - 150 mg/dl : Fair Control\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\nSample Collected on (SCT) :26 Aug 2019 18:00\\nSample Received on (SRT) 27 Aug 2019 22:50 Goole?\\nReport Released on (RRT) :28 Aug 2019 08:25 Oe <a\\n\\nSample Type bres. #EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2708040370/A6750\\n\\nRe . Page : 1 of 9\\nBarcode Ou :M9261080\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\ncentiieAte no: C2407\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\n\\nREF. BY + SELF (5311169953),PRABHU CLINICAL\\nLABORATORY,DR.YEKKALA RAMAKRISHNA\\n\\nTEST ASKED HBA,HEMOGRAM - 6 PART (DIFF) HOSPITAL RAMARAOPETA NARSIPATNAM\\n531116,531116\\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\n\\nTOTAL LEUCOCYTES COUNT 6.4 X103/pL  4.0-10.0\\n\\nNEUTROPHILS 49.7 % 40-80\\n\\nLYMPHOCYTE PERCENTAGE 42.8 % 20-40\\n\\nMONOCYTES 2.3 % 0-10\\n\\nEOSINOPHILS 4.7 % 0.0-6.0\\n\\nBASOPHILS 0.2 % <2\\n\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0-0.5\\n\\nNEUTROPHILS - ABSOLUTE COUNT 3.18 X103/uL  2.0-7.0\\n\\nLYMPHOCYTES - ABSOLUTE COUNT 2.74 X103/pL  1.0-3.0\\n\\nMONOCYTES - ABSOLUTE COUNT 0.15 X 103 / pL 0.2-1\\n\\nBASOPHILS - ABSOLUTE COUNT 0.01 X103/pL  0-0.1\\n\\nEOSINOPHILS - ABSOLUTE COUNT 0.3 X103/pL  0-0.5\\n\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0-0.3\\n\\nTOTAL RBC 6.13 X1046/pL 4.5-5.5\\n\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\n\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\n\\nHEMOGLOBIN 18.1 g/dL 13-17\\n\\nHEMATOCRIT(PCV) 50.68 % 40-50\\n\\nMEAN CORPUSCULAR VOLUME(MCV) 100.2 fl 83-101\\n\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 29.5 pq 27-32\\n\\nMEAN CORP.HEMO.CONC(MCHC) 29.5 g/dL 31.5-34.5\\n\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 62.9 fL 39-46\\n\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.6 % 11.6-14\\n\\nPLATELET DISTRIBUTION WIDTH(PDW) 11.1 fL 9.6-15.2\\n\\nMEAN PLATELET VOLUME(MPV) 9.4 fL 6.5-12\\n\\nPLATELET COUNT 222 X103/uL 150-400\\n\\nPLATELET TO LARGE CELL RATIO(PLCR) 20.5 % 19.7-42.4\\n\\nPLATELETCRIT(PCT) 0.21 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n:26 Aug 2019 18:00\\n227 Aug 2019 22:50\\n:28 Aug 2019 08:25\\n: EDTA\\n\\n: 2708040370/A6750\\n: M9261080\\n\\nln!\\n\\nra\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 9\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP orl Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT\\n\\n. (5311169953),PRABHU CLINICAL\\n\\nREF. BY + SELF LABORATORY,DR.YEKKALA RAMAKRISHNA\\nTEST ASKED : AAROGYAM B HOSPITAL RAMARAOPETA NARSIPATNAM\\n531116,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\n\\nIRON PHOTOMETRY 69.1 g/dl\\nReference Range :\\n\\nMale : 65-175\\n\\nFemale : 50 - 170\\n\\nMethod : _ FERROZINE METHOD WITHOUT DEPROTEINIZATION\\n\\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 348 g/dl\\nReference Range :\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n\\n% TRANSFERRIN SATURATION CALCULATED 19.86 %\\nReference Range :\\n\\n13-45\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\n\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :26 Aug 2019 18:00\\n\\nSample Received on (SRT) 127 Aug 2019 22:53 Goole?\\n\\nReport Released on (RRT) :28 Aug 2019 02:10 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2708040550/A6750\\n\\nPage : 3 of 9\\nBarcode =N7212022\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\nREF. BY : SELF (5311169953), PRABHU CLINICAL\\n\\nLABORATORY, DR.YEKKALA RAMAKRISHNA HOSPITAL\\nTEST ASKED  AAROGYAM B RAMARAOPETA NARSIPATNAM 531116,531116\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 64.5 U/L 45 - 129\\nBILIRUBIN - TOTAL PHOTOMETRY 0.35 mg/dl 0.3-1.2\\nBILIRUBIN -DIRECT PHOTOMETRY 0.08 mg/dl < 0.3\\nBILIRUBIN (INDIRECT) CALCULATED 0.27 mg/dl 0-0.9\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 91.1 u/I <55\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 22.5 u/| <35\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 21.4 u/| < 45\\nPROTEIN - TOTAL PHOTOMETRY 6.6 gm/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 41 gm/dl 3.2-4.8\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.64 Ratio 0.9-2\\nSERUM GLOBULIN PHOTOMETRY 2.5 gm/dL 2.5-3.4\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - MODIFIED IFCC METHOD\\n\\nBILT - VANADATE OXIDATION\\n\\nBILD - VANADATE OXIDATION\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - MODIFIED IFCC METHOD\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 26 Aug 2019 18:00\\n\\nSample Received on (SRT) : 27 Aug 2019 22:53 heen’\\n\\nReport Released on (RRT) : 28 Aug 2019 02:10 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2708040550/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7212022 Page : 4 of 9\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\ncanmwoheno. WOsor Think Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\nREF. BY : SELF (5311169953),PRABHU CLINICAL\\nLABORATORY,DR.YEKKALA RAMAKRISHNA HOSPITAL\\n\\n \\n\\nTEST ASKED  AAROGYAM B RAMARAOPETA NARSIPATNAM 531116,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nTOTAL CHOLESTEROL PHOTOMETRY 220 mg/dl 125-200\\n\\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 36 mg/dl 35-80\\n\\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 167 mg/dl 85-130\\nTRIGLYCERIDES PHOTOMETRY 188 mg/dl 25-200\\n\\nTC/ HDL CHOLESTEROL RATIO CALCULATED 6.1 Ratio 3-5\\n\\nLDL / HDL RATIO CALCULATED 4.7 Ratio 1.5-3.5\\n\\nVLDL CHOLESTEROL CALCULATED 37.6 mg/dl 5-40\\n\\nNON-HDL CHOLESTEROL CALCULATED 184.1 mg/dl < 160\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nCHOL - CHOD POD METHOD\\n\\nHCHO - ENZYME SELECTIVE PROTECTION METHOD\\n\\nLDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY\\n\\nTRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]\\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\nLDL/ - DERIVED FROM SERUM HDL AND LDL VALUES\\n\\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\\n\\nNHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\\n\\nTOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\\n\\nDESIRABLE <200 Low <40 OPTIMAL <100 NORMAL <150\\n\\nBORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\\n\\nHIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499\\nHIGH 160-189 VERY HIGH >500\\nVERY HIGH >190\\n\\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\\n\\nSample Collected on (SCT) : 26 Aug 2019 18:00\\n\\nSample Received on (SRT) : 27 Aug 2019 22:53 heen’\\n\\nReport Released on (RRT) : 28 Aug 2019 02:10 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2708040550/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7212022 Page : 5 of 9\\n\\x0cPROCESSED AT:\\n\\n \\n\\nThyrocare\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 axa eno. Oe?\\n\\n \\n\\nECAP, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT\\n\\n. (5311169953),PRABHU CLINICAL\\nREF. BY + SELF LABORATORY, DR.YEKKALA RAMAKRISHNA HOSPITAL\\nTEST ASKED : AAROGYAM B RAMARAOPETA NARSIPATNAM 531116,531116\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLA 99 ng/dl 60-200\\nTOTAL THYROXINE (T4) CLA 6.4 ug/dl 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) CLA 3.42 uIU/ml 0.3-5.5\\n\\nComments : SUGGESTING THYRONORMALCY\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nT3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nT4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nTSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nSample Collected on (SCT) : 26 Aug 2019 18:00\\nSample Received on (SRT) : 27 Aug 2019 22:53 ac tt?\\nReport Released on (RRT) : 28 Aug 2019 02:10 Oe -\\nSample Type : SERUM oo. .\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2708040550/A6750\\nPage : 6 of 9\\n\\nBarcode : N7212022\\n\\x0c',\n",
       " 'PROCESSED AT: grmontsng Hemoglobin Aye Testing\\nThyrocare @JNGsP\\nD-37/1,TTC MIDC,Turbhe, J\\n\\nNavi Mumbai-400 703 SESE\\n\\n    \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT\\n\\n. (5311169953),PRABHU CLINICAL\\nREF. BY + SELF LABORATORY,DR.YEKKALA RAMAKRISHNA\\nTEST ASKED : HBA,HEMOGRAM - 6 PART (DIFF) HOSPITAL RAMARAOPETA NARSIPATNAM\\n\\n531116,531116\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbAi1c - (HPLC - NGSP Certified)\\nH.P.L.C 8.3 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 192 mg/dl\\nReference Range :\\n90 - 120 mg/dl : Good Control\\n121 - 150 mg/dl : Fair Control\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\nSample Collected on (SCT) :26 Aug 2019 18:00\\nSample Received on (SRT) 27 Aug 2019 22:50 Goole?\\nReport Released on (RRT) :28 Aug 2019 08:25 Oe <a\\n\\nSample Type bres. #EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2708040370/A6750\\n\\nRe . Page : 1 of 9\\nBarcode Ou :M9261080\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\ncentiieAte no: C2407\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\n\\nREF. BY + SELF (5311169953),PRABHU CLINICAL\\nLABORATORY,DR.YEKKALA RAMAKRISHNA\\n\\nTEST ASKED HBA,HEMOGRAM - 6 PART (DIFF) HOSPITAL RAMARAOPETA NARSIPATNAM\\n531116,531116\\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\n\\nTOTAL LEUCOCYTES COUNT 6.4 X103/pL  4.0-10.0\\n\\nNEUTROPHILS 49.7 % 40-80\\n\\nLYMPHOCYTE PERCENTAGE 42.8 % 20-40\\n\\nMONOCYTES 2.3 % 0-10\\n\\nEOSINOPHILS 4.7 % 0.0-6.0\\n\\nBASOPHILS 0.2 % <2\\n\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0-0.5\\n\\nNEUTROPHILS - ABSOLUTE COUNT 3.18 X103/uL  2.0-7.0\\n\\nLYMPHOCYTES - ABSOLUTE COUNT 2.74 X103/pL  1.0-3.0\\n\\nMONOCYTES - ABSOLUTE COUNT 0.15 X 103 / pL 0.2-1\\n\\nBASOPHILS - ABSOLUTE COUNT 0.01 X103/pL  0-0.1\\n\\nEOSINOPHILS - ABSOLUTE COUNT 0.3 X103/pL  0-0.5\\n\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0-0.3\\n\\nTOTAL RBC 6.13 X1046/pL 4.5-5.5\\n\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\n\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\n\\nHEMOGLOBIN 18.1 g/dL 13-17\\n\\nHEMATOCRIT(PCV) 50.68 % 40-50\\n\\nMEAN CORPUSCULAR VOLUME(MCV) 100.2 fl 83-101\\n\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 29.5 pq 27-32\\n\\nMEAN CORP.HEMO.CONC(MCHC) 29.5 g/dL 31.5-34.5\\n\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 62.9 fL 39-46\\n\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.6 % 11.6-14\\n\\nPLATELET DISTRIBUTION WIDTH(PDW) 11.1 fL 9.6-15.2\\n\\nMEAN PLATELET VOLUME(MPV) 9.4 fL 6.5-12\\n\\nPLATELET COUNT 222 X103/uL 150-400\\n\\nPLATELET TO LARGE CELL RATIO(PLCR) 20.5 % 19.7-42.4\\n\\nPLATELETCRIT(PCT) 0.21 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n:26 Aug 2019 18:00\\n227 Aug 2019 22:50\\n:28 Aug 2019 08:25\\n: EDTA\\n\\n: 2708040370/A6750\\n: M9261080\\n\\nln!\\n\\nra\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 9\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP orl Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT\\n\\n. (5311169953),PRABHU CLINICAL\\n\\nREF. BY + SELF LABORATORY,DR.YEKKALA RAMAKRISHNA\\nTEST ASKED : AAROGYAM B HOSPITAL RAMARAOPETA NARSIPATNAM\\n531116,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\n\\nIRON PHOTOMETRY 69.1 g/dl\\nReference Range :\\n\\nMale : 65-175\\n\\nFemale : 50 - 170\\n\\nMethod : _ FERROZINE METHOD WITHOUT DEPROTEINIZATION\\n\\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 348 g/dl\\nReference Range :\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n\\n% TRANSFERRIN SATURATION CALCULATED 19.86 %\\nReference Range :\\n\\n13-45\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\n\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :26 Aug 2019 18:00\\n\\nSample Received on (SRT) 127 Aug 2019 22:53 Goole?\\n\\nReport Released on (RRT) :28 Aug 2019 02:10 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2708040550/A6750\\n\\nPage : 3 of 9\\nBarcode =N7212022\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\nREF. BY : SELF (5311169953), PRABHU CLINICAL\\n\\nLABORATORY, DR.YEKKALA RAMAKRISHNA HOSPITAL\\nTEST ASKED  AAROGYAM B RAMARAOPETA NARSIPATNAM 531116,531116\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 64.5 U/L 45 - 129\\nBILIRUBIN - TOTAL PHOTOMETRY 0.35 mg/dl 0.3-1.2\\nBILIRUBIN -DIRECT PHOTOMETRY 0.08 mg/dl < 0.3\\nBILIRUBIN (INDIRECT) CALCULATED 0.27 mg/dl 0-0.9\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 91.1 u/I <55\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 22.5 u/| <35\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 21.4 u/| < 45\\nPROTEIN - TOTAL PHOTOMETRY 6.6 gm/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 41 gm/dl 3.2-4.8\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.64 Ratio 0.9-2\\nSERUM GLOBULIN PHOTOMETRY 2.5 gm/dL 2.5-3.4\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - MODIFIED IFCC METHOD\\n\\nBILT - VANADATE OXIDATION\\n\\nBILD - VANADATE OXIDATION\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - MODIFIED IFCC METHOD\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 26 Aug 2019 18:00\\n\\nSample Received on (SRT) : 27 Aug 2019 22:53 heen’\\n\\nReport Released on (RRT) : 28 Aug 2019 02:10 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2708040550/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7212022 Page : 4 of 9\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\ncanmwoheno. WOsor Think Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\nREF. BY : SELF (5311169953),PRABHU CLINICAL\\nLABORATORY,DR.YEKKALA RAMAKRISHNA HOSPITAL\\n\\n \\n\\nTEST ASKED  AAROGYAM B RAMARAOPETA NARSIPATNAM 531116,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nTOTAL CHOLESTEROL PHOTOMETRY 220 mg/dl 125-200\\n\\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 36 mg/dl 35-80\\n\\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 167 mg/dl 85-130\\nTRIGLYCERIDES PHOTOMETRY 188 mg/dl 25-200\\n\\nTC/ HDL CHOLESTEROL RATIO CALCULATED 6.1 Ratio 3-5\\n\\nLDL / HDL RATIO CALCULATED 4.7 Ratio 1.5-3.5\\n\\nVLDL CHOLESTEROL CALCULATED 37.6 mg/dl 5-40\\n\\nNON-HDL CHOLESTEROL CALCULATED 184.1 mg/dl < 160\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nCHOL - CHOD POD METHOD\\n\\nHCHO - ENZYME SELECTIVE PROTECTION METHOD\\n\\nLDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY\\n\\nTRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]\\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\nLDL/ - DERIVED FROM SERUM HDL AND LDL VALUES\\n\\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\\n\\nNHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\\n\\nTOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\\n\\nDESIRABLE <200 Low <40 OPTIMAL <100 NORMAL <150\\n\\nBORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\\n\\nHIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499\\nHIGH 160-189 VERY HIGH >500\\nVERY HIGH >190\\n\\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\\n\\nSample Collected on (SCT) : 26 Aug 2019 18:00\\n\\nSample Received on (SRT) : 27 Aug 2019 22:53 heen’\\n\\nReport Released on (RRT) : 28 Aug 2019 02:10 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2708040550/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7212022 Page : 5 of 9\\n\\x0cPROCESSED AT:\\n\\n \\n\\nThyrocare\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 axa eno. Oe?\\n\\n \\n\\nECAP, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT\\n\\n. (5311169953),PRABHU CLINICAL\\nREF. BY + SELF LABORATORY, DR.YEKKALA RAMAKRISHNA HOSPITAL\\nTEST ASKED : AAROGYAM B RAMARAOPETA NARSIPATNAM 531116,531116\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLA 99 ng/dl 60-200\\nTOTAL THYROXINE (T4) CLA 6.4 ug/dl 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) CLA 3.42 uIU/ml 0.3-5.5\\n\\nComments : SUGGESTING THYRONORMALCY\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nT3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nT4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nTSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nSample Collected on (SCT) : 26 Aug 2019 18:00\\nSample Received on (SRT) : 27 Aug 2019 22:53 ac tt?\\nReport Released on (RRT) : 28 Aug 2019 02:10 Oe -\\nSample Type : SERUM oo. .\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2708040550/A6750\\nPage : 6 of 9\\n\\nBarcode : N7212022\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\nREF. BY : SELF (5311169953),PRABHU CLINICAL\\nLABORATORY,DR.YEKKALA RAMAKRISHNA HOSPITAL\\n\\n \\n\\nTEST ASKED  AAROGYAM B RAMARAOPETA NARSIPATNAM 531116,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nBLOOD UREA NITROGEN (BUN) PHOTOMETRY 12.26 mg/dl 7-25\\nCREATININE - SERUM PHOTOMETRY 0.74 mg/dl 0.6-1.1\\n\\nBUN / SR.CREATININE RATIO CALCULATED 16.57 Ratio 9:1-23:1\\nCALCIUM PHOTOMETRY 9.16 mg/dl 8.8-10.6\\n\\nURIC ACID PHOTOMETRY 3.3 mg/dl 4.2 -7.3\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nBUN - KINETIC UV ASSAY.\\n\\nSCRE - CREATININE ENZYMATIC METHOD\\n\\nB/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES\\nCALC - ARSENAZO III METHOD, END POINT.\\n\\nURIC - URICASE / PEROXIDASE METHOD\\n\\nSample Collected on (SCT) : 26 Aug 2019 18:00\\n\\nSample Received on (SRT) : 27 Aug 2019 22:53 heen’\\n\\nReport Released on (RRT) : 28 Aug 2019 02:10 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2708040550/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7212022 Page : 7 of 9\\n\\x0c',\n",
       " 'PROCESSED AT: grmontsng Hemoglobin Aye Testing\\nThyrocare @JNGsP\\nD-37/1,TTC MIDC,Turbhe, J\\n\\nNavi Mumbai-400 703 SESE\\n\\n    \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT\\n\\n. (5311169953),PRABHU CLINICAL\\nREF. BY + SELF LABORATORY,DR.YEKKALA RAMAKRISHNA\\nTEST ASKED : HBA,HEMOGRAM - 6 PART (DIFF) HOSPITAL RAMARAOPETA NARSIPATNAM\\n\\n531116,531116\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbAi1c - (HPLC - NGSP Certified)\\nH.P.L.C 8.3 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 192 mg/dl\\nReference Range :\\n90 - 120 mg/dl : Good Control\\n121 - 150 mg/dl : Fair Control\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\nSample Collected on (SCT) :26 Aug 2019 18:00\\nSample Received on (SRT) 27 Aug 2019 22:50 Goole?\\nReport Released on (RRT) :28 Aug 2019 08:25 Oe <a\\n\\nSample Type bres. #EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2708040370/A6750\\n\\nRe . Page : 1 of 9\\nBarcode Ou :M9261080\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\ncentiieAte no: C2407\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\n\\nREF. BY + SELF (5311169953),PRABHU CLINICAL\\nLABORATORY,DR.YEKKALA RAMAKRISHNA\\n\\nTEST ASKED HBA,HEMOGRAM - 6 PART (DIFF) HOSPITAL RAMARAOPETA NARSIPATNAM\\n531116,531116\\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\n\\nTOTAL LEUCOCYTES COUNT 6.4 X103/pL  4.0-10.0\\n\\nNEUTROPHILS 49.7 % 40-80\\n\\nLYMPHOCYTE PERCENTAGE 42.8 % 20-40\\n\\nMONOCYTES 2.3 % 0-10\\n\\nEOSINOPHILS 4.7 % 0.0-6.0\\n\\nBASOPHILS 0.2 % <2\\n\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0-0.5\\n\\nNEUTROPHILS - ABSOLUTE COUNT 3.18 X103/uL  2.0-7.0\\n\\nLYMPHOCYTES - ABSOLUTE COUNT 2.74 X103/pL  1.0-3.0\\n\\nMONOCYTES - ABSOLUTE COUNT 0.15 X 103 / pL 0.2-1\\n\\nBASOPHILS - ABSOLUTE COUNT 0.01 X103/pL  0-0.1\\n\\nEOSINOPHILS - ABSOLUTE COUNT 0.3 X103/pL  0-0.5\\n\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0-0.3\\n\\nTOTAL RBC 6.13 X1046/pL 4.5-5.5\\n\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\n\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\n\\nHEMOGLOBIN 18.1 g/dL 13-17\\n\\nHEMATOCRIT(PCV) 50.68 % 40-50\\n\\nMEAN CORPUSCULAR VOLUME(MCV) 100.2 fl 83-101\\n\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 29.5 pq 27-32\\n\\nMEAN CORP.HEMO.CONC(MCHC) 29.5 g/dL 31.5-34.5\\n\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 62.9 fL 39-46\\n\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.6 % 11.6-14\\n\\nPLATELET DISTRIBUTION WIDTH(PDW) 11.1 fL 9.6-15.2\\n\\nMEAN PLATELET VOLUME(MPV) 9.4 fL 6.5-12\\n\\nPLATELET COUNT 222 X103/uL 150-400\\n\\nPLATELET TO LARGE CELL RATIO(PLCR) 20.5 % 19.7-42.4\\n\\nPLATELETCRIT(PCT) 0.21 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n:26 Aug 2019 18:00\\n227 Aug 2019 22:50\\n:28 Aug 2019 08:25\\n: EDTA\\n\\n: 2708040370/A6750\\n: M9261080\\n\\nln!\\n\\nra\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 9\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP orl Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT\\n\\n. (5311169953),PRABHU CLINICAL\\n\\nREF. BY + SELF LABORATORY,DR.YEKKALA RAMAKRISHNA\\nTEST ASKED : AAROGYAM B HOSPITAL RAMARAOPETA NARSIPATNAM\\n531116,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\n\\nIRON PHOTOMETRY 69.1 g/dl\\nReference Range :\\n\\nMale : 65-175\\n\\nFemale : 50 - 170\\n\\nMethod : _ FERROZINE METHOD WITHOUT DEPROTEINIZATION\\n\\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 348 g/dl\\nReference Range :\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n\\n% TRANSFERRIN SATURATION CALCULATED 19.86 %\\nReference Range :\\n\\n13-45\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\n\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :26 Aug 2019 18:00\\n\\nSample Received on (SRT) 127 Aug 2019 22:53 Goole?\\n\\nReport Released on (RRT) :28 Aug 2019 02:10 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2708040550/A6750\\n\\nPage : 3 of 9\\nBarcode =N7212022\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\nREF. BY : SELF (5311169953), PRABHU CLINICAL\\n\\nLABORATORY, DR.YEKKALA RAMAKRISHNA HOSPITAL\\nTEST ASKED  AAROGYAM B RAMARAOPETA NARSIPATNAM 531116,531116\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 64.5 U/L 45 - 129\\nBILIRUBIN - TOTAL PHOTOMETRY 0.35 mg/dl 0.3-1.2\\nBILIRUBIN -DIRECT PHOTOMETRY 0.08 mg/dl < 0.3\\nBILIRUBIN (INDIRECT) CALCULATED 0.27 mg/dl 0-0.9\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 91.1 u/I <55\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 22.5 u/| <35\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 21.4 u/| < 45\\nPROTEIN - TOTAL PHOTOMETRY 6.6 gm/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 41 gm/dl 3.2-4.8\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.64 Ratio 0.9-2\\nSERUM GLOBULIN PHOTOMETRY 2.5 gm/dL 2.5-3.4\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - MODIFIED IFCC METHOD\\n\\nBILT - VANADATE OXIDATION\\n\\nBILD - VANADATE OXIDATION\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - MODIFIED IFCC METHOD\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 26 Aug 2019 18:00\\n\\nSample Received on (SRT) : 27 Aug 2019 22:53 heen’\\n\\nReport Released on (RRT) : 28 Aug 2019 02:10 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2708040550/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7212022 Page : 4 of 9\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\ncanmwoheno. WOsor Think Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\nREF. BY : SELF (5311169953),PRABHU CLINICAL\\nLABORATORY,DR.YEKKALA RAMAKRISHNA HOSPITAL\\n\\n \\n\\nTEST ASKED  AAROGYAM B RAMARAOPETA NARSIPATNAM 531116,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nTOTAL CHOLESTEROL PHOTOMETRY 220 mg/dl 125-200\\n\\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 36 mg/dl 35-80\\n\\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 167 mg/dl 85-130\\nTRIGLYCERIDES PHOTOMETRY 188 mg/dl 25-200\\n\\nTC/ HDL CHOLESTEROL RATIO CALCULATED 6.1 Ratio 3-5\\n\\nLDL / HDL RATIO CALCULATED 4.7 Ratio 1.5-3.5\\n\\nVLDL CHOLESTEROL CALCULATED 37.6 mg/dl 5-40\\n\\nNON-HDL CHOLESTEROL CALCULATED 184.1 mg/dl < 160\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nCHOL - CHOD POD METHOD\\n\\nHCHO - ENZYME SELECTIVE PROTECTION METHOD\\n\\nLDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY\\n\\nTRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]\\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\nLDL/ - DERIVED FROM SERUM HDL AND LDL VALUES\\n\\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\\n\\nNHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\\n\\nTOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\\n\\nDESIRABLE <200 Low <40 OPTIMAL <100 NORMAL <150\\n\\nBORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\\n\\nHIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499\\nHIGH 160-189 VERY HIGH >500\\nVERY HIGH >190\\n\\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\\n\\nSample Collected on (SCT) : 26 Aug 2019 18:00\\n\\nSample Received on (SRT) : 27 Aug 2019 22:53 heen’\\n\\nReport Released on (RRT) : 28 Aug 2019 02:10 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2708040550/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7212022 Page : 5 of 9\\n\\x0cPROCESSED AT:\\n\\n \\n\\nThyrocare\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 axa eno. Oe?\\n\\n \\n\\nECAP, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT\\n\\n. (5311169953),PRABHU CLINICAL\\nREF. BY + SELF LABORATORY, DR.YEKKALA RAMAKRISHNA HOSPITAL\\nTEST ASKED : AAROGYAM B RAMARAOPETA NARSIPATNAM 531116,531116\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLA 99 ng/dl 60-200\\nTOTAL THYROXINE (T4) CLA 6.4 ug/dl 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) CLA 3.42 uIU/ml 0.3-5.5\\n\\nComments : SUGGESTING THYRONORMALCY\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nT3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nT4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nTSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nSample Collected on (SCT) : 26 Aug 2019 18:00\\nSample Received on (SRT) : 27 Aug 2019 22:53 ac tt?\\nReport Released on (RRT) : 28 Aug 2019 02:10 Oe -\\nSample Type : SERUM oo. .\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2708040550/A6750\\nPage : 6 of 9\\n\\nBarcode : N7212022\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\nREF. BY : SELF (5311169953),PRABHU CLINICAL\\nLABORATORY,DR.YEKKALA RAMAKRISHNA HOSPITAL\\n\\n \\n\\nTEST ASKED  AAROGYAM B RAMARAOPETA NARSIPATNAM 531116,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nBLOOD UREA NITROGEN (BUN) PHOTOMETRY 12.26 mg/dl 7-25\\nCREATININE - SERUM PHOTOMETRY 0.74 mg/dl 0.6-1.1\\n\\nBUN / SR.CREATININE RATIO CALCULATED 16.57 Ratio 9:1-23:1\\nCALCIUM PHOTOMETRY 9.16 mg/dl 8.8-10.6\\n\\nURIC ACID PHOTOMETRY 3.3 mg/dl 4.2 -7.3\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nBUN - KINETIC UV ASSAY.\\n\\nSCRE - CREATININE ENZYMATIC METHOD\\n\\nB/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES\\nCALC - ARSENAZO III METHOD, END POINT.\\n\\nURIC - URICASE / PEROXIDASE METHOD\\n\\nSample Collected on (SCT) : 26 Aug 2019 18:00\\n\\nSample Received on (SRT) : 27 Aug 2019 22:53 heen’\\n\\nReport Released on (RRT) : 28 Aug 2019 02:10 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2708040550/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7212022 Page : 7 of 9\\n\\x0cPROCESSED AT:\\n\\nThyrocare Thyrocare’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\nREF. BY + SELF (5311169953),PRABHU CLINICAL\\n‘ . LABORATORY,DR.YEKKALA RAMAKRISHNA\\nTEST ASKED : AAROGYAM B HOSPITAL RAMARAOPETA NARSIPATNAM\\n531116,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\nEST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 117 mL/min/1.73 m2\\n\\nReference Range :-\\n\\n> = 90 : Normal\\n60 - 89 : Mild Decrease\\n45-59 : Mild to Moderate Decrease\\n\\n30-44 : Moderate to Severe Decrease\\n15-29 : Severe Decrease\\n\\nClinical Significance\\n\\nThe normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild\\nand moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical\\nlaboratories to routinely estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of\\nrenal function, and report the value when serum creatinine is measured for patients 18 and older, when appropriate\\nand feasible. It cannot be measured easily in clinical practice, instead, GFR is estimated from equations using serum\\ncreatinine, age, race and sex. This provides easy to interpret information for the doctor and patient on the degree of\\nrenal impairment since it approximately equates to the percentage of kidney function remaining. Application of\\nCKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and\\nmanagement of patients with CKD.\\n\\nReference\\n\\nLevey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular\\nfiltration rate. Ann Intern Med. 2009;150(9):604-12.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- CKD-EPI Creatinine Equation\\n\\n«ww End of report ~~\\n\\nSample Collected on (SCT) : 26 Aug 2019 18:00\\nSample Received on (SRT) 127 Aug 2019 22:53 Goole?\\nReport Released on (RRT) :28 Aug 2019 02:10 “ ™\\n\\nSample Type bres: SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2708040550/A6750\\n\\nBarcode RO :N7212022 Page : 8 of 9\\n\\x0c',\n",
       " 'PROCESSED AT: grmontsng Hemoglobin Aye Testing\\nThyrocare @JNGsP\\nD-37/1,TTC MIDC,Turbhe, J\\n\\nNavi Mumbai-400 703 SESE\\n\\n    \\n\\nabby Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT\\n\\n. (5311169953),PRABHU CLINICAL\\nREF. BY + SELF LABORATORY,DR.YEKKALA RAMAKRISHNA\\nTEST ASKED : HBA,HEMOGRAM - 6 PART (DIFF) HOSPITAL RAMARAOPETA NARSIPATNAM\\n\\n531116,531116\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbAi1c - (HPLC - NGSP Certified)\\nH.P.L.C 8.3 %\\nReference Range :\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n>8% : Poor Control\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 192 mg/dl\\nReference Range :\\n90 - 120 mg/dl : Good Control\\n121 - 150 mg/dl : Fair Control\\n151 - 180 mg/dl : Unsatisfactory Control\\n> 180 mg/dl : Poor Control\\nMethod : Derived from HBA1c_ values\\nPlease correlate with clinical conditions.\\nSample Collected on (SCT) :26 Aug 2019 18:00\\nSample Received on (SRT) 27 Aug 2019 22:50 Goole?\\nReport Released on (RRT) :28 Aug 2019 08:25 Oe <a\\n\\nSample Type bres. #EDTA Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2708040370/A6750\\n\\nRe . Page : 1 of 9\\nBarcode Ou :M9261080\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCAP\\nACCREDITED\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\ncentiieAte no: C2407\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\n\\nREF. BY + SELF (5311169953),PRABHU CLINICAL\\nLABORATORY,DR.YEKKALA RAMAKRISHNA\\n\\nTEST ASKED HBA,HEMOGRAM - 6 PART (DIFF) HOSPITAL RAMARAOPETA NARSIPATNAM\\n531116,531116\\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\n\\nTOTAL LEUCOCYTES COUNT 6.4 X103/pL  4.0-10.0\\n\\nNEUTROPHILS 49.7 % 40-80\\n\\nLYMPHOCYTE PERCENTAGE 42.8 % 20-40\\n\\nMONOCYTES 2.3 % 0-10\\n\\nEOSINOPHILS 4.7 % 0.0-6.0\\n\\nBASOPHILS 0.2 % <2\\n\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0-0.5\\n\\nNEUTROPHILS - ABSOLUTE COUNT 3.18 X103/uL  2.0-7.0\\n\\nLYMPHOCYTES - ABSOLUTE COUNT 2.74 X103/pL  1.0-3.0\\n\\nMONOCYTES - ABSOLUTE COUNT 0.15 X 103 / pL 0.2-1\\n\\nBASOPHILS - ABSOLUTE COUNT 0.01 X103/pL  0-0.1\\n\\nEOSINOPHILS - ABSOLUTE COUNT 0.3 X103/pL  0-0.5\\n\\nIMMATURE GRANULOCYTES(IG) 0.02 X103/pL  0-0.3\\n\\nTOTAL RBC 6.13 X1046/pL 4.5-5.5\\n\\nNUCLEATED RED BLOOD CELLS Nil X103/uL  <0.01\\n\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\n\\nHEMOGLOBIN 18.1 g/dL 13-17\\n\\nHEMATOCRIT(PCV) 50.68 % 40-50\\n\\nMEAN CORPUSCULAR VOLUME(MCV) 100.2 fl 83-101\\n\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 29.5 pq 27-32\\n\\nMEAN CORP.HEMO.CONC(MCHC) 29.5 g/dL 31.5-34.5\\n\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 62.9 fL 39-46\\n\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 17.6 % 11.6-14\\n\\nPLATELET DISTRIBUTION WIDTH(PDW) 11.1 fL 9.6-15.2\\n\\nMEAN PLATELET VOLUME(MPV) 9.4 fL 6.5-12\\n\\nPLATELET COUNT 222 X103/uL 150-400\\n\\nPLATELET TO LARGE CELL RATIO(PLCR) 20.5 % 19.7-42.4\\n\\nPLATELETCRIT(PCT) 0.21 % 0.19-0.39\\n\\nRemarks: ALERT !!! Anisocytosis\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\nSample Type\\n\\nLabcode\\n\\nBarcode\\n\\n:26 Aug 2019 18:00\\n227 Aug 2019 22:50\\n:28 Aug 2019 08:25\\n: EDTA\\n\\n: 2708040370/A6750\\n: M9261080\\n\\nln!\\n\\nra\\n\\nDr.Prachi Sinkar MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 2 of 9\\n\\x0cPROCESSED AT:\\n\\nThyrocare wi CAP orl Thyro Cc are’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n    \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT\\n\\n. (5311169953),PRABHU CLINICAL\\n\\nREF. BY + SELF LABORATORY,DR.YEKKALA RAMAKRISHNA\\nTEST ASKED : AAROGYAM B HOSPITAL RAMARAOPETA NARSIPATNAM\\n531116,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\n\\nIRON PHOTOMETRY 69.1 g/dl\\nReference Range :\\n\\nMale : 65-175\\n\\nFemale : 50 - 170\\n\\nMethod : _ FERROZINE METHOD WITHOUT DEPROTEINIZATION\\n\\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 348 g/dl\\nReference Range :\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n\\n% TRANSFERRIN SATURATION CALCULATED 19.86 %\\nReference Range :\\n\\n13-45\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\n\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :26 Aug 2019 18:00\\n\\nSample Received on (SRT) 127 Aug 2019 22:53 Goole?\\n\\nReport Released on (RRT) :28 Aug 2019 02:10 Oe <a\\n\\nSample Type #SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 2708040550/A6750\\n\\nPage : 3 of 9\\nBarcode =N7212022\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\nREF. BY : SELF (5311169953), PRABHU CLINICAL\\n\\nLABORATORY, DR.YEKKALA RAMAKRISHNA HOSPITAL\\nTEST ASKED  AAROGYAM B RAMARAOPETA NARSIPATNAM 531116,531116\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 64.5 U/L 45 - 129\\nBILIRUBIN - TOTAL PHOTOMETRY 0.35 mg/dl 0.3-1.2\\nBILIRUBIN -DIRECT PHOTOMETRY 0.08 mg/dl < 0.3\\nBILIRUBIN (INDIRECT) CALCULATED 0.27 mg/dl 0-0.9\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 91.1 u/I <55\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 22.5 u/| <35\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 21.4 u/| < 45\\nPROTEIN - TOTAL PHOTOMETRY 6.6 gm/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 41 gm/dl 3.2-4.8\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.64 Ratio 0.9-2\\nSERUM GLOBULIN PHOTOMETRY 2.5 gm/dL 2.5-3.4\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - MODIFIED IFCC METHOD\\n\\nBILT - VANADATE OXIDATION\\n\\nBILD - VANADATE OXIDATION\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - MODIFIED IFCC METHOD\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 26 Aug 2019 18:00\\n\\nSample Received on (SRT) : 27 Aug 2019 22:53 heen’\\n\\nReport Released on (RRT) : 28 Aug 2019 02:10 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2708040550/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7212022 Page : 4 of 9\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\ncanmwoheno. WOsor Think Thyroid. Think Thyrocare.\\n\\n \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\nREF. BY : SELF (5311169953),PRABHU CLINICAL\\nLABORATORY,DR.YEKKALA RAMAKRISHNA HOSPITAL\\n\\n \\n\\nTEST ASKED  AAROGYAM B RAMARAOPETA NARSIPATNAM 531116,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nTOTAL CHOLESTEROL PHOTOMETRY 220 mg/dl 125-200\\n\\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 36 mg/dl 35-80\\n\\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 167 mg/dl 85-130\\nTRIGLYCERIDES PHOTOMETRY 188 mg/dl 25-200\\n\\nTC/ HDL CHOLESTEROL RATIO CALCULATED 6.1 Ratio 3-5\\n\\nLDL / HDL RATIO CALCULATED 4.7 Ratio 1.5-3.5\\n\\nVLDL CHOLESTEROL CALCULATED 37.6 mg/dl 5-40\\n\\nNON-HDL CHOLESTEROL CALCULATED 184.1 mg/dl < 160\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nCHOL - CHOD POD METHOD\\n\\nHCHO - ENZYME SELECTIVE PROTECTION METHOD\\n\\nLDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY\\n\\nTRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]\\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\nLDL/ - DERIVED FROM SERUM HDL AND LDL VALUES\\n\\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\\n\\nNHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\\n\\nTOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\\n\\nDESIRABLE <200 Low <40 OPTIMAL <100 NORMAL <150\\n\\nBORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\\n\\nHIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499\\nHIGH 160-189 VERY HIGH >500\\nVERY HIGH >190\\n\\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\\n\\nSample Collected on (SCT) : 26 Aug 2019 18:00\\n\\nSample Received on (SRT) : 27 Aug 2019 22:53 heen’\\n\\nReport Released on (RRT) : 28 Aug 2019 02:10 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2708040550/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7212022 Page : 5 of 9\\n\\x0cPROCESSED AT:\\n\\n \\n\\nThyrocare\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 axa eno. Oe?\\n\\n \\n\\nECAP, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT\\n\\n. (5311169953),PRABHU CLINICAL\\nREF. BY + SELF LABORATORY, DR.YEKKALA RAMAKRISHNA HOSPITAL\\nTEST ASKED : AAROGYAM B RAMARAOPETA NARSIPATNAM 531116,531116\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLA 99 ng/dl 60-200\\nTOTAL THYROXINE (T4) CLA 6.4 ug/dl 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) CLA 3.42 uIU/ml 0.3-5.5\\n\\nComments : SUGGESTING THYRONORMALCY\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nT3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nT4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nTSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nSample Collected on (SCT) : 26 Aug 2019 18:00\\nSample Received on (SRT) : 27 Aug 2019 22:53 ac tt?\\nReport Released on (RRT) : 28 Aug 2019 02:10 Oe -\\nSample Type : SERUM oo. .\\nDr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2708040550/A6750\\nPage : 6 of 9\\n\\nBarcode : N7212022\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n \\n\\necap,, Thyrocare’\\n\\nCOLLEGE of AMERICAN PATHOLOGISTS\\n\\n \\n\\nThink Thyroid. Think Thyrocare.\\n\\nCERTIFICATE NO.: NC=2007\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\nNAME : MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\nREF. BY : SELF (5311169953),PRABHU CLINICAL\\nLABORATORY,DR.YEKKALA RAMAKRISHNA HOSPITAL\\n\\n \\n\\nTEST ASKED  AAROGYAM B RAMARAOPETA NARSIPATNAM 531116,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nBLOOD UREA NITROGEN (BUN) PHOTOMETRY 12.26 mg/dl 7-25\\nCREATININE - SERUM PHOTOMETRY 0.74 mg/dl 0.6-1.1\\n\\nBUN / SR.CREATININE RATIO CALCULATED 16.57 Ratio 9:1-23:1\\nCALCIUM PHOTOMETRY 9.16 mg/dl 8.8-10.6\\n\\nURIC ACID PHOTOMETRY 3.3 mg/dl 4.2 -7.3\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nBUN - KINETIC UV ASSAY.\\n\\nSCRE - CREATININE ENZYMATIC METHOD\\n\\nB/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES\\nCALC - ARSENAZO III METHOD, END POINT.\\n\\nURIC - URICASE / PEROXIDASE METHOD\\n\\nSample Collected on (SCT) : 26 Aug 2019 18:00\\n\\nSample Received on (SRT) : 27 Aug 2019 22:53 heen’\\n\\nReport Released on (RRT) : 28 Aug 2019 02:10 q OL “\\n\\nSample Type : SERUM .\\n\\nLabcode : 2708040550/A6750 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N7212022 Page : 7 of 9\\n\\x0cPROCESSED AT:\\n\\nThyrocare Thyrocare’\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nNAME = MR SRIKANTH (38Y/M) SAMPLE COLLECTED AT :\\nREF. BY + SELF (5311169953),PRABHU CLINICAL\\n‘ . LABORATORY,DR.YEKKALA RAMAKRISHNA\\nTEST ASKED : AAROGYAM B HOSPITAL RAMARAOPETA NARSIPATNAM\\n531116,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\nEST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 117 mL/min/1.73 m2\\n\\nReference Range :-\\n\\n> = 90 : Normal\\n60 - 89 : Mild Decrease\\n45-59 : Mild to Moderate Decrease\\n\\n30-44 : Moderate to Severe Decrease\\n15-29 : Severe Decrease\\n\\nClinical Significance\\n\\nThe normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild\\nand moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical\\nlaboratories to routinely estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of\\nrenal function, and report the value when serum creatinine is measured for patients 18 and older, when appropriate\\nand feasible. It cannot be measured easily in clinical practice, instead, GFR is estimated from equations using serum\\ncreatinine, age, race and sex. This provides easy to interpret information for the doctor and patient on the degree of\\nrenal impairment since it approximately equates to the percentage of kidney function remaining. Application of\\nCKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and\\nmanagement of patients with CKD.\\n\\nReference\\n\\nLevey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular\\nfiltration rate. Ann Intern Med. 2009;150(9):604-12.\\n\\nPlease correlate with clinical conditions.\\n\\nMethod:- CKD-EPI Creatinine Equation\\n\\n«ww End of report ~~\\n\\nSample Collected on (SCT) : 26 Aug 2019 18:00\\nSample Received on (SRT) 127 Aug 2019 22:53 Goole?\\nReport Released on (RRT) :28 Aug 2019 02:10 “ ™\\n\\nSample Type bres: SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2708040550/A6750\\n\\nBarcode RO :N7212022 Page : 8 of 9\\n\\x0cCONDITIONS OF REPORTING\\n\\n“ The reported results are for information and interpretation of the referring doctor only.\\n\\n“It is presumed that the tests performed on the specimen belong to the patient; named or identified.\\n\\n“Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the\\nsame patient.\\n\\n“Should the results indicate an unexpected abnormality, the same should be reconfirmed.\\n\\n“Only such medical professionals who understand reporting units, reference ranges and limitations of\\ntechnologies should interpret results.\\n\\n“This report is not valid for medico-legal purpose.\\n\\n“Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or\\ndamage that may be incurred by any person as a result of presuming the meaning or contents of the report.\\n\\nEXPLANATIONS\\n\\n“Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them\\nas \"Clients\".\\n\\n~* Name - The name is as declared by the client and recored by the personnel who collected the specimen.\\n\\n“  Ref.Dr - The name of the doctor who has recommended testing as declared by the client.\\n\\n“ Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.\\n\\n“Barcode - This is the specimen identity number and it states that the results are for the specimen bearing\\nthe barcode (irrespective of the name).\\n\\nSCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by\\nthe client.\\n\\n“SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.\\n\\n“SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.\\n\\n“* RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.\\n\\n“ Reference Range - Means the range of values in which 95% of the normal population would fall.\\n\\nSUGGESTIONS\\n\\n“+ Values out of reference range requires reconfirmation before starting any medical treatment.\\n\\n“* Retesting is needed if you suspect any quality shortcomings.\\n\\n“* Testing or retesting should be done in accredited laboratories.\\n\\n“For suggestions, complaints or feedback, write to us at info@thyrocare.com or call us on\\n022-3090 0000 / 4125 2525\\n\\n“* SMS:<Labcode No.> to 9870666333\\n\\nPreventive Healthcare is now at your fingertips!\\nt=)\\nBooking\\n\\nTrack your\\nConfirmatios Technician\\n\\n     \\n \\n\\n \\n\\n \\n\\n       \\n\\n       \\n      \\n  \\n\\nRig tT Nt\\n\\n \\n\\n        \\n\\nLy\\n\\nSample\\nTesting\\n\\n=\\na &\\n&\\n\\nexplore & Select\\nTest / Profil\\n\\n     \\n\\n     \\n\\n  \\n\\nBlood\\nCollection\\n\\n   \\n\\n \\n\\n \\n\\n   \\n\\nFocus TB\\n\\nTowards a TB free world\\n\\n   \\n\\n“Fight TB with power of\\nRapid Technology”\\n\\n  \\n \\n \\n \\n \\n \\n \\n \\n   \\n\\nFocus TB, powered by Thyrocare.\\nA brand that will focus on TB, which is one of the major public health\\n\\nproblems in the country. Call : 022 - 3090 0000/4125 2525\\n\\nTuberculosis (TB) is a transmissible, airborne infection caused by info@focustb.com\\nMycobacterium tuberculosis (MTB). \\\\t transpires usually when a\\nperson inhales microscopic droplet nuclei containing viable\\nbacteria, spread through coughing by persons who have\\ninfectious TB.\\n\\nPage : 9 of 9\\n\\x0c',\n",
       " 'PROCESSED AT:\\n\\nThyrocare Th CO ®\\nH. NO. 1-9-645,Vidyanagar, yr Care\\n\\nAdikmet Road,Near SBH,\\n\\nThink Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : HEMOGRAM - 6 PART (DIFF),HBA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbAi1c - (HPLC - NGSP Certified)\\n\\nH.P.L.C 7.2 %\\n\\nReference Range :\\n\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\n\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n\\n>8% : Poor Control\\n\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\n\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 160 mg/dl\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n\\n> 180 mg/dl : Poor Control\\n\\nMethod : Derived from HBA1c_ values\\n\\nPlease correlate with clinical conditions.\\nSample Collected on (SCT) :17 May 2019 08:00\\nSample Received on (SRT) :18 May 2019 16:03 “\\nReport Released on (RRT) 218 May 2019 17:08 wt\\nSample Type bres. #EDTA Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 1805072695/A6750\\n\\nRe . Page : 1 of 9\\nBarcode Ou 1M9261454\\n\\x0c',\n",
       " 'PROCESSED AT:\\n\\nThyrocare Th CO ®\\nH. NO. 1-9-645,Vidyanagar, yr Care\\n\\nAdikmet Road,Near SBH,\\n\\nThink Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : HEMOGRAM - 6 PART (DIFF),HBA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbAi1c - (HPLC - NGSP Certified)\\n\\nH.P.L.C 7.2 %\\n\\nReference Range :\\n\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\n\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n\\n>8% : Poor Control\\n\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\n\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 160 mg/dl\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n\\n> 180 mg/dl : Poor Control\\n\\nMethod : Derived from HBA1c_ values\\n\\nPlease correlate with clinical conditions.\\nSample Collected on (SCT) :17 May 2019 08:00\\nSample Received on (SRT) :18 May 2019 16:03 “\\nReport Released on (RRT) 218 May 2019 17:08 wt\\nSample Type bres. #EDTA Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 1805072695/A6750\\n\\nRe . Page : 1 of 9\\nBarcode Ou 1M9261454\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nH. NO. 1-9-645,Vidyanagar,\\n\\nAdikmet Road,Near SBH,\\n\\nHyderabad-500 044\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\n \\n\\nNAME MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED HEMOGRANM - 6 PART (DIFF),HBA PRADESH,531116\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 6.6 X 103 / uL 4.0-10.0\\nNEUTROPHILS 58.1 % 40-80\\nLYMPHOCYTE PERCENTAGE 26.7 % 20.0-40.0\\nMONOCYTES 3.9 % 0.0-10.0\\nEOSINOPHILS 10.2 % 0.0-6.0\\nBASOPHILS 0.8 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 3.83 X 103 / uL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 1.76 X 103 / ul 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.26 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.05 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.67 X 103 / pL  0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / uL 0.0-0.3\\nTOTAL RBC 4.19 X10%6/uL =: 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 12.1 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 43.4 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 103.6 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 28.9 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.9 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 59.7 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 15.9 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 19 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 12.9 fL 6.5-12\\nPLATELET COUNT 231 X 103 / uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 47.3 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.3 % 0.19-0.39\\nRemarks: = ALERT !!! Eosinophilia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\n217 May 2019 08:00\\n:18 May 2019 16:03\\n218 May 2019 17:08\\n\\nSample Type : EDTA . .\\nDr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 1805072695/A6750\\nPage : 2 of 9\\nBarcode : M9261454\\n\\x0c',\n",
       " 'PROCESSED AT:\\n\\nThyrocare Th CO ®\\nH. NO. 1-9-645,Vidyanagar, yr Care\\n\\nAdikmet Road,Near SBH,\\n\\nThink Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : HEMOGRAM - 6 PART (DIFF),HBA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbAi1c - (HPLC - NGSP Certified)\\n\\nH.P.L.C 7.2 %\\n\\nReference Range :\\n\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\n\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n\\n>8% : Poor Control\\n\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\n\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 160 mg/dl\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n\\n> 180 mg/dl : Poor Control\\n\\nMethod : Derived from HBA1c_ values\\n\\nPlease correlate with clinical conditions.\\nSample Collected on (SCT) :17 May 2019 08:00\\nSample Received on (SRT) :18 May 2019 16:03 “\\nReport Released on (RRT) 218 May 2019 17:08 wt\\nSample Type bres. #EDTA Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 1805072695/A6750\\n\\nRe . Page : 1 of 9\\nBarcode Ou 1M9261454\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nH. NO. 1-9-645,Vidyanagar,\\n\\nAdikmet Road,Near SBH,\\n\\nHyderabad-500 044\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\n \\n\\nNAME MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED HEMOGRANM - 6 PART (DIFF),HBA PRADESH,531116\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 6.6 X 103 / uL 4.0-10.0\\nNEUTROPHILS 58.1 % 40-80\\nLYMPHOCYTE PERCENTAGE 26.7 % 20.0-40.0\\nMONOCYTES 3.9 % 0.0-10.0\\nEOSINOPHILS 10.2 % 0.0-6.0\\nBASOPHILS 0.8 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 3.83 X 103 / uL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 1.76 X 103 / ul 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.26 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.05 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.67 X 103 / pL  0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / uL 0.0-0.3\\nTOTAL RBC 4.19 X10%6/uL =: 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 12.1 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 43.4 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 103.6 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 28.9 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.9 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 59.7 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 15.9 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 19 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 12.9 fL 6.5-12\\nPLATELET COUNT 231 X 103 / uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 47.3 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.3 % 0.19-0.39\\nRemarks: = ALERT !!! Eosinophilia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\n217 May 2019 08:00\\n:18 May 2019 16:03\\n218 May 2019 17:08\\n\\nSample Type : EDTA . .\\nDr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 1805072695/A6750\\nPage : 2 of 9\\nBarcode : M9261454\\n\\x0cPROCESSED AT:\\n\\nThyrocare Thyr O Cc are’\\n\\nH. NO. 1-9-645,Vidyanagar,\\n\\nAdikmet Road,Near SBH, Think Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM B PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nIRON PHOTOMETRY 55.2 g/dl\\n\\nReference Range :\\n\\nMale : 65-175\\n\\nFemale : 50 - 170\\n\\nMethod : _ FERROZINE METHOD WITHOUT DEPROTEINIZATION\\n\\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 394 g/dl\\nReference Range :\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n\\n% TRANSFERRIN SATURATION CALCULATED 14.01 %\\nReference Range :\\n\\n13-45\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\n\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :17 May 2019 08:00\\n\\nSample Received on (SRT) 218 May 2019 12:28 “\\n\\nReport Released on (RRT) 218 May 2019 20:33 wt\\n\\nSample Type #SERUM Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 1805067131/A6750\\n\\nPage : 3 of 9\\nBarcode =N3120413\\n\\x0c',\n",
       " 'PROCESSED AT:\\n\\nThyrocare Th CO ®\\nH. NO. 1-9-645,Vidyanagar, yr Care\\n\\nAdikmet Road,Near SBH,\\n\\nThink Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : HEMOGRAM - 6 PART (DIFF),HBA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbAi1c - (HPLC - NGSP Certified)\\n\\nH.P.L.C 7.2 %\\n\\nReference Range :\\n\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\n\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n\\n>8% : Poor Control\\n\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\n\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 160 mg/dl\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n\\n> 180 mg/dl : Poor Control\\n\\nMethod : Derived from HBA1c_ values\\n\\nPlease correlate with clinical conditions.\\nSample Collected on (SCT) :17 May 2019 08:00\\nSample Received on (SRT) :18 May 2019 16:03 “\\nReport Released on (RRT) 218 May 2019 17:08 wt\\nSample Type bres. #EDTA Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 1805072695/A6750\\n\\nRe . Page : 1 of 9\\nBarcode Ou 1M9261454\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nH. NO. 1-9-645,Vidyanagar,\\n\\nAdikmet Road,Near SBH,\\n\\nHyderabad-500 044\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\n \\n\\nNAME MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED HEMOGRANM - 6 PART (DIFF),HBA PRADESH,531116\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 6.6 X 103 / uL 4.0-10.0\\nNEUTROPHILS 58.1 % 40-80\\nLYMPHOCYTE PERCENTAGE 26.7 % 20.0-40.0\\nMONOCYTES 3.9 % 0.0-10.0\\nEOSINOPHILS 10.2 % 0.0-6.0\\nBASOPHILS 0.8 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 3.83 X 103 / uL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 1.76 X 103 / ul 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.26 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.05 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.67 X 103 / pL  0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / uL 0.0-0.3\\nTOTAL RBC 4.19 X10%6/uL =: 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 12.1 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 43.4 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 103.6 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 28.9 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.9 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 59.7 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 15.9 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 19 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 12.9 fL 6.5-12\\nPLATELET COUNT 231 X 103 / uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 47.3 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.3 % 0.19-0.39\\nRemarks: = ALERT !!! Eosinophilia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\n217 May 2019 08:00\\n:18 May 2019 16:03\\n218 May 2019 17:08\\n\\nSample Type : EDTA . .\\nDr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 1805072695/A6750\\nPage : 2 of 9\\nBarcode : M9261454\\n\\x0cPROCESSED AT:\\n\\nThyrocare Thyr O Cc are’\\n\\nH. NO. 1-9-645,Vidyanagar,\\n\\nAdikmet Road,Near SBH, Think Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM B PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nIRON PHOTOMETRY 55.2 g/dl\\n\\nReference Range :\\n\\nMale : 65-175\\n\\nFemale : 50 - 170\\n\\nMethod : _ FERROZINE METHOD WITHOUT DEPROTEINIZATION\\n\\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 394 g/dl\\nReference Range :\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n\\n% TRANSFERRIN SATURATION CALCULATED 14.01 %\\nReference Range :\\n\\n13-45\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\n\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :17 May 2019 08:00\\n\\nSample Received on (SRT) 218 May 2019 12:28 “\\n\\nReport Released on (RRT) 218 May 2019 20:33 wt\\n\\nSample Type #SERUM Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 1805067131/A6750\\n\\nPage : 3 of 9\\nBarcode =N3120413\\n\\x0cPROCESSED AT:\\n\\nThyrecar Thyrocare’\\n\\nH. NO. 1-9-645,Vidyanagar,\\nAdikmet Road,Near SBH, Think Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\nTEST ASKED : AAROGYAM B ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 48.68 U/L 45 - 129\\nBILIRUBIN - TOTAL PHOTOMETRY 0.48 mg/dl 0.3-1.2\\nBILIRUBIN -DIRECT PHOTOMETRY 0.15 mg/dl < 0.3\\nBILIRUBIN (INDIRECT) CALCULATED 0.33 mg/dl 0-0.9\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 12.3 U/I < 38\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.4 u/I <31\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 27.9 U/I < 34\\n\\nPROTEIN - TOTAL PHOTOMETRY 7.5 gm/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 4.3 gm/dl 3.2-4.8\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.34 Ratio 0.9-2\\n\\nSERUM GLOBULIN PHOTOMETRY 3.2 gm/dL 2.5-3.4\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - MODIFIED IFCC METHOD\\n\\nBILT - VANADATE OXIDATION\\n\\nBILD - VANADATE OXIDATION\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - MODIFIED IFCC METHOD\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 17 May 2019 08:00\\n\\nSample Received on (SRT) : 18 May 2019 12:28 4\\n\\nReport Released on (RRT) : 18 May 2019 20:33 “\\n\\nSample Type : SERUM .\\n\\nLabcode : 1805067131/A6750 Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N3120413 Page : 4 of 9\\n\\x0c',\n",
       " 'PROCESSED AT:\\n\\nThyrocare Th CO ®\\nH. NO. 1-9-645,Vidyanagar, yr Care\\n\\nAdikmet Road,Near SBH,\\n\\nThink Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : HEMOGRAM - 6 PART (DIFF),HBA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbAi1c - (HPLC - NGSP Certified)\\n\\nH.P.L.C 7.2 %\\n\\nReference Range :\\n\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\n\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n\\n>8% : Poor Control\\n\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\n\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 160 mg/dl\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n\\n> 180 mg/dl : Poor Control\\n\\nMethod : Derived from HBA1c_ values\\n\\nPlease correlate with clinical conditions.\\nSample Collected on (SCT) :17 May 2019 08:00\\nSample Received on (SRT) :18 May 2019 16:03 “\\nReport Released on (RRT) 218 May 2019 17:08 wt\\nSample Type bres. #EDTA Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 1805072695/A6750\\n\\nRe . Page : 1 of 9\\nBarcode Ou 1M9261454\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nH. NO. 1-9-645,Vidyanagar,\\n\\nAdikmet Road,Near SBH,\\n\\nHyderabad-500 044\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\n \\n\\nNAME MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED HEMOGRANM - 6 PART (DIFF),HBA PRADESH,531116\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 6.6 X 103 / uL 4.0-10.0\\nNEUTROPHILS 58.1 % 40-80\\nLYMPHOCYTE PERCENTAGE 26.7 % 20.0-40.0\\nMONOCYTES 3.9 % 0.0-10.0\\nEOSINOPHILS 10.2 % 0.0-6.0\\nBASOPHILS 0.8 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 3.83 X 103 / uL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 1.76 X 103 / ul 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.26 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.05 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.67 X 103 / pL  0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / uL 0.0-0.3\\nTOTAL RBC 4.19 X10%6/uL =: 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 12.1 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 43.4 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 103.6 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 28.9 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.9 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 59.7 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 15.9 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 19 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 12.9 fL 6.5-12\\nPLATELET COUNT 231 X 103 / uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 47.3 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.3 % 0.19-0.39\\nRemarks: = ALERT !!! Eosinophilia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\n217 May 2019 08:00\\n:18 May 2019 16:03\\n218 May 2019 17:08\\n\\nSample Type : EDTA . .\\nDr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 1805072695/A6750\\nPage : 2 of 9\\nBarcode : M9261454\\n\\x0cPROCESSED AT:\\n\\nThyrocare Thyr O Cc are’\\n\\nH. NO. 1-9-645,Vidyanagar,\\n\\nAdikmet Road,Near SBH, Think Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM B PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nIRON PHOTOMETRY 55.2 g/dl\\n\\nReference Range :\\n\\nMale : 65-175\\n\\nFemale : 50 - 170\\n\\nMethod : _ FERROZINE METHOD WITHOUT DEPROTEINIZATION\\n\\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 394 g/dl\\nReference Range :\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n\\n% TRANSFERRIN SATURATION CALCULATED 14.01 %\\nReference Range :\\n\\n13-45\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\n\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :17 May 2019 08:00\\n\\nSample Received on (SRT) 218 May 2019 12:28 “\\n\\nReport Released on (RRT) 218 May 2019 20:33 wt\\n\\nSample Type #SERUM Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 1805067131/A6750\\n\\nPage : 3 of 9\\nBarcode =N3120413\\n\\x0cPROCESSED AT:\\n\\nThyrecar Thyrocare’\\n\\nH. NO. 1-9-645,Vidyanagar,\\nAdikmet Road,Near SBH, Think Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\nTEST ASKED : AAROGYAM B ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 48.68 U/L 45 - 129\\nBILIRUBIN - TOTAL PHOTOMETRY 0.48 mg/dl 0.3-1.2\\nBILIRUBIN -DIRECT PHOTOMETRY 0.15 mg/dl < 0.3\\nBILIRUBIN (INDIRECT) CALCULATED 0.33 mg/dl 0-0.9\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 12.3 U/I < 38\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.4 u/I <31\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 27.9 U/I < 34\\n\\nPROTEIN - TOTAL PHOTOMETRY 7.5 gm/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 4.3 gm/dl 3.2-4.8\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.34 Ratio 0.9-2\\n\\nSERUM GLOBULIN PHOTOMETRY 3.2 gm/dL 2.5-3.4\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - MODIFIED IFCC METHOD\\n\\nBILT - VANADATE OXIDATION\\n\\nBILD - VANADATE OXIDATION\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - MODIFIED IFCC METHOD\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 17 May 2019 08:00\\n\\nSample Received on (SRT) : 18 May 2019 12:28 4\\n\\nReport Released on (RRT) : 18 May 2019 20:33 “\\n\\nSample Type : SERUM .\\n\\nLabcode : 1805067131/A6750 Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N3120413 Page : 4 of 9\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nH. NO. 1-9-645,Vidyanagar,\\n\\nAdikmet Road,Near SBH,\\n\\nHyderabad-500 044\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nTEST ASKED : AAROGYAM B ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\n\\nTOTAL CHOLESTEROL PHOTOMETRY 148 mg/dl 125-200\\n\\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 23 mg/dl 35-80\\n\\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 91 mg/dl 85-130\\n\\nTRIGLYCERIDES PHOTOMETRY 201 mg/dl 25-200\\n\\nTC/ HDL CHOLESTEROL RATIO CALCULATED 6.5 Ratio 3-5\\n\\nLDL / HDL RATIO CALCULATED 4 Ratio 1.5-3.5\\n\\nVLDL CHOLESTEROL CALCULATED 40.19 mg/dl 5-40\\n\\nNON-HDL CHOLESTEROL CALCULATED 125.1 ma/dl < 160\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nCHOL - CHOD POD METHOD\\n\\nHCHO - ENZYME SELECTIVE PROTECTION METHOD\\n\\nLDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY\\n\\nTRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]\\n\\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\nLDL/ - DERIVED FROM SERUM HDL AND LDL VALUES\\n\\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\\n\\nNHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\\n\\nTOTAL CHOLESTEROL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\\n\\nDESIRABLE <40 OPTIMAL <100 NORMAL <150\\n\\nBORDERLINE HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\\n\\nHIGH BORDERLINE HIGH 130-159 HIGH 200-499\\nHIGH 160-189 VERY HIGH >500\\nVERY HIGH >190\\n\\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type\\nLabcode\\nBarcode\\n\\n: 1805067131/A6750\\n\\n: 17 May 2019 08:00\\n: 18 May 2019 12:28\\n: 18 May 2019 20:33\\n\\nDr.Siva Ranjan MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\n\\nPage : 5 of 9\\n\\x0c',\n",
       " 'PROCESSED AT:\\n\\nThyrocare Th CO ®\\nH. NO. 1-9-645,Vidyanagar, yr Care\\n\\nAdikmet Road,Near SBH,\\n\\nThink Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : HEMOGRAM - 6 PART (DIFF),HBA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbAi1c - (HPLC - NGSP Certified)\\n\\nH.P.L.C 7.2 %\\n\\nReference Range :\\n\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\n\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n\\n>8% : Poor Control\\n\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\n\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 160 mg/dl\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n\\n> 180 mg/dl : Poor Control\\n\\nMethod : Derived from HBA1c_ values\\n\\nPlease correlate with clinical conditions.\\nSample Collected on (SCT) :17 May 2019 08:00\\nSample Received on (SRT) :18 May 2019 16:03 “\\nReport Released on (RRT) 218 May 2019 17:08 wt\\nSample Type bres. #EDTA Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 1805072695/A6750\\n\\nRe . Page : 1 of 9\\nBarcode Ou 1M9261454\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nH. NO. 1-9-645,Vidyanagar,\\n\\nAdikmet Road,Near SBH,\\n\\nHyderabad-500 044\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\n \\n\\nNAME MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED HEMOGRANM - 6 PART (DIFF),HBA PRADESH,531116\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 6.6 X 103 / uL 4.0-10.0\\nNEUTROPHILS 58.1 % 40-80\\nLYMPHOCYTE PERCENTAGE 26.7 % 20.0-40.0\\nMONOCYTES 3.9 % 0.0-10.0\\nEOSINOPHILS 10.2 % 0.0-6.0\\nBASOPHILS 0.8 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 3.83 X 103 / uL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 1.76 X 103 / ul 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.26 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.05 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.67 X 103 / pL  0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / uL 0.0-0.3\\nTOTAL RBC 4.19 X10%6/uL =: 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 12.1 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 43.4 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 103.6 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 28.9 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.9 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 59.7 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 15.9 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 19 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 12.9 fL 6.5-12\\nPLATELET COUNT 231 X 103 / uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 47.3 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.3 % 0.19-0.39\\nRemarks: = ALERT !!! Eosinophilia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\n217 May 2019 08:00\\n:18 May 2019 16:03\\n218 May 2019 17:08\\n\\nSample Type : EDTA . .\\nDr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 1805072695/A6750\\nPage : 2 of 9\\nBarcode : M9261454\\n\\x0cPROCESSED AT:\\n\\nThyrocare Thyr O Cc are’\\n\\nH. NO. 1-9-645,Vidyanagar,\\n\\nAdikmet Road,Near SBH, Think Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM B PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nIRON PHOTOMETRY 55.2 g/dl\\n\\nReference Range :\\n\\nMale : 65-175\\n\\nFemale : 50 - 170\\n\\nMethod : _ FERROZINE METHOD WITHOUT DEPROTEINIZATION\\n\\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 394 g/dl\\nReference Range :\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n\\n% TRANSFERRIN SATURATION CALCULATED 14.01 %\\nReference Range :\\n\\n13-45\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\n\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :17 May 2019 08:00\\n\\nSample Received on (SRT) 218 May 2019 12:28 “\\n\\nReport Released on (RRT) 218 May 2019 20:33 wt\\n\\nSample Type #SERUM Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 1805067131/A6750\\n\\nPage : 3 of 9\\nBarcode =N3120413\\n\\x0cPROCESSED AT:\\n\\nThyrecar Thyrocare’\\n\\nH. NO. 1-9-645,Vidyanagar,\\nAdikmet Road,Near SBH, Think Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\nTEST ASKED : AAROGYAM B ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 48.68 U/L 45 - 129\\nBILIRUBIN - TOTAL PHOTOMETRY 0.48 mg/dl 0.3-1.2\\nBILIRUBIN -DIRECT PHOTOMETRY 0.15 mg/dl < 0.3\\nBILIRUBIN (INDIRECT) CALCULATED 0.33 mg/dl 0-0.9\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 12.3 U/I < 38\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.4 u/I <31\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 27.9 U/I < 34\\n\\nPROTEIN - TOTAL PHOTOMETRY 7.5 gm/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 4.3 gm/dl 3.2-4.8\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.34 Ratio 0.9-2\\n\\nSERUM GLOBULIN PHOTOMETRY 3.2 gm/dL 2.5-3.4\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - MODIFIED IFCC METHOD\\n\\nBILT - VANADATE OXIDATION\\n\\nBILD - VANADATE OXIDATION\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - MODIFIED IFCC METHOD\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 17 May 2019 08:00\\n\\nSample Received on (SRT) : 18 May 2019 12:28 4\\n\\nReport Released on (RRT) : 18 May 2019 20:33 “\\n\\nSample Type : SERUM .\\n\\nLabcode : 1805067131/A6750 Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N3120413 Page : 4 of 9\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nH. NO. 1-9-645,Vidyanagar,\\n\\nAdikmet Road,Near SBH,\\n\\nHyderabad-500 044\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nTEST ASKED : AAROGYAM B ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\n\\nTOTAL CHOLESTEROL PHOTOMETRY 148 mg/dl 125-200\\n\\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 23 mg/dl 35-80\\n\\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 91 mg/dl 85-130\\n\\nTRIGLYCERIDES PHOTOMETRY 201 mg/dl 25-200\\n\\nTC/ HDL CHOLESTEROL RATIO CALCULATED 6.5 Ratio 3-5\\n\\nLDL / HDL RATIO CALCULATED 4 Ratio 1.5-3.5\\n\\nVLDL CHOLESTEROL CALCULATED 40.19 mg/dl 5-40\\n\\nNON-HDL CHOLESTEROL CALCULATED 125.1 ma/dl < 160\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nCHOL - CHOD POD METHOD\\n\\nHCHO - ENZYME SELECTIVE PROTECTION METHOD\\n\\nLDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY\\n\\nTRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]\\n\\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\nLDL/ - DERIVED FROM SERUM HDL AND LDL VALUES\\n\\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\\n\\nNHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\\n\\nTOTAL CHOLESTEROL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\\n\\nDESIRABLE <40 OPTIMAL <100 NORMAL <150\\n\\nBORDERLINE HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\\n\\nHIGH BORDERLINE HIGH 130-159 HIGH 200-499\\nHIGH 160-189 VERY HIGH >500\\nVERY HIGH >190\\n\\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type\\nLabcode\\nBarcode\\n\\n: 1805067131/A6750\\n\\n: 17 May 2019 08:00\\n: 18 May 2019 12:28\\n: 18 May 2019 20:33\\n\\nDr.Siva Ranjan MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\n\\nPage : 5 of 9\\n\\x0cPROCESSED AT:\\n\\nThyrocare Thyro C are’\\n\\nH. NO. 1-9-645,Vidyanagar, . . .\\nAdikmet Road,Near SBH, Think Thyroid. Think Thyrocare.\\n\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n\\nREF. BY : SELF CNDHRX PRADESH SSI Iie CENTRE,NARSIPATNAM,\\nTEST ASKED : AAROGYAM B\\n\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\n\\nTOTAL TRIIODOTHYRONINE (T3) C.M.1.A 87 ng/di 58-159\\n\\nTOTAL THYROXINE (T4) C.L.L.A 12.1 ug/dl 4.5-12\\n\\nTHYROID STIMULATING HORMONE (TSH) C.M.1.A 2.27 HIU/ml 0.35 - 4.94\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nT3 - Fully Automated Chemi Luminescent Microparticle Immunoassay\\nT4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nTSH - Fully Automated Chemi Luminescent Microparticle Immunoassay\\nPregnancy reference ranges for TSH\\n\\n1st Trimester : 0.10 - 2.50\\n\\n2nd Trimester : 0.20 - 3.00\\n\\n3rd Trimester : 0.30 - 3.00\\n\\nReference:\\nGuidelines of American Thyroid Association for the Diagnosis and Management of Thyroid Disease During\\nPregnancy and Postpartum, Thyroid, 2011, 21; 1-46\\n\\nSample Collected on (SCT) : 17 May 2019 08:00\\nSample Received on (SRT) : 18 May 2019 12:28 ‘\\nReport Released on (RRT) : 18 May 2019 20:33 -\\nSample Type : SERUM . . .\\nDr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 1805067131/A6750\\nPage : 6 of 9\\n\\nBarcode : N3120413\\n\\x0c',\n",
       " 'PROCESSED AT:\\n\\nThyrocare Th CO ®\\nH. NO. 1-9-645,Vidyanagar, yr Care\\n\\nAdikmet Road,Near SBH,\\n\\nThink Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : HEMOGRAM - 6 PART (DIFF),HBA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbAi1c - (HPLC - NGSP Certified)\\n\\nH.P.L.C 7.2 %\\n\\nReference Range :\\n\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\n\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n\\n>8% : Poor Control\\n\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\n\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 160 mg/dl\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n\\n> 180 mg/dl : Poor Control\\n\\nMethod : Derived from HBA1c_ values\\n\\nPlease correlate with clinical conditions.\\nSample Collected on (SCT) :17 May 2019 08:00\\nSample Received on (SRT) :18 May 2019 16:03 “\\nReport Released on (RRT) 218 May 2019 17:08 wt\\nSample Type bres. #EDTA Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 1805072695/A6750\\n\\nRe . Page : 1 of 9\\nBarcode Ou 1M9261454\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nH. NO. 1-9-645,Vidyanagar,\\n\\nAdikmet Road,Near SBH,\\n\\nHyderabad-500 044\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\n \\n\\nNAME MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED HEMOGRANM - 6 PART (DIFF),HBA PRADESH,531116\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 6.6 X 103 / uL 4.0-10.0\\nNEUTROPHILS 58.1 % 40-80\\nLYMPHOCYTE PERCENTAGE 26.7 % 20.0-40.0\\nMONOCYTES 3.9 % 0.0-10.0\\nEOSINOPHILS 10.2 % 0.0-6.0\\nBASOPHILS 0.8 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 3.83 X 103 / uL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 1.76 X 103 / ul 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.26 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.05 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.67 X 103 / pL  0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / uL 0.0-0.3\\nTOTAL RBC 4.19 X10%6/uL =: 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 12.1 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 43.4 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 103.6 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 28.9 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.9 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 59.7 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 15.9 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 19 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 12.9 fL 6.5-12\\nPLATELET COUNT 231 X 103 / uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 47.3 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.3 % 0.19-0.39\\nRemarks: = ALERT !!! Eosinophilia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\n217 May 2019 08:00\\n:18 May 2019 16:03\\n218 May 2019 17:08\\n\\nSample Type : EDTA . .\\nDr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 1805072695/A6750\\nPage : 2 of 9\\nBarcode : M9261454\\n\\x0cPROCESSED AT:\\n\\nThyrocare Thyr O Cc are’\\n\\nH. NO. 1-9-645,Vidyanagar,\\n\\nAdikmet Road,Near SBH, Think Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM B PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nIRON PHOTOMETRY 55.2 g/dl\\n\\nReference Range :\\n\\nMale : 65-175\\n\\nFemale : 50 - 170\\n\\nMethod : _ FERROZINE METHOD WITHOUT DEPROTEINIZATION\\n\\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 394 g/dl\\nReference Range :\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n\\n% TRANSFERRIN SATURATION CALCULATED 14.01 %\\nReference Range :\\n\\n13-45\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\n\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :17 May 2019 08:00\\n\\nSample Received on (SRT) 218 May 2019 12:28 “\\n\\nReport Released on (RRT) 218 May 2019 20:33 wt\\n\\nSample Type #SERUM Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 1805067131/A6750\\n\\nPage : 3 of 9\\nBarcode =N3120413\\n\\x0cPROCESSED AT:\\n\\nThyrecar Thyrocare’\\n\\nH. NO. 1-9-645,Vidyanagar,\\nAdikmet Road,Near SBH, Think Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\nTEST ASKED : AAROGYAM B ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 48.68 U/L 45 - 129\\nBILIRUBIN - TOTAL PHOTOMETRY 0.48 mg/dl 0.3-1.2\\nBILIRUBIN -DIRECT PHOTOMETRY 0.15 mg/dl < 0.3\\nBILIRUBIN (INDIRECT) CALCULATED 0.33 mg/dl 0-0.9\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 12.3 U/I < 38\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.4 u/I <31\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 27.9 U/I < 34\\n\\nPROTEIN - TOTAL PHOTOMETRY 7.5 gm/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 4.3 gm/dl 3.2-4.8\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.34 Ratio 0.9-2\\n\\nSERUM GLOBULIN PHOTOMETRY 3.2 gm/dL 2.5-3.4\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - MODIFIED IFCC METHOD\\n\\nBILT - VANADATE OXIDATION\\n\\nBILD - VANADATE OXIDATION\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - MODIFIED IFCC METHOD\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 17 May 2019 08:00\\n\\nSample Received on (SRT) : 18 May 2019 12:28 4\\n\\nReport Released on (RRT) : 18 May 2019 20:33 “\\n\\nSample Type : SERUM .\\n\\nLabcode : 1805067131/A6750 Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N3120413 Page : 4 of 9\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nH. NO. 1-9-645,Vidyanagar,\\n\\nAdikmet Road,Near SBH,\\n\\nHyderabad-500 044\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nTEST ASKED : AAROGYAM B ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\n\\nTOTAL CHOLESTEROL PHOTOMETRY 148 mg/dl 125-200\\n\\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 23 mg/dl 35-80\\n\\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 91 mg/dl 85-130\\n\\nTRIGLYCERIDES PHOTOMETRY 201 mg/dl 25-200\\n\\nTC/ HDL CHOLESTEROL RATIO CALCULATED 6.5 Ratio 3-5\\n\\nLDL / HDL RATIO CALCULATED 4 Ratio 1.5-3.5\\n\\nVLDL CHOLESTEROL CALCULATED 40.19 mg/dl 5-40\\n\\nNON-HDL CHOLESTEROL CALCULATED 125.1 ma/dl < 160\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nCHOL - CHOD POD METHOD\\n\\nHCHO - ENZYME SELECTIVE PROTECTION METHOD\\n\\nLDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY\\n\\nTRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]\\n\\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\nLDL/ - DERIVED FROM SERUM HDL AND LDL VALUES\\n\\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\\n\\nNHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\\n\\nTOTAL CHOLESTEROL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\\n\\nDESIRABLE <40 OPTIMAL <100 NORMAL <150\\n\\nBORDERLINE HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\\n\\nHIGH BORDERLINE HIGH 130-159 HIGH 200-499\\nHIGH 160-189 VERY HIGH >500\\nVERY HIGH >190\\n\\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type\\nLabcode\\nBarcode\\n\\n: 1805067131/A6750\\n\\n: 17 May 2019 08:00\\n: 18 May 2019 12:28\\n: 18 May 2019 20:33\\n\\nDr.Siva Ranjan MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\n\\nPage : 5 of 9\\n\\x0cPROCESSED AT:\\n\\nThyrocare Thyro C are’\\n\\nH. NO. 1-9-645,Vidyanagar, . . .\\nAdikmet Road,Near SBH, Think Thyroid. Think Thyrocare.\\n\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n\\nREF. BY : SELF CNDHRX PRADESH SSI Iie CENTRE,NARSIPATNAM,\\nTEST ASKED : AAROGYAM B\\n\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\n\\nTOTAL TRIIODOTHYRONINE (T3) C.M.1.A 87 ng/di 58-159\\n\\nTOTAL THYROXINE (T4) C.L.L.A 12.1 ug/dl 4.5-12\\n\\nTHYROID STIMULATING HORMONE (TSH) C.M.1.A 2.27 HIU/ml 0.35 - 4.94\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nT3 - Fully Automated Chemi Luminescent Microparticle Immunoassay\\nT4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nTSH - Fully Automated Chemi Luminescent Microparticle Immunoassay\\nPregnancy reference ranges for TSH\\n\\n1st Trimester : 0.10 - 2.50\\n\\n2nd Trimester : 0.20 - 3.00\\n\\n3rd Trimester : 0.30 - 3.00\\n\\nReference:\\nGuidelines of American Thyroid Association for the Diagnosis and Management of Thyroid Disease During\\nPregnancy and Postpartum, Thyroid, 2011, 21; 1-46\\n\\nSample Collected on (SCT) : 17 May 2019 08:00\\nSample Received on (SRT) : 18 May 2019 12:28 ‘\\nReport Released on (RRT) : 18 May 2019 20:33 -\\nSample Type : SERUM . . .\\nDr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 1805067131/A6750\\nPage : 6 of 9\\n\\nBarcode : N3120413\\n\\x0cPROCESSED AT:\\n\\nThyrecar Thyrocare’\\n\\nH. NO. 1-9-645,Vidyanagar,\\nAdikmet Road,Near SBH, Think Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\nTEST ASKED : AAROGYAM B ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nBLOOD UREA NITROGEN (BUN) PHOTOMETRY 7.38 mg/dl 7-25\\nCREATININE - SERUM PHOTOMETRY 0.54 mg/dl 0.5-0.8\\n\\nBUN / SR.CREATININE RATIO CALCULATED 13.67 Ratio 9:1-23:1\\nCALCIUM PHOTOMETRY 9.04 mg/dl 8.8-10.6\\n\\nURIC ACID PHOTOMETRY 3.9 mg/dl 3.2-6.1\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nBUN - KINETIC UV ASSAY.\\n\\nSCRE - CREATININE ENZYMATIC METHOD\\n\\nB/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES\\nCALC - ARSENAZO III METHOD, END POINT.\\n\\nURIC - URICASE / PEROXIDASE METHOD\\n\\nSample Collected on (SCT) : 17 May 2019 08:00\\n\\nSample Received on (SRT) : 18 May 2019 12:28 4\\n\\nReport Released on (RRT) : 18 May 2019 20:33 “\\n\\nSample Type : SERUM .\\n\\nLabcode : 1805067131/A6750 Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N3120413 Page : 7 of 9\\n\\x0c',\n",
       " 'PROCESSED AT:\\n\\nThyrocare Th CO ®\\nH. NO. 1-9-645,Vidyanagar, yr Care\\n\\nAdikmet Road,Near SBH,\\n\\nThink Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : HEMOGRAM - 6 PART (DIFF),HBA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbAi1c - (HPLC - NGSP Certified)\\n\\nH.P.L.C 7.2 %\\n\\nReference Range :\\n\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\n\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n\\n>8% : Poor Control\\n\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\n\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 160 mg/dl\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n\\n> 180 mg/dl : Poor Control\\n\\nMethod : Derived from HBA1c_ values\\n\\nPlease correlate with clinical conditions.\\nSample Collected on (SCT) :17 May 2019 08:00\\nSample Received on (SRT) :18 May 2019 16:03 “\\nReport Released on (RRT) 218 May 2019 17:08 wt\\nSample Type bres. #EDTA Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 1805072695/A6750\\n\\nRe . Page : 1 of 9\\nBarcode Ou 1M9261454\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nH. NO. 1-9-645,Vidyanagar,\\n\\nAdikmet Road,Near SBH,\\n\\nHyderabad-500 044\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\n \\n\\nNAME MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED HEMOGRANM - 6 PART (DIFF),HBA PRADESH,531116\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 6.6 X 103 / uL 4.0-10.0\\nNEUTROPHILS 58.1 % 40-80\\nLYMPHOCYTE PERCENTAGE 26.7 % 20.0-40.0\\nMONOCYTES 3.9 % 0.0-10.0\\nEOSINOPHILS 10.2 % 0.0-6.0\\nBASOPHILS 0.8 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 3.83 X 103 / uL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 1.76 X 103 / ul 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.26 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.05 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.67 X 103 / pL  0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / uL 0.0-0.3\\nTOTAL RBC 4.19 X10%6/uL =: 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 12.1 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 43.4 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 103.6 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 28.9 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.9 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 59.7 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 15.9 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 19 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 12.9 fL 6.5-12\\nPLATELET COUNT 231 X 103 / uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 47.3 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.3 % 0.19-0.39\\nRemarks: = ALERT !!! Eosinophilia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\n217 May 2019 08:00\\n:18 May 2019 16:03\\n218 May 2019 17:08\\n\\nSample Type : EDTA . .\\nDr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 1805072695/A6750\\nPage : 2 of 9\\nBarcode : M9261454\\n\\x0cPROCESSED AT:\\n\\nThyrocare Thyr O Cc are’\\n\\nH. NO. 1-9-645,Vidyanagar,\\n\\nAdikmet Road,Near SBH, Think Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM B PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nIRON PHOTOMETRY 55.2 g/dl\\n\\nReference Range :\\n\\nMale : 65-175\\n\\nFemale : 50 - 170\\n\\nMethod : _ FERROZINE METHOD WITHOUT DEPROTEINIZATION\\n\\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 394 g/dl\\nReference Range :\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n\\n% TRANSFERRIN SATURATION CALCULATED 14.01 %\\nReference Range :\\n\\n13-45\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\n\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :17 May 2019 08:00\\n\\nSample Received on (SRT) 218 May 2019 12:28 “\\n\\nReport Released on (RRT) 218 May 2019 20:33 wt\\n\\nSample Type #SERUM Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 1805067131/A6750\\n\\nPage : 3 of 9\\nBarcode =N3120413\\n\\x0cPROCESSED AT:\\n\\nThyrecar Thyrocare’\\n\\nH. NO. 1-9-645,Vidyanagar,\\nAdikmet Road,Near SBH, Think Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\nTEST ASKED : AAROGYAM B ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 48.68 U/L 45 - 129\\nBILIRUBIN - TOTAL PHOTOMETRY 0.48 mg/dl 0.3-1.2\\nBILIRUBIN -DIRECT PHOTOMETRY 0.15 mg/dl < 0.3\\nBILIRUBIN (INDIRECT) CALCULATED 0.33 mg/dl 0-0.9\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 12.3 U/I < 38\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.4 u/I <31\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 27.9 U/I < 34\\n\\nPROTEIN - TOTAL PHOTOMETRY 7.5 gm/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 4.3 gm/dl 3.2-4.8\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.34 Ratio 0.9-2\\n\\nSERUM GLOBULIN PHOTOMETRY 3.2 gm/dL 2.5-3.4\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - MODIFIED IFCC METHOD\\n\\nBILT - VANADATE OXIDATION\\n\\nBILD - VANADATE OXIDATION\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - MODIFIED IFCC METHOD\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 17 May 2019 08:00\\n\\nSample Received on (SRT) : 18 May 2019 12:28 4\\n\\nReport Released on (RRT) : 18 May 2019 20:33 “\\n\\nSample Type : SERUM .\\n\\nLabcode : 1805067131/A6750 Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N3120413 Page : 4 of 9\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nH. NO. 1-9-645,Vidyanagar,\\n\\nAdikmet Road,Near SBH,\\n\\nHyderabad-500 044\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nTEST ASKED : AAROGYAM B ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\n\\nTOTAL CHOLESTEROL PHOTOMETRY 148 mg/dl 125-200\\n\\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 23 mg/dl 35-80\\n\\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 91 mg/dl 85-130\\n\\nTRIGLYCERIDES PHOTOMETRY 201 mg/dl 25-200\\n\\nTC/ HDL CHOLESTEROL RATIO CALCULATED 6.5 Ratio 3-5\\n\\nLDL / HDL RATIO CALCULATED 4 Ratio 1.5-3.5\\n\\nVLDL CHOLESTEROL CALCULATED 40.19 mg/dl 5-40\\n\\nNON-HDL CHOLESTEROL CALCULATED 125.1 ma/dl < 160\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nCHOL - CHOD POD METHOD\\n\\nHCHO - ENZYME SELECTIVE PROTECTION METHOD\\n\\nLDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY\\n\\nTRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]\\n\\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\nLDL/ - DERIVED FROM SERUM HDL AND LDL VALUES\\n\\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\\n\\nNHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\\n\\nTOTAL CHOLESTEROL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\\n\\nDESIRABLE <40 OPTIMAL <100 NORMAL <150\\n\\nBORDERLINE HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\\n\\nHIGH BORDERLINE HIGH 130-159 HIGH 200-499\\nHIGH 160-189 VERY HIGH >500\\nVERY HIGH >190\\n\\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type\\nLabcode\\nBarcode\\n\\n: 1805067131/A6750\\n\\n: 17 May 2019 08:00\\n: 18 May 2019 12:28\\n: 18 May 2019 20:33\\n\\nDr.Siva Ranjan MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\n\\nPage : 5 of 9\\n\\x0cPROCESSED AT:\\n\\nThyrocare Thyro C are’\\n\\nH. NO. 1-9-645,Vidyanagar, . . .\\nAdikmet Road,Near SBH, Think Thyroid. Think Thyrocare.\\n\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n\\nREF. BY : SELF CNDHRX PRADESH SSI Iie CENTRE,NARSIPATNAM,\\nTEST ASKED : AAROGYAM B\\n\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\n\\nTOTAL TRIIODOTHYRONINE (T3) C.M.1.A 87 ng/di 58-159\\n\\nTOTAL THYROXINE (T4) C.L.L.A 12.1 ug/dl 4.5-12\\n\\nTHYROID STIMULATING HORMONE (TSH) C.M.1.A 2.27 HIU/ml 0.35 - 4.94\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nT3 - Fully Automated Chemi Luminescent Microparticle Immunoassay\\nT4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nTSH - Fully Automated Chemi Luminescent Microparticle Immunoassay\\nPregnancy reference ranges for TSH\\n\\n1st Trimester : 0.10 - 2.50\\n\\n2nd Trimester : 0.20 - 3.00\\n\\n3rd Trimester : 0.30 - 3.00\\n\\nReference:\\nGuidelines of American Thyroid Association for the Diagnosis and Management of Thyroid Disease During\\nPregnancy and Postpartum, Thyroid, 2011, 21; 1-46\\n\\nSample Collected on (SCT) : 17 May 2019 08:00\\nSample Received on (SRT) : 18 May 2019 12:28 ‘\\nReport Released on (RRT) : 18 May 2019 20:33 -\\nSample Type : SERUM . . .\\nDr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 1805067131/A6750\\nPage : 6 of 9\\n\\nBarcode : N3120413\\n\\x0cPROCESSED AT:\\n\\nThyrecar Thyrocare’\\n\\nH. NO. 1-9-645,Vidyanagar,\\nAdikmet Road,Near SBH, Think Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\nTEST ASKED : AAROGYAM B ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nBLOOD UREA NITROGEN (BUN) PHOTOMETRY 7.38 mg/dl 7-25\\nCREATININE - SERUM PHOTOMETRY 0.54 mg/dl 0.5-0.8\\n\\nBUN / SR.CREATININE RATIO CALCULATED 13.67 Ratio 9:1-23:1\\nCALCIUM PHOTOMETRY 9.04 mg/dl 8.8-10.6\\n\\nURIC ACID PHOTOMETRY 3.9 mg/dl 3.2-6.1\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nBUN - KINETIC UV ASSAY.\\n\\nSCRE - CREATININE ENZYMATIC METHOD\\n\\nB/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES\\nCALC - ARSENAZO III METHOD, END POINT.\\n\\nURIC - URICASE / PEROXIDASE METHOD\\n\\nSample Collected on (SCT) : 17 May 2019 08:00\\n\\nSample Received on (SRT) : 18 May 2019 12:28 4\\n\\nReport Released on (RRT) : 18 May 2019 20:33 “\\n\\nSample Type : SERUM .\\n\\nLabcode : 1805067131/A6750 Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N3120413 Page : 7 of 9\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nH. NO. 1-9-645,Vidyanagar,\\nAdikmet Road,Near SBH,\\nHwdarahad-S0n NAA\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\nNAME = MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n\\n(18900), INDIRA DIAGNOSTIC\\n\\nCENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\n\\nREF. BY : SELF\\n\\nTEST ASKED : AAROGYAM B\\n\\nTEST NAME TECHNOLOGY\\nEST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED\\n\\nReference Range :-\\n\\n> = 90 : Normal\\n60 - 89 : Mild Decrease\\n45-59 : Mild to Moderate Decrease\\n\\n30-44 : Moderate to Severe Decrease\\n15-29 : Severe Decrease\\n\\nClinical Significance\\n\\nVALUE UNITS\\n125 mL/min/1.73 m2\\n\\nThe normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild\\nand moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical\\nlaboratories to routinely estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of\\nrenal function, and report the value when serum creatinine is measured for patients 18 and older, when appropriate\\nand feasible. It cannot be measured easily in clinical practice, instead, GFR is estimated from equations using serum\\ncreatinine, age, race and sex. This provides easy to interpret information for the doctor and patient on the degree of\\nrenal impairment since it approximately equates to the percentage of kidney function remaining. Application of\\nCKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and\\n\\nmanagement of patients with CKD.\\n\\nReference\\n\\nLevey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular\\n\\nfiltration rate. Ann Intern Med. 2009;150(9):604-12.\\nPlease correlate with clinical conditions.\\nMethod:- CKD-EPI Creatinine Equation\\n\\n«ww End of report ~~\\n\\nSample Collected on (SCT) :17 May 2019 08:00\\nSample Received on (SRT) :18 May 2019 12:28 ‘\\nReport Released on (RRT) :18 May 2019 20:33\\n\\nSample Type Orie ? SERUM Dr.Siva Ranjan MD(Path)\\nLabcode : 1805067131/A6750\\n\\nBarcode RO :N3120413\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 8 of 9\\n\\x0c',\n",
       " 'PROCESSED AT:\\n\\nThyrocare Th CO ®\\nH. NO. 1-9-645,Vidyanagar, yr Care\\n\\nAdikmet Road,Near SBH,\\n\\nThink Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n. (18900), INDIRA DIAGNOSTIC\\n\\nREF. BY + SELF CENTRE, NARSIPATNAM, ANDHRA\\nTEST ASKED : HEMOGRAM - 6 PART (DIFF),HBA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\nHbAi1c - (HPLC - NGSP Certified)\\n\\nH.P.L.C 7.2 %\\n\\nReference Range :\\n\\nReference Range: As per ADA Guidelines Guidance For Known Diabetics\\n\\nBelow 5.7% : Normal Below 6.5% : Good Control\\n\\n5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control\\n\\n>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control\\n\\n>8% : Poor Control\\n\\nMethod : Fully Automated H.P.L.C. using Biorad Variant II Turbo, NGSP Certified.\\n\\nAVERAGE BLOOD GLUCOSE (ABG) CALCULATED 160 mg/dl\\nReference Range :\\n\\n90 - 120 mg/dl : Good Control\\n\\n121 - 150 mg/dl : Fair Control\\n\\n151 - 180 mg/dl : Unsatisfactory Control\\n\\n> 180 mg/dl : Poor Control\\n\\nMethod : Derived from HBA1c_ values\\n\\nPlease correlate with clinical conditions.\\nSample Collected on (SCT) :17 May 2019 08:00\\nSample Received on (SRT) :18 May 2019 16:03 “\\nReport Released on (RRT) 218 May 2019 17:08 wt\\nSample Type bres. #EDTA Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 1805072695/A6750\\n\\nRe . Page : 1 of 9\\nBarcode Ou 1M9261454\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nH. NO. 1-9-645,Vidyanagar,\\n\\nAdikmet Road,Near SBH,\\n\\nHyderabad-500 044\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\n \\n\\nNAME MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT_:\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC\\nCENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED HEMOGRANM - 6 PART (DIFF),HBA PRADESH,531116\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL LEUCOCYTES COUNT 6.6 X 103 / uL 4.0-10.0\\nNEUTROPHILS 58.1 % 40-80\\nLYMPHOCYTE PERCENTAGE 26.7 % 20.0-40.0\\nMONOCYTES 3.9 % 0.0-10.0\\nEOSINOPHILS 10.2 % 0.0-6.0\\nBASOPHILS 0.8 % <2\\nIMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4\\nNEUTROPHILS - ABSOLUTE COUNT 3.83 X 103 / uL 2.0-7.0\\nLYMPHOCYTES - ABSOLUTE COUNT 1.76 X 103 / ul 1.0-3.0\\nMONOCYTES - ABSOLUTE COUNT 0.26 X 103 / ul 0.2-1.0\\nBASOPHILS - ABSOLUTE COUNT 0.05 X 103 / ul 0.02-0.1\\nEOSINOPHILS - ABSOLUTE COUNT 0.67 X 103 / pL  0.02-0.5\\nIMMATURE GRANULOCYTES(IG) 0.02 X 103 / uL 0.0-0.3\\nTOTAL RBC 4.19 X10%6/uL =: 3.9-4.8\\nNUCLEATED RED BLOOD CELLS Nil X 103 / ul <0.01\\nNUCLEATED RED BLOOD CELLS % Nil % <0.01\\nHEMOGLOBIN 12.1 g/dL 12.0-15.0\\nHEMATOCRIT(PCV) 43.4 % 36.0-46.0\\nMEAN CORPUSCULAR VOLUME(MCV) 103.6 fL 83.0-101.0\\nMEAN CORPUSCULAR HEMOGLOBIN(MCH) 28.9 pq 27.0-32.0\\nMEAN CORP.HEMO.CONC(MCHC) 27.9 g/dL 31.5-34.5\\nRED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 59.7 fL 39.0-46.0\\nRED CELL DISTRIBUTION WIDTH (RDW-CV) 15.9 % 11.6-14.0\\nPLATELET DISTRIBUTION WIDTH(PDW) 19 fL 9.6-15.2\\nMEAN PLATELET VOLUME(MPV) 12.9 fL 6.5-12\\nPLATELET COUNT 231 X 103 / uL 150-400\\nPLATELET TO LARGE CELL RATIO(PLCR) 47.3 % 19.7-42.4\\nPLATELETCRIT(PCT) 0.3 % 0.19-0.39\\nRemarks: = ALERT !!! Eosinophilia\\n\\nPlease Correlate with clinical conditions.\\n\\nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\\n\\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow\\nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)\\n\\n \\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\n217 May 2019 08:00\\n:18 May 2019 16:03\\n218 May 2019 17:08\\n\\nSample Type : EDTA . .\\nDr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 1805072695/A6750\\nPage : 2 of 9\\nBarcode : M9261454\\n\\x0cPROCESSED AT:\\n\\nThyrocare Thyr O Cc are’\\n\\nH. NO. 1-9-645,Vidyanagar,\\n\\nAdikmet Road,Near SBH, Think Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\nREPORT\\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n\\n. (18900), INDIRA DIAGNOSTIC\\nREF. BY + SELF CENTRE,NARSIPATNAM, ANDHRA\\nTEST ASKED : AAROGYAM B PRADESH,531116\\nTEST NAME TECHNOLOGY VALUE UNITS\\nIRON PHOTOMETRY 55.2 g/dl\\n\\nReference Range :\\n\\nMale : 65-175\\n\\nFemale : 50 - 170\\n\\nMethod : _ FERROZINE METHOD WITHOUT DEPROTEINIZATION\\n\\nTOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 394 g/dl\\nReference Range :\\n\\nMale: 225 - 535 ug/dl Female: 215 - 535 ug/dl\\n\\nMethod : _SPECTROPHOTOMETRIC ASSAY\\n\\n% TRANSFERRIN SATURATION CALCULATED 14.01 %\\nReference Range :\\n\\n13-45\\n\\nMethod : DERIVED FROM IRON AND TIBC VALUES\\n\\nPlease correlate with clinical conditions.\\n\\n \\n\\nSample Collected on (SCT) :17 May 2019 08:00\\n\\nSample Received on (SRT) 218 May 2019 12:28 “\\n\\nReport Released on (RRT) 218 May 2019 20:33 wt\\n\\nSample Type #SERUM Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode 1 1805067131/A6750\\n\\nPage : 3 of 9\\nBarcode =N3120413\\n\\x0cPROCESSED AT:\\n\\nThyrecar Thyrocare’\\n\\nH. NO. 1-9-645,Vidyanagar,\\nAdikmet Road,Near SBH, Think Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\nTEST ASKED : AAROGYAM B ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 48.68 U/L 45 - 129\\nBILIRUBIN - TOTAL PHOTOMETRY 0.48 mg/dl 0.3-1.2\\nBILIRUBIN -DIRECT PHOTOMETRY 0.15 mg/dl < 0.3\\nBILIRUBIN (INDIRECT) CALCULATED 0.33 mg/dl 0-0.9\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 12.3 U/I < 38\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.4 u/I <31\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 27.9 U/I < 34\\n\\nPROTEIN - TOTAL PHOTOMETRY 7.5 gm/dl 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 4.3 gm/dl 3.2-4.8\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.34 Ratio 0.9-2\\n\\nSERUM GLOBULIN PHOTOMETRY 3.2 gm/dL 2.5-3.4\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nALKP - MODIFIED IFCC METHOD\\n\\nBILT - VANADATE OXIDATION\\n\\nBILD - VANADATE OXIDATION\\n\\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\\nGGT - MODIFIED IFCC METHOD\\n\\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\\nPROT - BIURET METHOD\\n\\nSALB - ALBUMIN BCG:METHOD (COLORIMETRIC ASSAY ENDPOINT)\\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\\n\\nSample Collected on (SCT) : 17 May 2019 08:00\\n\\nSample Received on (SRT) : 18 May 2019 12:28 4\\n\\nReport Released on (RRT) : 18 May 2019 20:33 “\\n\\nSample Type : SERUM .\\n\\nLabcode : 1805067131/A6750 Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N3120413 Page : 4 of 9\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nH. NO. 1-9-645,Vidyanagar,\\n\\nAdikmet Road,Near SBH,\\n\\nHyderabad-500 044\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\n\\nTEST ASKED : AAROGYAM B ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\n\\nTOTAL CHOLESTEROL PHOTOMETRY 148 mg/dl 125-200\\n\\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 23 mg/dl 35-80\\n\\nLDL CHOLESTEROL - DIRECT PHOTOMETRY 91 mg/dl 85-130\\n\\nTRIGLYCERIDES PHOTOMETRY 201 mg/dl 25-200\\n\\nTC/ HDL CHOLESTEROL RATIO CALCULATED 6.5 Ratio 3-5\\n\\nLDL / HDL RATIO CALCULATED 4 Ratio 1.5-3.5\\n\\nVLDL CHOLESTEROL CALCULATED 40.19 mg/dl 5-40\\n\\nNON-HDL CHOLESTEROL CALCULATED 125.1 ma/dl < 160\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nCHOL - CHOD POD METHOD\\n\\nHCHO - ENZYME SELECTIVE PROTECTION METHOD\\n\\nLDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY\\n\\nTRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING]\\n\\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\nLDL/ - DERIVED FROM SERUM HDL AND LDL VALUES\\n\\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\\n\\nNHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\\n\\n*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\\n\\nTOTAL CHOLESTEROL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)\\n\\nDESIRABLE <40 OPTIMAL <100 NORMAL <150\\n\\nBORDERLINE HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199\\n\\nHIGH BORDERLINE HIGH 130-159 HIGH 200-499\\nHIGH 160-189 VERY HIGH >500\\nVERY HIGH >190\\n\\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.\\n\\nSample Collected on (SCT)\\nSample Received on (SRT)\\nReport Released on (RRT)\\n\\nSample Type\\nLabcode\\nBarcode\\n\\n: 1805067131/A6750\\n\\n: 17 May 2019 08:00\\n: 18 May 2019 12:28\\n: 18 May 2019 20:33\\n\\nDr.Siva Ranjan MD(Path)\\n\\nDr.Caesar Sengupta MD(Micro)\\n\\nPage : 5 of 9\\n\\x0cPROCESSED AT:\\n\\nThyrocare Thyro C are’\\n\\nH. NO. 1-9-645,Vidyanagar, . . .\\nAdikmet Road,Near SBH, Think Thyroid. Think Thyrocare.\\n\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n\\nREF. BY : SELF CNDHRX PRADESH SSI Iie CENTRE,NARSIPATNAM,\\nTEST ASKED : AAROGYAM B\\n\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\n\\nTOTAL TRIIODOTHYRONINE (T3) C.M.1.A 87 ng/di 58-159\\n\\nTOTAL THYROXINE (T4) C.L.L.A 12.1 ug/dl 4.5-12\\n\\nTHYROID STIMULATING HORMONE (TSH) C.M.1.A 2.27 HIU/ml 0.35 - 4.94\\n\\n \\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nT3 - Fully Automated Chemi Luminescent Microparticle Immunoassay\\nT4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nTSH - Fully Automated Chemi Luminescent Microparticle Immunoassay\\nPregnancy reference ranges for TSH\\n\\n1st Trimester : 0.10 - 2.50\\n\\n2nd Trimester : 0.20 - 3.00\\n\\n3rd Trimester : 0.30 - 3.00\\n\\nReference:\\nGuidelines of American Thyroid Association for the Diagnosis and Management of Thyroid Disease During\\nPregnancy and Postpartum, Thyroid, 2011, 21; 1-46\\n\\nSample Collected on (SCT) : 17 May 2019 08:00\\nSample Received on (SRT) : 18 May 2019 12:28 ‘\\nReport Released on (RRT) : 18 May 2019 20:33 -\\nSample Type : SERUM . . .\\nDr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 1805067131/A6750\\nPage : 6 of 9\\n\\nBarcode : N3120413\\n\\x0cPROCESSED AT:\\n\\nThyrecar Thyrocare’\\n\\nH. NO. 1-9-645,Vidyanagar,\\nAdikmet Road,Near SBH, Think Thyroid. Think Thyrocare.\\nHyderabad-500 044\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT :\\n\\nREF. BY : SELF (18900), INDIRA DIAGNOSTIC CENTRE,NARSIPATNAM,\\nTEST ASKED : AAROGYAM B ANDHRA PRADESH,531116\\n\\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\\nBLOOD UREA NITROGEN (BUN) PHOTOMETRY 7.38 mg/dl 7-25\\nCREATININE - SERUM PHOTOMETRY 0.54 mg/dl 0.5-0.8\\n\\nBUN / SR.CREATININE RATIO CALCULATED 13.67 Ratio 9:1-23:1\\nCALCIUM PHOTOMETRY 9.04 mg/dl 8.8-10.6\\n\\nURIC ACID PHOTOMETRY 3.9 mg/dl 3.2-6.1\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nBUN - KINETIC UV ASSAY.\\n\\nSCRE - CREATININE ENZYMATIC METHOD\\n\\nB/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES\\nCALC - ARSENAZO III METHOD, END POINT.\\n\\nURIC - URICASE / PEROXIDASE METHOD\\n\\nSample Collected on (SCT) : 17 May 2019 08:00\\n\\nSample Received on (SRT) : 18 May 2019 12:28 4\\n\\nReport Released on (RRT) : 18 May 2019 20:33 “\\n\\nSample Type : SERUM .\\n\\nLabcode : 1805067131/A6750 Dr.Siva Ranjan MD(Path) Dr.Caesar Sengupta MD(Micro)\\n\\nBarcode : N3120413 Page : 7 of 9\\n\\x0cPROCESSED AT:\\nThyrocare\\n\\nH. NO. 1-9-645,Vidyanagar,\\nAdikmet Road,Near SBH,\\nHwdarahad-S0n NAA\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\nThyrocare’\\n\\nThink Thyroid. Think Thyrocare.\\n\\n \\n\\nNAME = MRS K SANDYA (32Y/F) SAMPLE COLLECTED AT\\n\\n(18900), INDIRA DIAGNOSTIC\\n\\nCENTRE,NARSIPATNAM, ANDHRA PRADESH,531116\\n\\nREF. BY : SELF\\n\\nTEST ASKED : AAROGYAM B\\n\\nTEST NAME TECHNOLOGY\\nEST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED\\n\\nReference Range :-\\n\\n> = 90 : Normal\\n60 - 89 : Mild Decrease\\n45-59 : Mild to Moderate Decrease\\n\\n30-44 : Moderate to Severe Decrease\\n15-29 : Severe Decrease\\n\\nClinical Significance\\n\\nVALUE UNITS\\n125 mL/min/1.73 m2\\n\\nThe normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild\\nand moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical\\nlaboratories to routinely estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of\\nrenal function, and report the value when serum creatinine is measured for patients 18 and older, when appropriate\\nand feasible. It cannot be measured easily in clinical practice, instead, GFR is estimated from equations using serum\\ncreatinine, age, race and sex. This provides easy to interpret information for the doctor and patient on the degree of\\nrenal impairment since it approximately equates to the percentage of kidney function remaining. Application of\\nCKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and\\n\\nmanagement of patients with CKD.\\n\\nReference\\n\\nLevey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular\\n\\nfiltration rate. Ann Intern Med. 2009;150(9):604-12.\\nPlease correlate with clinical conditions.\\nMethod:- CKD-EPI Creatinine Equation\\n\\n«ww End of report ~~\\n\\nSample Collected on (SCT) :17 May 2019 08:00\\nSample Received on (SRT) :18 May 2019 12:28 ‘\\nReport Released on (RRT) :18 May 2019 20:33\\n\\nSample Type Orie ? SERUM Dr.Siva Ranjan MD(Path)\\nLabcode : 1805067131/A6750\\n\\nBarcode RO :N3120413\\n\\nDr.Caesar Sengupta MD(Micro)\\nPage : 8 of 9\\n\\x0cCONDITIONS OF REPORTING\\n\\n“ The reported results are for information and interpretation of the referring doctor only.\\n\\n“It is presumed that the tests performed on the specimen belong to the patient; named or identified.\\n\\n“Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the\\nsame patient.\\n\\n“Should the results indicate an unexpected abnormality, the same should be reconfirmed.\\n\\n“Only such medical professionals who understand reporting units, reference ranges and limitations of\\ntechnologies should interpret results.\\n\\n“This report is not valid for medico-legal purpose.\\n\\n“Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or\\ndamage that may be incurred by any person as a result of presuming the meaning or contents of the report.\\n\\nEXPLANATIONS\\n\\n“Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them\\nas \"Clients\".\\n\\n~* Name - The name is as declared by the client and recored by the personnel who collected the specimen.\\n\\n“  Ref.Dr - The name of the doctor who has recommended testing as declared by the client.\\n\\n“ Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.\\n\\n“Barcode - This is the specimen identity number and it states that the results are for the specimen bearing\\nthe barcode (irrespective of the name).\\n\\nSCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by\\nthe client.\\n\\n“SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.\\n\\n“SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.\\n\\n“* RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.\\n\\n“ Reference Range - Means the range of values in which 95% of the normal population would fall.\\n\\nSUGGESTIONS\\n\\n“+ Values out of reference range requires reconfirmation before starting any medical treatment.\\n\\n“* Retesting is needed if you suspect any quality shortcomings.\\n\\n“* Testing or retesting should be done in accredited laboratories.\\n\\n“For suggestions, complaints or feedback, write to us at info@thyrocare.com or call us on\\n022-3090 0000 / 4125 2525\\n\\n“* SMS:<Labcode No.> to 9870666333\\n\\nPreventive Healthcare is now at your fingertips!\\nt=)\\nBooking\\n\\nTrack your\\nConfirmatios Technician\\n\\n     \\n \\n\\n \\n\\n \\n\\n       \\n\\n       \\n      \\n  \\n\\nRig tT Nt\\n\\n \\n\\n        \\n\\nLy\\n\\nSample\\nTesting\\n\\n=\\na &\\n&\\n\\nexplore & Select\\nTest / Profil\\n\\n     \\n\\n     \\n\\n  \\n\\nBlood\\nCollection\\n\\n   \\n\\n \\n\\n \\n\\n   \\n\\nFocus TB\\n\\nTowards a TB free world\\n\\n   \\n\\n“Fight TB with power of\\nRapid Technology”\\n\\n  \\n \\n \\n \\n \\n \\n \\n \\n   \\n\\nFocus TB, powered by Thyrocare.\\nA brand that will focus on TB, which is one of the major public health\\n\\nproblems in the country. Call : 022 - 3090 0000/4125 2525\\n\\nTuberculosis (TB) is a transmissible, airborne infection caused by info@focustb.com\\nMycobacterium tuberculosis (MTB). \\\\t transpires usually when a\\nperson inhales microscopic droplet nuclei containing viable\\nbacteria, spread through coughing by persons who have\\ninfectious TB.\\n\\nPage : 9 of 9\\n\\x0c',\n",
       " 'PROCESSED AT:\\n\\nThyrocare meCAP Thyro C ar eC\\n\\nD-37/1,TTC MIDC,Turbhe, COLLEGE of AMERICAN PATHOLOGISTS . . .\\nNavi Mumbai-400 703 ceanthewo. NSsaor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS K DEVI (35Y/F) SAMPLE COLLECTED AT\\n. (5311164139),MYTHRI MEDICAL CENTRE,MAIN RD,\\nREF. BY : DR G VIJAYASANTHI MBBS DGO,OTHER NARSIPATNAM, ANDHRA PRADESH, 531116\\nTEST ASKED : T3-T4-TSH\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) C.LI.A 118 ng/d| 60-200\\nTOTAL THYROXINE (T4) C.L.L.A 12.9 ug/dl 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) C.LI.A 5.14 HIU/ml 0.3-5.5\\n\\nComments: IF NOT ON DRUGS SUGGESTED FT3 & FT4 ESTIMATION\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nT3 - Competitive Chemi Luminescent Immuno Assay\\n\\nT4 - Competitive Chemi Luminescent Immuno Assay\\nTSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY\\nPregnancy reference ranges for TSH\\n\\n1st Trimester : 0.10 - 2.50\\n\\n2nd Trimester : 0.20 - 3.00\\n\\n3rd Trimester : 0.30 - 3.00\\n\\nReference:\\nGuidelines of American Thyroid Association for the Diagnosis and Management of Thyroid Disease During\\nPregnancy and Postpartum, Thyroid, 2011, 21; 1-46\\n\\n~~ End of report ~~\\n\\nSample Collected on (SCT) : 26 Aug 2019 17:00\\n\\nSample Received on (SRT) : 27 Aug 2019 22:52 ac tt?\\nReport Released on (RRT) : 28 Aug 2019 02:22 Oe ea\\n\\nSample Type OF . © : SERUM io .\\n= Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2708040474/A6750\\n\\nF100) . Page : 1 of 2\\nBarcode Ou : 00274398\\n\\x0c',\n",
       " 'PROCESSED AT:\\n\\nThyrocare meCAP Thyro C ar eC\\n\\nD-37/1,TTC MIDC,Turbhe, COLLEGE of AMERICAN PATHOLOGISTS . . .\\nNavi Mumbai-400 703 ceanthewo. NSsaor Think Thyroid. Think Thyrocare.\\n\\n   \\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 8691866066 4 wellness@thyrocare.com (www.thyrocare.com\\n\\n \\n\\n \\n\\nNAME : MRS K DEVI (35Y/F) SAMPLE COLLECTED AT\\n. (5311164139),MYTHRI MEDICAL CENTRE,MAIN RD,\\nREF. BY : DR G VIJAYASANTHI MBBS DGO,OTHER NARSIPATNAM, ANDHRA PRADESH, 531116\\nTEST ASKED : T3-T4-TSH\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) C.LI.A 118 ng/d| 60-200\\nTOTAL THYROXINE (T4) C.L.L.A 12.9 ug/dl 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) C.LI.A 5.14 HIU/ml 0.3-5.5\\n\\nComments: IF NOT ON DRUGS SUGGESTED FT3 & FT4 ESTIMATION\\n\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\nT3 - Competitive Chemi Luminescent Immuno Assay\\n\\nT4 - Competitive Chemi Luminescent Immuno Assay\\nTSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY\\nPregnancy reference ranges for TSH\\n\\n1st Trimester : 0.10 - 2.50\\n\\n2nd Trimester : 0.20 - 3.00\\n\\n3rd Trimester : 0.30 - 3.00\\n\\nReference:\\nGuidelines of American Thyroid Association for the Diagnosis and Management of Thyroid Disease During\\nPregnancy and Postpartum, Thyroid, 2011, 21; 1-46\\n\\n~~ End of report ~~\\n\\nSample Collected on (SCT) : 26 Aug 2019 17:00\\n\\nSample Received on (SRT) : 27 Aug 2019 22:52 ac tt?\\nReport Released on (RRT) : 28 Aug 2019 02:22 Oe ea\\n\\nSample Type OF . © : SERUM io .\\n= Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)\\nLabcode : 2708040474/A6750\\n\\nF100) . Page : 1 of 2\\nBarcode Ou : 00274398\\n\\x0cCONDITIONS OF REPORTING\\n\\n“ The reported results are for information and interpretation of the referring doctor only.\\n\\n“It is presumed that the tests performed on the specimen belong to the patient; named or identified.\\n\\n“Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the\\nsame patient.\\n\\n“Should the results indicate an unexpected abnormality, the same should be reconfirmed.\\n\\n“Only such medical professionals who understand reporting units, reference ranges and limitations of\\ntechnologies should interpret results.\\n\\n“This report is not valid for medico-legal purpose.\\n\\n“Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or\\ndamage that may be incurred by any person as a result of presuming the meaning or contents of the report.\\n\\nEXPLANATIONS\\n\\n“Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them\\nas \"Clients\".\\n\\n~* Name - The name is as declared by the client and recored by the personnel who collected the specimen.\\n\\n“  Ref.Dr - The name of the doctor who has recommended testing as declared by the client.\\n\\n“ Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.\\n\\n“Barcode - This is the specimen identity number and it states that the results are for the specimen bearing\\nthe barcode (irrespective of the name).\\n\\nSCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by\\nthe client.\\n\\n“SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.\\n\\n“SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.\\n\\n“* RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.\\n\\n“ Reference Range - Means the range of values in which 95% of the normal population would fall.\\n\\nSUGGESTIONS\\n\\n“+ Values out of reference range requires reconfirmation before starting any medical treatment.\\n\\n“* Retesting is needed if you suspect any quality shortcomings.\\n\\n“* Testing or retesting should be done in accredited laboratories.\\n\\n“For suggestions, complaints or feedback, write to us at info@thyrocare.com or call us on\\n022-3090 0000 / 4125 2525\\n\\n“* SMS:<Labcode No.> to 9870666333\\n\\nPreventive Healthcare is now at your fingertips!\\nt=)\\nBooking\\n\\nTrack your\\nConfirmatios Technician\\n\\n     \\n \\n\\n \\n\\n \\n\\n       \\n\\n       \\n      \\n  \\n\\nRig tT Nt\\n\\n \\n\\n        \\n\\nLy\\n\\nSample\\nTesting\\n\\n=\\na &\\n&\\n\\nexplore & Select\\nTest / Profil\\n\\n     \\n\\n     \\n\\n  \\n\\nBlood\\nCollection\\n\\n   \\n\\n \\n\\n \\n\\n   \\n\\nFocus TB\\n\\nTowards a TB free world\\n\\n   \\n\\n“Fight TB with power of\\nRapid Technology”\\n\\n  \\n \\n \\n \\n \\n \\n \\n \\n   \\n\\nFocus TB, powered by Thyrocare.\\nA brand that will focus on TB, which is one of the major public health\\n\\nproblems in the country. Call : 022 - 3090 0000/4125 2525\\n\\nTuberculosis (TB) is a transmissible, airborne infection caused by info@focustb.com\\nMycobacterium tuberculosis (MTB). \\\\t transpires usually when a\\nperson inhales microscopic droplet nuclei containing viable\\nbacteria, spread through coughing by persons who have\\ninfectious TB.\\n\\nPage : 2 of 2\\n\\x0c']"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "main"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'text1' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "\u001b[0;32m<ipython-input-8-151d16ddfe84>\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[1;32m      1\u001b[0m \u001b[0mdata\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;34m[\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 2\u001b[0;31m \u001b[0;32mfor\u001b[0m \u001b[0mrow\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mtext1\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0msplit\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m'\\n'\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      3\u001b[0m     \u001b[0;32mfor\u001b[0m \u001b[0mword\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mlist\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mword_list\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      4\u001b[0m         \u001b[0;32mif\u001b[0m \u001b[0mrow\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mstartswith\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mword\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      5\u001b[0m             \u001b[0mword\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mrow\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0msplit\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;31mNameError\u001b[0m: name 'text1' is not defined"
     ]
    }
   ],
   "source": [
    "    data = []\n",
    "    for row in text1.split('\\n'):\n",
    "        for word in list(word_list):\n",
    "            if row.startswith(word):\n",
    "                word = row.split()\n",
    "                word = word\n",
    "                for word_name in list(word):  \n",
    "                    if word_name in stopwords:\n",
    "\n",
    "                        word.remove(word_name)\n",
    "\n",
    "                for i in word:\n",
    "                    if  solve(i):\n",
    "                        null = i\n",
    "                        word.remove(null)\n",
    "                        i = float(i)\n",
    "\n",
    "                word = [x for x in word if not isinstance(x, int)]   \n",
    "                word = [' '.join(word)]\n",
    "                print(word)\n",
    "                word.append(i)\n",
    "                #word.remove(str(i))\n",
    "                print(word)\n",
    "                data.append(word)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    " extracted_DataFrame = pd.DataFrame(data)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "   #Data Cleaning\n",
    "        extracted_DataFrame.columns = ['Keys','Values']\n",
    "    #        extracted_DataFrame.rename(columns={'Keys':'Values'},inplace=True)\n",
    "        extracted_DataFrame['Keys'] = extracted_DataFrame['Keys'].str.replace('\\d+', '')\n",
    "        extracted_DataFrame['Keys'] = extracted_DataFrame['Keys'].str.replace('\\.','')\n",
    "        extracted_DataFrame['Keys'] = extracted_DataFrame['Keys'].str.replace('\\-','')\n",
    "        extracted_DataFrame['Keys'] = extracted_DataFrame['Keys'].str.rstrip()\n",
    "        extracted_DataFrame['Values'] = extracted_DataFrame['Values'].apply(lambda x: pd.to_numeric(x, errors = 'coerce')).dropna()\n",
    "        extracted_DataFrame = extracted_DataFrame.dropna(axis=0)\n",
    "        #DataFrame to Dictionary\n",
    "        extracted_Dictionary = extracted_DataFrame.set_index('Keys')['Values'].to_dict()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    " Report_Dictionary = {}\n",
    "\n",
    "        if 'HPLC' in extracted_Dictionary.keys():\n",
    "            HPLC = extracted_Dictionary['HPLC']\n",
    "            Report_Dictionary[\"HPLC\"] = HPLC\n",
    "        else:\n",
    "            Report_Dictionary[\"HPLC\"] = None\n",
    "        if 'AVERAGE BLOOD GLUCOSE (ABG)' in extracted_Dictionary.keys():\n",
    "            AVERAGE_BLOOD_GLUCOSE = extracted_Dictionary['AVERAGE BLOOD GLUCOSE (ABG)']\n",
    "            Report_Dictionary[\"AVERAGE_BLOOD_GLUCOSE\"] = AVERAGE_BLOOD_GLUCOSE\n",
    "        else:\n",
    "            Report_Dictionary[\"AVERAGE_BLOOD_GLUCOSE\"] = None\n",
    "        if 'TOTAL LEUCOCYTES COUNT' in extracted_Dictionary.keys():\n",
    "            TOTAL_LEUCOCYTES_COUNT = extracted_Dictionary['TOTAL LEUCOCYTES COUNT']\n",
    "            Report_Dictionary[\"TOTAL_LEUCOCYTES_COUNT\"] = TOTAL_LEUCOCYTES_COUNT\n",
    "        else:\n",
    "            Report_Dictionary[\"TOTAL_LEUCOCYTES_COUNT\"] = None\n",
    "\n",
    "        if 'NEUTROPHILS' in extracted_Dictionary.keys():\n",
    "            NEUTROPHILS = extracted_Dictionary['NEUTROPHILS']\n",
    "            Report_Dictionary[\"NEUTROPHILS\"] = NEUTROPHILS\n",
    "        else:\n",
    "            Report_Dictionary[\"NEUTROPHILS\"] = None\n",
    "\n",
    "        if 'LYMPHOCYTE PERCENTAGE' in extracted_Dictionary.keys():\n",
    "            LYMPHOCYTE_PERCENTAGE = extracted_Dictionary['LYMPHOCYTE PERCENTAGE']\n",
    "            Report_Dictionary[\"LYMPHOCYTE_PERCENTAGE\"] = LYMPHOCYTE_PERCENTAGE\n",
    "        else:\n",
    "            Report_Dictionary[\"LYMPHOCYTE_PERCENTAGE\"] = None\n",
    "\n",
    "        if 'MONOCYTES' in extracted_Dictionary.keys():\n",
    "            MONOCYTES = extracted_Dictionary['MONOCYTES']\n",
    "            Report_Dictionary[\"MONOCYTES\"] = MONOCYTES\n",
    "        else:\n",
    "            Report_Dictionary[\"MONOCYTES\"] = None\n",
    "\n",
    "        if 'EOSINOPHILS' in extracted_Dictionary.keys():\n",
    "            EOSINOPHILS = extracted_Dictionary['EOSINOPHILS']\n",
    "            Report_Dictionary[\"EOSINOPHILS\"] = EOSINOPHILS\n",
    "        else:\n",
    "            Report_Dictionary[\"EOSINOPHILS\"] = None\n",
    "\n",
    "        if 'BASOPHILS' in extracted_Dictionary.keys():\n",
    "            BASOPHILS = extracted_Dictionary['BASOPHILS']\n",
    "            Report_Dictionary[\"BASOPHILS\"] = BASOPHILS\n",
    "        else:\n",
    "            Report_Dictionary[\"BASOPHILS\"] = None\n",
    "\n",
    "        if 'IMMATURE GRANULOCYTE' in extracted_Dictionary.keys():\n",
    "            IMMATURE_GRANULOCYTE_PERCENTAGE = extracted_Dictionary['IMMATURE GRANULOCYTE']\n",
    "            Report_Dictionary[\"IMMATURE_GRANULOCYTE_PERCENTAGE\"] = IMMATURE_GRANULOCYTE_PERCENTAGE\n",
    "        else:\n",
    "            Report_Dictionary[\"IMMATURE_GRANULOCYTE_PERCENTAGE\"] = None\n",
    "\n",
    "        if 'NEUTROPHILS ABSOLUTE COUNT' in extracted_Dictionary.keys():\n",
    "            NEUTROPHILS_ABSOLUTE_COUNT = extracted_Dictionary['NEUTROPHILS ABSOLUTE COUNT']\n",
    "            Report_Dictionary[\"NEUTROPHILS_ABSOLUTE_COUNT\"] = NEUTROPHILS_ABSOLUTE_COUNT\n",
    "        else:\n",
    "            Report_Dictionary[\"NEUTROPHILS_ABSOLUTE_COUNT\"] = None\n",
    "\n",
    "        if 'LYMPHOCYTES ABSOLUTE COUNT' in extracted_Dictionary.keys():\n",
    "            LYMPHOCYTES_ABSOLUTE_COUNT = extracted_Dictionary['LYMPHOCYTES ABSOLUTE COUNT']\n",
    "            Report_Dictionary[\"LYMPHOCYTES_ABSOLUTE_COUNT\"] = LYMPHOCYTES_ABSOLUTE_COUNT\n",
    "        else:\n",
    "            Report_Dictionary[\"LYMPHOCYTES_ABSOLUTE_COUNT\"] = None\n",
    "\n",
    "        if 'MONOCYTES ABSOLUTE COUNT' in extracted_Dictionary.keys():\n",
    "            MONOCYTES_ABSOLUTE_COUNT = extracted_Dictionary['MONOCYTES ABSOLUTE COUNT']\n",
    "            Report_Dictionary[\"MONOCYTES_ABSOLUTE_COUNT\"] = MONOCYTES_ABSOLUTE_COUNT\n",
    "        else:\n",
    "            Report_Dictionary[\"MONOCYTES_ABSOLUTE_COUNT\"] = None\n",
    "\n",
    "        if 'BASOPHILS ABSOLUTE COUNT' in extracted_Dictionary.keys():\n",
    "            BASOPHILS_ABSOLUTE_COUNT = extracted_Dictionary['BASOPHILS ABSOLUTE COUNT']\n",
    "            Report_Dictionary[\"BASOPHILS_ABSOLUTE_COUNT\"] = BASOPHILS_ABSOLUTE_COUNT\n",
    "        else:\n",
    "            Report_Dictionary[\"BASOPHILS_ABSOLUTE_COUNT\"] = None\n",
    "\n",
    "        if 'EOSINOPHILS ABSOLUTE COUNT' in extracted_Dictionary.keys():\n",
    "            EOSINOPHILS_ABSOLUTE_COUNT = extracted_Dictionary['EOSINOPHILS ABSOLUTE COUNT']\n",
    "            Report_Dictionary[\"EOSINOPHILS_ABSOLUTE_COUNT\"] = EOSINOPHILS_ABSOLUTE_COUNT\n",
    "        else:\n",
    "            Report_Dictionary[\"EOSINOPHILS_ABSOLUTE_COUNT\"] = None\n",
    "\n",
    "        if 'IMMATURE GRANULOCYTES(IG)' in extracted_Dictionary.keys():\n",
    "            IMMATURE_GRANULOCYTES = extracted_Dictionary['IMMATURE GRANULOCYTES(IG)']\n",
    "            Report_Dictionary[\"IMMATURE_GRANULOCYTES\"] = IMMATURE_GRANULOCYTES\n",
    "        else:\n",
    "            Report_Dictionary[\"IMMATURE_GRANULOCYTES\"] = None\n",
    "\n",
    "        if 'TOTAL RBC' in extracted_Dictionary.keys():\n",
    "            TOTAL_RBC = extracted_Dictionary['TOTAL RBC']\n",
    "            Report_Dictionary[\"TOTAL_RBC\"] = TOTAL_RBC\n",
    "        else:\n",
    "            Report_Dictionary[\"TOTAL_RBC\"] = None\n",
    "\n",
    "        if 'NUCLEATED RED BLOOD CELLS' in extracted_Dictionary.keys():\n",
    "            NUCLEATED_RED_BLOOD_CELLS = extracted_Dictionary['NUCLEATED RED BLOOD CELLS']\n",
    "            Report_Dictionary[\"NUCLEATED_RED_BLOOD_CELLS\"] = NUCLEATED_RED_BLOOD_CELL\n",
    "\n",
    "        else:\n",
    "            Report_Dictionary[\"NUCLEATED_RED_BLOOD_CELLS\"] = None\n",
    "\n",
    "\n",
    "        if 'HEMOGLOBIN' in extracted_Dictionary.keys():\n",
    "            HEMOGLOBIN = extracted_Dictionary['HEMOGLOBIN']\n",
    "            Report_Dictionary[\"HEMOGLOBIN\"] = HEMOGLOBIN\n",
    "        else:\n",
    "            Report_Dictionary[\"HEMOGLOBIN\"] = None\n",
    "\n",
    "        if 'HEMATOCRIT(PCV)' in extracted_Dictionary.keys():\n",
    "            HEMATOCRIT = extracted_Dictionary['HEMATOCRIT(PCV)']\n",
    "            Report_Dictionary[\"HEMATOCRIT\"] = HEMATOCRIT\n",
    "        else:\n",
    "            Report_Dictionary[\"HEMATOCRIT\"] = None\n",
    "\n",
    "        if 'MEAN CORPUSCULAR VOLUME(MCV)' in extracted_Dictionary.keys():\n",
    "            MEAN_CORPUSCULAR_VOLUME = extracted_Dictionary['MEAN CORPUSCULAR VOLUME(MCV)']\n",
    "            Report_Dictionary[\"MEAN_CORPUSCULAR_VOLUME\"] = MEAN_CORPUSCULAR_VOLUME\n",
    "        else:\n",
    "            Report_Dictionary[\"MEAN_CORPUSCULAR_VOLUME\"] = None\n",
    "\n",
    "        if 'MEAN CORPUSCULAR HEMOGLOBIN(MCH)' in extracted_Dictionary.keys():\n",
    "            MEAN_CORPUSCULAR_HEMOGLOBIN = extracted_Dictionary['MEAN CORPUSCULAR HEMOGLOBIN(MCH)']\n",
    "            Report_Dictionary[\"MEAN_CORPUSCULAR_HEMOGLOBIN\"] = MEAN_CORPUSCULAR_HEMOGLOBIN\n",
    "        else:\n",
    "            Report_Dictionary[\"MEAN_CORPUSCULAR_HEMOGLOBIN\"] = None\n",
    "\n",
    "        if 'MEAN CORPHEMOCONC(MCHC)' in extracted_Dictionary.keys():\n",
    "            MEAN_CORP_HEMO_CONC = extracted_Dictionary['MEAN CORPHEMOCONC(MCHC)']\n",
    "            Report_Dictionary[\"MEAN_CORP_HEMO_CONC\"] = MEAN_CORP_HEMO_CONC\n",
    "        else:\n",
    "            Report_Dictionary[\"MEAN_CORP_HEMO_CONC\"] = None\n",
    "\n",
    "        if 'RED CELL DISTRIBUTION WIDTH SD(RDWSD)' in extracted_Dictionary.keys():\n",
    "            RED_CELL_DISTRIBUTION_WIDTH_SD = extracted_Dictionary['RED CELL DISTRIBUTION WIDTH SD(RDWSD)']\n",
    "            Report_Dictionary[\"RED_CELL_DISTRIBUTION_WIDTH_SD\"] = RED_CELL_DISTRIBUTION_WIDTH_SD\n",
    "        else:\n",
    "            Report_Dictionary[\"RED_CELL_DISTRIBUTION_WIDTH_SD\"] = None\n",
    "\n",
    "        if 'RED CELL DISTRIBUTION WIDTH (RDWCV)' in extracted_Dictionary.keys():\n",
    "            RED_CELL_DISTRIBUTION_WIDTH_CV = extracted_Dictionary['RED CELL DISTRIBUTION WIDTH (RDWCV)']\n",
    "            Report_Dictionary[\"RED_CELL_DISTRIBUTION_WIDTH_CV\"] = RED_CELL_DISTRIBUTION_WIDTH_CV\n",
    "        else:\n",
    "            Report_Dictionary[\"RED_CELL_DISTRIBUTION_WIDTH_CV\"] = None\n",
    "\n",
    "        if 'PLATELET DISTRIBUTION WIDTH(PDW)' in extracted_Dictionary.keys():\n",
    "            PLATELET_DISTRIBUTION_WIDTH = extracted_Dictionary['PLATELET DISTRIBUTION WIDTH(PDW)']\n",
    "            Report_Dictionary[\"PLATELET_DISTRIBUTION_WIDTH\"] = PLATELET_DISTRIBUTION_WIDTH\n",
    "        else:\n",
    "            Report_Dictionary[\"PLATELET_DISTRIBUTION_WIDTH\"] = None\n",
    "\n",
    "        if 'MEAN PLATELET VOLUME(MPV)' in extracted_Dictionary.keys():\n",
    "            MEAN_PLATELET_VOLUME = extracted_Dictionary['MEAN PLATELET VOLUME(MPV)']\n",
    "            Report_Dictionary[\"MEAN_PLATELET_VOLUME\"] = MEAN_PLATELET_VOLUME\n",
    "        else:\n",
    "            Report_Dictionary[\"MEAN_PLATELET_VOLUME\"] = None\n",
    "\n",
    "        if 'PLATELET COUNT' in extracted_Dictionary.keys():\n",
    "            PLATELET_COUNT = extracted_Dictionary['PLATELET COUNT']\n",
    "            Report_Dictionary[\"PLATELET_COUNT\"] = PLATELET_COUNT\n",
    "        else:\n",
    "            Report_Dictionary[\"PLATELET_COUNT\"] = None\n",
    "\n",
    "        if 'PLATELET TO LARGE CELL RATIO(PLCR)' in extracted_Dictionary.keys():\n",
    "            PLATELET_TO_LARGE_CELL_RATIO = extracted_Dictionary['PLATELET TO LARGE CELL RATIO(PLCR)']\n",
    "            Report_Dictionary[\"PLATELET_TO_LARGE_CELL_RATIO\"] = PLATELET_TO_LARGE_CELL_RATIO\n",
    "        else:\n",
    "            Report_Dictionary[\"PLATELET_TO_LARGE_CELL_RATIO\"] = None\n",
    "\n",
    "        if 'PLATELETCRIT(PCT)' in extracted_Dictionary.keys():\n",
    "            PLATELETCRIT = extracted_Dictionary['PLATELETCRIT(PCT)']\n",
    "            Report_Dictionary[\"PLATELETCRIT\"] = PLATELETCRIT\n",
    "        else:\n",
    "            Report_Dictionary[\"PLATELETCRIT\"] = None\n",
    "\n",
    "        if 'ARSENIC' in extracted_Dictionary.keys():\n",
    "            ARSENIC = extracted_Dictionary['ARSENIC']\n",
    "            Report_Dictionary[\"ARSENIC\"] = ARSENIC\n",
    "        else:\n",
    "            Report_Dictionary[\"ARSENIC\"] = None\n",
    "\n",
    "\n",
    "        if 'CADMIUM' in extracted_Dictionary.keys():\n",
    "            CADMIUM = extracted_Dictionary['CADMIUM']\n",
    "            Report_Dictionary[\"CADMIUM\"] = CADMIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"CADMIUM\"] = None\n",
    "\n",
    "\n",
    "        if 'MERCURY' in extracted_Dictionary.keys():\n",
    "            MERCURY = extracted_Dictionary['MERCURY']\n",
    "            Report_Dictionary[\"MERCURY\"] = MERCURY\n",
    "        else:\n",
    "            Report_Dictionary[\"MERCURY\"] = None\n",
    "\n",
    "\n",
    "        if 'LEAD' in extracted_Dictionary.keys():\n",
    "            LEAD = extracted_Dictionary['LEAD']\n",
    "            Report_Dictionary[\"LEAD\"] = LEAD\n",
    "        else:\n",
    "            Report_Dictionary[\"LEAD\"] = None\n",
    "\n",
    "\n",
    "        if 'CHROMIUM' in extracted_Dictionary.keys():\n",
    "            CHROMIUM = extracted_Dictionary['CHROMIUM']\n",
    "            Report_Dictionary[\"CHROMIUM\"] = CHROMIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"CHROMIUM\"] = None\n",
    "\n",
    "\n",
    "        if 'BARIUM' in extracted_Dictionary.keys():\n",
    "            BARIUM = extracted_Dictionary['BARIUM']\n",
    "            Report_Dictionary[\"BARIUM\"] = BARIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"BARIUM\"] = None\n",
    "\n",
    "\n",
    "        if 'COBALT' in extracted_Dictionary.keys():\n",
    "            COBALT = extracted_Dictionary['COBALT']\n",
    "            Report_Dictionary[\"COBALT\"] = COBALT\n",
    "        else:\n",
    "            Report_Dictionary[\"COBALT\"] = None\n",
    "\n",
    "\n",
    "        if 'CAESIUM' in extracted_Dictionary.keys():\n",
    "            CAESIUM = extracted_Dictionary['CAESIUM']\n",
    "            Report_Dictionary[\"CAESIUM\"] = CAESIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"CAESIUM\"] = None\n",
    "\n",
    "\n",
    "        if 'THALLIUM' in extracted_Dictionary.keys():\n",
    "            THALLIUM = extracted_Dictionary['THALLIUM']\n",
    "            Report_Dictionary[\"THALLIUM\"] = THALLIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"THALLIUM\"] = None\n",
    "\n",
    "\n",
    "        if 'URANIUM' in extracted_Dictionary.keys():\n",
    "            URANIUM = extracted_Dictionary['URANIUM']\n",
    "            Report_Dictionary[\"URANIUM\"] = URANIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"URANIUM\"] = None\n",
    "\n",
    "\n",
    "        if 'STRONTIUM' in extracted_Dictionary.keys():\n",
    "            STRONTIUM = extracted_Dictionary['STRONTIUM']\n",
    "            Report_Dictionary[\"STRONTIUM\"] = STRONTIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"STRONTIUM\"] = None\n",
    "\n",
    "\n",
    "        if 'ANTIMONY' in extracted_Dictionary.keys():\n",
    "            ANTIMONY = extracted_Dictionary['ANTIMONY']\n",
    "            Report_Dictionary[\"ANTIMONY\"] = ANTIMONY\n",
    "        else:\n",
    "            Report_Dictionary[\"ANTIMONY\"] = None\n",
    "\n",
    "\n",
    "        if 'TIN' in extracted_Dictionary.keys():\n",
    "            TIN = extracted_Dictionary['TIN']\n",
    "            Report_Dictionary[\"TIN\"] = TIN\n",
    "        else:\n",
    "            Report_Dictionary[\"TIN\"] = None\n",
    "\n",
    "\n",
    "        if 'MOLYBDENUM' in extracted_Dictionary.keys():\n",
    "            MOLYBDENUM = extracted_Dictionary['MOLYBDENUM']\n",
    "            Report_Dictionary[\"MOLYBDENUM\"] = MOLYBDENUM\n",
    "        else:\n",
    "            Report_Dictionary[\"MOLYBDENUM\"] = None\n",
    "\n",
    "\n",
    "\n",
    "        if 'SILVER' in extracted_Dictionary.keys():\n",
    "            SILVER = extracted_Dictionary['SILVER']\n",
    "            Report_Dictionary[\"SILVER\"] = SILVER\n",
    "        else:\n",
    "            Report_Dictionary[\"SILVER\"] = None\n",
    "\n",
    "\n",
    "        if 'VANADIUM' in extracted_Dictionary.keys():\n",
    "            VANADIUM = extracted_Dictionary['VANADIUM']\n",
    "            Report_Dictionary[\"VANADIUM\"] = VANADIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"VANADIUM\"] = None\n",
    "\n",
    "\n",
    "        if 'BERYLLIUM' in extracted_Dictionary.keys():\n",
    "            BERYLLIUM = extracted_Dictionary['BERYLLIUM']\n",
    "            Report_Dictionary[\"BERYLLIUM\"] = BERYLLIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"BERYLLIUM\"] = None\n",
    "\n",
    "\n",
    "\n",
    "        if 'BISMUTH' in extracted_Dictionary.keys():\n",
    "            BISMUTH = extracted_Dictionary['BISMUTH']\n",
    "            Report_Dictionary[\"BISMUTH\"] = BISMUTH\n",
    "        else:\n",
    "            Report_Dictionary[\"BISMUTH\"] = None\n",
    "\n",
    "\n",
    "        if 'SELENIUM' in extracted_Dictionary.keys():\n",
    "            SELENIUM = extracted_Dictionary['SELENIUM']\n",
    "            Report_Dictionary[\"SELENIUM\"] = SELENIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"SELENIUM\"] = None\n",
    "\n",
    "\n",
    "        if 'ALUMINIUM' in extracted_Dictionary.keys():\n",
    "            ALUMINIUM = extracted_Dictionary['ALUMINIUM']\n",
    "            Report_Dictionary[\"ALUMINIUM\"] = ALUMINIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"ALUMINIUM\"] = None\n",
    "\n",
    "\n",
    "        if 'NICKEL' in extracted_Dictionary.keys():\n",
    "            NICKEL = extracted_Dictionary['NICKEL']\n",
    "            Report_Dictionary[\"NICKEL\"] = NICKEL\n",
    "        else:\n",
    "            Report_Dictionary[\"NICKEL\"] = None\n",
    "\n",
    "\n",
    "        if 'MANGANESE' in extracted_Dictionary.keys():\n",
    "            MANGANESE = extracted_Dictionary['MANGANESE']\n",
    "            Report_Dictionary[\"MANGANESE\"] = MANGANESE\n",
    "        else:\n",
    "            Report_Dictionary[\"MANGANESE\"] = None\n",
    "\n",
    "\n",
    "        if 'HOMOCYSTEINE' in extracted_Dictionary.keys():\n",
    "            HOMOCYSTEINE = extracted_Dictionary['HOMOCYSTEINE']\n",
    "            Report_Dictionary[\"HOMOCYSTEINE\"] = HOMOCYSTEINE\n",
    "        else:\n",
    "            Report_Dictionary[\"HOMOCYSTEINE\"] = None\n",
    "\n",
    "\n",
    "        if 'CYSTATIN C' in extracted_Dictionary.keys():\n",
    "            CYSTATIN_C = extracted_Dictionary['CYSTATIN C']\n",
    "            Report_Dictionary[\"CYSTATIN_C\"] = CYSTATIN_C\n",
    "        else:\n",
    "            Report_Dictionary[\"CYSTATIN_C\"] = None\n",
    "\n",
    "        if 'LIPOPROTEIN' in extracted_Dictionary.keys():\n",
    "            LIPOPROTEIN = extracted_Dictionary['LIPOPROTEIN']\n",
    "            Report_Dictionary[\"LIPOPROTEIN\"] = LIPOPROTEIN\n",
    "        else:\n",
    "            Report_Dictionary[\"LIPOPROTEIN\"] = None\n",
    "\n",
    "\n",
    "        if 'VITAMIN B' in extracted_Dictionary.keys():\n",
    "            VITAMIN_B = extracted_Dictionary['VITAMIN B']\n",
    "            Report_Dictionary[\"VITAMIN_B\"] = VITAMIN_B\n",
    "        else:\n",
    "            Report_Dictionary[\"VITAMIN_B\"] = None\n",
    "\n",
    "\n",
    "        if 'APOLIPOPROTEIN A (APOA)' in extracted_Dictionary.keys():\n",
    "            APOLIPOPROTEIN_A_APOA = extracted_Dictionary['APOLIPOPROTEIN A (APOA)']\n",
    "            Report_Dictionary[\"APOLIPOPROTEIN_A_APOA\"] = APOLIPOPROTEIN_A_APOA\n",
    "        else:\n",
    "            Report_Dictionary[\"APOLIPOPROTEIN_A_APOA\"] = None\n",
    "\n",
    "\n",
    "        if 'APOLIPOPROTEIN B (APOB)' in extracted_Dictionary.keys():\n",
    "            APOLIPOPROTEIN_B_APOB = extracted_Dictionary['APOLIPOPROTEIN B (APOB)']\n",
    "            Report_Dictionary[\"APOLIPOPROTEIN_B_APOB\"] = APOLIPOPROTEIN_B_APOB\n",
    "        else:\n",
    "            Report_Dictionary[\"APOLIPOPROTEIN_B_APOB\"] = None\n",
    "\n",
    "        if 'APO B APO Ai (APO B/A)' in extracted_Dictionary.keys():\n",
    "            APOB_APOA_RATIO = extracted_Dictionary['APO B APO Ai (APO B/A)']\n",
    "            Report_Dictionary[\"APOB_APOA_RATIO\"] = APOB_APOA_RATIO\n",
    "        else:\n",
    "            Report_Dictionary[\"APOB_APOA_RATIO\"] = None\n",
    "\n",
    "\n",
    "\n",
    "        if 'HIGH SENSITIVITY CREACTIVE PROTEIN (HSCRP)' in extracted_Dictionary.keys():\n",
    "            HSCRP = extracted_Dictionary['HIGH SENSITIVITY CREACTIVE PROTEIN (HSCRP)']\n",
    "            Report_Dictionary[\"HSCRP\"] = HSCRP\n",
    "        else:\n",
    "            Report_Dictionary[\"HSCRP\"] = None\n",
    "\n",
    "\n",
    "        if 'SERUM COPPER' in extracted_Dictionary.keys():\n",
    "            SERUM_COPPER = extracted_Dictionary['SERUM COPPER']\n",
    "            Report_Dictionary[\"SERUM_COPPER\"] = SERUM_COPPER\n",
    "        else:\n",
    "            Report_Dictionary[\"SERUM_COPPER\"] = None\n",
    "\n",
    "\n",
    "        if 'SERUM ZINC' in extracted_Dictionary.keys():\n",
    "            SERUM_ZINC = extracted_Dictionary['SERUM ZINC']\n",
    "            Report_Dictionary[\"SERUM_ZINC\"] = SERUM_ZINC\n",
    "        else:\n",
    "            Report_Dictionary[\"SERUM_ZINC\"] = None\n",
    "\n",
    "\n",
    "        if 'TESTOSTERONE' in extracted_Dictionary.keys():\n",
    "            TESTOSTERONE = extracted_Dictionary['TESTOSTERONE']\n",
    "            Report_Dictionary[\"TESTOSTERONE\"] = TESTOSTERONE\n",
    "        else:\n",
    "            Report_Dictionary[\"TESTOSTERONE\"] = None\n",
    "\n",
    "        if 'IRON' in extracted_Dictionary.keys():\n",
    "            IRON = extracted_Dictionary['IRON']\n",
    "            Report_Dictionary[\"IRON\"] = IRON\n",
    "        else:\n",
    "            Report_Dictionary[\"IRON\"] = None\n",
    "\n",
    "        if 'TOTAL IRON BINDING CAPACITY (TIBC)' in extracted_Dictionary.keys():\n",
    "            TOTAL_IRON_BINDING_CAPACITY = extracted_Dictionary['TOTAL IRON BINDING CAPACITY (TIBC)']\n",
    "            Report_Dictionary[\"TOTAL_IRON_BINDING_CAPACITY\"] = TOTAL_IRON_BINDING_CAPACITY\n",
    "        else:\n",
    "            Report_Dictionary[\"TOTAL_IRON_BINDING_CAPACITY\"] = None\n",
    "\n",
    "\n",
    "        if 'TRANSFERRIN SATURATION' in extracted_Dictionary.keys():\n",
    "            TRANSFERRIN_SATURATION = extracted_Dictionary['TRANSFERRIN SATURATION']\n",
    "            Report_Dictionary[\"TRANSFERRIN_SATURATION\"] = TRANSFERRIN_SATURATION\n",
    "        else:\n",
    "            Report_Dictionary[\"TRANSFERRIN_SATURATION\"] = None\n",
    "\n",
    "        if 'ALKALINE PHOSPHATASE' in extracted_Dictionary.keys():\n",
    "            ALKALINE_PHOSPHATASE = extracted_Dictionary['ALKALINE PHOSPHATASE']\n",
    "            Report_Dictionary[\"ALKALINE_PHOSPHATASE\"] = ALKALINE_PHOSPHATASE\n",
    "        else:\n",
    "            Report_Dictionary[\"ALKALINE_PHOSPHATASE\"] = None\n",
    "\n",
    "        if 'BILIRUBIN TOTAL' in extracted_Dictionary.keys():\n",
    "            BILIRUBIN_TOTAL = extracted_Dictionary['BILIRUBIN TOTAL']\n",
    "            Report_Dictionary[\"BILIRUBIN_TOTAL\"] = BILIRUBIN_TOTAL\n",
    "        else:\n",
    "            Report_Dictionary[\"BILIRUBIN_TOTAL\"] = None\n",
    "\n",
    "        if 'BILIRUBIN DIRECT' in extracted_Dictionary.keys():\n",
    "            BILIRUBIN_DIRECT = extracted_Dictionary['BILIRUBIN DIRECT']\n",
    "            Report_Dictionary[\"BILIRUBIN_DIRECT\"] = BILIRUBIN_DIRECT\n",
    "        else:\n",
    "            Report_Dictionary[\"BILIRUBIN_DIRECT\"] = None\n",
    "\n",
    "        if 'BILIRUBIN (INDIRECT)' in extracted_Dictionary.keys():\n",
    "            BILIRUBIN_INDIRECT = extracted_Dictionary['BILIRUBIN (INDIRECT)']\n",
    "            Report_Dictionary[\"BILIRUBIN_INDIRECT\"] = BILIRUBIN_INDIRECT\n",
    "        else:\n",
    "            Report_Dictionary[\"BILIRUBIN_INDIRECT\"] = None\n",
    "\n",
    "        if 'GAMMA GLUTAMYL TRANSFERASE (GGT)' in extracted_Dictionary.keys():\n",
    "            GAMMA_GLUTAMYL_TRANSFERASE = extracted_Dictionary['GAMMA GLUTAMYL TRANSFERASE (GGT)']\n",
    "            Report_Dictionary[\"GAMMA_GLUTAMYL_TRANSFERASE\"] = GAMMA_GLUTAMYL_TRANSFERASE\n",
    "        else:\n",
    "            Report_Dictionary[\"GAMMA_GLUTAMYL_TRANSFERASE\"] = None\n",
    "\n",
    "\n",
    "        if 'ASPARTATE AMINOTRANSFERASE' in extracted_Dictionary.keys():\n",
    "            ASPARTATE_AMINOTRANSFERASE = extracted_Dictionary['ASPARTATE AMINOTRANSFERASE']\n",
    "            Report_Dictionary[\"ASPARTATE_AMINOTRANSFERASE\"] = ASPARTATE_AMINOTRANSFERASE\n",
    "        else:\n",
    "            Report_Dictionary[\"ASPARTATE_AMINOTRANSFERASE\"] = None\n",
    "\n",
    "        if 'ALANINE TRANSAMINASE (SGPT)' in extracted_Dictionary.keys():\n",
    "            ALANINE_TRANSAMINASE = extracted_Dictionary['ALANINE TRANSAMINASE (SGPT)']\n",
    "            Report_Dictionary[\"ALANINE_TRANSAMINASE\"] = ALANINE_TRANSAMINASE\n",
    "        else:\n",
    "            Report_Dictionary[\"ALANINE_TRANSAMINASE\"] = None\n",
    "\n",
    "        if 'PROTEIN TOTAL' in extracted_Dictionary.keys():\n",
    "            PROTEIN_TOTAL = extracted_Dictionary['PROTEIN TOTAL']\n",
    "            Report_Dictionary[\"PROTEIN_TOTAL\"] = PROTEIN_TOTAL\n",
    "        else:\n",
    "            Report_Dictionary[\"PROTEIN_TOTAL\"] = None\n",
    "\n",
    "        if 'ALBUMIN SERUM' in extracted_Dictionary.keys():\n",
    "            ALBUMIN_SERUM = extracted_Dictionary['ALBUMIN SERUM']\n",
    "            Report_Dictionary[\"ALBUMIN_SERUM\"] = ALBUMIN_SERUM\n",
    "        else:\n",
    "            Report_Dictionary[\"ALBUMIN_SERUM\"] = None\n",
    "\n",
    "        if 'SERUM ALB/GLOBULIN' in extracted_Dictionary.keys():\n",
    "            SERUM_ALB = extracted_Dictionary['SERUM ALB/GLOBULIN']\n",
    "            Report_Dictionary[\"SERUM_ALB\"] = SERUM_ALB\n",
    "        else:\n",
    "            Report_Dictionary[\"SERUM_ALB\"] = None\n",
    "\n",
    "        if 'SERUM GLOBULIN' in extracted_Dictionary.keys():\n",
    "            SERUM_GLOBULIN = extracted_Dictionary['SERUM GLOBULIN']\n",
    "            Report_Dictionary[\"SERUM_GLOBULIN\"] = SERUM_GLOBULIN\n",
    "        else:\n",
    "            Report_Dictionary[\"SERUM_GLOBULIN\"] = None\n",
    "\n",
    "        if 'TOTAL CHOLESTEROL' in extracted_Dictionary.keys():\n",
    "            TOTAL_CHOLESTEROL = extracted_Dictionary['TOTAL CHOLESTEROL']\n",
    "            Report_Dictionary[\"TOTAL_CHOLESTEROL\"] = TOTAL_CHOLESTEROL\n",
    "        else:\n",
    "            Report_Dictionary[\"TOTAL_CHOLESTEROL\"] = None\n",
    "\n",
    "        if 'HDL CHOLESTEROL DIRECT' in extracted_Dictionary.keys():\n",
    "            HDL_CHOLESTEROL_DIRECT = extracted_Dictionary['HDL CHOLESTEROL DIRECT']\n",
    "            Report_Dictionary[\"HDL_CHOLESTEROL_DIRECT\"] = HDL_CHOLESTEROL_DIRECT\n",
    "        else:\n",
    "            Report_Dictionary[\"HDL_CHOLESTEROL_DIRECT\"] = None\n",
    "\n",
    "        if 'LDL CHOLESTEROL DIRECT' in extracted_Dictionary.keys():\n",
    "            LDL_CHOLESTEROL_DIRECT = extracted_Dictionary['LDL CHOLESTEROL DIRECT']\n",
    "            Report_Dictionary[\"LDL_CHOLESTEROL_DIRECT\"] = LDL_CHOLESTEROL_DIRECT\n",
    "        else:\n",
    "            Report_Dictionary[\"LDL_CHOLESTEROL_DIRECT\"] = None\n",
    "\n",
    "        if 'TRIGLYCERIDES' in extracted_Dictionary.keys():\n",
    "            TRIGLYCERIDES = extracted_Dictionary['TRIGLYCERIDES']\n",
    "            Report_Dictionary[\"TRIGLYCERIDES\"] = TRIGLYCERIDES\n",
    "        else:\n",
    "            Report_Dictionary[\"TRIGLYCERIDES\"] = None\n",
    "\n",
    "        if 'TC/ HDL CHOLESTEROL' in extracted_Dictionary.keys():\n",
    "            TC_HDL_CHOLESTEROL_RATIO = extracted_Dictionary['TC/ HDL CHOLESTEROL']\n",
    "            Report_Dictionary[\"TC_HDL_CHOLESTEROL_RATIO\"] = TC_HDL_CHOLESTEROL_RATIO\n",
    "        else:\n",
    "            Report_Dictionary[\"TC_HDL_CHOLESTEROL_RATIO\"] = None\n",
    "\n",
    "        if 'LDL HDL' in extracted_Dictionary.keys():\n",
    "            LDL_HDL_RATIO = extracted_Dictionary['LDL HDL']\n",
    "            Report_Dictionary[\"LDL_HDL_RATIO\"] = LDL_HDL_RATIO\n",
    "        else:\n",
    "            Report_Dictionary[\"LDL_HDL_RATIO\"] = None\n",
    "\n",
    "\n",
    "        if 'VLDL CHOLESTEROL' in extracted_Dictionary.keys():\n",
    "            VLDL_CHOLESTEROL = extracted_Dictionary['VLDL CHOLESTEROL']\n",
    "            Report_Dictionary[\"VLDL_CHOLESTEROL\"] = VLDL_CHOLESTEROL\n",
    "        else:\n",
    "            Report_Dictionary[\"VLDL_CHOLESTEROL\"] = None\n",
    "\n",
    "        if 'NONHDL CHOLESTEROL' in extracted_Dictionary.keys():\n",
    "            NON_HDL_CHOLESTEROL = extracted_Dictionary['NONHDL CHOLESTEROL']\n",
    "            Report_Dictionary[\"NON_HDL_CHOLESTEROL\"] = NON_HDL_CHOLESTEROL\n",
    "        else:\n",
    "            Report_Dictionary[\"NON_HDL_CHOLESTEROL\"] = None\n",
    "\n",
    "\n",
    "        if 'TOTAL TRIIODOTHYRONINE (T)' in extracted_Dictionary.keys():\n",
    "            TOTAL_TRIIODOTHYRONINE = extracted_Dictionary['TOTAL TRIIODOTHYRONINE (T)']\n",
    "            Report_Dictionary[\"TOTAL_TRIIODOTHYRONINE\"] = TOTAL_TRIIODOTHYRONINE\n",
    "        else:\n",
    "            Report_Dictionary[\"TOTAL_TRIIODOTHYRONINE\"] = None\n",
    "\n",
    "        if 'TOTAL THYROXINE (T)' in extracted_Dictionary.keys():\n",
    "            TOTAL_THYROXINE = extracted_Dictionary['TOTAL THYROXINE (T)']\n",
    "            Report_Dictionary[\"TOTAL_THYROXINE\"] = TOTAL_THYROXINE\n",
    "        else:\n",
    "            Report_Dictionary[\"TOTAL_THYROXINE\"] = None\n",
    "\n",
    "        if 'THYROID STIMULATING HORMONE (TSH)' in extracted_Dictionary.keys():\n",
    "            THYROID_STIMULATING_HORMONE = extracted_Dictionary['THYROID STIMULATING HORMONE (TSH)']\n",
    "            Report_Dictionary[\"THYROID_STIMULATING_HORMONE\"] = THYROID_STIMULATING_HORMONE\n",
    "        else:\n",
    "            Report_Dictionary[\"THYROID_STIMULATING_HORMONE\"] = None\n",
    "\n",
    "        if 'BLOOD UREA NITROGEN (BUN)' in extracted_Dictionary.keys():\n",
    "            BLOOD_UREA_NITROGEN = extracted_Dictionary['BLOOD UREA NITROGEN (BUN)']\n",
    "            Report_Dictionary[\"BLOOD_UREA_NITROGEN\"] = BLOOD_UREA_NITROGEN\n",
    "        else:\n",
    "            Report_Dictionary[\"BLOOD_UREA_NITROGEN\"] = None\n",
    "\n",
    "        if 'CREATININE SERUM' in extracted_Dictionary.keys():\n",
    "            CREATININE_SERUM = extracted_Dictionary['CREATININE SERUM']\n",
    "            Report_Dictionary[\"CREATININE_SERUM\"] = CREATININE_SERUM\n",
    "        else:\n",
    "            Report_Dictionary[\"CREATININE_SERUM\"] = None\n",
    "\n",
    "        if 'BUN SRCREATININE' in extracted_Dictionary.keys():\n",
    "            BUN_SR_CREATININE_RATIO = extracted_Dictionary['BUN SRCREATININE']\n",
    "            Report_Dictionary[\"BUN_SR_CREATININE_RATIO\"] = BUN_SR_CREATININE_RATIO\n",
    "        else:\n",
    "            Report_Dictionary[\"BUN_SR_CREATININE_RATIO\"] = None\n",
    "\n",
    "        if 'CALCIUM' in extracted_Dictionary.keys():\n",
    "            CALCIUM = extracted_Dictionary['CALCIUM']\n",
    "            Report_Dictionary[\"CALCIUM\"] = CALCIUM\n",
    "        else:\n",
    "            Report_Dictionary[\"CALCIUM\"] = None\n",
    "\n",
    "        if 'URIC ACID' in extracted_Dictionary.keys():\n",
    "            URIC_ACID = extracted_Dictionary['URIC ACID']\n",
    "            Report_Dictionary[\"URIC_ACID\"] = URIC_ACID\n",
    "        else:\n",
    "            Report_Dictionary[\"URIC_ACID\"] = None\n",
    "\n",
    "\n",
    "        if 'EST GLOMERULAR FILTRATION RATE' in extracted_Dictionary.keys():\n",
    "            EST_GLOMERULAR_FILTRATION_RATE = extracted_Dictionary['EST GLOMERULAR FILTRATION RATE']\n",
    "            Report_Dictionary[\"EST_GLOMERULAR_FILTRATION_RATE\"] = EST_GLOMERULAR_FILTRATION_RATE\n",
    "        else:\n",
    "            Report_Dictionary[\"EST_GLOMERULAR_FILTRATION_RATE\"] = None\n",
    "\n",
    "\n",
    "\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
